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Abstract	
Physical	membrane	contact	sites	between	the	ER	and	mitochondria	play	a	critical	
role	in	regulating	a	variety	of	processes	including	calcium	signalling,	lipid	exchange,	
controlling	mitochondrial	dynamics	and	cell	death	signalling.	These	contact	sites	are	
formed	 at	 specialised	 regions	 of	 membrane,	 termed	 mitochondrial	 associated	
membranes	or	MAMs,	that	are	enriched	for	a	group	of	proteins	acting	as	tethers	to	
hold	 the	 ER	 and	 mitochondria	 at	 appropriate	 distances	 from	 one	 another.	 The	
distance	 of	 these	 junctions	 is	 usually	 defined	 between	 10-30	 nm	but	 can	 vary	 in	
response	to	certain	cellular	conditions	and	it	 is	believed	that	heterogeneity	in	the	
distance	of	the	contact	sites	may	be	reflective	of	different	protein	compositions	or	
activities	 at	 these	 sites.	 Abnormal	 alterations	 to	 ER-mitochondria	 contacts	 are	
observed	 in	 numerous	 neurodegenerative	 disorders	 including	 Alzheimer’s,	
Parkinson’s	and	amyotrophic	lateral	sclerosis	(ALS)	and	therefore,	it	is	believed	that	
a	dysfunction	to	the	MAMs	may	be	a	common	pathogenic	mechanism	underlying	
neuronal	cell	death.	
Due	to	the	associated	dysfunction	of	organelle	contact	sites	in	neurodegenerative	
disorders,	the	ability	to	detect	these	structures	could	provide	critical	information	on	
the	pathogenic	mechanisms	of	neuronal	cell	death.	Existing	techniques	for	detecting	
MAMs	have	numerous	limitations	or	are	restricted	to	fixed	samples.	The	aim	of	this	
thesis	was	to	develop	a	fluorescent-based	method	for	the	visualisation	of	contact	
sites	that	can	also	be	applied	to	living	systems	to	study	organelle	contact	dynamics.	
Here,	we	have	generated	split	fluorescent	Venus	fragments	targeted	to	the	ER	and	
outer	mitochondrial	membrane	 respectively,	 as	 the	 basis	 for	 our	 bi-fluorescence	
complementation	 (BiFC)	 system	 for	 the	 detection	 and	quantification	 of	MAMs	 in	
living	cells.	The	principle	of	 this	 technique	 relies	on	close	spatial	proximity	of	 the	
reporter	probes	for	the	restoration	of	the	fluorescent	protein	and	the	emission	of	a	
detectable	 signal.	 Validation	 of	 this	method	 highlighted	 several	 advantages	 over	
existing	methods	of	detecting	ER-mitochondria	contacts	and	we	were	able	to	report	
on	 changes	 in	 agreement	 with	 previously	 published,	 high-resolution	 electron	
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microscopy	studies.	Adaptations	to	the	technique	allow	for	the	detection	of	other	
organelle	 contact	 sites	 by	 varying	 the	 targeting	 sequence	 of	 the	 complementary	
Venus	fragments.			
As	these	reporter	proteins	detect	junctions	of	a	maximum	distance	of	around	6-10	
nm,	 we	 could	 use	 the	 BiFC	 system	 to	 correlate	 the	 Venus	 signal	 with	 specific	
functions	 of	 the	MAMs	 to	 try	 and	 elucidate	 the	 functional	 significance	 of	 these	
particularly	tight	contact	sites.	Our	results	suggest	that	some	of	these	contact	sites	
may	 represent	 sites	 of	 actively	 dividing	 mitochondria.	 Furthermore,	 our	 results	
indicated	that	these	tight	ER-mitochondria	contacts	are	formed	on	a	sub-population	
of	 mitochondria	 of	 higher	 than	 average	 resting	 membrane	 potential	 and	
mitochondrial	 calcium	 levels,	 which	may	 indicate	 differences	 in	 the	 bioenergetic	
state	or	the	health	of	mitochondria	with	tight	ER-mitochondria	contact	sites.			
Finally,	this	technique	was	used	to	investigate	the	role	of	a	MAM-enriched	protein,	
VAPB,	of	which	a	proline	to	serine	missense	mutation	is	associated	with	a	dominantly	
inherited	form	of	ALS	termed	ALS8.	The	data	shows	that	expression	of	the	mutant	
disease-linked	VAPBP56S	significantly	increases	the	mean	number	of	contact	sites	per	
cell	 whereas	 altering	 the	 levels	 of	 wild-type	 VAPB	 has	 no	 significant	 effect.	 This	
finding	 suggests	 that	 the	 expression	 of	 VAPBP56S	 induces	 abnormalities	 in	 ER-
mitochondria	tethering	but	it	is	still	unclear	whether	this	is	through	direct	binding	
properties	 of	mutant	 VAPB	 or	 through	 an	 indirect	 secondary	mechanism.	 As	 the	
MAMs	 regulate	 many	 of	 the	 pathways	 that	 are	 commonly	 perturbed	 in	
neurodegenerative	 disorders,	 alterations	 in	 ER-mitochondria	 contact	 sites	 may	
represent	a	key	early	pathogenic	event	in	ALS.	
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Lay	Summary	
Within	a	cell	there	are	a	number	of	different	structures	termed	organelles	that	carry	
out	unique	processes	 that	ensure	 the	correct	 functioning	and	survival	of	 the	cell.	
These	organelles	do	not	function	in	isolation	but	are	constantly	interacting	with	one	
another	 via	 complex	mechanisms	 to	 regulate	 their	 activity.	One	 of	 the	ways	 this	
coordination	takes	place	is	by	the	formation	of	physical	contact	sites	between	closely	
apposed	 organelles.	 These	 contact	 sites	 are	 formed	 by	 the	 binding	 of	 particular	
proteins	on	the	surface	membranes	of	the	respective	organelles	that	tether	them	at	
an	appropriate	distance	 from	one	another.	One	of	 the	best	characterised	 type	of	
contact	 sites	 are	 between	 organelles	 known	 as	 the	 endoplasmic	 reticulum	 (ER),	
which	 is	 responsible	 for	 synthesising	 proteins,	 and	 the	mitochondria,	 involved	 in	
energy	 production	 and	 these	 contacts	 are	 formed	 at	 specialised	 regions	 of	
membrane	termed	mitochondrial	associated	membranes	or	MAMs.		
A	disruption	to	ER-mitochondria	contacts	has	been	observed	in	a	number	of	diseases	
including	 Alzheimer’s	 disease,	 Parkinson’s	 disease	 and	 motor	 neuron	
disease/amyotrophic	 lateral	sclerosis	 (ALS).	Therefore,	 it	 is	 important	 for	us	to	be	
able	to	detect	and	visualise	these	contact	sites	within	cells	to	try	and	investigate	how	
changes	could	be	linked	to	disease	progression.		
In	this	thesis,	we	have	developed	a	technique	for	the	visualisation	and	quantification	
of	contact	sites	in	living	cells	based	on	split	fluorescent	protein	fragments	targeted	
to	 the	 ER	 and	 mitochondria	 membranes	 respectively.	 The	 principle	 behind	 this	
technique	 is	 that	neither	protein	 fragment	alone	will	 fluoresce	but	when	brought	
within	 close	 proximity	 at	 organelle	 contact	 sites,	 the	 fluorescent	 protein	 will	 be	
restored	 and	 a	 signal	 will	 be	 emitted	 that	 can	 be	 detected	 by	 a	 fluorescent	
microscope.	 Validation	 of	 this	 method	 has	 highlighted	 several	 advantages	 over	
existing	techniques	for	investigating	ER-mitochondria	contacts	and	through	this,	we	
have	investigated	the	role	of	a	motor	neuron	disease-linked	protein	called	VAPB	on	
contact	 sites.	 Our	 results	 have	 demonstrated	 that	 the	 presence	 of	 the	 disease-
causing	mutant	 form	 of	 VAPB	 increases	 the	 average	 number	 of	 ER-mitochondria	
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contact	sites	within	a	cell,	providing	supporting	evidence	that	a	dysfunction	to	the	
MAMs	may	be	playing	a	role	in	cell	death.		
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Chapter	1	
Introduction	
1.1	Inter-organelle	contact	sites	
Organelles	of	the	cell	do	not	function	in	isolation	but	rather,	complex,	coordinated	
signalling	between	the	various	subcellular	compartments	plays	an	essential	role	in	
regulating	a	wide	range	of	physiological	processes.	An	emerging	body	of	evidence	
has	shown	that	perturbations	in	the	maintenance	or	structure	of	these	membrane	
contact	sites	can	result	 in	a	dysfunction	to	a	variety	of	cellular	processes	and	has	
been	 highlighted	 as	 a	 potential	 pathogenic	 mechanism	 in	 diseases	 such	 as	
neurodegenerative	disorders	(Paillusson	et	al.,	2016).		
The	ER,	a	vast	network	of	interconnected,	membrane-bound	tubules,	can	be	viewed	
as	a	central	hub	for	organelle	interactions	with	physical	contact	sites	being	observed	
between	the	ER	membrane	and	many	organelles	including	mitochondria,	the	plasma	
membrane,	 endosomes,	 lysosomes,	 peroxisomes	 and	 the	 Golgi	 apparatus	 [As	
reviewed	by	(English	and	Voeltz,	2013)]	(Fig1.1).	Many	of	the	pathogenic	molecular	
mechanisms	associated	with	neurodegeneration	can	be	attributed	to	a	dysfunction	
in	the	cellular	processes	mediated	by	organelle	contact	sites.	Different	examples	of	
inter-organelle	contacts	will	be	discussed	in	more	detail	in	the	following	sections.			
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Fig	1.1:	Schematic	illustration	of	various	inter-organelle	contact	sites	within	a	cell.	
The	ER	forms	membrane	contact	sites	with	a	variety	of	different	organelles	within	a	
cell.	 Coloured	 boxes	 indicate	 some	 examples	 of	 known	 protein	 binding	 pairs	
mediating	physical	ER	contact	sites.	Adapted	from	(Raiborg	et	al.,	2015a).		
	
1.1.1	ER-mitochondria	contacts	
Mitochondria	 are	 highly	 dynamic	 organelles,	 bound	 by	 an	 outer	 mitochondrial	
membrane	 (OMM)	 and	 an	 inner	 mitochondrial	 membrane	 (IMM)	 with	 several	
invaginations	 called	 cristae,	 and	 play	 a	 central	 role	 in	 the	 bioenergetics	 of	 a	 cell	
through	 the	 catabolism	 of	 sugars	 and	 fatty	 acids	 to	 recycle	 ADP	 to	 ATP.	 The	
morphology	of	 the	organelle	 varies	 between	 cells,	most	 often	being	 found	 as	 an	
interconnected	mitochondrial	network.	However,	structural	changes	can	be	induced	
in	response	to	a	number	of	factors,	including	the	energetic	state	of	the	cell,	a	process	
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which	is	regulated	by	a	delicate	balance	between	mitochondrial	fission	and	fusion	
events	(Scorrano,	2013;	Youle	and	van	der	Bliek,	2012).	
	Coordinated	signalling	between	the	endoplasmic	reticulum	and	mitochondria	is	vital	
for	a	number	of	physiological	processes	including	lipid	biosynthesis	and	transport,	
the	maintenance	of	calcium	homeostasis,	regulating	mitochondrial	morphology	and	
the	execution	of	 cell	death	pathways	 (Hayashi	et	al.,	2009;	van	Vliet	et	al.,	2014;	
Friedman	et	al.,	2011).	Sites	of	close	proximity	between	these	two	organelles	were	
first	defined	by	Jean	Vance	in	1990	as	distinct,	tightly	associated	structures	that	can	
be	purified	by	 cell	 fractionation	 (Vance,	 1990).	Regions	of	 ER	membrane	 in	 close	
apposition	to	the	OMM	are	referred	to	as	mitochondrial	associated	membranes	or	
MAMs.	 Ultrastructural	 studies	 have	 revealed	 that	 regions	 of	 ER	 membrane	 in	
juxtaposition	 to	 the	mitochondria	 can	vary	between	discrete	points	of	 contact	 to	
almost	complete	circumscription	of	the	outer	mitochondrial	membrane	(Sherrington	
et	al.,	1995)	(Friedman	et	al.,	2011).	These	contact	points	also	vary	in	the	distance	of	
the	junctions,	ranging	approximately	between	9-16	nm	between	the	mitochondria	
and	smooth	ER	and	19-30	nm	at	the	rough	ER,	as	quantified	by	electron	microscopy,	
with	approximately	12%	of	the	mitochondrial	perimeter	being	in	close	proximity	to	
the	ER	 (Csordas	et	al.,	2006).	 It	 is	believed	that	 the	organelles	are	tethered	at	an	
appropriate	 distance	 from	 one	 another	 by	 the	 formation	 of	 protein	 complexes	
between	 the	 ER	 and	OMM	and	 the	 recent	 identification	 of	 several	 proteins	who	
appear	 to	 regulate	 the	 nature	 of	 these	 contact	 points	 has	 strengthened	 this	
observation	(Table	1.1).         
Although	several	proteins	are	found	to	be	enriched	in	the	MAM	fraction,	it	is	unclear	
what	signalling	mechanisms	target	the	proteins	to	these	specific	sub-domains	of	ER	
membranes.	Palmitoylation	is	the	post-translational	addition	of	fatty	acids	including	
palmitic	 acid	 and	 it	 has	 been	 shown	 that	 the	 palmitoylation	 of	 calnexin	 and	
thioredoxin-related	oxidoreductase	 (TMX),	 is	essential	 for	 their	 localisation	to	 the	
MAMs	((Lynes	et	al.,	2012).	Similarly,	a	5-amino	acid	sequence	was	identified	in	the	
cytosolic	domain	of	diacylglycerol	acyltransferase	2	(DGAT2)	that	is	required	for	the	
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proteins	targeting	to	ER-mitochondria	contact	sites	(Stone	et	al.,	2009).	However,	
the	 presence	 of	 a	 MAM-targeting	 motif	 has	 not	 been	 identified	 in	 other	MAM-
enriched	 proteins	 and	 so	 further	 research	 on	 these	 signalling	 mechanisms	 is	
required.								
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Table	 1.1:	 Examples	 of	 proteins	 implicated	 in	 regulating	 ER-mitochondria	
associations,	their	general	function	at	the	MAMs,	their	localisation	site	along	with	
the	corresponding	references.	
Protein	name	
(Abbreviation)	
Specific	Function	at	the	
MAMs	
Localisation	 Reference	
Mitofusin	2	(MFN2)	 Regulating	 ER	
morphology	 and	
mitochondrial	fusion	
ER/OMM	 (de Brito and Scorrano, 
2008)	 (Filadi et al., 2015)	
(Leal et al., 2016)	(Cosson 
et al., 2012)		
Phospho-acidic	 cluster	
sorting	 protein	 2	 (PACS-
2)	
ER	 trafficking	 and	
homeostasis	
ER	 (Simmen et al., 2005)	
VAMP-associated	protein	
B	(VAPB)	
Vesicular	 trafficking	and	
regulating	 ER	
morphology	
ER	 (De	Vos	et	al.,	2012)	
(Stoica	et	al.,	2014)	
Protein	 tyrosine	
phosphatase	 interacting	
protein	51	(PTPIP51)	
Apoptosis	 and	 the	
regulation	 of	 cell	
morphology	
OMM	 (De	Vos	et	al.,	2012)	
(Stoica	et	al.,	2014)	
Inositol	 1,4,5-
triphosphate	 receptor	
(IP3R)	
Calcium	signalling	 ER	 (Szabadkai et al., 2006)	
Voltage-dependent	
anion	channel	(VDAC)	
Calcium	signalling	 OMM	 (Szabadkai et al., 2006)	
(Rapizzi et al., 2002)	
B-cell	 receptor-
associated	 protein	 31	
(Bap31)	
Apoptotic	signalling	 ER	 (Iwasawa et al., 2011)	
Fission	 homologue	 1	
(Fis1)	
Mitochondrial	 fission	
and	apoptotic	signalling	
OMM	 (Iwasawa et al., 2011)	
Mitochondrial	 Rho	
GTPase	(Miro)	
Mitochondrial	
movement	
OMM	 (Kornmann et al., 2011)	(Yi 
et al., 2004)	
Truncated	S1T	variant	of	
sarco/endoplasmic	
reticulum	 Ca
2+
	 ATPase	
(SERCA1)	
Ca2+	ATPase	 ER	 (Chami	et	al.,	2008)	
PKR-like	ER	kinase	[PERK]	 ER	stress	 ER	 (Harding	et	al.,	1999)	
Receptor	 expression	
enhancing	 protein	 1	
(REEP1)	
ER	 membrane	 shaping	
protein	
ER	 (Lim	et	al.,	2015)	
Presenilin	1	(PS-1)	 g-secretase	 protease	
complex	
Predominantly	ER		 (Area-Gomez	et	al.,	2012)	
Presenilin	2	(PS-2)	 g-secretase	 protease	
complex	
Predominantly	ER	 (Area-Gomez	et	al.,	2012)	
(Zampese	et	al.,	2011)	
a-Synuclein	 Mitochondrial	function	 Cytosol/OMM	 (Cali	et	al.,	2012)	
Parkin	 Mitophagy	 Cytosol/OMM	 (Cali	et	al.,	2013)	
(Celardo	et	al.,	2016)	
PTEN-induced	 putative	
kinase	1	(PINK1)	
Mitophagy	 Cytosol/OMM	 (Celardo	et	al.,	2016)	
Sigma-1	Receptor	 Calcium	signalling	 ER	and	nucleus	 (Hayashi	and	Su,	2007)	
(Bernard-Marissal	 et	 al.,	
2015)	
Amyloid	 Precursor	
Protein	 C-terminal	
fragment	(99aa)	(C99)	
Intermediate	 fragment	
in	Ab	generation	
Predominantly	
endosomes	
(Pera	et	al.,	2017)	
PDZ	domain	containing	8	
(PDZD8)	
Cytoskeletal	
organisation		
ER	
	
	 	
(Hirabayashi	et	al.,	2017)	
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1.1.2	Functions	of	MAMs	
1.1.2.1	MAMs	and	lipid	biosynthesis	and	exchange	
Maintaining	the	lipid	composition	of	cellular	and	organelle	membranes	is	a	tightly	
regulated	 process	 and	 relies	 on	 efficient	 lipid	 trafficking	 from	 the	 ER	membrane	
where	the	majority	of	lipid	synthesis	occurs.	The	inner	membrane	of	mitochondria	
is	 highly	 enriched	 for	 phosphatidylethanolamine	 (PE)	 and	 a	 reduction	 in	 the	 PE	
content	 is	 associated	 with	 abnormal	 mitochondrial	 morphology,	 oxygen	
consumption	and	ATP	production	(Tasseva	et	al.,	2013).	One	of	the	major	pathways	
in	 which	 PE	 is	 synthesised	 is	 in	 the	 mitochondria	 by	 the	 decarboxylation	 of	
phosphatidylserine	(PS)	but	in	order	for	this	to	take	place,	PS	must	be	transported	
from	its	site	of	synthesis	in	the	ER	to	the	inner	mitochondrial	membrane	(Zborowski	
et	al.,	1983).	The	diffusion	of	lipids	through	the	aqueous	environment	of	the	cytosol	
is	an	energetically	unfavourable	process	and	so	the	possibility	has	been	raised	that	
non-vesicular	 trafficking	 of	 lipids	may	 take	 place	 at	 the	MAMs	 (Vance,	 2014).	 In	
support	of	this,	the	two	proteins	that	synthesise	PS,	PS	synthase	1	and	2,	are	highly	
enriched	in	the	MAMs	in	comparison	to	the	rest	of	the	ER	(Stone	and	Vance,	2000).	
An	 experiment	 inhibiting	 PS	 decarboxylase	 using	 hydroxylamine	 resulted	 in	 an	
increase	in	the	levels	of	PS	in	the	MAM	fraction	which	stayed	constant,	in	contrast	
to	 untreated	 cells	 in	 which	 the	 PS	 pool	 gradually	 declined	 (Shiao	 et	 al.,	 1995).	
Similarly,	 depleting	ATP	 levels,	which	 is	 essential	 for	 phospholipid	 transport,	 also	
caused	PS	to	accumulate	in	the	MAM	fraction	(Shiao	et	al.,	1995).	In	hepatocytes,	
newly	synthesised	PE	is	transported	from	the	mitochondria	back	to	the	ER	where	it	
is	methylated	to	form	phosphatidylcholine	(PC),	further	supporting	a	key	role	of	the	
ER-mitochondria	interface	in	lipid	biosynthesis	(Voelker,	2005).				
Enzymes	involved	in	the	synthesis	of	cholesterol	and	cholesteryl	esters	are	found	to	
be	enriched	in	the	MAMs	including	3-hydroxy-3-methylglutaryl-CoA	reductase	and	
acyl-CoA	acyltransferase	which	implicates	a	role	of	these	contact	sites	in	cholesterol	
synthesis	(Rusinol	et	al.,	1994).	In	comparison	to	the	bulk	ER,	the	MAMs	are	enriched	
with	cholesterol	(Hayashi	and	Fujimoto,	2010)	and	depleting	the	levels	of	cholesterol	
increases	 ER-mitochondria	 associations	 (Fujimoto	 et	 al.,	 2012).	 The	 transport	 of	
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cholesterol	 from	 the	ER	 to	 the	mitochondria	 is	 essential	 for	 steroid	and	bile	 acid	
production	and	while	evidence	may	suggest	 that	 this	 transfer	could	occur	via	 the	
MAMs,	a	direct	role	of	these	contact	sites	in	cholesterol	transport	has	not	yet	been	
elucidated.	In	CHO	cells,	a	reduction	in	VDAC1	levels	decreases	cholesterol	transfer	
to	the	IMM	which	suggests	a	role	of	this	protein,	that	is	highly	enriched	at	the	MAMs,	
in	cholesterol	transport	(Kennedy	et	al.,	2012).	Similarly,	the	AAA	domain-containing	
protein	 3	 (ATAD3)	 is	 present	 at	 the	 MAMs	 and	 plays	 a	 key	 role	 in	 cholesterol	
transport,	indicating	a	possible	role	of	the	contact	sites	in	this	process	(Issop	et	al.,	
2015).						
1.1.2.2	MAMs	and	calcium	homeostasis			
The	endoplasmic	reticulum	is	a	major	store	for	calcium	ions	that	play	a	critical	role	
in	a	wide	host	of	signalling	pathways	within	the	cell	and	upon	the	release	of	calcium	
ions	 into	 the	 cytoplasm,	mitochondria	 can	 act	 as	 buffers	 to	 uptake	 calcium	 and	
maintain	appropriate	cytosolic	ion	concentrations	(van	Vliet	et	al.,	2014).	The	intake	
of	extra-mitochondrial	calcium	exerts	a	strong	effect	over	the	phosphorylation	states	
of	 several	 metabolic	 enzymes	 in	 the	 mitochondrial	 matrix,	 including	 pyruvate	
dehydrogenase	and	isocitrate	dehydrogenase	and	therefore	plays	an	important	role	
in	metabolic	regulation	(Nicholls	and	Budd,	2000;	Hopper	et	al.,	2006).		
This	calcium	exchange	function	was	attributed	to	the	MAMs	upon	the	discovery	that	
mitochondria	 are	 exposed	 to	 higher	 concentrations	 of	 Ca2+	 in	 comparison	 to	 the	
cytosol,	 following	 Ca2+	 release	 from	 the	 ER	 (Rizzuto	 et	 al.,	 1998)	 and	 that	
mitochondria	in	very	close	proximity	to	the	ER	had	higher	calcium	levels	than	those	
that	 were	 not	 (Rutter	 and	 Rizzuto,	 2000).	 The	 mitochondrial	 calcium	 channel	
uniporter	 (MCU)	 is	 the	 protein	 that	 allows	 Ca2+	 to	 be	 transported	 in	 to	 the	
mitochondrial	matrix	across	the	electrochemical	gradient	(De	Stefani	et	al.,	2011).	
However,	an	apparent	discrepancy	exists	between	the	low	affinity	of	MCU	for	Ca2+	
and	 the	 steep	 rise	 in	 mitochondrial	 Ca2+	 following	 release	 from	 the	 ER.	 This	
inconsistency	can	be	explained	by	the	fact	that	this	calcium	exchange	takes	place	at	
tight	 ER-mitochondria	 junctions	 that	 are	 enriched	 for	 IP3R	 (mediating	 ER	 calcium	
release)	 and	 voltage-dependent	 anion	 channels	 (VDAC)	 that	 allow	 Ca2+	 ions	 to	
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transverse	the	OMM	(Rapizzi	et	al.,	2002;	Szabadkai	et	al.,	2006).	The	MAMs	provide	
a	 site	where	mitochondria	 can	 sense	microdomains	 of	 high	 cytosolic	 Ca2+	 	 levels	
following	release	from	IP3R	and	rapidly	uptake	Ca
2+	within	the	mitochondrial	matrix	
(Csordas	 et	 al.,	 2010;	 Rizzuto	 et	 al.,	 2012).	 The	 sigma-1	 receptor	 protein	 that	 is	
involved	in	regulating	calcium	exchange	between	the	two	organelles	is	also	enriched	
at	the	MAMs	(Hayashi	and	Su,	2007).		
Studies	have	shown	that	altering	the	distance	between	the	ER	and	mitochondria	at	
the	MAMs	has	an	impact	on	the	ability	of	mitochondria	to	uptake	calcium.	Treatment	
with	 trypsin	 or	 proteinase	 K	 loosened	 ER-mitochondria	 contacts	 and	 disrupted	
calcium	 exchange	 between	 the	 organelles	 without	 effecting	 IP3R-mediated	 ER	
calcium	release	or	the	actual	ability	of	mitochondria	to	uptake	calcium	ions	(Csordas	
et	al.,	2006).	In	contrast,	transfecting	cells	with	artificial	linker	proteins	consisting	of	
an	 N-terminus	 OMM	 targeting	 sequence	 and	 a	 C-terminus	 ER	 targeting	 domain	
tightened	 the	 junctions,	 increasing	 mitochondrial	 calcium	 uptake	 capacity	 and	
making	them	susceptible	to	calcium	overloading	and	opening	of	the	MPT	to	activate	
apoptosis	 (Csordas	et	al.,	2006).	The	 influence	of	MAMs	over	calcium	 levels	 is	bi-
directional	as	the	association	of	the	ER	with	the	mitochondria	can	also	be	regulated	
by	cytosolic	calcium	levels	(Wang	et	al.,	2000;	Goetz	et	al.,	2007).		
1.1.2.3	MAMs	and	mitochondrial	morphology	
In	 mammalian	 cells,	 fission	 events	 rely	 on	 dynamin-related	 protein	 1	 (Drp1)	
(Dynamin-1/Dnm1	 in	 yeast),	 a	 cytoplasmic	 protein	 that	 is	 capable	 of	 self-
oligomerising	into	helices	that	surround	and	constrict	the	mitochondrial	membrane	
for	 division.	 The	 activity	 of	 this	 protein	 is	 controlled	 by	 calcium-mediated	
phosphorylation/dephosphorylation	of	Ser656	by	the	OMM	protein	kinase	A	(PKA)	
(Dickey	and	Strack,	2011;	Ingerman	et	al.,	2005).	Mitochondrial	fusion	events	on	the	
other	 hand,	 are	 regulated	 by	 a	 number	 of	 proteins	 including	 Mitofusin-1	 and	 2	
(MFN1/MFN2)	(Chen	et	al.,	2003).	Some	of	the	factors	controlling	fission	and	fusion	
events	of	the	mitochondrial	network	can	also	regulate	cristae	morphology	which	has	
been	shown	to	alter	structurally,	depending	on	the	respiratory	state	of	the	cell,	as	
revealed	by	electron	tomography	studies	(Mannella	et	al.,	2001;	Pich	et	al.,	2005).	
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As	the	IMM	possesses	the	proteins	necessary	for	ATP	synthesis,	the	tight	regulation	
of	mitochondrial	fission	and	fusion	events	has	important	 implications	for	not	only	
the	structure	of	the	mitochondria	but	for	their	function	in	metabolism.	
Through	 fluorescent	 live-cell	 imaging	 of	 yeast	 cells,	 Dnm1	 puncta	 were	 seen	 to	
localise	to	the	points	of	contact	of	fluorescently	labelled	ER	and	mitochondria	in	the	
vast	majority	of	mitochondrial	division	events	(87%),	suggesting	that	these	fission	
events	 occur	 predominantly	 at	 the	MAMs	 (Friedman	 et	 al.,	 2011).	 Furthermore,	
Drp1-dependent	mitochondrial	division	is	regulated	by	fission	1	homologue	(Fis1),	a	
protein	believed	to	be	involved	in	ER-mitochondria	tethering	through	the	formation	
of	 a	 complex	 with	 the	 integral	 ER	 membrane	 protein	 B-cell	 receptor-associated	
protein	31	(Bap31)	(Iwasawa	et	al.,	2011;	Ingerman	et	al.,	2005).				
Mitofusin-2	(MFN2)	is	one	of	the	best	studied	tethers	between	the	mitochondria	and	
ER	 and	 plays	 a	 role	 in	 regulating	mitochondrial	morphology	 and	 directing	 fusion	
events.	The	protein	has	both	an	ER	and	mitochondrial	localisation	but	is	enriched	14-
fold	 in	 the	MAM	 fraction	 in	 comparison	 to	 the	mitochondrial	 fraction	 in	 Percoll-
purified	 subcellular	 fractions	 (de	 Brito	 and	 Scorrano,	 2008).	 In	 order	 to	 form	ER-
mitochondria	 contacts,	 MFN2	 forms	 homotypic	 interactions	 with	 other	 MFN2	
proteins	 or	 heterotypic	 fusions	 with	 MFN1	 that	 is	 found	 only	 on	 the	 outer	
mitochondrial	membrane	(de	Brito	and	Scorrano,	2008).	While	it	is	generally	agreed	
that	 altering	 the	 levels	 of	MFN2	 impacts	 ER-mitochondria	 contacts,	 confounding	
evidence	exists	 as	 to	what	 the	exact	nature	of	 this	 change	 is.	 Some	studies	have	
demonstrated	an	increase	in	the	association	of	the	ER	with	mitochondria	following	
knock-down	 of	 MFN2	 expression	 with	 a	 consequent	 increase	 in	 mitochondrial	
calcium	levels	(Filadi	et	al.,	2015;	Leal	et	al.,	2016;	Cosson	et	al.,	2012),	while	others	
have	observed	a	 reduction	 in	ER-mitochondria	associations	 causing	a	decrease	 in	
mitochondrial	calcium	uptake	and	lower	levels	of	phosphotidylserine	incorporated	
into	phosphotidylethanolamine	(de	Brito	and	Scorrano,	2008).						
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1.1.2.4	MAMs	and	cell	survival	and	death	
The	regulation	of	mitochondrial	calcium	levels	is	intrinsically	linked	to	apoptosis,	a	
mechanism	 of	 programmed	 cell	 death	 that	 activates	 in	 response	 to	 a	 variety	 of	
initiator	stimuli	and	manifests	as	characteristic	cell	morphological	changes	and	the	
destruction	 of	 the	 cell	 (Kerr	 et	 al.,	 1972).	 Upon	 excessive	 calcium	 uptake	 by	 the	
mitochondria,	 changes	are	 induced	 to	mitochondria	membrane	potential	and	 the	
oligomerisation	 of	 a	 protein	 called	 BAX	 (Bcl-2	 associated	 X	 protein)	 is	 promoted	
(Nicotera	and	Orrenius,	1998)	(Scorrano	et	al.,	2003).	This	results	in	the	opening	of	
the	mitochondrial	permeability	transition	(MPT)	pore	that	allows	for	the	consequent	
release	of	pro-apoptotic	factors	such	as	cytochrome	c	into	the	cytosol,	resulting	in	
the	death	of	the	cell	(Nicotera	and	Orrenius,	1998).	Therefore,	a	relationship	exists	
between	apoptotic	cell	death	and	the	regulation	of	the	MAMs.		
One	of	the	hallmark	features	of	apoptosis	is	the	fragmentation	of	the	mitochondrial	
network	 due	 to	 the	 recruitment	 of	 Drp1	 protein	 to	 the	 outer	 mitochondrial	
membrane	to	induce	fission	events,	a	process	which	takes	place	specifically	at	the	
MAMs	(Frank	et	al.,	2001).	Furthermore,	expression	of	a	dominant-negative	form	of	
Drp1	blocks	apoptosis	and	prevents	cell	death,	strengthening	the	link	between	Drp1	
activity	at	the	MAMs	and	apoptosis	(Frank	et	al.,	2001).	Silencing	expression	of	the	
ER-mitochondria	tether	protein	PACS2	results	in	the	upregulation	of	pro-apoptotic	
factors	 illustrating	how	disrupting	ER-mitochondria	associations	can	 lead	 to	a	cell	
death	response	(Simmen	et	al.,	2005).			
Although	a	role	of	the	MAMs	in	apoptosis	was	implicated,	the	mechanism	by	which	
cell	death	signals	were	communicated	between	the	two	organelles	was	unclear	until	
the	 identification	of	a	Fis1-Bap31	complex	spanning	the	ER-mitochondria	 junction	
(Iwasawa	et	 al.,	 2011).	Bap31	 localises	 to	 the	ER	membrane	and	 forms	a	protein	
complex	with	several	known	regulators	of	apoptosis	such	as	B-cell	lymphoma	2	(Bcl-
2)	 (Ng	et	 al.,	 1997).	 The	binding	of	Bap31	 to	 the	outer	mitochondrial	membrane	
protein	Fis1	not	only	acts	as	a	tether	for	ER-mitochondria	interactions	but	generates	
a	 platform	 for	 pro-caspase	 8	 recruitment	 to	 cleave	 Bap31	 and	 propagate	 pro-
apoptotic	 signals	 (Iwasawa	 et	 al.,	 2011)(Fig	 1.2).	 The	 cleavage	 product	 of	 Bap31	
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promotes	 the	 emptying	 of	 ER	 calcium	 stores	 thereby	 resulting	 in	 an	 increase	 in	
mitochondrial	calcium	levels	to	promote	MPT	pore	opening.	
								
Fig	1.2:	Schematic	illustration	of	the	Fis1/Bap31	protein	complex	in	promoting	ER	
calcium	 release.	 The	 Fis1/Bap31	 protein	 complex	 is	 formed	 at	 regions	 of	 close	
apposition	 between	 the	 ER	 and	 mitochondria	 and	 creates	 a	 platform	 for	 the	
recruitment	 of	 caspase-8	 under	 cellular	 stress	 conditions.	 Proteolytic	 activity	 of	
caspase-8	 generates	 the	 p20Bap31	 truncation	 product	 that	 induces	 IP3R	 calcium	
release.	 Subsequent	mitochondrial	 calcium	uptake	can	 trigger	 the	 release	of	pro-
apoptotic	 factors	 into	 the	 cytoplasm.	 Illustration	 was	 produced	 on	 BioRender	
[Available	at	https://app.biorender.io].			
	
1.1.2.5	MAMs	and	the	initiation	of	autophagosome	formation	
Autophagy	is	one	of	the	main	intracellular	protein	degradation	pathways	involving	
the	 bulk	 sequestration	 of	 cytoplasmic	 contents	 in	 double-membraned	 vesicles	
termed	autophagosomes	and	the	eventual	degradation	and	recycling	of	the	contents	
via	 fusion	with	 late	 endosomes	 and	 lysosomes.	 The	 role	 of	 autophagy	 has	 been	
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linked	to	a	wide	number	of	physiological	process	 including	adaptation	to	nutrient	
starvation,	 the	 clearance	 of	 misfolded	 proteins	 or	 protein	 aggregates,	 the	 aging	
process,	elimination	of	microorganisms	and	cell	death	[For	a	review	see	(Mizushima,	
2005)].	 The	 process	 of	 autophagosome	membrane	 formation	 is	 highly	 conserved	
between	 species	 and	 involves	 a	 family	of	proteins	 termed	 the	autophagy	 related	
(atg)	proteins,	identified	from	yeast	genetic	screens	(Klionsky	et	al.,	2003).	Nutrient	
deprivation	 is	 a	 key	 inducer	 of	 autophagy	 through	 the	 mammalian	 target	 of	
rapamycin	 (mTOR)	 signalling	 pathway	 in	 which	 the	 TOR	 complex	 1	 (TORC1)	 is	 a	
negative	regulator	of	autophagy	in	both	yeast	and	mammals	(Mizushima	et	al.,	2011;	
Ravikumar	et	al.,	2004).	
	
In	mammalian	cells,	Unc-51-like	kinase	1/2	(ULK)	(the	homologue	of	yeast	Atg1)	is	a	
serine/threonine	 kinase	 that	 forms	 a	 stable	 complex	 and	 can	 bind	 to	 the	
phosphatidylinositol	 3-kinase	 (PI3K)	 complex,	 which	 includes	 Atg14	 and	 Beclin-1	
(Hosokawa	 et	 al.,	 2009;	 Itakura	 et	 al.,	 2008;	 Mizushima	 et	 al.,	 2011).	 The	 ULK1	
protein	 complex	 is	 constitutively	 formed	 but	 is	 deactivated	 by	 mTORC1	
phosphorylation	 under	 nutrient	 rich	 conditions	 (Hosokawa	 et	 al.,	 2009).	 These	
complexes	then	translocate	to	the	autophagosome	formation	site	upon	suppression	
of	 mTORC1	 where	 PI3K	 produces	 phosphatidylinositol	 3-phosphate	 (PI3P),	 an	
essential	component	for	autophagosomes	formation	(Obara	et	al.,	2008;	Mizushima	
et	 al.,	 2011;	 Axe	 et	 al.,	 2008).	 Atg14	 is	 likely	 the	 determinant	 for	 the	 specific	
localisation	of	the	PI3K	complex	to	the	ER	membrane	as	ectopic	localisation	of	Atg14	
to	 the	 plasma	 membrane	 also	 results	 in	 the	 localisation	 of	 Beclin-1	 and	 other	
proteins	of	 the	PI3K	complex	 to	be	 found	at	 this	site	 (Matsunaga	et	al.,	2010).	 In	
nutrient-rich	conditions,	Bcl-2	binds	to	Beclin-1	to	inhibit	its	autophagic	function	but	
under	starvation	conditions,	JNK1	(c-Jun	N-terminal	protein	kinase	1)	phosphorylates	
Bcl-2	to	promote	its	dissociation	from	Beclin-1	(Wei	et	al.,	2008).	Atg12-Atg5-Atg16L	
form	 a	 protein	 complex	 conjugation	 system	 that	 forms	 regardless	 of	 nutrient	
conditions	on	the	outside	of	the	autophagosome	membrane	during	the	elongation	
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process	and	dissociates	once	the	membrane	formation	is	completed	(Mizushima	et	
al.,	2001;	Mizushima	et	al.,	2011).	
	
Although	many	of	 the	 steps	 in	 the	autophagosome	 formation	process	have	been	
elucidated,	controversial	evidence	exists	as	to	where	the	source	of	the	membrane	
comes	from,	particularly	as	the	majority	of	proteins	involved	are	cytosolic	(Xie	and	
Klionsky,	2007).	The	endoplasmic	reticulum	is	probably	the	best	candidate	for	the	
pre-existing	source	of	membranes	for	autophagosome	formation.	Atg14	is	essential	
for	the	translocation	of	the	PI3K	complex	to	the	ER	membrane	(Matsunaga	et	al.,	
2010)	and	electron	microscopy	images	suggest	that	the	ER	membrane	may	form	a	
template	 for	 the	 elongation	 of	 the	 autophagosome	 and	 provide	 the	 lipid	
components	necessary	for	this	process	(Mizushima	et	al.,	2011;	Hayashi-Nishino	et	
al.,	2009).						
Atg9	is	the	only	known	transmembrane	Atg	protein	and	while	its	function	is	not	well	
understood,	it	has	been	seen	to	shuttle	between	omegasomes	(autophagy-related	
structures),	endosomes	and	the	trans-Golgi	network,	highlighting	these	as	potential	
membrane	 sources	 (Young	 et	 al.,	 2006;	 Tooze	 and	 Yoshimori,	 2010).	 In	 further	
support	of	this,	in	yeast	cells	some	of	the	proteins	involved	in	vesicle	exit	from	the	
Golgi	have	also	been	implicated	in	the	early	stages	of	autophagy	(Geng	et	al.,	2010;	
van	der	Vaart	et	al.,	2010).	
Recently,	it	has	been	proposed	that	the	MAMs	may	be	the	sites	of	autophagosome	
formation.	 Under	 starvation	 conditions,	 fluorescently-tagged	 Atg14	 and	 Atg5	
relocalised	 into	 puncta	 that	 appeared	 at	 the	 sites	 of	 ER-mitochondria	 contact	
(Hamasaki	et	al.,	2013).	Furthermore,	Percoll	centrifugation	was	used	to	isolate	the	
MAMs	and	indicated	that	Atg14	as	well	as	other	components	of	the	PI3K	complex	
shifted	to	the	MAM	fraction	under	starvation	conditions	(Hamasaki	et	al.,	2013).	In	
starved	cells,	when	the	expression	of	either	of	two	ER-mitochondria	protein	tethers,	
PACS-2	 or	 MFN2	 was	 knocked-down	 in	 vitro	 to	 decrease	 ER-mitochondria	
associations,	 it	 prevented	 the	 relocalisation	 of	 Atg14	 to	 the	MAMs	 and	 inhibited	
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autophagosome	 formation	 (Hamasaki	 et	 al.,	 2013).	 An	 additional	 study	
demonstrated	 that	 under	 starvation	 conditions,	 fluorescently	 labelled	
phosphotidylserine	transferred	from	the	ER	to	the	mitochondria	at	the	MAMs	was	
incorporated	in	to	autophagosomes	and	knocking-down	MFN2	inhibited	this	process	
(Hailey	et	al.,	2010).					
1.1.2.6	MAMs	and	ER	stress	
The	endoplasmic	reticulum	is	the	primary	site	where	proteins	are	synthesised,	folded	
and	post-translationally	modified	and	as	such,	this	organelle	has	evolved	to	be	rich	
in	 various	 ER	 chaperone	 proteins	 and	 enzymes	 involved	 with	 post-translational	
modifications.	The	concentration	of	proteins	 in	the	ER	lumen	is	very	high	and	the	
simultaneous	folding	of	thousands	of	polypeptides	creates	a	risk	of	folding	errors	or	
protein	 aggregation	 (Stevens	 and	 Argon,	 1999).	 Protein	 folding	 is	 an	 energy	
demanding	 process	with	many	 ER	 chaperone	 proteins	 being	 sensitive	 to	 ER	 Ca2+	
levels	and	requiring	ATP	(Corbett	et	al.,	1999;	Blond-Elguindi	et	al.,	1993).	If	a	cellular	
state	 is	 reached	 whereby	 the	 folding	 load	 of	 the	 ER	 lumen	 exceeds	 the	 protein	
folding	 capacity	 of	 the	 ER,	 it	 is	 referred	 to	 as	 ER	 stress.	 Cells	 have	 an	 adaptive	
unfolded	protein	response	(UPR)	to	detect	and	overcome	the	presence	of	ER	stress	
[as	reviewed	by	(Oslowski	and	Urano,	2011)].	The	three	ER	proteins	that	sense	ER	
stress	 are	 Activating	 Transcription	 Factor	 6	 (ATF6)	 (Shen	 et	 al.,	 2002),	 Inositol	
Requiring	1	(IRE1)	(Wang	et	al.,	1998)	and	PKR-like	ER	kinase	[PERK]	(Harding	et	al.,	
1999)	(Fig	1.3).		
IRE1	is	a	type	I	ER	membrane	kinase	that	senses	an	accumulation	of	misfolded	or	
unfolded	proteins	and	autophosphorylates	to	become	activated.	Once	active,	 this	
protein	 splices	 XBP1	 (X-box	 binding	 protein	 1)	 mRNA	 that	 then	 encodes	 for	 a	
transcription	 factor	 to	 upregulate	 the	 expression	 of	 UPR	 genes	 including	 the	 ER	
folding	protein	disulphide	isomerase	(PDI)	and	ATF6	(Lee	et	al.,	2003;	Calfon	et	al.,	
2002).	Additionally,	under	prolonged	periods	of	ER	stress,	activated	IRE1	can	recruit	
TNF-receptor-associated	 factor	 2	 (TRAF2),	 leading	 to	 JNK	 activation	 and	 the	
promotion	of	apoptotic	signalling	(Urano	et	al.,	2000b;	Urano	et	al.,	2000a).									
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PERK	 is	 another	 type	 I	 ER	 membrane	 kinase	 that	 is	 self-activated	 by	
autophosphorylation	under	ER	stress	conditions,	phosphorylating	and	activating	the	
a	subunit	of	eukaryotic	 initiation	factor	2	(eIF2a)	(Harding	et	al.,	1999).	Activated	
eIF2a	 inhibits	 mRNA	 translation	 globally	 in	 an	 attempt	 to	 alleviate	 the	 protein	
folding	load	of	the	ER	(Harding	et	al.,	2000b).	However,	while	the	translation	of	most	
mRNA	 is	 repressed,	 eIF2a	 activation	 selectively	 promotes	 the	 translation	 of	
Activating	Transcription	Factor	4	(ATF4)	which	in	turn	upregulates	the	pro-apoptotic	
protein	 CHOP	 (CCAAT/enhancer-binding	 protein	 (C/EBP)	 homologous	 protein)	 in	
periods	of	prolonged	ER	stress	(Harding	et	al.,	2000a).			
ATF6	 is	 a	 90	 kDa	 type	 II	 integral	 ER	 transmembrane	 protein	 that	 undergoes	 a	
proteolytic	 cleavage	 by	 Site-1	 protease	 (S1P)	 and	 Site-2	 protease	 (S2P)	 upon	 the	
induction	of	ER	stress	to	generate	an	activated	basic-leucine	zipper	(b-ZIP)	factor	that	
translocates	to	the	nucleus	and	upregulates	genes	 involved	in	protein	folding	and	
degradation	(Ye	et	al.,	2000;	Haze	et	al.,	1999).	
	
During	 the	 early	 adaptive	 stage	 of	 ER	 stress,	 several	 studies	 have	 shown	 an	
associated	increase	in	the	number	of	ER-mitochondria	contacts	(Chami	et	al.,	2008;	
Csordas	et	al.,	2006;	Bravo	et	al.,	2011).	Cells	treated	with	tunicamycin,	an	inhibitor	
of	N-linked	glycosylation,	demonstrated	a	migration	of	the	mitochondrial	network	
towards	 the	 nucleus	 coinciding	 with	 increased	 ER-mitochondria	 associations,	
hyperpolarisation	 of	 mitochondrial	 membrane	 potential	 and	 increased	 ATP	
production	suggesting	that	increased	ER-mitochondria	contacts	may	be	a	response	
mechanism	to	the	energy	demands	of	ER	stress	(Bravo	et	al.,	2011).	Under	periods	
of	prolonged	ER	stress,	a	truncated	S1T	isoform	of	the	sarco/endoplasmic	reticulum	
Ca2+	 ATPase	 (SERCA1)	 was	 seen	 to	 localise	 to	 the	 MAMs,	 resulting	 in	 increased	
associations	 between	 the	 two	 organelles	 and	 eventual	 mitochondrial	 calcium	
overload	and	pro-apoptotic	signalling	(Chami	et	al.,	2008).	The	expression	of	S1T	is	
mediated	by	ATF4,	activated	through	the	PERK-eIF2a	signalling	pathway	during	UPR	
(Chami	et	al.,	2008).	PERK	also	seems	to	have	a	direct	influence	on	ER-mitochondria	
contacts,	independent	of	the	UPR,	as	this	protein	was	found	to	be	enriched	in	the	
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MAMs	and	genetic	deletion	of	PERK	in	mouse	embryonic	fibroblasts	(MEFs)	reduced	
ER-mitochondria	associations	(Verfaillie	et	al.,	2012).	A	direct	interaction	between	
PERK	and	MFN2	at	 these	contact	 sites	has	been	 identified.	Knock-down	of	MFN2	
expression	was	shown	to	upregulate	markers	of	UPR	(Ngoh	et	al.,	2012)	although	
there	was	defective	apoptotic	and	autophagic	responses	to	ER	stress	(Munoz	et	al.,	
2013).	Under	 basal	 conditions,	MFN2	 directly	 interacts	with	 PERK	 and	 negatively	
regulates	 it	 and	 an	 ablation	 of	 MFN2	 expression	 is	 linked	 with	 enhanced	
phosphorylation	 of	 PERK	 and	 increased	 mitochondrial	 Ca2+	 levels	 (Munoz	 et	 al.,	
2013).	 In	 addition	 to	 ER-mitochondria	 contacts,	 PERK	 has	 also	 recently	 been	
implicated	 in	 establishing	 contact	 sites	 between	 the	 ER	 and	 plasma	 membrane	
through	the	interaction	with	Filamin	A	(van	Vliet	et	al.,	2017).									
	
Figure	 1.3:	 Schematic	 illustration	 of	 the	 unfolded	 protein	 response	 (UPR).	 The	
induction	of	ER	stress	activates	the	three	main	pathways	of	the	UPR;	ATF6,	PERK	and	
IRE1/XBP1	pathways	that	work	to	alleviate	protein	load,	upregulate	the	expression	
of	 UPR	 target	 genes	 involved	 in	 protein	 folding	 and	 degradation.	 In	 periods	 of	
extended	ER	stress,	the	PERK	pathway	can	upregulate	pro-apoptotic	factors.	Figure	
as	published	in	(Walter	and	Ron,	2011).	Reprinted	with	permission	from	AAAS.									
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1.1.2.7	MAMs	and	mitochondrial/ER	movements	
The	endoplasmic	reticulum	and	mitochondria	are	highly	dynamic	organelles	that	are	
capable	of	moving	in	a	bidirectional	fashion	with	the	assistance	of	the	motor	proteins	
dynein	and	kinesin	along	the	microtubule	network	(Wozniak	et	al.,	2009;	Pilling	et	
al.,	 2006).	 Live-cell	 imaging	 experiments	 have	 demonstrated	 that	 the	 ER	 and	
mitochondria	appear	to	stay	in	contact	with	one	another	as	the	organelles	move	and	
that	the	two	organelles	colocalised	over	post-translationally	acetylated	microtubules	
(Friedman	 et	 al.,	 2010).	 It	 has	 been	 suggested	 that	 this	 post-translational	
modification	 may	 be	 a	 regulatory	 mechanism	 ensuring	 the	 migration	 of	 the	
organelles	 along	 the	 same	 microtubule	 or	 potentially,	 the	 movement	 of	 one	
organelle	may	be	dominant	and	pull	the	tethered	membrane	of	the	other	organelle	
along	with	it	(Friedman	et	al.,	2010;	Rowland	and	Voeltz,	2012).	Controlling	ER	and	
mitochondrial	 movements	 may	 be	 one	 mechanism	 by	 which	 the	 formation	 of	
contact	 sites	 at	 the	 MAMs	 is	 promoted.	 In	 mammalian	 cells,	 mitochondrial	
movements	 involve	 the	OMM	mitochondrial	Rho	GTPase	 subfamily	Miro	1	and	2	
proteins	 which	 binds	 to	 milton	 which	 is	 in	 turn	 bound	 to	 kinesin-1	 on	 the	
microtubules	 (Glater	 et	 al.,	 2006).	 Miro	 proteins	 localise	 well	 to	 the	 MAMs	
(Kornmann	et	al.,	2011)	and	are	sensitive	to	elevated	cytosolic	calcium	levels,	halting	
mitochondrial	mobility	in	response	(Saotome	et	al.,	2008).			Stopping	mitochondrial	
movements	encourages	the	formation	of	close	contacts	with	the	ER,	enhancing	their	
calcium	uptake	ability	and	ATP	production	when	the	demand	is	high	(Lee	et	al.,	2016;	
Saotome	et	al.,	2008;	Yi	et	al.,	2004).				
1.1.2.8	MAMs	and	mtDNA	replication	
In	mammalian	cells,	mitochondrial	DNA	(mtDNA)	is	packaged	within	nucleoids	that	
are	evenly	distributed	throughout	the	mitochondrial	network	(Garrido	et	al.,	2003).	
The	 spatiotemporal	 regulation	 of	 mtDNA	 replication	 is	 functionally	 linked	 to	
mitochondrial	 fission,	 that	 occurs	 at	 ER-mitochondria	 contact	 sites,	 as	 disrupting	
fission	events	leads	to	nucleoid	aggregation	and	mtDNA	abnormalities	(Ishihara	et	
al.,	2015;	Itoh	et	al.,	2013).	Accordingly,	nucleoids	were	seen	to	be	spatially	linked	
to	ER-mitochondria	contact	sites	in	both	yeast	and	mammalian	cells	(Murley	et	al.,	
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2013;	 Lewis	 et	 al.,	 2016).	 Although	 there	 are	 many	 physical	 interaction	 sites	
between	 the	 ER	 and	mitochondria	 in	 a	 given	 cell,	 only	 a	 small	 subset	 of	 contact	
points	 are	 associated	 with	 mitochondrial	 division	 events.	 Specific	 fluorescent	
labelling	 of	 a	 sub-set	 of	 nucleoids	 actively	 undergoing	mtDNA	 synthesis	 (approx.	
10%)	revealed	that	the	majority	of	mitochondrial	 fission	events	occurred	within	1	
µm	of	 nucleoids	 engaged	 in	mtDNA	 synthesis	 (Lewis	 et	 al.,	 2016).	 The	 evidence	
illustrates	 that	 replicating	 nucleoids	 mark	 nascent	 mitochondrial	 fission	 events	
proximal	 to	 sites	 of	 close	 physical	 apposition	 of	 the	 ER	 and	 mitochondria,	 and	
precedes	the	recruitment	of	Drp1	(Lewis	et	al.,	2016).	Disruption	of	the	ER	structure	
reduced	the	number	of	replicating	nucleoids	within	the	mitochondrial	network,	and	
so	 it	 is	 hypothesised	 that	 efficient	 ER-mitochondria	 contact	 formation	 permits	
mtDNA	synthesis,	perhaps	by	creating	a	platform	for	the	recruitment	of	proteins	and	
other	components	involved	in	mtDNA	replication	(Lewis	et	al.,	2016).	
	
1.1.2	ER-endosome	contacts	
As	stated,	the	ER	does	not	only	form	physical	complexes	with	the	mitochondria	but	
with	 many	 other	 organelles	 including	 endosomes	 (Raiborg	 et	 al.,	 2015b).	 The	
endocytic	pathway	involves	the	uptake	and	transport	of	materials	by	inward	budding	
of	the	plasma	membrane	to	form	early	endosomes	that	sort	cargo	to	their	target	
destinations	(Conner	and	Schmid,	2003).	Early	endosomes	gradually	mature	into	late	
endosomes	 that	 fuse	with	 the	 lysosome	 for	 the	 degradation	 of	 remaining	 cargo.	
Fluorescence	resonance	energy	transfer	(FRET)	studies	provided	evidence	of	close	
physical	interaction	between	endosomes	and	the	ER	by	quantifying	FRET	between	
Cy3-conjugated	tyrosine	phosphatase	PTP1B	localised	on	the	ER	and	a	GFP-tagged	
receptor	tyrosine	kinase,	epidermal	growth	factor	receptor	(EGFRs)	contained	within	
early	endosomes	(Haj	et	al.,	2002).	This	permitted	the	identification	of	sites	of	direct	
EGFR	dephosphorylation	by	PTP1B	and	identified	these	sites	as	the	physical	contact	
points	between	the	ER	and	endosomes	(Haj	et	al.,	2002),	an	observation	that	was	
subsequently	confirmed	by	electron	microscopy	(Eden	et	al.,	2010).	ER-endosome	
contact	sites	appear	to	increase	as	endosomes	mature	and	it	is	estimated	that	99%	
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of	 late	 endosomes	 will	 have	 a	 contact	 site	 with	 ER	 membrane,	 covering	
approximately	5%	of	the	endosome	surface	area	(Friedman	et	al.,	2013).	Electron	
microscopy	images	have	defined	these	contact	sites	as	being	between	3-15	nm	on	
average	(Alpy	et	al.,	2013).	A	key	regulator	of	ER-endosome	contacts	is	the	integral	
ER	membrane	protein	VAPA	which	can	bind	to	the	FFAT	motifs	(two	phenylalanines	
[FF]	 in	 an	 acidic	 tract)	 of	 various	 endosomal	 proteins	 including	 OSBP	 (Oxysterol-
related	binding	protein)-related	protein	1L	(ORP1L)	(Rocha	et	al.,	2009),	STAR	related	
lipid	transfer	domain	containing	3	(STARD3)	and	STARD3	N-terminal	like	(STARD3NL)	
(Alpy	et	al.,	2013)	to	hold	the	organelles	in	close	apposition.	FFAT	motifs	contain	the	
amino	acid	sequence	EFFDAxE	and	are	found	within	lipid-binding	proteins	(Loewen	
et	 al.,	 2003).	 Similar	 to	 the	 function	 of	 MAMs,	 ER-endosome	 contact	 sites	 are	
involved	in	cholesterol	transfer	from	late	endosomes	to	the	ER	through	the	binding	
of	 the	 ER	 protein	 oxysterol-binding	 protein-related	 	 protein	 5	 (ORP5)	 with	 the	
endosome-membrane	associated	Niemann-Pick	disease	type	C1	(NPC1)	cholesterol	
transporter	(Du	et	al.,	2011).		
Further	commonalities	exist	between	the	functions	of	ER-endosome	contacts	and	
ER-mitochondria	 contacts.	 During	 lysosomal	 permeabilisation,	 localised	 spikes	 in	
cytosolic	calcium	levels	induce	IP3R	mediated	ER	calcium	release	and	this	coupling	is	
bi-directional	 as	 ER	 calcium	 release	 can	 be	 accumulated	 by	 lysosomes	 (Lopez-
Sanjurjo	et	al.,	2013).	Ca2+	channel	opening	generates	microdomains	of	elevated	Ca2+	
concentrations	and	therefore	it	is	likely	that	this	Ca2+	signalling	is	occurring	at	sites	
of	close	apposition	between	the	ER	and	lysosomes	(Shuai	and	Parker,	2005;	van	der	
Kant	and	Neefjes,	2014).	The	biological	relevance	of	this	calcium	coupling	is	believed	
to	 be	 in	 endosomal	 fusion	 and	maturation	 as	 some	 studies	 suggest	 that	 Ca2+	 	 is	
necessary	for	early	endosomal	fusion	(Colombo	et	al.,	1997)	and	for	the	fusion	of	
late	 endosomes	 to	 the	 lysosome	 (Pryor	 et	 al.,	 2000).	 A	 role	 of	 the	 ER	 tubules	 in	
defining	sites	of	fission	events	also	seems	to	be	conserved	across	organelles.	Live-
cell	 imaging	 has	 revealed	 the	 movement	 of	 an	 ER	 tubule	 to	 constrict	 early	
endosomes,	preceding	endosomal	budding	and	fission	events	(Rowland	et	al.,	2014).												
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An	additional	role	of	ER-endosome	contacts	is	to	regulate	endosomal	motility	and	
position.	 Protrudin	 is	 an	 ER	 membrane	 protein	 that	 binds	 RAB7	 and	
phosphatidylinositol	 3-phosphate	 (ptdIns3P)	 on	 the	 late	 endosome	membrane	 in	
order	to	form	a	physical	inter-organelle	link	(Raiborg	et	al.,	2015a).	Protrudin	then	
binds	to	the	heavy	chain	of	the	microtubule	motor	protein	kinesin-1	to	facilitate	its	
binding	to	FYCO1	(FYVE	and	coiled-coil	domain	containing	1),	guiding	the	movement	
of	the	endosomes	to	the	cell	periphery	where	it	can	promote	the	outward	growth	of	
neurites	(Raiborg	et	al.,	2015a).			
1.1.3	ER-plasma	membrane	contacts	(ER-PM)	
Numerous	 proteins	 have	 been	 implicated	 in	 forming	 membrane	 contact	 sites	
between	the	ER	and	the	plasma	membrane	(PM),	which	are	believed	to	play	a	role	
in	 calcium	 signalling	 and	 lipid	 transfer.	 Under	 conditions	 of	 reduced	 ER	 lumen	
calcium	concentrations,	the	ER-protein	stromal	interacting	molecule	1	(STIM1)	can	
accumulate	at	existing	ER-PM	contact	sites	while	also	inducing	the	formation	of	new	
contact	sites	where	it	binds	to	the	plasma	membrane	protein	Orai1	(calcium-release	
activated	calcium	channel	protein	1)	(Wu	et	al.,	2006).	The	binding	of	STIM1	to	Orai1	
induces	an	influx	of	extracellular	calcium	ions	through	the	store	operated	calcium	
entry	 (SOCE)	system	to	 replenish	ER	calcium	 levels	and	maintain	homeostasis	 [As	
reviewed	by	(Lewis,	2007)].	Using	single-molecule	tracking	to	analyse	diffusion	rates	
of	STIM1	and	Orai1	illustrated	that	once	bound	to	one	another,	their	movement	is	
trapped	within	these	junctional	complexes	which	suggests	that	ER-PM	contact	sites	
may	represent	regions	of	distinct	microenvironments	(Henne	et	al.,	2015;	Wu	et	al.,	
2014).	VAPs	have	also	been	implicated	in	regulating	ER-PM	contacts	through	their	
interaction	with	the	FFAT	motif	of	Oxysterol	binding	homology	(OSH)	proteins	that	
possess	phosphatidylinositol	4-phosphate	 (PI4P)	PH	(Pleckstrin	homology)	binding	
domains	 that	 allow	 them	 to	 interact	 directly	 with	 the	 PM	 (Stefan	 et	 al.,	 2011).	
Through	this	interaction,	ER-PM	contact	sites	are	involved	in	the	transfer	of	sterols,	
bound	to	OSH	proteins	such	as	Osh3,	 from	the	ER	to	the	PM	(Stefan	et	al.,	2011;	
Henne	et	al.,	2015).	ER-PM	junctions	are	consistently	between	10–25	nm	and	are	
formed	at	regions	of	ER	membrane	that	lack	ribosomes	(Henne	et	al.,	2015).	As	VAP	
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proteins	are	relatively	shorter	 than	other	proteins	 implicated	 in	mediating	ER-PM	
contacts,	 it	 is	believed	that	the	recruitment	of	binding	partners	via	FFAT	motifs	 is	
essential	in	order	to	span	the	width	of	the	ER-PM	junction	(Henne	et	al.,	2015).						
1.1.4	ER-Golgi	contacts	
The	Golgi	apparatus	in	eukaryotic	cells	has	a	characteristic	structure	composed	of	
membrane-enclosed	cisternae	arranged	 in	stacks	that	can	be	sub-divided	 into	cis,	
medial	and	trans	cisternae	(Day	et	al.,	2013).	ER	exit	sites	(ERES)	are	believed	to	be	
the	 site	 of	Golgi	 organelle	 generation	where	 it	 receives	 COPII	 vesicles	 containing	
newly	 synthesised	 proteins	 from	 the	 ER	 (Suda	 and	 Nakano,	 2012).	 The	 Golgi	
apparatus	 then	 plays	 a	 critical	 role	 in	 protein	 modification,	 as	 it	 is	 enriched	 for	
glycosylation	and	other	enzymes,	and	mediates	 transport	of	 the	proteins	 to	 their	
final	destinations	[As	reviewed	by	(Stanley,	2011)].		
Similar	to	other	inter-organelle	contact	sites,	membrane	contact	sites	between	the	
ER	and	Golgi	apparatus	also	play	a	key	role	in	the	non-vesicular	transport	of	lipids.	
Several	proteins	have	been	identified	that	are	localised	to	these	junctions	including	
CERT	 (ceramide	 transfer	 protein)	 (Kawano	et	 al.,	 2006),	 the	 phosphatidylinositol-
transfer	protein	NIR2	(Pyk2	N-terminal	domain-interacting	receptor	2)	that	regulates	
DAG	(diacylglycerol)	 levels	 in	 the	Golgi	 (Litvak	et	al.,	2005),	 the	glycosylceramide-
transfer	 protein	 Golgi-associated	 four-phosphate	 adaptor	 protein	 2	 (FAPP2)	
(D'Angelo	et	al.,	2007)	and	OSBP	(Mesmin	et	al.,	2013).	All	of	these	proteins	possess	
a	PH	domain	allowing	them	to	bind	PI4P	on	the	Golgi	and	FFAT	motifs	allowing	them	
to	 interact	with	VAP	which	again	highlights	the	VAP	protein	family	as	being	a	key	
modulator	of	organelle	contact	site	formation	(Phillips	and	Voeltz,	2016).	Depletion	
of	 VAP	 levels	 results	 in	 the	 mislocalisation	 of	 the	 previously	 mentioned	 lipid	
transport	 proteins	 and	 a	 consequent	 disruption	 of	 Golgi	 structure	 (Peretti	 et	 al.,	
2008).	 The	 regulation	 of	 ER-Golgi	 contact	 sites	 and	 correct	maintenance	 of	 lipid	
homeostasis	within	the	Golgi	 is	also	critical	 for	the	efficient	vesicular	transport	of	
proteins	[as	reviews	by	(McMaster,	2001)].					
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1.1.5	ER-peroxisome	contacts	
Peroxisomes	 are	 organelles	 derived	 from	 ER	 membrane	 that	 function	 in	 the	
metabolism	 of	 lipids	 and	 reactive	 oxygen	 species	 (Hoepfner	 et	 al.,	 2005).	 The	
function	of	 the	peroxisome	depends	on	close	spatial	proximity	 to	 the	ER	and	 the	
formation	of	 a	 protein	 complex	 tethering	 the	 two	organelles	 has	 been	 identified	
through	 the	 binding	 of	 the	 ER	 membrane	 protein	 VAPB	 to	 the	 peroxisomal	
membrane	protein	acyl-coenzyme	A-binding	domain	protein	5	(ACBD5)	(Costello	et	
al.,	2017).	Co-expression	of	VAPB	and	ACBD5	increased	ER-peroxisome	associations	
and	tightened	the	distance	of	the	junction	between	these	organelles	while	silencing	
the	 expression	 of	 either	 protein	 reduced	 contacts	 (Costello	 et	 al.,	 2017).	
Peroxisomes	 lack	 enzymes	 necessary	 for	 lipid	 biosynthesis	 and	 so	 an	 important	
function	 of	 the	 tight	 physical	 association	 between	 the	 ER	 and	 peroxisome	 is	 the	
nonvesicular	transport	of	lipids	from	the	ER	to	rapidly	provide	the	lipids	required	for	
peroxisome	membrane	formation	and	maintenance	(Raychaudhuri	and	Prinz,	2008).		
	
Due	to	the	wide	variety	of	processes	that	are	regulated	by	inter-organelle	contact	
sites,	it	is	unsurprising	that	a	perturbation	to	the	correct	formation	and	maintenance	
of	 these	 structures	 has	 been	 implicated	 in	 a	 number	 of	 diseases	 including	
neurodegenerative	disorders.	As	will	be	covered	in	the	following	sections,	some	of	
the	 main	 pathways	 implicated	 in	 the	 neuropathological	 process	 of	
neurodegeneration	are	linked	with	organelle	membrane	contact	sites.	Using	three	
examples	of	neurodegenerative	disorders,	evidence	for	how	a	dysfunction	to	these	
contact	sites	could	link	the	molecular	mechanisms	of	neurodegeneration	together	
will	be	discussed.				
1.2	Molecular	mechanisms	of	neurodegeneration	
Neurodegeneration	 is	 an	umbrella	 term	encompassing	a	group	of	heterogeneous	
disorders	 characterised	 by	 the	 progressive	 death	 of	 specific	 neuronal	 subtypes.	
Common	 examples	 of	 neurodegenerative	 disorders	 include	 Alzheimer’s	 disease	
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(AD),	 Parkinson’s	 disease	 (PD)	 and	 amyotrophic	 lateral	 sclerosis	 (ALS).	 Although	
these	 diseases	 vary	 greatly	 in	 their	 underlying	 genetic	 causes	 and	 clinical	
manifestations,	 the	 pathogenic	 mechanisms	 of	 neurodegeneration	 converge	 on	
several,	 seemingly	 disparate	 cellular	 pathways.	 The	 broad	 range	 of	 molecular	
mechanisms	involved	in	neurodegeneration	has	presented	a	significant	challenge	to	
therapeutics	 and	 therefore	 it	 is	 of	 particular	 research	 interest	 to	 elucidate	
commonalities	in	the	pathogenic	mechanisms	of	neuronal	cell	death.		
1.2.1	Mitochondrial	dysfunction	and	oxidative	stress	
Due	 to	 the	 high	 energy	 demands	 of	 neurons,	 an	 impairment	 of	 mitochondrial	
function	can	have	devastating	consequences	to	the	cell	and	is	observed	in	a	number	
of	 neurodegenerative	 diseases	 [As	 reviewed	 by	 (Johri	 and	 Beal,	 2012)].	
Perturbations	 to	 the	 mitochondria	 can	 result	 in	 three	 main	 metabolic	 defects,	
creating	 a	 pathogenic	 “mitochondrial	 spiral”	 in	 which	 any	 one	 of	 the	 functional	
impairments	 can	 induce	 the	 other	 two	 in	 a	 downward	 spiral	 towards	 cell	 death	
(Blass,	2000).	These	main	defects	are	insufficient	energy	metabolism,	dysregulation	
of	calcium	homeostasis	and	oxidative	stress	(excessive	production	of	oxidants	as	a	
by-product	of	respiration	or	an	impairment	to	the	antioxidant	system),	all	of	which	
can	 result	 in	 a	 release	 of	 pro-apoptotic	 signals	 from	 the	mitochondria	 to	 induce	
neuronal	degeneration	(Blass,	2000).	An	abundance	of	evidence	exists	for	the	role	of	
mitochondrial	dysfunction	in	neurodegeneration	as	illustrated	in	the	following	three	
examples.		
1.2.1.1	Mitochondrial	dysfunction	in	PD	
Parkinson’s	 disease	 is	 a	 neurodegenerative	 disease	 arising	 from	 the	 gradual	
degeneration	of	dopaminergic	neurons	of	the	substantia	nigra	pars	compacta	and	is	
characterised	 by	 the	 presence	 of	 Lewy	 body	 protein	 aggregates	 containing	 a-
synuclein	(Hirsch	et	al.,	1999;	Spillantini	et	al.,	1997).	Approximately	10%	of	PD	cases	
arise	from	autosomal	recessive	mutations	in	genes	encoding	PINK1	(PTEN	Putative	
Kinase	1)	and	parkin	and	autosomal-dominant	mutations	in	a-synuclein	(Valente	et	
al.,	2004;	Shimura	et	al.,	2000;	Polymeropoulos	et	al.,	1997).			
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The	PD	associated	PINK1	protein	is	a	mitochondrial	serine/threonine	kinase	involved	
in	the	regulation	of	mitochondrial	structure	and	function	and	mitophagy,	a	selective	
degradative	pathway	involved	with	the	specific	clearance	of	damaged	mitochondria	
(Rogov	 et	 al.,	 2014;	 Scarffe	 et	 al.,	 2014).	 PINK1	 accumulates	 on	 the	 surface	 of	
depolarised	mitochondria	where	it	phosphorylates	and	recruits	ubiquitin	and	parkin,	
which	in	turn	causes	the	ubiquitination	and	degradation	of	mitochondrial	proteins	
(Koyano	 et	 al.,	 2014;	 Yoshii	 et	 al.,	 2011).	 Due	 to	 the	 role	 of	 these	 proteins	 in	
mitochondrial	 quality	 control,	 it	 is	 feasible	 to	 predict	 that	 an	 impairment	 to	
mitophagy	 may	 contribute	 to	 PD	 pathogenesis,	 inefficiently	 clearing	 damaged	
mitochondria	that	can	then	induce	further	damage	within	the	cell.	
The	PD-associated	a-synuclein	protein	also	plays	a	role	in	regulating	mitochondrial	
fission/fusion	 (Kamp	 et	 al.,	 2010;	 Nakamura	 et	 al.,	 2011).	 In	mutant	a-synuclein	
transgenic	 mouse	 models	 of	 PD,	 abnormal	 morphological	 changes	 in	 the	
mitochondrial	network	were	observed	along	with	increased	reactive	oxygen	species	
production	 and	 a	 loss	 of	 membrane	 potential	 (Martin	 et	 al.,	 2006).	 Similar	
mitochondrial	defects	were	observed	in	cells	overexpressing	a-synuclein	(Shavali	et	
al.,	2008;	Hsu	et	al.,	2000).		
While	 the	 evidence	 shows	 that	 mitochondrial	 defects	 occur	 in	 PD	 disease	
progression,	it	is	not	entirely	certain	whether	these	defects	are	the	cause	of	neuronal	
degeneration	 or	 arise	 as	 a	 secondary	 effect	 of	 other	 pathogenic	 insults.	 Some	
evidence	 for	 mitochondrial	 defects	 being	 a	 cause	 rather	 than	 a	 consequence	 of	
dopaminergic	neurodegeneration	comes	 from	mouse	models	with	a	knock-out	of	
the	 mitochondrial	 transcription	 factor	 A	 (Tfam),	 involved	 with	 regulating	
mitochondrial	DNA	(mtDNA)	transcription	and	copy	number	 (Larsson	et	al.,	1998;	
Ekstrand	et	al.,	2007).	Mitochondrial	DNA	encodes	for	13	key	subunits	involved	in	
energy	metabolism	and	therefore,	defects	in	the	regulation	of	mtDNA	can	result	in	
respiratory	defects.	In	agreement	with	this,	mice	with	a	knock-out	of	Tfam	develop	
severe	mitochondrial	metabolic	defects	and	a	Parkinsonian	phenotype	in	adulthood,	
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providing	 strong	 evidence	 that	 mitochondrial	 defects	 can	 be	 an	 early	 primary	
pathogenic	event	in	neurodegeneration	(Ekstrand	et	al.,	2007).		
Defects	 in	 energy	 production	 are	 not	 the	 only	 evidence	 for	 mitochondrial	
dysfunction	in	PD	and	a	role	of	oxidative	stress	has	also	been	implicated.	In	the	brains	
of	PD	patients,	lipid	peroxidation	and	cholesterol	lipid	hydroperoxides	are	detected	
at	 excessive	 levels	 in	 comparison	 to	 age-matched	 controls,	 a	 consequence	 of	
excessive	free	radical	species	production	(Dexter	et	al.,	1989).	It	was	suggested	that	
this	 lipid	peroxidation	could	be	due	 to	an	 impairment	of	 the	antioxidant	defence	
system	 as	 suggested	 by	 the	 decreased	 levels	 of	 the	 antioxidant	 enzyme	 activity,	
glutathione	 peroxidase,	 resulting	 in	 excessive	 free	 radical	 toxicity	 (Dexter	 et	 al.,	
1989;	Johannsen	et	al.,	1991).	The	combined	data	suggests	that	both	oxidative	and	
metabolic	mitochondrial	defects	are	pathogenic	events	in	PD.							
1.2.1.2	Mitochondrial	dysfunction	in	ALS	
Amyotrophic	 lateral	 sclerosis	 is	 a	 fatal	 neurodegenerative	 disease	 involving	
degeneration	of	both	the	upper	and	lower	motor	neurons	in	the	brainstem,	ventral	
horn	of	the	spinal	cord	and	motor	cortex.	The	age	of	onset	and	rate	of	progression	
of	the	disease	is	variable	but	most	commonly	occurs	in	patients	over	the	age	of	55,	
manifesting	 as	 symptoms	 such	 as	 muscle	 atrophy	 and	 weakness,	 spasticity	 and	
ultimately	death	[As	reviewed	by	(Robberecht	and	Philips,	2013)].	Some	ALS	cases	
also	 present	 with	 frontotemporal	 lobe	 dementia	 (FTD)	 suggesting	 that	 ALS	
pathogenesis	 is	 not	 only	 restricted	 to	 the	 motor	 neurons	 and	 indeed,	 C9Orf72	
(Chromosome	9	open	reading	frame	72)	expansions,	which	are	the	most	common	
cause	 of	 familial	 ALS,	 are	 also	 one	 of	 the	most	 common	 forms	 of	 inherited	 FTD	
(Renton	et	al.,	2011).	Other	genetic	causes	of	ALS	include	the	copper/zinc	superoxide	
dismutase	 (SOD1)	 (Rosen	 et	 al.,	 1993),	 alsin	 (Yang	 et	 al.,	 2001),	 senataxin	 (SETX)	
(Chen	et	al.,	2004),	TAR	DNA-binding	protein	43	(TDP43)	(Sreedharan	et	al.,	2008),	
Fused	 in	 Sarcoma	 (FUS)	 (Vance	 et	 al.,	 2009),	 Valosin-containing	 protein	 (VCP)	
(Johnson	et	al.,	2010),	VAMP-associated	protein	B	(VAPB)	(Nishimura	et	al.,	2004)	
and	sigma-1	receptor	protein	(Al-Saif	et	al.,	2011).		
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In	 human	 sporadic	 ALS	 (SALS)	 cases,	 clustering	 of	 mitochondria	 with	 abnormal	
morphology	 has	 been	 observed	 within	 the	 intramuscular	 nerves	 (Atsumi,	 1981).	
Additionally,	in	SALS	skeletal	tissue	samples	there	was	a	clear	decrease	in	respiratory	
chain	activity	 (Wiedemann	et	al.,	1998).	However,	 it	 is	not	clear	whether	this	 is	a	
primary	 or	 secondary	 pathogenic	 event	 in	 ALS	 pathogenesis.	 When	 ALS-linked	
mutant	 SOD1	 is	 expressed	 in	 primary	 motor	 neuronal	 cultures	 it	 causes	 a	
depolarisation	of	mitochondrial	membrane	potential	with	a	higher	level	of	reactive	
oxygen	 species	 (ROS)	produced	 (Rizzardini	 et	 al.,	 2006).	Mutant	 SOD1	expressing	
cells	 had	 adverse	 bioenergetics	 defects	 and	 were	 more	 sensitive	 to	 cell	 death	
induced	by	inhibition	of	the	glycolytic	pathway	(Menzies	et	al.,	2002).						
Furthermore,	mutations	in	two	mitochondrial	genes,	cyclooxygenase	1	(COX1)	and	
mitochondrial	 transfer	 RNA	 isoleucine	 (tRNAIle),	 results	 in	 the	 degeneration	 of	
motor	 neurons	 with	 a	 phenotype	 resembling	 that	 of	 ALS	 (Comi	 et	 al.,	 1998;	
Borthwick	et	al.,	2006).	This	suggests	that	perturbations	to	mitochondrial	function	
may	be	an	underlying	cause	of	neuronal	degeneration.					
1.2.1.3	Mitochondrial	dysfunction	in	AD	
Alzheimer’s	 disease	 (AD)	 is	 a	 neurodegenerative	 disease	 characterised	 by	 the	
presence	of	extracellular	plaques	predominantly	 composed	of	b-amyloid	 (Ab),	 an	
accumulation	of	neurofibrillary	tangles	containing	hyperphosphorylated	tau	protein	
and	 progressive	 neuronal	 death	 in	 the	 cortex	 and	 hippocampus	 [as	 reviewed	 by	
(Goedert	and	Spillantini,	2006)].	Most	cases	of	AD	are	sporadic	but	approximately	
1%	of	cases	arise	from	an	inherited	autosomal-dominant	mutation	in	the	amyloid-b-
precursor	protein	[APP],	presenilin-1	(PSEN1)	or	presenilin-2	(PSEN2)	genes	(Goate	
et	 al.,	 1991;	 Rogaev	 et	 al.,	 1995;	 Sherrington	 et	 al.,	 1995).	 Ab	 is	 generated	 from	
proteolytic	processing	of	the	APP	protein	into	fragments	of	various	lengths,	the	most	
common	of	which	are	a	40	amino	acid	length	fragment	(Ab40)	or	the	more	pathogenic	
42aa	length	fragment	(Ab42)	(Iwatsubo	et	al.,	1994;	Kang	et	al.,	1987).	This	cleavage	
event	is	carried	out	initially	by	the	b-site	APP-cleaving	enzyme	1	(BACE1/b-secretase)	
followed	by	a	further	cleavage	by	the	g-secretase	complex	containing	presenilin	1	
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(PS-1)	 and	 presenilin	 2	 (PS-2)	 (Wolfe	 et	 al.,	 1999).	 One	 proposed	 model	 for	 AD	
pathogenesis	is	the	amyloid	cascade	hypothesis,	which	states	that	the	accumulation	
of	toxic	Ab42	into	neuritic	plaques	causes	an	increase	in	intracellular	calcium	levels	
with	a	consequent	upregulation	of	tau	phosphorylation	(Hardy	and	Higgins,	1992).		
In	AD	pathogenesis,	several	reports	have	shown	that	the	presence	of	pathogenic	Ab	
species	affects	mitochondrial	integrity,	resulting	in	defects	to	the	respiratory	cycle	
and	excessive	release	of	ROS,	causing	oxidative	stress	(Pappolla	et	al.,	1998;	Bozner	
et	al.,	1997;	Lustbader	et	al.,	2004).	In	support	of	this,	lipoperoxidative,	glycoxidative	
and	 other	 oxidative	 markers	 are	 readily	 detectable	 in	 the	 brains	 of	 AD	 patients	
(Smith	 et	 al.,	 1995).	 In	 Tg2576	 mouse	 models	 of	 AD,	 a	 positive	 correlation	 was	
detected	between	levels	of	soluble	Ab	and	hydrogen	peroxide	production,	providing	
evidence	 that	Ab	 is	 causing	oxidative	stress	 in	AD	models	 (Manczak	et	al.,	2006).	
With	respect	to	the	other	functions	of	the	mitochondria,	gene	expression	profiling	
in	brain	 slices	 from	Tg2576	mice	 showed	an	upregulation	of	 genes	 involved	with	
mitochondrial	energy	production	and	apoptosis	in	comparison	to	age-matched	litter	
controls	(Reddy	et	al.,	2004).	Furthermore,	in	Tg2576	mice	and	mouse	N2a	(Neuro-
2a)	cells	expressing	human	mutant	APP	or	wild-type	APP,	both	Ab	monomers	and	
oligomers	were	found	to	be	associated	predominantly	with	the	inner	mitochondrial	
membrane	and	matrix	in	mutant	APP	expressing	cells	but	not	in	wild-type	APP	cells,	
confirming	a	direct	relationship	between	Ab	and	mitochondria	and	it	is	hypothesised	
that	this	IMM	localisation	of	Ab	may	perturb	the	electron	transport	chain	and	energy	
metabolism	 (Manczak	 et	 al.,	 2006).	 In	 support	 of	 this,	 there	 was	 a	 decrease	 in	
cytochrome	c	oxidase	activity,	a	major	enzyme	component	of	the	electron	transport	
chain,	in	Tg2576	mice	(Manczak	et	al.,	2006).				
Additionally,	 in	 fibroblast	 cells	 from	 AD	 patients,	 mitochondria	 were	 more	
interconnected	 than	 in	 wild-type	 controls	 which	 was	 suggestive	 of	 a	 shift	 in	
mitochondrial	dynamics	towards	fusion	events	i.e.	less	fission	(Wang	et	al.,	2008).	In	
AD	fibroblasts,	Drp1	levels	were	significantly	decreased	while	optic	atrophy	protein	
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1	(OPA1)	 levels,	a	protein	 involved	with	mitochondrial	 fusion,	remained	the	same	
(Wang	et	al.,	2008).		
In	 summary,	 the	 evidence	 suggests	 that	 a	 dysfunction	 to	mitochondria,	 involving	
both	 structural	 and	 functional	 deficits,	 is	 a	 common	 early	 pathogenic	 event	 in	
neurodegenerative	 disorders	 and	 the	 mitochondrial	 defects	 conform	 with	 the	
amyloid	cascade	hypothesis	due	to	the	observed	relationship	between	Ab	and	the	
mitochondria.					
1.2.2	Dysregulation	of	calcium	homeostasis	
Although	mutant	genes	associated	with	neurodegeneration	are	often	ubiquitously	
expressed,	only	a	subset	of	neurons,	characteristic	to	each	specific	disease	are	seen	
to	 degenerate.	 In	 ALS,	 it	 has	 been	 hypothesised	 that	 the	 specific	 vulnerability	 of	
motor	neurons	may	be	due	to	a	lower	Ca2+	buffering	capacity	(Palecek	et	al.,	1999).	
In	support	of	this,	oculomotor	neurons,	that	are	more	resistant	to	ALS	pathology,	
have	 higher	 calcium	 binding	 capabilities	 (Vanselow	 and	 Keller,	 2000).	 The	 high	
density	 of	 Ca2+	 permeable	 AMPA	 (a-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic	acid	receptor)	receptors	on	motor	neurons,	in	combination	with	
the	 low	 Ca2+	buffering	 capacity,	may	 induce	 a	 particular	 sensitivity	 to	 excitotoxic	
conditions	(Van	Den	Bosch	et	al.,	2000;	Grosskreutz	et	al.,	2010).		
In	 familial	 presenilin-linked	 AD,	 there	 is	 increased	 activity	 and/or	 expression	 of	
calcium	 receptors	 including	 ryanodine	 receptors	 (RyR)	 and	 inositol	 1,4,5-
triphosphate	 receptors	 (IP3R),	 causing	 excessive	 release	 of	 Ca
2+	 from	 ER	 calcium	
stores	(Chan	et	al.,	2000;	Hayrapetyan	et	al.,	2008;	Cheung	et	al.,	2010).	Similarly,	in	
human	induced	pluripotent	stem	cell	(iPSC)	neurons	exposed	to	tau	oligomers,	the	
formation	of	aggregated,	hyperphosphorylated	pathogenic	tau	was	induced	with	a	
consequent	 elevation	 of	 intracellular	 Ca2+	 levels	 (Usenovic	 et	 al.,	 2015).	 In	 the	
previous	section,	 I	have	already	mentioned	how	elevated	cytosolic	Ca2+	levels	can	
cause	 excessive	 mitochondrial	 calcium	 uptake	 and	 the	 release	 of	 pro-apoptotic	
factors	but	in	addition	to	this,	increased	Ca2+	ion	concentrations	can	disrupt	neuronal	
signal	 transmissions.	 Neuronal	 calcium	 signalling	 is	 a	 key	 modulator	 of	
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neurotransmitter	release	and	in	neurons	exposed	to	pathogenic	tau	oligomers	there	
was	a	significant	increase	in	inhibitory	neuronal	GABA	(gamma-aminobutyric	acid)	
release,	 following	 the	 consequent	 rise	 in	 Ca2+	 levels	 (Usenovic	 et	 al.,	 2015).	
Furthermore,	 in	 iPSCs	 from	 frontotemporal	 lobar	 degeneration	 tauopathy	 (FTLD-
Tau)	 patients,	 increases	 in	 intracellular	 calcium	 levels	 in	 response	 to	 electrical	
stimulation	 were	 greater	 than	 control	 neurons,	 suggesting	 increased	 excitability	
(Imamura	et	al.,	2016).		
1.2.3	Protein	aggregation	and	perturbed	degradative	pathways		
A	 common	 hallmark	 of	 many	 neurodegenerative	 disorders	 is	 the	 appearance	 of	
protein	inclusions	within	degenerating	neurons.	Skein-like	inclusions	that	positively	
label	for	ubiquitin	and	small	cytoplasmic,	ubiquitin-negative	Bunina	bodies	are	often	
found	 within	 spinal	 cord	 and	 brainstem	motor	 neurons	 of	 ALS	 patients	 and	 are	
considered	to	be	specific	hallmarks	of	the	disorder	(Kato,	2008).	Most	of	the	ALS-
linked	gene	mutations	encode	for	proteins	with	a	high	propensity	to	aggregate	and	
these	 are	 often	 found	within	 protein	 inclusions	 [As	 reviewed	 by	 (Bendotti	 et	 al.,	
2012)].	 Similar	 to	 skein-like	 inclusions,	 PD	 associated	 Lewy	 bodies	 containing	a-
synuclein	 also	 contain	 some	 cytoskeletal	 and	 proteasomal	 proteins	 and	 can	 be	
positively	labelled	for	ubiquitin	(Ross	and	Poirier,	2004).	Although	the	exact	role	of	
protein	 aggregates	 in	 neurodegeneration	 has	 not	 been	 elucidated,	 a	 positive	
correlation	 has	 been	 identified	 between	 the	 proportion	 of	 skein-like	 inclusion	
containing	neurons	and	the	extent	of	neuronal	cell	death	(van	Welsem	et	al.,	2002).	
In	contrast,	there	is	only	a	very	weak	correlation	between	neuritic	plaque	density	in	
post-mortem	tissue	of	AD	patients	and	ante-mortem	cognitive	decline	(Terry	et	al.,	
1991).	Cells	have	two	main	degradative	pathways	in	place	to	clear	insoluble	protein	
aggregates	 and	 dysfunctions	 to	 these	 clearance	 systems	 are	 often	 observed	 in	
neurodegeneration.	Opposing	points	of	view	state	that	protein	aggregates	may	be	a	
secondary	pathogenic	event	as	a	consequence	of	defects	in	the	cellular	degradative	
pathways	or	they	themselves	may	induce	defects	to	the	clearance	systems	by	a	toxic	
gain-of-function	mechanism	or	by	sequestering	core	degradative	proteins	(Navone	
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et	al.,	2015).	The	following	sections	will	outline	the	two	major	cellular	degradative	
systems.		
1.2.3.1	Ubiquitin-Proteasome	system	(UPS)			
The	UPS	 is	 a	 complex,	multi-component	process	whereby	abnormal	or	misfolded	
proteins	are	tagged	with	ubiquitin	and	degraded	within	a	central	cavity	of	a	 large	
protease	 complex	 called	 the	 proteasome.	 The	 fact	 that	 many	 of	 the	 protein	
inclusions	observed	within	degenerating	neurons	 label	positively	for	ubiquitin	has	
implicated	 this	 pathway	 in	 disease	 pathogenesis	 (Leigh	 et	 al.,	 1988;	 Kato,	 2008).	
More	 direct	 evidence	 for	 a	 role	 of	 the	 UPS	 in	 neurodegeneration	 comes	 from	
transgenic	mice	with	a	knock-down	of	the	critical	UPS	component	regulatory	particle	
triple-ATPase	subunit	3	(Rpt3)	which	is	a	major	subunit	of	the	26S	proteasome	(the	
major	 cellular	 mammalian	 protease)	 (Tashiro	 et	 al.,	 2012;	 Bedford	 et	 al.,	 2010).	
These	mice	develop	a	degenerative	motor	neuron	phenotype	with	the	appearance	
of	ALS-associated	protein	aggregates,	illustrating	how	a	dysfunction	of	the	UPS	can	
directly	lead	to	neurodegeneration	(Tashiro	et	al.,	2012).	Pharmacological	inhibition	
of	 UPS	 activity	 also	 results	 in	 an	 accumulation	 of	 protein	 aggregates	 while	
overexpressing	proteins	with	a	propensity	to	aggregate	can	suppress	UPS	activity,	
suggesting	that	misfolded	protein	aggregates	may	be	both	a	cause	and	a	product	of	
UPS	suppression	in	a	positive-feedback	mechanism	(Moumen	et	al.,	2011;	Kuijpers	
et	 al.,	 2013a).	 Additional	 evidence	 for	 an	 impairment	 of	 UPS	 activity	 in	
neurodegeneration	 comes	 from	 neurodegenerative-linked	 genetic	 mutations	 in	
proteins	 associated	 with	 the	 UPS	 for	 example,	 mutations	 in	 VCP	 or	 ubiquilin	 2	
(UBQLN2)	result	in	a	familial	form	of	ALS	(Johnson	et	al.,	2010;	Deng	et	al.,	2011).	
VCP	is	a	chaperone	protein	involved	with	the	recognition	and	targeting	of	misfolded	
proteins	 in	 the	 ER	 or	mitochondrial	membranes	 or	within	 protein	 complexes	 for	
proteasomal	degradation	(Yamanaka	et	al.,	2012;	Stolz	et	al.,	2011).	VCP	was	also	
detected	at	high	levels	in	protein	inclusions	in	VAPB-linked	ALS	suggesting	that	an	
impairment	of	the	UPS	chaperone	protein	function	may	play	a	more	general	role	in	
ALS	pathogenesis	(Kuijpers	et	al.,	2013a).	A	recent	study	has	shown	that	a	neuronal	
specific	knock-down	of	the	VCP	associated	co-factors	ubiquitin	fusion	degradation	1	
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(Ufd1)	or	nuclear	protein	localization	homolog	4	(Npl4)	induces	a	neurodegenerative	
phenotype	in	Drosophila	models,	providing	further	evidence	that	dysfunctional	UPS	
activity	 may	 be	 a	 primary	 pathogenic	 event	 in	 neurodegeneration	 (Byrne	 et	 al.,	
2017).																													
1.2.3.2	Autophagy	
Autophagy	 is	 an	 effective	 clearance	 pathway	 for	 protein	 aggregates	 and	 their	
oligomeric	 precursors,	 clearing	 both	 spontaneously	 generated	misfolded	proteins	
and	 those	 aggregate-prone	 proteins	 associated	 with	 neurodegenerative	 diseases	
(Levine	and	Kroemer,	2008;	Navone	et	al.,	2015).	In	neurons,	autophagosomes	form	
preferentially	at	the	axon	tip	where	they	sequester	ubiquitinated	protein	aggregates	
and	migrate	towards	the	cell	soma,	assisted	by	dynein	motor	proteins	for	fusion	with	
lysosomes	(Navone	et	al.,	2015).	Mice	with	a	knock-down	of	the	essential	autophagy-
related	5	(Atg5)	protein	 in	neurons	presented	with	progressive	 locomotor	defects	
and	 in	 Atg5	 knock-out	 cells,	 an	 accumulation	 of	 protein	 inclusion	 bodies	 was	
detected	indicating	that	a	dysfunction	to	basal	autophagy	can	induce	a	degenerative	
phenotype	(Hara	et	al.,	2006).		
Genetic	 mutations	 underlying	 inherited	 forms	 of	 neurodegenerative	 diseases	
provide	compelling	evidence	for	a	link	between	autophagy	and	disease	pathology.	
As	 previously	 mentioned,	 familial	 PD	 is	 associated	 with	 mutations	 of	 PINK1	 and	
Parkin	which	play	a	role	in	selective	mitophagic	clearance	of	damaged	mitochondria	
(Shimura	et	al.,	2000;	Valente	et	al.,	2004).	Similarly,	mutations	 in	optinuerin	are	
associated	with	 ALS	 and	 impair	 the	 recruitment	 of	 the	 autophagic	machinery	 to	
damaged	mitochondria	as	well	as	impairing	autophagosome	maturation	(Maruyama	
et	 al.,	 2010;	 Wong	 and	 Holzbaur,	 2014).	 In	 addition	 to	 familial	 cases	 of	
neurodegeneration,	 autophagy	 is	 also	 linked	 to	 sporadic	 forms	 of	 disease	 e.g.	 in	
sporadic	ALS	patients,	autophagy	is	upregulated	as	shown	by	an	increased	number	
of	autophagosomes	within	patient	motor	neuron	cells	(Sasaki,	2011).			
In	most	circumstances,	autophagy	plays	a	protective	role	within	the	cell	however,	
pathways	regulating	autophagy	are	intricately	linked	to	those	regulating	apoptotic	
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cell	death	and	molecular	inducers	of	one	pathway	may	activate	the	other	(Maiuri	et	
al.,	 2007).	 Additionally,	 it	 can	 be	 difficult	 to	 distinguish	 an	 upregulation	 of	
autophagosomes	 as	 being	 a	 pro-survival	 mechanism	 or	 as	 a	 consequence	 of	
defective	 autophagic	 clearance	 and	 therefore,	 there	 is	 some	 controversy	
surrounding	the	exact	role	of	autophagy	in	neurodegenerative	events.						
1.2.4	Alterations	in	lipid	metabolism		
The	tight	regulation	of	cell	membrane	lipid	composition	is	essential	for	maintaining	
the	structural	integrity	and	function	of	cell	membranes.	Alterations	to	lipid	levels	or	
lipid	processing	have	been	identified	in	patients	with	a	variety	of	neurodegenerative	
diseases	 suggesting	 that	 dysfunctional	 lipid	 metabolism	 may	 be	 involved	 in	 the	
neuropathological	process.			
Sphingolipids	are	a	group	of	lipids	derived	from	sphingosine	that	are	enriched	within	
the	nervous	system	and	play	important	structural	and	signalling	roles	(Haughey	et	
al.,	2010).	Ceramide	is	a	core	component	of	complex	sphingolipids	and	is	comprised	
of	 several	 subspecies	 that	 differ	 in	 their	 number	 of	 carbons.	 The	 ratios	 of	 these	
ceramide	subgroups	to	one	another	is	very	tightly	regulated	and	although	this	ratio	
does	 not	 differ	 in	 tissue	 undergoing	 neurodegeneration,	 an	 overall	 elevation	 of	
ceramide	 levels	has	been	detected	 in	post-mortem	brain	 tissue	 from	AD	patients	
(Filippov	et	al.,	2012).	Additionally,	the	expression	of	two	sphingomyelinase	genes,	
involved	in	ceramide	biosynthesis	from	the	catabolic	breakdown	of	sphingomyelin,	
was	significantly	upregulated	in	AD	samples	(Filippov	et	al.,	2012).	Elevated	levels	of	
ceramide	have	been	shown	to	decrease	respiratory	cycle	protein	complex	activity	
and	 alter	 mitochondrial	 membrane	 potential	 and	 permeability	 (Kogot-Levin	 and	
Saada,	 2014).	 Ceramide	 can	 also	 induce	 neuronal	 death	 by	 activating	 ceramide	
associated	 protein	 kinases	 (CAPK)	 and	 phosphatases	 (CAPP)	 to	 trigger	 apoptotic	
death	signalling	pathways	(Haughey	et	al.,	2010)	Furthermore,	AD	patients	also	show	
significantly	reduced	plasma	levels	of	phosphatidylcholine	(Mapstone	et	al.,	2014)	
and	 decreased	 levels	 of	 phosphatidylinositol	 in	 the	 hippocampus	 (Prasad	 et	 al.,	
1998).	 The	 decrease	 in	 phospholipid	 species	 is	 likely	 due	 to	 an	 increase	 in	
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phospholipid	 processing	 as	 increases	 in	 the	 phospholipid	 catabolite,	
glycerophosphocholine,	are	also	detected	in	AD	patients	(Nitsch	et	al.,	1992).					
A	similar	reduction	in	phospholipids	and	sphingolipids	is	detected	in	spinal	cords	of	
SOD1	mouse	models	of	ALS,	at	both	the	symptomatic	and	pre-symptomatic	stages	
of	disease,	with	a	prominent	change	in	sphingolipid	metabolism	(Henriques	et	al.,	
2015).	 Glucosylceramide	 synthase,	 involved	 with	 glycosphingolipid	 biosynthesis,	
shows	upregulated	expression	levels	in	the	muscles	of	ALS	patients	and	co-localises	
with	TDP-43	inclusion	bodies	in	degenerating	cells	(Henriques	et	al.,	2015).	As	the	
occurrence	of	lipid	metabolism	defects	takes	place	before	the	onset	of	symptoms,	it	
suggests	that	these	defects	may	be	an	early,	primary	pathogenic	event	 in	disease	
progression.			
1.2.5	ER	Stress		
As	prolonged	ER	stress	can	induce	apoptosis,	it	is	hypothesised	that	severe	ER	stress	
proceeds	various	cell	insults	built	up	over	time	and	is	responsible	for	the	selective	
death	of	neurons	in	neurodegenerative	disorders.	In	spinal	cord	motor	neurons	of	
sALS	patients,	all	three	UPR	pathways	described	above	were	found	to	be	activated	
(Atkin	et	al.,	2008).	Furthermore,	expression	levels	of	eIF2a	and	PDI	were	elevated	
(Ilieva	et	al.,	2007).	In	SOD1G93A	and	SOD1G85R	transgenic	mouse	models	of	ALS,	the	
accumulation	of	SOD1	protein	triggers	an	ER	stress	response	exclusively	in	the	spinal	
cord	at	the	final	stages	of	disease	progression	(Kikuchi	et	al.,	2006).	SOD1	may	also	
increase	the	severity	of	the	ER	stress	by	inhibiting	the	protein	folding	activity	of	PDI	
(Atkin	 et	 al.,	 2006).	 In	 mice	 with	 frontotemporal	 dementia	 pathology	 there	 is	
continuous	activation	of	the	PERK	pathway	resulting	in	a	reduction	of	global	protein	
synthesis	in	the	central	nervous	system	(CNS)	leading	to	neuronal	cell	death	(Radford	
et	al.,	2015).		
1.2.6	Fragmentation	of	the	Golgi	apparatus		
Morphological	 and	 functional	 alterations	 to	 the	 Golgi	 are	 a	 hallmark	 of	 several	
neurodegenerative	disorders.	In	sALS	spinal	cord	motor	neurons,	the	Golgi	appears	
as	 disconnected	 components	 dispersed	 throughout	 the	 cell.	 The	 number	 of	
	 34	
immunolabelled	components	doubled	in	degenerating	motor	neurons	in	comparison	
to	control	cells,	but	the	average	size	was	dramatically	reduced	(Gonatas	et	al.,	1992).	
Similar	fragmentation	of	the	Golgi	cisternae	was	observed	in	transgenic	SOD1	mouse	
models	 of	 ALS	 which	 was	 detectable	 several	 months	 before	 the	 onset	 of	motor	
deficits	(Mourelatos	et	al.,	1996).	Furthermore,	in	cells	expressing	Parkinson’s	linked	
mutant	 a-synuclein	 protein,	 Golgi	 defects	 occurred	 before	 the	 appearance	 of	
protein	 aggregates	 (Gosavi	 et	 al.,	 2002)	 and	 in	 Alzheimer’s,	 Golgi	 fragmentation	
occurred	within	hippocampal	neurons	of	AD	patients,	when	not	in	the	presence	of	
neurofibrillary	 tangles	 (Stieber	 et	 al.,	 1996).	 Overall,	 the	 evidence	 suggests	 that	
fragmentation	 of	 the	Golgi	 apparatus	 is	 a	 common,	 preclinical	 hallmark	 of	many	
neurodegenerative	diseases.			
From	 the	 evidence	 presented	 above,	 there	 are	 a	 number	 of	 clear	 and	 distinct	
pathways	that	are	commonly	perturbed	in	neurodegenerative	disorders	with	early	
insults	 such	 as	 mitochondria	 abnormalities	 or	 defects	 in	 cellular	 degradative	
pathways	leading	to	the	induction	of	ER	stress	and	subsequent	apoptotic	cell	death.	
However,	it	is	not	always	clear	how	the	expression	of	a	single	neurodegenerative-
linked	mutant	protein	could	perturb	so	many	distinct	cellular	processes.	It	is	possible	
that	 these	 molecular	 mechanisms	 of	 neurodegeneration	 could	 converge	 on	 a	
dysfunction	 to	 organelle	membrane	 contact	 sites.	 The	 evidence	 linking	 organelle	
contact	sites	and	neurodegeneration	will	be	discussed	in	the	proceeding	sections.																						
	1.2.7	ER-mitochondria	contacts	and	neurodegeneration	
There	 is	 a	 clear	 overlap	 between	 many	 of	 the	 processes	 regulated	 by	 ER-
mitochondria	interaction	sites	and	those	pathways	that	are	commonly	implicated	in	
the	neurodegeneration.	Specific	examples	of	defective	ER-mitochondria	contacts	in	
AD,	PD	and	ALS	pathogenesis	are	presented	below.			
1.2.7.1	ER-mitochondria	contacts	in	Alzheimer’s	disease	(AD)	
The	 cleavage	 of	 APP	 to	 Ab	 occurs	 at	 the	 MAMs	 where	 g-secretase	 activity	 is	
predominantly	localised	(Area-Gomez	et	al.,	2009).	In	PSEN1	and/or	PSEN2	knockout	
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MEFs	there	was	a	significant	increase	in	MAM	activity	as	measured	by	elevated	levels	
of	cholesteryl	ester	synthesis	and	phospholipid	synthesis	(Area-Gomez	et	al.,	2012).	
In	addition	to	increased	MAM	function,	PSEN1/2	knockout	cells	showed	an	increase	
in	the	percentage	surface	area	of	mitochondria	in	close	apposition	to	the	ER	and	this	
was	also	observed	in	fibroblast	cells	from	both	familial	AD	and	sporadic	AD	patients	
(Area-Gomez	et	al.,	2012).	In	contrast,	another	study	showed	that	ER-mitochondria	
associations	were	 increased	upon	overexpression	of	wild-type	or	FAD-linked	PS-2	
with	altered	mitochondrial	calcium	homeostasis	whereas	altering	the	levels	of	PS-1	
expression	had	no	impact	on	the	extent	of	ER-mitochondria	associations	(Zampese	
et	 al.,	 2011).	 Although	 PS-1/2	 has	 no	 direct	 tethering	 role	 at	 the	 MAMs,	 the	
regulation	of	ER-mitochondria	associations	by	PS-2	seems	to	be	dependent	on	the	
presence	of	MFN2	at	these	junctions	suggesting	that	PS-2	may	interact	with	MFN2	
at	the	MAMs	to	impact	its	role	as	a	negative	regulator	of	ER-mitochondria	contacts	
(Filadi	et	al.,	2016).	To	further	strengthen	the	link	between	the	g-secretase	complex	
and	MFN2,	it	was	shown	that	Ab	production	and	processing	was	decreased	in	MFN2	
knockdown	 cells,	 despite	 there	 being	 an	 increase	 in	 the	 amount	 of	 close	 ER-
mitochondria	associations,	and	this	effect	was	due	to	a	defect	in	g-secretase	complex	
maturation	and	activity	(Leal	et	al.,	2016).		
Preceding	the	cleavage	event	by	g-secretase	to	generate	Ab,	an	initial	cleavage	event	
of	APP	is	carried	out	by	b-secretase	complex	to	generate	a	99-aa	C-terminal	fragment	
(C99)	and	it	has	been	suggested	that	increased	levels	of	C99	may	contribute	to	AD	
pathogenesis	(Lee	et	al.,	2006)	(Fig	1.4).	A	recent	study	has	demonstrated	that	C99	
fragments	 are	 enriched	 at	 the	 MAMs,	 in	 agreement	 with	 g-secretase	 activity	
occurring	in	these	compartments,	and	levels	of	C99	were	significantly	increased	in	
tissue	 from	AD	patients	and	 in	mutant	PS-1M146V	mouse	models,	especially	 in	 the	
MAM	 fraction	 (Pera	 et	 al.,	 2017).	 In	 PS-1/PS-2	 double	 knock-out	 cells	 that	 have	
increased	ER-mitochondria	associations	and	increased	levels	of	C99,	the	inhibition	
of	b-secretase	activity	to	halt	C99	production	could	rescue	this	increased	apposition	
phenotype,	suggesting	that	the	accumulation	of	C99	at	the	MAMs	can	increase	ER-
mitochondria	contacts	(Pera	et	al.,	2017).	Furthermore,	there	was	a	reduction	of	the	
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conversion	of	cholersterol	to	cholersteryl	esters	upon	treatment	with	a	b-secretase	
inhibitor,	 indicating	 that	C99	can	enhance	MAMs	both	physically	and	 functionally	
(Pera	et	al.,	2017).	C99-mediated	upregulation	of	ER-mitochondria	interactions	was	
further	associated	with	increased	phosphatidylserine	and	sphingomyelinase	activity	
at	 the	MAMs	with	an	associated	 increase	 in	 ceramide	 levels	 at	 the	mitochondria	
(Pera	et	al.,	2017).	Therefore,	it	has	been	hypothesised	that	the	respiratory	defects	
observed	 in	 AD,	 could	 be	 accounted	 for	 by	 C99-mediated	 upregulation	 of	 ER-
mitochondria	associations	and	consequent	perturbations	to	 lipid	biosynthesis	and	
enhanced	ceramide	levels.			
	
Fig	 1.4:	 C99	 fragment	 generation	 in	 the	 amyloidogenic	 pathway.	 APP	 is	 initially	
processed	by	the	b-secretase	complex	in	the	amyloidogenic	pathway	to	generate	the	
soluble	 amyloid	 precursor	 protein	 b	 (sAPP-b)	 and	 the	 C-terminal	 C99	 fragment.	
Increased	levels	of	C99	promote	an	increase	in	ER-mitochondria	associations	with	a	
consequent	 elevation	 in	 phosphatidylserine	 and	 ceramide	 production.	 Further	
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processing	 of	 C99	 by	 the	 γ-secretase	 complex	 generates	 Ab	 and	 the	 AbPP	
intracellular	domain	(AICD).	Illustrations	was	generated	in	BioRender.	
	
Due	 to	 the	 fact	 that	 alterations	 to	 the	MAMs	 are	 observed	 in	 both	 familial	 and	
sporadic	AD	cases	with	no	known	mutations	in	APP,	PS-1	or	PS-2,	(Area-Gomez	et	al.,	
2012)	 it	 has	 led	 to	 the	 suggestion	 that	 MAM	 dysfunction	 may	 be	 a	 common	
denominator	underlying	AD	pathogenesis.	 Indeed,	many	of	 the	 cellular	pathways	
that	are	seen	to	be	perturbed	in	AD	can	be	attributed	to	the	functions	of	the	MAMs	
including	 abnormal	 cholesterol	 synthesis	 (Stefani	 and	 Liguri,	 2009),	 dysregulated	
calcium	 signalling	 (Bezprozvanny	 and	 Mattson,	 2008)	 and	 mitochondrial	
abnormalities	(Su	et	al.,	2010),	suggesting	that	dysfunction	to	these	pathways	could	
be	secondary	pathogenic	effects	arising	from	disruptions	to	the	MAMs	(Pera	et	al.,	
2017).				
1.2.7.2	ER-mitochondria	contacts	in	Parkinson’s	disease	(PD)	
As	 described	 previously,	 PINK1	 accumulates	 on	 the	 surface	 of	 damaged	
mitochondria	and	recruits	parkin	to	target	the	organelle	for	mitophagic	clearance.	
Parkin	 can	 also	 be	 recruited	 by	 the	 pro-autophagic	 Beclin-1	 protein	 that	 is	 a	
constituent	of	 the	PI3K	 complex	 (Choubey	et	al.,	 2014).	PINK1	and	Beclin-1	were	
both	identified	at	the	ER-mitochondria	interface	and	their	levels	in	the	MAM	fraction	
are	enhanced	upon	carbonyl	cyanide	m-chlorophenyl	hydrazone	(CCCP)	treatment,	
a	 chemical	 uncoupler	 of	 the	 proton	 gradient	 established	 during	 the	 electron	
transport	chain	that	consequently	dissipates	the	mitochondrial	membrane	potential	
and	can	be	used	to	induce	mitophagy	(Lim	et	al.,	2001;	Gelmetti	et	al.,	2017).	The	
relocalisation	of	beclin-1	to	the	MAMs	 is	dependent	on	the	presence	of	PINK1	as	
beclin-1	levels	failed	to	increase	following	CCCP	exposure	in	PINK1	knock-down	cells	
(Gelmetti	 et	 al.,	 2017).	 Similarly,	 parkin	 also	 relocalises	 to	 the	 MAMs	 after	 the	
induction	 of	 mitophagy	 in	 a	 PINK1-dependent	 manner	 (Gelmetti	 et	 al.,	 2017).	
Previous	work	has	shown	that	increasing	the	levels	of	parkin	favours	increased	ER-
mitochondria	associations	while	knocking-down	expression	reduces	contacts	(Cali	et	
al.,	 2013).	 The	exact	 role	of	PINK1	and	parkin	on	ER-mitochondria	associations	 is	
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unclear	however	as	other	studies	have	shown	a	tightening	of	the	MAM	junctions	in	
parkin	 knock-out	 mice,	 primary	 fibroblasts	 from	 parkin-linked	 PD	 patients	 and	
neurons	derived	from	iPS	cells	from	a	patient	with	parkin	mutations	(Gautier	et	al.,	
2016).	The	ER-mitochondria	tether	MFN2	is	a	substrate	of	parkin,	through	which	it	
is	 ubiquitinated	 and	 degraded	 (Ziviani	 et	 al.,	 2010).	 Drosophila	 loss-of-function	
mutants	of	PINK1	and	parkin	show	an	accumulation	of	MFN2	and	in	increase	in	ER-
mitochondria	contact	points	indicating	that	the	influence	PINK1	and	parkin	exert	on	
the	nature	of	the	contacts	may	be	through	a	MFN2-dependent	mechanism	(Celardo	
et	al.,	2016).	The	increase	in	MAMs	was	accompanied	by	activation	of	the	PERK	ER	
stress	 pathway	 and	 knocking	 down	 MFN2	 expression	 could	 attenuate	 the	 PERK	
signalling	pathway	(Celardo	et	al.,	2016)	(Fig	1.1).				
In	addition	 to	PINK1	and	parkin,	 the	overexpression	of	a-synuclein	has	also	been	
seen	to	cause	a	significant	increase	in	mitochondrial	calcium	levels	and	uptake	ability	
as	a	consequence	of	increased	ER-mitochondria	contacts	in	cell	culture	(Cali	et	al.,	
2012).	In	contrast,	siRNA-mediated	knock-down	of	a-synuclein	in	mammalian	cells	
decreased	the	ability	to	uptake	Ca2+	and	altered	the	structure	of	the	mitochondrial	
network	to	give	a	fragmented	appearance	suggesting	that	endogenous	levels	of	a-
synuclein	are	required	to	maintain	calcium	homeostasis	(Cali	et	al.,	2012).								
1.2.7.3	ER-mitochondria	contacts	in	amyotrophic	lateral	sclerosis	(ALS)	
Mutations	 in	 the	 sigma-1	 receptor	protein	are	associated	with	a	 juvenile	 form	of	
inherited	ALS	(ALS16)	(Al-Saif	et	al.,	2011).	As	mentioned	previously,	this	protein	is	
enriched	 at	 the	 MAMs	 and	 regulates	 calcium	 exchange	 between	 the	 ER	 and	
mitochondria	 (Hayashi	 and	 Su,	 2007).	 In	 spinal	 cord	 tissue	 samples	 from	 sALS	
patients,	sigma-1	receptor	levels	were	significantly	reduced	in	comparison	to	healthy	
control	samples	and	in	primary	neuronal	cultures,	a	knock-down	of	sigma-1	receptor	
protein	expression	resulted	in	a	reduction	of	ER-mitochondria	contact	sites	(Prause	
et	al.,	2013;	Bernard-Marissal	et	al.,	2015).							
Our	 lab	 has	 a	 particular	 research	 interest	 in	 the	 ALS-linked	 VAPB	 protein	 that	 is	
believed	to	be	involved	in	tethering	the	ER	and	mitochondria	at	close	proximity	by	
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forming	a	link	with	the	outer	mitochondrial	membrane	protein	tyrosine	phosphatase	
interacting	protein	51	(PTPIP51)	(De	Vos	et	al.,	2012;	Stoica	et	al.,	2014).	The	VAMP-
associated	protein	(VAP)	family	are	a	group	of	integral	ER	membrane	proteins	all	of	
which	 are	 structured	 with	 an	 N-terminal	 major	 sperm	 protein	 (MSP)	 domain,	 a	
central	 coiled-coil	 domain	 and	 a	 C-terminal	 hydrophobic	 transmembrane	domain	
(TMD)	(Fig	1.5A)	(Nishimura	et	al.,	1999).	VAP	was	first	identified	as	a	33-kilodalton	
protein,	 VAP-33,	 interacting	 with	 vesicle	 associated	 membrane	 protein	
(VAMP)/synaptobrevin	in	Aplysia	californica	(Skehel	et	al.,	1995).	Subsequently,	the	
mammalian	VAP	homologues,	VAPA	and	VAPB,	sharing	63%	sequence	identity,	were	
cloned	 and	 an	 alternative	 splice	 form	 of	 VAPB	 termed	 VAPC	 was	 identified,	
consisting	 of	 the	 first	 70	 amino	 acids	 of	 VAPB	 plus	 an	 additional	 27	 amino	 acids	
(Nishimura	et	al.,	1999).	In	addition	to	interacting	with	VAMP,	mammalian	VAPA	and	
VAPB	undergo	homo-	and	hetero-dimerization	and	deletion	of	the	TMD	from	either	
protein	 prevents	 this	 interaction	 (Nishimura	 et	 al.,	 1999).	 Northern	 blot	 analysis	
revealed	 that	 VAPB	 is	 ubiquitously	 expressed	 in	 all	 mouse	 tissue	 examined	 and	
predominantly	 shows	 a	 reticular	 pattern	 but	 also	 appears	 to	 associate	 with	
microtubule	and	cytoskeletal	proteins	(Skehel	et	al.,	2000).	VAPA	is	also	found	on	
the	ER	but	appears	to	be	present	on	distinct	regions	of	the	ER	to	VAPB,	with	only	a	
modest	level	of	co-localisation	between	the	two	VAP	proteins	(Gkogkas	et	al.,	2008).	
Mammalian	 VAP	 proteins	 have	 also	 been	 observed	 on	 other	 intracellular	
membranes	 such	 as	 the	 Golgi	 apparatus,	 recycling	 endosomes	 and	 the	
neuromuscular	junctions	(Soussan	et	al.,	1999;	Pennetta	et	al.,	2002).	Specifically	in	
the	CNS,	VAPB	is	highly	abundant	and	is	particularly	enriched	in	motor	neurons	of	
the	spinal	cord	and	caudal	brainstem	(Teuling	et	al.,	2007).		
Altering	the	 levels	of	VAPB	or	 its	binding	partner	PTPIP51	 in	cultured	mammalian	
cells	perturbed	contact	sites	and	influenced	mitochondrial	calcium	levels,	supporting	
VAPBs	role	as	an	ER-mitochondria	tether	(De	Vos	et	al.,	2012;	Stoica	et	al.,	2014).	
The	 identification	 of	 TDP-43	 as	 a	 regulator	 of	 the	 VAPB/PTPIP51	 interaction	 has	
highlighted	the	relevance	of	VAPB	to	the	wider	field	of	ALS	pathogenesis	(Stoica	et	
al.,	2014).	As	mentioned	in	section	1.2.1.2,	mutations	in	TDP-43	are	associated	with	
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familial	 forms	of	ALS	but	 this	protein	 is	 also	 found	as	a	 significant	 component	of	
protein	 aggregates	 in	 several	 other	 forms	 of	 ALS	 and	 FTD	 and	 as	 such,	 TDP-43	
aggregates	are	considered	to	be	a	pathological	hallmark	of	the	disease	(Sreedharan	
et	 al.,	 2008;	 Neumann	 et	 al.,	 2006).	 Overexpression	 of	wild-type	 TDP-43	 or	 ALS-
linked	 mutant	 TDP-43	 (TDP-43Q331K,	 TDP-43A382T	 or	 TDP-43G348C)	 disrupted	 ER-
mitochondria	 contact	 sites	 while	 siRNA-mediated	 knock-down	 of	 TDP-43	 had	 no	
influence	over	the	MAMs	(Stoica	et	al.,	2014).	TDP-43	does	not	directly	bind	to	either	
VAPB	or	PTPIP51	but	rather,	 influences	their	association	through	the	activation	of	
glycogen	 synthase	 kinase-3b	 (GSK-3b)	 however,	 the	 mechanism	 by	 which	 this	
regulates	VAPB/PTPIP51	binding	has	not	yet	been	elucidated	(Stoica	et	al.,	2014).	
The	role	of	VAPB	at	the	MAMs	is	discussed	in	greater	detail	in	chapter	five	of	this	
thesis.				
1.2.7.4	Other	forms	of	inter-organelle	contact	sites	and	neurodegeneration	
In	 addition	 to	 ER-mitochondria	 contacts,	 ER-endosome	 contact	 defects	may	 also	
associated	with	neurodegeneration.	Niemann-Pick	disease	type	C	is	characterised	by	
progressive	neuronal	degeneration	beginning	in	childhood	and	is	characterised	by	
abnormal	 lipid	 and	 cholesterol	 compositions	 of	 late	 endosomes	 and	 lysosomes	
(Mukherjee	and	Maxfield,	2004).	Furthermore,	a	polymorphism	in	the	ER-endosome	
tethering	 protein	 Protrudin	 has	 been	 linked	 with	 hereditary	 spastic	 paraplegia	
(Mannan	et	al.,	2006)	and	a	knock-out	of	expression	of	the	ALS-linked	VAP	proteins	
resulted	 in	 endosomal	 trafficking	 and	 Golgi	 defects,	 common	 hallmarks	 of	
neurodegenerative	disorders	(Dong	et	al.,	2016).	The	pathology	of	these	disorders	
may,	in	part,	arise	from	defects	to	ER-endosomal	contact	sites.		
The	 proper	 maintenance	 of	 peroxisome	 function	 is	 important	 for	 neuronal	
development	and	defects	in	peroxisome	biogenesis,	as	regulated	by	ER-peroxisome	
junctions,	 has	 been	 linked	 to	 neurodegenerative	 diseases	 including	 Zellweger	
syndrome	and	X-linked	adrenoleukodystrophy	(Wanders	and	Poll-The,	2017).								
	
	 41	
1.3	The	VAP	protein	family	
From	the	evidence	presented	above,	 it	 is	 clear	 that	 the	VAMP-associated	protein	
(VAP)	 protein	 family	 plays	 a	 critical	 role	 in	 regulating	 a	 variety	 of	 organelle	
membrane	contact	 sites.	As	previously	mentioned,	VAPs	consist	of	an	N-terminal	
MSP	domain,	a	central	coiled-coil	domain	and	a	C-terminal	transmembrane	domain.	
The	transmembrane	domain	is	embedded	in	the	ER	membrane	while	the	N-terminus	
of	VAP	is	cytosolic.	These	protein	domains	will	be	discussed	in	further	detail	in	the	
following	sections.			
	
Fig	1.5:	Schematic	representation	of	the	VAP	protein	domains	and	location	of	the	
ALS-linked	point	mutation.	(A)	All	VAP	proteins	possess	an	N-terminal	major	sperm	
protein	(MSP)	domain	(amino	acids	1-125),	a	central	coiled-coil	domain	(amino	acids	
158-211)	and	a	C-terminal	 transmembrane	domain	 (TMD)	 (amino	acids	220-243).	
Boxed	region	indicates	a	representative	8	amino	acid	sequence	taken	from	within	
the	16	amino	acid	VAP	MSP	consensus	sequence	that	is	highly	conserved	between	
species,	aligned	by	CLUSTAL	W	(Lev	et	al.,	2008).	The	location	of	the	proline	residue	
associated	with	ALS8	is	highlighted	in	red.	Image	adapted	from	(Lev	et	al.,	2008).	(B)	
The	structure	of	VAPB	MSP	domain	is	composed	of	seven-stranded	immunoglobulin-
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like	 β	 strands	 that	 form	 a	 highly-coiled	 structure.	 The	 proline	 to	 serine	 point	
mutation	perturbs	the	native	coiled	structure	and	renders	the	protein	insoluble	(Shi	
et	al.,	2010).							 
1.3.1	VAP	transmembrane	domain	
The	 VAP	 C-terminal	 transmembrane	 domain	 (amino	 acids	 220-243)	 anchors	 the	
protein	to	its	target	membrane	location	and	the	expression	of	VAP	with	a	deletion	
of	the	TMD	has	a	diffuse,	cytosolic	distribution	(Teuling	et	al.,	2007).	The	TMD	of	
VAPs	 also	possess	 a	GXXXG	dimerization	motif	 consisting	of	 two	 glycine	 residues	
separated	by	three	amino	acids	(Kim	et	al.,	2010).	This	motif	mediates	the	interaction	
of	two	transmembrane	helices	and	has	been	implicated	in	TMD	interactions	of	more	
than	20	different	proteins	(Russ	and	Engelman,	2000;	Teese	and	Langosch,	2015).	
This	 dimerization	 motif	 is	 crucial	 for	 the	 oligomerisation	 of	 VAP	 TMDs	 but	 is	
dispensable	 for	 the	 oligomerization	 of	 full-length	 VAPs,	 which	 suggests	 the	
involvement	of	other	structural	motifs	(Kim	et	al.,	2010).										
1.3.2	VAP	coiled-coil	domain	
The	central	coiled-coil	domain	(amino	acids	158-211)	of	VAP	proteins	is	a	common	
motif	 found	 in	 many	 soluble	 NSF	 (N-ethylmaleimide	 sensitive	 fusion	 protein)	
attachment	protein	receptor	(SNARE)	proteins.	SNARE	proteins	are	a	class	of	integral	
membrane	proteins	that	provide	the	fundamental	machinery	for	vesicular	trafficking	
and	membrane	fusion	and	are	sub-divided	into	v-SNAREs	on	the	transport	vesicles	
that	 recognise	 complementary	 t-SNAREs	 on	 the	 target	 membrane	 sites	 which	
provides	specificity	to	fusion	events	(Sollner	et	al.,	1993).	The	coiled-coil	domain	is	
also	a	highly	versatile	folding	motif	and	mediates	oligomerization	in	a	large	number	
of	 proteins	 (Burkhard	 et	 al.,	 2001).	 In	 VAPB,	 deletion	 of	 the	 coiled-coil	 domain	
prevented	 its	 dimerization	 highlighting	 the	 importance	 of	 this	 domain	 in	 VAP	
oligomerization	in	addition	to	the	GXXXG	motif	of	the	TMD	(Kim	et	al.,	2010).							
1.3.3	VAP	MSP	Domain	
The	MSP	domain	sequence	(amino	acids	1-125)	is	highly	conserved	among	species	
and	is	named	due	to	its	similarity	to	the	nematode	major	sperm	protein	(Nishimura	
et	al.,	1999).	MSP	is	a	dimeric	protein	comprised	of	two	helical	subfilaments	spiralling	
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around	 each	 other	 and	 functions	 in	 the	 locomotion	 of	 nematode	 sperm	 cells	
(Stewart	et	al.,	1994;	Bottino	et	al.,	2002).	Additionally,	MSP	is	secreted	from	sperm	
cells	where	it	acts	as	a	ligand	for	VAB-1	Ephrin	receptors	to	induce	oocyte	maturation	
(Miller	et	al.,	2003).	The	MSP	domain	of	VAP	proteins	is	also	cleaved	and	secreted	
and	 in	 mammalian	 cells	 it	 competitively	 binds	 to	 the	 EphA4	 receptor	 that	 is	
abundantly	expressed	throughout	the	nervous	system	and	skeletal	muscle	(Tsuda	et	
al.,	2008;	Lai	et	al.,	2001).	Cleaved	forms	of	VAPA	are	detectable	in	almost	all	tissue	
types	 however	 the	 proteolytic	 cleavage	 of	 the	 VAPB	 MSP	 domain	 seems	 to	
selectively	occur	in	neurons	(Gkogkas	et	al.,	2008).	Furthermore,	cleaved	VAPA	MSP	
domains	were	readily	 identified	in	both	embryonic	and	adult	rat	brain	 lysates	but	
the	 predominant	 VAPB	 signal	 in	 embryonic	 tissue	 was	 the	 full-length	 protein	
indicating	that	the	cleavage	of	the	MSP	domain	may	be	developmentally	regulated	
(Gkogkas	et	al.,	2011).							
1.4	VAPs	and	neurodegeneration	–	Functional	consequences	
of	the	VAPBP56S	mutation		
As	described	above,	there	 is	a	strong	 link	between	organelle	contact	sites	and	
neurodegeneration	with	many	disease-linked	proteins	being	identified	as	having	
a	direct	impact	on	the	regulation	of	membrane	contacts.	In	support	of	this,	the	
ER-mitochondria	 tether	 VAPB	 was	 linked	 with	 neurodegeneration	 upon	 the	
identification	 of	 a	 proline	 to	 serine	 (P56S)	 point	 mutation	 within	 the	 highly	
conserved	MSP	domain.	 This	mutation	was	originally	 found	 in	 seven	Brazilian	
families	exhibiting	phenotypes	ranging	from	an	atypical	form	of	ALS	termed	ALS	
type	8	(ALS8),	to	late-onset	slowly	progressive	ALS	or	late-onset	spinal	muscular	
atrophy	 (SMA),	 inherited	 in	an	autosomal	dominant	manner	 (Nishimura	et	al.,	
2004).	In	wild-type	VAPB,	proline	56	lies	within	a	conserved	motif	distal	to	the	
protein	dimerization	face	and	forms	an	unusual	cis-peptide	bond	conformation	
that	 is	essential	 for	maintaining	the	S-shaped	 loop	and	highly-folded	structure	
of	 the	 MSP	 domain,	 constituted	 by	 seven-stranded	 immunoglobulin-like	 β	
strands	(Shi	et	al.,	2010).	As	a	consequence	of	the	proline	to	serine	substitution	
seen	in	ALS,	the	protein	lacks	its	native	tightly-packed	structure	and	is	rendered	
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insoluble	in	buffer	and	prone	to	aggregation	(Fig1.5(B))	(Shi	et	al.,	2010).	In	this	
thesis,	we	have	a	specific	focus	on	the	VAP	protein	family	to	investigate	how	a	
mutation	 in	 a	 protein	 with	 a	 MAM-specific	 function	 can	 lead	 to	
neurodegeneration.	 The	 functions	 of	 VAP	 proteins	 in	 the	 context	 of	 the	
pathogenic	VAPBP56S	mutation	will	be	discussed	in	the	following	sections.			 
The	P56S	mutation	disrupts	the	subcellular	localisation	of	VAPB,	causing	it	to	form	
large	intracellular	aggregates	(Nishimura	et	al.,	2004).	The	mutation	also	reduces	the	
solubility	of	VAPB	and	induces	its	misfolding	and	polyubiquitination	(Kanekura	et	al.,	
2006).	However,	it	is	not	entirely	clear	whether	VAPB-P56S	acts	in	a	gain-of-function	
or	 loss-of-function	manner	or	 in	some	combination	of	the	two.	In	cells	expressing	
VAPB-P56S,	 there	 is	 a	 significant	 recruitment	of	 endogenous	wild-type	VAPA	and	
VAPB	 within	 the	 cytoplasmic	 aggregates	 which	 could	 account	 for	 the	 dominant	
nature	of	the	mutation	in	ALS	patients	(Teuling	et	al.,	2007).	VAPB-P56S	undergoes	
dimerization	 similar	 to	 wild-type	 VAPB	 and	 deletion	 of	 the	 coiled-coil	 domain	
reduces	 its	 dimerization	 capabilities	 and	 in	 conjunction	 with	 a	 mutation	 of	 the	
GXXXG	motif,	completely	abolishes	it	(Kim	et	al.,	2010).	However,	the	reduction	in	
dimerization	is	not	as	significant	as	that	seen	with	wild-type	VAPB	and	therefore,		it	
has	been	suggested	that	an	enhancement	to	the	dimerization	ability	of	VAPB-P56S	
could	account	for	the	sequestration	of	endogenous	VAP	proteins	within	aggregates	
which	could	then	phenocopy	a	loss	of	VAP	function	(Kim	et	al.,	2010).	In	pull-down	
assays	in	mammalian	cell	lines,	it	was	demonstrated	that	the	P56S	mutation	inhibits	
the	binding	of	VAPB	to	FFAT	motif-containing	proteins	(Teuling	et	al.,	2007).	As	VAPB	
interacts	 with	 a	 variety	 of	 proteins	 via	 the	 FFAT	 domain	 to	 mediate	 functions	
including	the	non-vesicular	transport	of	 lipids	at	membrane	contact	sites,	 it	could	
indicate	that	the	P56S	mutation	operates	through	a	loss	of	normal	VAP	function.	
Interestingly,	the	expression	of	the	ALS-linked	VAPB	mutation	in	the	mammalian	cell	
lines	HeLa	or	Cos-1	did	not	significantly	increase	cell	death	however,	a	greater	rate	
of	 cell	death	was	observed	 in	 comparison	 to	controls	when	expressed	 in	primary	
neurons	 which	 conforms	 to	 the	 specific	 vulnerability	 of	 neuronal	 cells	 in	 ALS	
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pathology	 (Teuling	 et	 al.,	 2007).	 Knocking-down	 of	 VAPB	 expression	 caused	 no	
significant	changes	in	neuronal	death	but	a	loss	of	VAPA	reduced	survival	and	this	
effect	was	enhanced	even	further	upon	silencing	of	expression	of	both	VAPA	and	
VAPB	which	 supports	 that	 the	 pathology	 of	 VAPB-P56S	 is	 through	 a	 loss	 of	 VAP	
function	(Teuling	et	al.,	2007).	A	study	by	Langou	et	al	however,	showed	a	selective	
vulnerability	of	motorneurons	to	an	overexpression	of	either	wild-type	or	mutant	
VAPB	but	no	change	in	survival	with	an	overexpression	of	VAPA	(Langou	et	al.,	2010).	
The	overexpression	of	wild-type	or	mutant	VAPB	induced	a	consequent	increase	in	
IRE1	 phosphorylation	 and	 treatment	 of	 the	 motorneuronal	 cultures	 with	 the	 ER	
stress	 inhibitor	 salubrinal	 prevented	 the	VAPB-induced	 cell	 death	 suggesting	 that	
VAPB-P56S	could	cause	cell	death	through	a	gain-of-function	mutation	inducing	an	
ER	stress	response	(Langou	et	al.,	2010).		
1.4.1	VAPs	and	the	regulation	of	the	unfolded	protein	response	
As	described	above,	the	unfolded	protein	response	is	a	cellular	mechanism	induced	
by	ER	stress	to	try	and	alleviate	protein	overload	in	the	ER	lumen.	The	exact	role	of	
VAP	proteins	in	the	UPR	is	controversial	and	conflicting	evidence	exists	on	the	role	
the	P56S	mutation	plays	 in	 this	process.	While	 Langou	et	al	showed	an	ER	 stress	
response	 to	 an	 AAV-mediated	 overexpression	 of	 wild-type	 and	 mutant	 VAPB,	
another	 group	 demonstrated	 that	 an	 overexpression	 of	wild-type	 VAPA	 or	 VAPB	
triggers	 an	 unfolded	 protein	 response	 via	 IRE1-mediated	 XBP1	 splicing	 but	
expressing	VAPB-P56S	to	the	same	level	does	not	(Kanekura	et	al.,	2006;	Langou	et	
al.,	2010).	Furthermore,	silencing	VAP	expression	inhibited	the	activation	of	UPR	in	
response	to	chemical-induced	ER	stress	indicating	that	VAPB	is	a	positive	regulator	
of	the	UPR	(Kanekura	et	al.,	2006).	This	positive	regulation	of	the	IRE1/XBP1	pathway	
is	dependent	on	the	ability	of	VAP	to	interact	with	FFAT	motifs	as	the	overexpression	
of	two	mutant	VAPB	constructs	deficient	in	FFAT	binding	did	not	induce	XBP1	splicing	
(Suzuki	et	al.,	2009).							
The	ER	stress	protein	ATF6	was	also	 identified	as	an	 interactor	of	both	VAPA	and	
VAPB	via	the	MSP	domains	from	a	yeast	two-hybrid	screen	(Gkogkas	et	al.,	2008).	
Using	a	luciferase-based	transcriptional	assay,	it	was	revealed	that	ATF6-dependent	
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transcriptional	levels	were	reduced	upon	overexpression	of	VAPB	or	VAPB-P56S	and	
additionally,	there	was	a	significant	reduction	in	tunicamycin-induced	activation	of	
ATF6-dependent	transcription	(Gkogkas	et	al.,	2008).	In	contrast,	silencing	of	VAPB	
expression	 increased	 the	 levels	 of	 ATF6-dependent	 transcription	 (Gkogkas	 et	 al.,	
2008).	This	data	suggests	that	VAPB	is	a	negative	regulator	of	the	ATF6	pathway	of	
the	UPR	and	the	VAPB-P56S	mutation	can	inhibit	this	process	at	much	lower	protein	
levels	than	wild-type	VAPB	(Gkogkas	et	al.,	2008).		
In	C2C12	cells,	a	mouse	myoblast	cell	 line,	expression	of	VAPB-P56S	 inhibited	the	
activation	of	the	IRE1-XBP1	pathway	following	the	induction	of	ER	stress	and	overall	
XBP1	levels	were	reduced	during	differentiation	from	expression	of	mutant	but	not	
wild-type	 VAPB	 (Tokutake	 et	 al.,	 2015).	 The	 collective	 data	 suggests	 that	 a	
dysfunction	of	UPR	may	be	a	pathogenic	consequence	of	the	VAPB-P56S	mutation	
however,	 the	 exact	 nature	 of	 VAPB	 as	 a	 positive	 or	 negative	 regulator	 of	 this	
response	is	still	uncertain.	It	also	appears	that	expression	of	VAPB-P56S	may	lead	to	
a	 higher	 susceptibility	 to	 ER	 stress	 related	 cell	 death	 as	 shown	 by	 a	 significant	
reduction	 in	cell	viability	of	cells	expressing	VAPB-P56S	 in	comparison	 to	controls	
when	incubated	with	the	ER	stress	inducer	thapsigargin,	an	inhibitor	of	Ca2+	ATPase	
(SERCA)	that	depletes	ER	calcium	stores	(Suzuki	et	al.,	2009;	Rogers	et	al.,	1995).																										
1.4.2	VAPs	and	the	maintenance	of	ER	structure	
The	 endoplasmic	 reticulum	 is	 a	 continuous	 network	 of	 interconnected	 tubules	
extending	throughout	the	cytoplasm	that	is	divided	into	structurally	distinct	regions,	
namely	 the	nuclear	envelope,	 rough	ER	containing	 the	 ribosomes	and	smooth	ER	
(Terasaki	 et	 al.,	 1994;	 Voeltz	 et	 al.,	 2002).	 The	 ER	 is	 a	 highly	 dynamic	 organelle,	
moving	along	microtubule	and	cytoskeletal	elements	and	rearranging	in	response	to	
certain	 physiological	 conditions	 or	 changes	 in	 the	 levels	 of	 specific	 ER	 resident	
proteins	[as	reviewed	by	(Powell	and	Latterich,	2000)].	An	interaction	of	VAPB	with	
the	 phosphatidylinositol	 transfer	 protein	 Nir2	 was	 already	 described	 above	 as	
playing	a	 role	 in	ER	to	Golgi	 lipid	 transport	however,	 this	 interaction	with	the	Nir	
protein	family	 including	Nir1	and	3	via	their	FFAT	motif	also	affects	the	structural	
integrity	 of	 the	 ER	 (Amarilio	 et	 al.,	 2005).	 The	 overexpression	 of	 VAPB	with	Nir2	
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results	 in	 the	 appearance	 of	 large	 granular	 structures	 composed	 of	 multiple	
membrane	arrays	originating	from	the	ER	which	inhibits	protein	export	from	the	ER.	
When	 VAPB	 and	 Nir3	 are	 overexpressed	 together,	 it	 results	 in	 a	 striking	 re-
localisation	 of	 VAPB	 and	 modifies	 the	 ER	 into	 a	 tubular-like	 structure.	 Similarly,	
microtubule	 structure	was	 reorganised	 and	 aligned	with	 VAPB	 and	Nir3	 staining,	
suggesting	 that	 the	 VAPB-Nir3	 interaction	 connects	 the	 ER	 and	 microtubule	
networks	(Amarilio	et	al.,	2005).	Overexpression	of	VAPA	or	a	VAPA	FFAT	binding	
mutant	 disrupted	 ER	 morphology,	 suggesting	 that	 similar	 to	 the	 VAPB-Nir	
interactions,	the	binding	of	VAPA	to	different	cytosolic	proteins	containing	an	FFAT-
motif	plays	a	 role	 in	 regulating	and	maintaining	ER	structure	 (Kaiser	et	al.,	2005).	
Overexpression	of	the	mutant	VAPBP56S	induces	the	formation	of	aggregates	that	are	
continuous	with	the	ER	membrane	but	seem	to	exclude	membrane	proteins	of	the	
rough	ER	(Fasana	et	al.,	2010).	High	resolution	electronic	microscopy	images	of	these	
aggregates	 revealed	 the	 presence	 of	 electron-dense	 structures	 surrounding	 the	
nucleus	composed	of	parallel	ER	cisternae,	a	structural	feature	which	had	not	been	
previously	described	and	was	termed	to	be	a	novel	 form	of	organised	smooth	ER	
(OSER)	(Fasana	et	al.,	2010).	Although	it	had	been	shown	that	the	presence	of	the	
P56S	mutation	in	VAPB	distorts	the	helical	conformation	of	the	MSP	domain,	a	later	
study	demonstrated	that	in	the	presence	of	the	lipid	dodecylphosphocholine	(DPC),	
the	P56S-MSP	domain	transforms	into	a	highly	helical	formation	and	it	was	stated	
that	this	may	rationalise	the	mutant	proteins	specific	ability	to	restructure	the	ER	
membrane	(Qin	et	al.,	2013).												
1.4.3	VAPs	and	vesicular	protein	trafficking	
The	early	secretory	pathway	involves	the	transport	of	newly	synthesised	proteins	to	
the	 cis-Golgi	 membrane	 for	 further	 processing	 and	 delivering	 to	 their	 target	
locations.	Yip1-interacting	factor	homologue	A	(YIF1A)	is	a	transmembrane	protein	
that	was	identified	as	an	interactor	of	VAPs	and	plays	a	role	in	the	early	secretory	
pathway	(Matern	et	al.,	2000;	Kuijpers	et	al.,	2013b).	YIF1A	has	a	reticular	pattern	of	
distribution	 within	 neurons	 and	 partially	 co-localises	 with	 VAPB	 however,	 when	
vesicular	 trafficking	 is	 blocked,	 YIF1A	 accumulates	 at	 the	 Golgi	 and	 is	 found	
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predominantly	at	the	ER-Golgi	intermediate	compartment	(ERGIC).	When	VAPA	or	
VAPB	expression	 is	 silenced,	YIF1A	 re-localises	 to	 the	Golgi	and	conversely,	when	
VAPB	is	overexpressed	it	binds	YIF1A	to	the	ER	and	inhibits	its	cycling	to	the	Golgi	
suggesting	 that	 the	 distribution	 of	 YIF1A	 is	 dependent	 on	 the	 expression	 of	 VAP	
proteins.	 In	VAP	or	YIF1A	knockdown	neurons,	an	 impairment	of	transport	to	the	
dendrites	 was	 observed	 with	 a	 consequent	 reduction	 in	 dendritic	 tree	 branch	
number	and	length	(Kuijpers	et	al.,	2013b).	When	VAPB-P56S	is	expressed	in	cells,	
YIF1A	can	be	identified	as	a	component	of	the	intracellular	aggregates,	causing	it	to	
lose	 its	 localisation	to	 the	ERGIC	even	after	pharmaceutical	 inhibition	of	vesicular	
trafficking	(Kuijpers	et	al.,	2013b).	Therefore,	defects	in	the	early	secretory	pathway	
could	represent	a	pathogenic	event	in	ALS8.						
A	 distinct	 function	 of	 VAPA	 in	 vesicular	 protein	 trafficking	 has	 been	 identified	
whereby	an	overexpression	of	VAPA,	but	not	VAPB,	inhibits	the	incorporation	of	ER	
proteins	within	membrane	vesicles	during	ER	to	Golgi	transport	(Prosser	et	al.,	2008).	
Furthermore,	 VAPA	 overexpression	 repressed	 the	 lateral	 diffusion	 of	 membrane	
proteins	 to	 ER	 exit	 sites	 through	 its	 MSP-domain	 mediated	 interaction	 with	 the	
microtubule	network	that	could	create	impassable	objects	(Prosser	et	al.,	2008).		
1.4.4	VAPs	and	bouton	formation	at	NMJs	
In	Drosophila	melanogaster	models,	the	Drosophila	homologue	of	mammalian	VAP,	
DVAP-33A	 is	 present	 at	 the	 neuromuscular	 junctions	 (NMJs)	 and	 plays	 a	 role	 in	
synaptic	bouton	budding	(Pennetta	et	al.,	2002).	During	larval	development,	bouton	
number,	in	part,	increases	by	asymmetric	division	of	pre-existing	boutons	(Zito	et	al.,	
1999).	Knocking	down	DVAP-33A	expression	caused	a	decrease	 in	 the	number	of	
boutons	but	 an	 increase	 in	 their	 size	while	 conversely,	 overexpressing	DVAP-33A	
increased	 bouton	 number	 but	 they	 were	 smaller	 in	 size	 (Pennetta	 et	 al.,	 2002).	
Compensatory	 quantal	 size	 changes	were	 identified	 in	 response	 to	 alterations	 in	
synaptic	bouton	size	and	number	and	therefore,	normal	synaptic	transmission	was	
maintained	in	both	DVAP-33A	null	and	overexpression	models	(Chai	et	al.,	2008).	In	
transgenic	 flies	expressing	VapP58S	within	neurons,	the	equivalent	mutation	 to	 the	
mammalian	ALS-linked	point	mutation,	there	was	a	significant	increase	in	average	
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synaptic	bouton	size,	similar	to	the	phenotype	observed	from	a	knock-down	of	VAP	
expression	(Ratnaparkhi	et	al.,	2008).	Furthermore,	in	a	Drosophila	mutant	lacking	
full-length	endogenous	VAP	protein,	neuronal	expression	of	wild-type	VAP	but	not	
VAP-P58S	could	rescue	abnormalities	in	bouton	size,	providing	supporting	evidence	
that	the	ALS8	point	mutation	may	act	in	a	dominant	negative	manner	(Ratnaparkhi	
et	al.,	2008).																
1.4.5	VAPs	and	mitochondrial	motility	and	function	
In	Drosophila	models,	VAP	has	been	shown	 to	associate	with	microtubules	and	a	
knock-out	of	expression	perturbed	the	organisation	of	the	microtubules	at	the	NMJs	
(Pennetta	et	al.,	2002).	Similarly,	overexpression	of	VAP-P58S	but	not	wild-type	VAP	
induced	 microtubule	 disorganisation	 comparable	 to	 that	 of	 null	 mutants	
(Ratnaparkhi	et	al.,	2008).	In	neurons,	expression	of	VAPB-P56S	caused	a	significant	
reduction	in	mitochondria	motility	and	the	anterograde	movement	of	mitochondria	
along	 the	axon	was	particularly	 affected	 (Morotz	et	 al.,	 2012).	 This	was	due	 to	a	
disruption	in	the	interaction	of	tubulin	with	the	OMM	protein	Miro1	that	mediates	
mitochondrial	movements	in	response	to	calcium	levels	(Morotz	et	al.,	2012).		
Furthermore,	 in	 C.	 elegans	mutant	 VAP	models,	 the	mitochondrial	 network	 was	
composed	of	thin,	highly	branched	tubular	networks	which	is	in	stark	contrast	to	the	
largely	unbranched	tubules	of	wild-type	C.	elegans.	This	change	in	morphology	was	
accompanied	by	a	significant	reduction	in	resting	membrane	potential	and	impaired	
generation	of	ATP	and	ROS	(Han	et	al.,	2012).													
1.4.6	VAPs	and	cellular	degradative	pathways	
As	 previously	 described,	 ALS	 is	 characterised	 by	 the	 presence	 of	 ubiquitinated	
aggregates	and	the	expression	of	VAPB-P56S	leads	to	the	presence	of	intracellular	
aggregates	that	are	continuous	with	the	ER.	It	was	shown	that	VAPB-P56S	aggregates	
are	positive	 for	ubiquitin	and	 treatment	of	 cells	expressing	mutant	VAPB	with	an	
inhibitor	of	the	proteasome	almost	completely	attenuated	the	degradation	of	the	
mutant	protein	suggesting	that	mutant	VAPB	is	a	target	of	the	UPS	(Papiani	et	al.,	
2012).	 In	 contrast,	 treatment	 of	 cells	 with	 an	 inhibitor	 of	 autophagy	 had	 no	
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significant	effect	on	the	level	of	aggregates	(Papiani	et	al.,	2012).	Co-expression	of	
VAPB-P56S	 with	 an	 ALS-linked	 mutant	 VCP	 increased	 the	 levels	 of	 aggregated	
protein,	further	implicating	mutant	VAPB	as	a	target	of	the	UPS	(Papiani	et	al.,	2012).					
The	alpha	5	subunit	of	the	proteasome	and	several	subunits	of	the	20S	proteasome	
particle	 were	 identified	 as	 constituents	 of	 VAPB	 inclusions	 and	 co-
immunoprecipitated	 with	 the	 mutant	 protein,	 suggesting	 that	 VAPB-P56S	
aggregates	 can	 impair	 UPS	 activity	 (Moumen	 et	 al.,	 2011).	 In	 addition,	 over-
expression	 of	 wild-type	 or	 mutant	 VAPB	 resulted	 in	 elevated	 levels	 of	 three	
fluorescent	substrates	of	the	UPS	whereas	overexpression	of	VAPA	or	SOD1	had	no	
significant	effect,	indicating	that	the	P56S	mutation	induces	a	global	defect	in	UPS	
activity	(Moumen	et	al.,	2011).	
Recently,	 it	was	shown	that	VAPA/B	 interact	with	 the	autophagy-related	proteins	
FIP200	 (focal	 adhesion	 kinase	 family	 interacting	 protein	 of	 200	 kD)	and	 ULK1	 to	
mediate	the	 initiation	of	autophagosome	formation	and	depletion	of	VAPs	within	
cells	inhibited	autophagy	by	preventing	the	progression	of	the	isolation	membranes	
into	fully	formed	autophagosomes	(Zhao	et	al.,	2018).					
1.5	Additional	pathogenic	VAPB	mutations	
1.5.1	VAPBT46I		
After	the	identification	of	the	P56S	mutation	in	VAPB,	a	second	mutation	in	VAPB	
was	detected	in	a	familial	ALS	patient	with	a	threonine	to	isoleucine	point	mutation	
at	codon	46	(VAPBT46I)	(Chen	et	al.,	2010).	Like	the	P56S	mutation,	the	T46I	mutation	
occurs	within	the	highly	conserved	VAP	consensus	sequence	of	the	MSP	domain	and	
induces	the	mislocalisation	of	the	protein	from	the	ER	into	large	protein	aggregates.	
Expression	of	VAPB-T46I	upregulates	pro-apoptotic	markers	in	transfected	cells	and	
was	capable	of	inducing	protein	aggregation	in	neighbouring,	non-transfected	cells.	
Furthermore,	co-expression	of	VAPB-T46I	with	wild-type	VAPB	inhibits	the	wild-type	
protein’s	activation	of	the	IRE1	pathway	(Chen	et	al.,	2010).				
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1.5.2	VAPBV234I	
An	additional	pathogenic	mutation	in	VAPB,	a	valine	to	isoleucine	point	mutation	at	
amino	acid	position	234	(VAPBV234I)	was	identified	in	one	ALS	patient	who	also	had	a	
C9Orf72	repeat	expansion	(van	Blitterswijk	et	al.,	2012).	Unlike	the	P56S	and	T46I	
mutations,	this	point	mutation	occurs	within	the	transmembrane	domain	of	VAPB.	
In	Drosophila	 models,	 expression	 of	 the	 equivalent	VapbV260I	 mutation	 disrupted	
microtubule	organisation	and	induced	locomotor	defects	in	larvae	(Sanhueza	et	al.,	
2014).				
1.6	VAPA	and	neurodegeneration	
Although	VAPA	and	VAPB	share	extensive	sequence	similarity	and	function	 in	the	
same	 cellular	 pathways,	 mutations	 in	 VAPA	 have	 not	 been	 linked	 to	
neurodegeneration.	The	equivalent	P56S	point	mutation	in	VAPA,	VAPA-P56S,	does	
form	aggregates	that	are	similar	in	appearance	to	VAPB-P56S	aggregates	however,	
a	 significant	 proportion	 of	 VAPA-P56S	 still	 localises	 to	 the	 ER	 in	 addition	 to	 the	
aggregated	 protein	 (Teuling	 et	 al.,	 2007).	 Moreover,	 in	 contrast	 to	 VAPB-P56S,	
mutant	VAPA	does	not	induce	the	aggregation	of	wild-type	VAPA	and	VAPB	proteins	
and	shows	greater	solubility	(Suzuki	et	al.,	2009;	Prosser	et	al.,	2008).	Within	the	VAP	
consensus	sequence	of	the	MSP	domain,	VAPB	possesses	two	proline	residues	while	
VAPA	contains	3	and	it	is	believed	that	this	extra	proline	residue	infers	the	resistance	
of	VAPA	to	the	P56S	mutation.	In	support	of	this,	a	double	point	mutation	replacing	
the	extra	proline	residue	in	VAPA	(VAPAP56S,P63A)	caused	the	protein	to	relocalise	into	
large	membranous	 aggregates	 that	were	 indistinguishable	 from	VAPB-P56S	while	
VAPA-P56S	alone	showed	a	reticular	pattern	of	staining	(Nakamichi	et	al.,	2011).				
In	summary,	a	number	of	the	pathways	disrupted	by	the	expression	of	VAPB-P56S	
specifically	are	common	pathogenic	hallmarks	of	neurodegenerative	disorders	and	
indeed,	a	large	proportion	of	these	pathways	are	also	regulated	by	organelle	contact	
sites.	Therefore,	it	is	plausible	to	hypothesise	that	a	dysfunction	to	organelle	contact	
sites	 and	 predominantly	 ER-mitochondria	 contacts,	 induced	 by	 the	 expression	 of	
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VAPB-P56S,	 could	 represent	 an	 early	 pathogenic	 event	 in	 ALS8,	 preceding	 the	
cellular	perturbations	described	above.			
	
							
1.7	Aims	and	approaches		
In	 light	of	all	 the	evidence	presented	above,	 the	overall	aim	of	 this	 thesis	was	 to	
develop	a	high-throughput,	bi-fluorescence	complementation	(BiFC)	system	for	the	
detection	and	visualisation	of	membrane	contact	sites	that	can	be	used	in	both	fixed	
and	living	cells,	with	a	particular	focus	on	ER-mitochondria	interactions.	We	aimed	
to	validate	this	technique	for	the	quantification	of	contact	sites	by	replicating	known	
changes	 to	 ER-mitochondria	 contacts,	 the	 data	 of	 which	 is	 presented	 in	 chapter	
three	of	this	thesis.	The	majority	of	the	data	presented	in	chapter	three	has	been	
published	in	(Harmon	et	al.,	2017).		
As	 our	 BiFC	 reporter	 proteins	 detect	 ER-mitochondria	 junctions	 of	 a	 maximum	
distance	 of	 <10	 nm,	 we	 aimed	 to	 use	 this	 technique	 to	 try	 and	 correlate	 the	
fluorescent	 signal	 with	 known	 functions	 of	 the	 MAMs	 to	 elucidate	 the	 specific	
functional	 significance	 of	 these	 particularly	 tight	 contact	 sites,	 which	 we	 have	
reported	on	in	chapter	four.		
Finally,	using	the	BiFC	approach	and	other	molecular	techniques,	we	investigated	the	
role	of	VAPs	and	the	mutant	VAPB-P56S	protein	on	ER-mitochondria	contact	sites	in	
cells	and	in	transgenic	rat	models	in	order	to	gain	some	insight	into	the	molecular	
mechanisms	of	ALS8	pathogenesis,	detailed	in	chapter	five.				
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Chapter	2	
Materials	and	Methods	
2.1	Plasmids	and	primers		
2.1.1	Venus	expression	plasmids:	Full-length	coding	sequences	for	mouse	VAPA	and	
VAPB	were	previously	amplified	by	polymerase	chain	reaction	(PCR)	and	sub-cloned	
into	pcDNA3.1(zeo)-Venus[1]	plasmids	(Remy	et	al.,	2002)	as	described	in	(Gkogkas	
et	al.,	2008)	to	generate	full-length	Venus1-VAPB	(V1-VAPB)	and	Venus1-VAPA	(V1-
VAPA)	 plasmids	 respectively.	 Previous	 work	 in	 the	 Skehel	 lab	 generated	 V1-ER	
expression	plasmids,	derived	from	V1-VAPB	by	deletion	PCR	mutagenesis	with	the	
primers	 gggtcctccggaatgggcctgagcgcccggctgct	 and	 cattccggaggacccaccacctccagagc	
to	generate	a	Venus1	fragment	fused	at	its	C-terminus	to	the	C-terminal	25	amino	
acids	from	mouse	VAPB,	GLSARLLALVVLFFIVGVIIGKIAL,	with	a	14	amino	acid	linker	
sequence,	as	published	in	(Harmon	et	al.,	2017)(Fig	2.1).		
Venus2-Mito	(V2-Mito)	was	generated	from	human	TOMM20	(Translocase	of	Outer	
Mitochondrial	 Membrane	 20)	 cDNA	 by	 PCR	 using	 primers	 5’-
cggcggccgctccggaccatggtgggccggaacagcgcc-3’		
and	5’-atctagattaatcgattgcagacccgatgccgctgc-3’	to	amplify	the	first	34	amino	acids	
MVGRNSAIAAGVCGALFIGYCIYFDRKRRSDPN	(Fig	2.1).	The	PCR	product	was	digested	
and	 ligated	 to	NotI	 and	ClaI	 restriction	 sites	 of	 a	 pcDNA3.1	 Venus[2]-zip	 plasmid	
(Kindly	gifted	by	S.W.Michnick)(Harmon	et	al.,	2017).		
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Fig	2.1:	Protein	maps	of	V1-ER	and	V2-Mito	constructs.	V1-ER	construct	consists	of	
an	N-terminal	Venus	1	fragment	of	158	amino	acids	and	a	14	amino	acid	poly-G	linker	
sequence	fused	to	the	25	amino	acids	of	the	VAPB	transmembrane	domain.	V2-Mito	
is	comprised	of	an	N-terminal	Venus	2	fragment,	88	amino	acids	in	length,	fused	to	
the	N-terminal	34	amino	acids	of	TOMM20	with	a	14	amino	acid	linker	sequence	in	
between.	
In	order	to	detect	and	quantify	ER-endosome	contacts,	Venus2-VAMP4	and	Venus2-
VAMP4-CT	 plasmids	 composed	 of	 the	 full-length	 VAMP4	 sequence	 or	 just	 the	 C-
terminal	endosomal	targeting	sequence	were	previously	generated	in	the	lab	by	Ms.	
Emma	Lund	(unpublished	data).	Briefly,	a	VAMP4-pHluorin	template	plasmid	(kindly	
provided	by	Prof.	Mike	Cousin,	University	of	Edinburgh,	as	published	in	(Nicholson-
Fish	et	al.,	2016))	was	used	to	PCR	amplify	the	full-length	VAMP4	sequence	using	a	
forward	 primer	 sequence	 5’-ggtgggtcctccggaatgcctcccaagtttaagcgccac-3’	 and	 a	
reverse	 primer	 sequence	 5’-ttcgccaactaatttttaagtacggtatttcatgactataag-3’	 which	
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was	subsequently	cloned	into	the	Venus	vector	backbones	using	Gibson	Assembly	
cloning	as	per	manufacturer’s	instructions	(New	England	Biolabs).	For	generation	of	
the	 VAMP4-CT	 sequence,	 a	 51	 amino	 acid	 gBlock	 sequence,	
SGGGGSSGMWWRGCKIKAIMALAAAILLLMIITQIILHLKK*KLVGER*SR	 was	 ordered	
from	 Integrated	 DNA	 Technologies	 whereby	 an	 *	 indicates	 a	 stop	 codon,	 and	
subsequently	cloned	into	the	Venus	vectors	using	the	Gibson	Assembly	kit.			
2.1.2	Other	expression	vectors:	pECFP-Golgi	and	pDsRed2-ER	(Clontech)	were	used	
to	 label	the	Golgi	and	ER	respectively.	CMV-Globin	(kindly	provided	by	Prof.	Giles	
Hardingham,	University	of	Edinburgh)	was	used	as	a	balancer	 transfectant	where	
equivalent	 total	 DNA	 concentrations	 across	 different	 experimental	 groups	 was	
required.		
For	the	overexpression	of	VAPB,	double-tagged	constructs	were	previously	cloned	in	
the	Skehel	lab	to	generate	plasmids	expressing	wild-type	VAPB,	VAPB-P56S	or	VAPB-
N29S	with	an	N-terminal	Myc	epitope	and	a	C-terminal	HA	epitope	at	the	C-terminus	
of	VAPB	to	generate	the		Myc-VAPB-HA,	Myc-VAPB-P56S-HA	and	Myc-VAPB-N29S-
HA	constructs	respectively.		
A	mitochondrially	 targeted,	 genetically	 encoded	 pMito-RCaMP	 (Akerboom	 et	 al.,	
2013),	 previously	 cloned	 in	 the	 lab	 from	a	 pMito-GCaMP6	 template	 (Chen	et	 al.,	
2013),	and	a	cytoplasmically	targeted	pGCaMP2-Cyto	(Tallini	et	al.,	2006)	were	used	
for	mitochondrial	calcium	imaging	experiments	(both	kindly	provided	by	Prof.	Giles	
Hardingham).		
mCherry-ATG14-C-18	was	a	gift	from	Michael	Davidson	(Addgene	plasmid	#	54989).	
pJ603-NGFP-p55	 encoding	 for	 POLG2-GFP	 was	 kindly	 gifted	 from	 Dr.	 William	
Copeland,	National	Institute	of	Environmental	Health	Sciences	(Young	et	al.,	2015).			
pAAV-EF1a-DIO-hM3D(Gq)-mCherry	(referred	to	in	the	rest	of	this	thesis	as	EF1a-
DIO-Gq-mCherry)	is	a	double	floxed	Gq-coupled	hM3D	DREADD	receptor	fused	with	
a	 fluorescent	mCherry	probe	under	the	control	of	a	ubiquitous	EF1a	promoter	 in	
which	 the	 expression	 depends	 on	 Cre	 and	 was	 gifted	 by	 Bryan	 Roth	 (Addgene	
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plasmid	#50460)	which	in	turn	was	kindly	gifted	to	use	by	Prof.	Giles	Hardingham,	
University	of	Edinburgh.	The	pAAV-Ef1a-Cre	plasmid	used	in	combination	with	this	
to	activate	expression	was	gifted	by	Karl	Deisseroth	(Addgene	plasmid	#55636)	and	
was	also	kindly	provided	to	use	by	Prof.	Giles	Hardingham’s	group.		
	
2.2	Cloning	and	PCR	
2.2.1	Cloning	of	plasmids	expressing	POLG2-DsRed2:	POLG2-DsRed2	and	POLG21-
25-DsRed2	expression	plasmids	were	generated	by	in-fusion	cloning	from	1	ng	of	a	
pJ603-NGFP-p55	 template	 containing	 a	 GFP	 open	 reading	 frame	 fused	 in-frame	
between	 the	 N-terminal	 25	 codons	 of	 POLG2,	 encoding	 for	 the	 predicted	
mitochondrial	 targeting	sequence,	and	the	remaining	C-terminal	POLG2	sequence	
(as	 published	 in	 (Young	 et	 al.,	 2015).	 Linearized	 vector	 backbone	 sequence	
containing	 the	POLG2	 cDNA	without	 the	GFP	ORF	was	 amplified	by	PCR	 reaction	
using	the	primer	pairs	agatgcggggcagccggagctgttg	and	actcgacccccaaacccagacaaca.	
DsRed2	 insert	 sequences	 were	 amplified	 by	 PCR	 from	 1	 ng	 of	 an	 ER-DsRed2	
(Clontech)	 vector	 template	 using	 the	 forward	 primer	
gtttgggggtcgagtaatggcctcctccgagaacgtcatc	with	either	a	reverse	primer	of	sequence	
ggctgccccgcatctctacaggaacaggtggtggcggccc	 to	 include	 the	 DsRed2	 stop	 codon	 or	
with	 a	 reverse	 primer	 of	 sequence	 ggctgccccgcatctcgagccaggaagaggtggtggcgg	 to	
incorporate	 a	 point	 mutation	 in	 the	 stop	 codon,	 replacing	 it	 with	 a	 serine.	 The	
presence	of	a	stop	codon	results	 in	the	translation	of	only	the	first	N-terminal	25	
amino	acids	of	POLG2	(POLG21-25-DsRed2).	Insert	sequences	were	amplified	with	5’	
15-bp	 extensions	 complementary	 to	 the	 ends	 of	 the	 amplified,	 linearized	 vector	
sequence	for	In-Fusion	cloning.			
2.2.2	Polymerase	chain	reaction	(PCR):	PCR	reactions	were	carried	out	in	a	total	
volume	 of	 25	 µl	 using	 Phusion	 high	 fidelity	 DNA	 polymerase	 (Thermo	 Fisher	
Scientific)	or	Taq	DNA	polymerase	(2.5	units/µl)	(Qiagen)	along	with	0.5	µM	of	
each	 primer,	 200	 µm	 of	 each	 dNTP	 and	 Phusion	 HF	 buffer	 providing	 1.5	mM	
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MgCl2	 (Thermo	 Fisher	 Scientific).	 DNA	was	 amplified	 in	 a	 thermocycler	 at	 the	
following	settings:	
• Initial	denaturation	step	of	98°C	for	30	seconds		
• 20-25	cycles	of		
• Denaturation	at	98°C	for	15	seconds		
• Annealing	at	55-56°C	(ranging	from	15	seconds	to	30	seconds)		
• Extension	at	72°C	(15	seconds	to	7	minutes)		
• Final	extension	step	of	72°C	for	10	minutes.				
2.2.3	Gel	electrophoresis:	PCR	products	were	run	on	a	0.7-3.5%	(w/v)	TAE	agarose	
gel	 depending	 on	 the	 size	 of	 the	 band	 of	 interest,	 made	 from	 NuSieve	 3:1	
Agarose.	 In	most	 cases,	gels	were	 run	at	65	V	except	 for	when	 the	 splicing	of	
XBP1	mRNA	was	 being	 investigated	whereby	 gels	were	 run	 at	 45	 V	 to	 obtain	
better	separation	of	DNA	bands.	PCR	products	were	visualised	through	staining	
with	SyberSafe	(Invitrogen)	and	detection	under	UV	 light,	using	a	UVITEC	 light	
box	(Thistle	Scientific).		
2.2.4	 Gel	 purification:	 PCR	 bands	 of	 interest	 were	 cut	 out	 of	 the	 gel	 using	 a	
sterile	scalpel	blade	and	purified	using	the	Zymoclean	Gel	DNA	Recovery	kit	as	
per	manufacturer’s	 instructions	 (Zymo	Research).	 In	 summary,	 gel	 slices	were	
mixed	with	agarose	dissolving	buffer	and	incubated	in	a	50°C	water	bath	for	15	
minutes.	 DNA	was	 then	 purified	 by	 a	 series	 of	 centrifugation	 steps	 using	 the	
Zymo-spin	columns	followed	by	wash	steps	with	DNA	wash	buffer.	Purified	DNA	
was	eluted	in	10	µl	of	DNA	elution	buffer.								
2.2.5	 In-fusion	 cloning:	DsRed2	 insert	 sequences	were	 cloned	 into	 POLG2	 vector	
backbone	 sequences	 using	 the	 In-Fusion	 HD	 cloning	 kit	 as	 per	 manufacturer’s	
instructions	(Clontech),	scaled	down	to	a	total	reaction	volume	of	5	µl	per	reaction	
mix.	Cloning	was	performed	with	an	insert	to	vector	molar	ratio	of	2:1	for	15	min	in	
a	water	bath	set	to	50°C.		
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2.2.6	 Bacterial	 transformation:	 Bacterial	 transformation	 of	 In-Fusion	 cloning	
products	into	competent	E.Coli	cells	were	carried	out	by	the	following	steps:	
• 2.5	 µl	 of	 each	 cloning	 reaction	 was	 mixed	 with	 25	 µl	 of	 NEB	 10-beta	
competent	E.coli	(NEB)	and	kept	on	ice	for	30	min.		
• E.coli	 cells	were	 then	heat-shocked	 at	 42°C	 for	 exactly	 40	 seconds	before	
being	placed	back	on	ice	for	a	further	2	min.		
• Proceeding	this,	200	µl	of	SOC	outgrowth	media	(NEB)	was	added	to	the	cells	
which	were	shook	for	45	min	at	150	rpm	at	37°C.		
• The	entire	reaction	mix	was	spread	on	LB	agar	plates	containing	ampicillin	
100	µg/ml	and	incubated	overnight	at	37°C.		
2.2.7	 DNA	 extraction:	 Single	 bacterial	 colonies	 were	 selected	 and	 grown	
overnight	in	LB	media	with	100	µg/ml	ampicillin,	shaken	at	200	rpm	at	37°C.	DNA	
extraction	 was	 carried	 out	 using	 a	 QIAGEN	 plasmid	 miniprep	 kit	 as	 per	
manufacturer’s	 instructions.	 The	 correct	 plasmid	 sequence	 was	 confirmed	 by	
Sanger	sequencing	at	the	Edinburgh	Genomics	GenePool	facility.												
	
2.3	Cell	culture	and	transfection	
2.3.1	Mammalian	cell	culture	and	maintenance:	NSC34	(Cashman	et	al.,	1992),	COS-
7	(Gluzman,	1981)	and	HEK293	(Graham	et	al.,	1977)	were	grown	at	37°C	with	5%	
CO2	 in	Dulbecco’s	modified	 Eagle’s	medium	 (DMEM)	 containing	high	 glucose	 and	
supplemented	with	10%	(v/v)	fetal	bovine	serum	and	1%	(v/v)	antibiotic-antimycotic	
(Thermo	Fisher	Scientific).	In	preparation	for	imaging,	cells	were	plated	on	13	mm	
glass	 coverslips	 that	 had	 been	 coated	 with	 poly-L-lysine	 (50	 µg/ml)	 and	 bovine	
plasma	fibronectin	(10	µg/ml)	(Life	Technologies)	for	at	least	2	hours	each.		
2.3.2	DNA	transfection:	Plasmid	transfections	were	carried	out	using	Lipofectamine	
2000	(Invitrogen)	in	Opti-MEM	media	(Thermo	Fisher	Scientific).	For	12-well	plates	
containing	1	ml	DMEM,	50	µl	of	Opti-MEM	containing	the	DNA	mix	and	50	µl	of	
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Opti-MEM	containing	Lipofectamine	2000	was	made	and	 let	sit	 for	5	min.	The	
DNA	and	Lipofectamine	mixes	were	 then	added	together	and	mixed	by	gentle	
flicking	of	the	tube	and	let	stand	at	room	temperature	for	20	min.	 	For	NSC34	
cells,	a	Lipofectamine:DNA	ratio	of	1:1	µl:µg	was	used	while	for	HEK293	and	COS-
7	 cells	 a	 ratio	 of	 0.5:1	 µl:µg	 was	 used.	 Media	 was	 changed	 4	 hours	 post-
transfection	 to	 remove	 traces	 of	 Lipofectamine.	 V1-ER	 and	 V2-Mito	 reporter	
plasmids	were	 transfected	 in	 a	 1:1	 ratio.	 In	 cases	where	particular	 protein	 levels	
were	titrated	within	a	single	experiment,	CMV-Globin	plasmid	was	used	as	balancer	
DNA	to	ensure	that	equal	concentrations	of	 total	DNA	were	transfected	per	well.	
Cells	 were	 fixed	 48	 h	 post-transfection	 with	 4%	 (w/v)	 Paraformaldehyde	 in	
Phosphate-buffered	saline	(PBS)(Roche)	or	with	ice-cold	methanol	for	5	min	at	-20°C.	
Different	fixation	methods	were	used	depending	on	what	antibodies	were	required	
(as	indicated	in	table	2.1).	Coverslips	were	mounted	on	glass	slides	using	ProLong	
Diamond	 Antifade	mountant	 (Thermo	 Fisher	 Scientific)	 or	 Vectashield	 with	 DAPI	
(Vector	Laboratories,	 Inc.	Burlingame,	CA	94010)	and	left	overnight	 in	a	darkened	
area	before	imaging.						
2.3.3	siRNA	transfection:	Silencing	of	protein	expression	was	performed	by	siRNA	
transfection	 using	 Lipofectamine	 RNAi	 Max	 (Invitrogen)	 and	 Opti-MEM	 media	
(Thermo	 Fisher	 Scientific).	 A	 total	 siRNA	 concentration	 of	 50	 nM	 was	 used	 and	
protein	was	 harvested	 48	 h	 post-transfection.	 All	 surfaces	were	 decontaminated	
prior	 to	 transfection	 using	 RNase	 AWAY	 decontamination	 reagent	 (Invitrogen).	
siRNA	plasmids	used	were	as	follows:		
Mouse	MFN2	ON-TARGETplus	SMART	pool	(Dharmacon).		
ON-TARGETplus	 control	 non-targeting	 pool	 was	 used	 for	 control	 transfections	
(Dharmacon).		
Proprietary	stealth	siRNA	and	scramble	sequences	from	Invitrogen	were	used	for	the	
knock-down	of	mouse	VAPA	and	VAPB.	VAPA	product	numbers	887S	and	657S.	VAPB	
product	numbers	675S	and	1465S.	25	nM	of	each	siRNA	pair	was	transfected.						
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Validation	 and	quantification	of	 protein	 knock-down	was	determined	by	western	
blotting.		
2.3.4	Stable	 cell	 line	generation:	NSC34	 cells	 stably	 expressing	 V1-ER/V2-Mito,	
V1-VAPB/V2-Mito	 or	 V1-VAPA/V2-Mito	 respectively	 were	 generated	 by	
Lipofectamine	 transfection	 followed	 by	 Zeocin	 (Invitrogen)	 selection	 at	 200	
µg/ml.	Clonal	populations	were	obtained	by	serial	dilutions	of	stably	transfected	cells	
in	96-well	plates	(Greiner	Bio-One)	under	Zeocin	selection.				
2.3.5	RNA	extraction	and	PCR:	Total	RNA	was	extracted	from	NSC34	cells	using	
the	RNeasy	mini	kit	 (Qiagen)	as	per	manufacturer’s	 instructions.	 In	short,	cells	
are	trypsinized	from	a	12-well	plate	and	lysed	in	the	presence	of	a	lysis	buffer	to	
extract	 RNA	 while	 simultaneously	 deactivating	 RNases.	 The	 lysate	 is	
homogenised	 by	 centrifugation	 through	 a	 QIAshredder	 spin	 column	 and	
subsequently	spun	through	a	silica	RNeasy	spin	column	to	purify	RNA.	Following	
wash	steps,	RNA	is	eluted	in	50	µl	of	RNase-free	water.	Reverse-transcription	PCR	
was	 performed	 using	 the	 Omniscript	 reverse	 transcription	 kit	 (Qiagen)	 to	
generate	cDNA,	 followed	by	PCR	amplification	using	Phusion	high	fidelity	DNA	
polymerase	 (Thermo	 Fisher	 Scientific)	 or	 Taq	 DNA	 polymerase	 (Qiagen).	 PCR	
products	were	visualised	on	a	3.5%	(w/v)	TAE	agarose	gel	stained	with	SyberSafe	
(Invitrogen)	 and	 detected	 under	 UV	 light,	 using	 a	 UVITEC	 light	 box	 (Thistle	
Scientific).			
2.3.6	Cell	treatments:	ER	Stress	was	induced	by	treating	cells	with	2	µg/ml	or	10	
µg/ml	 tunicamycin	 (Calbiochem)	 for	 6	 h	 before	 fixation	 of	 the	 samples.	 An	
equivalent	volume	of	DMSO	was	used	as	a	vehicle	only	control.	For	the	induction	
of	 serum	 deprivation,	 cells	 were	 grown	 in	 serum-free	 DMEM	 for	 24	 h	 post-
transfection.	To	increase	mitochondrial	membrane	potential,	cells	were	treated	
with	5	µg/ml	oligomycin	(Sigma)	for	24	h	post-transfection.					
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2.4	Immunocytochemistry	
2.4.1	Immunofluorescent	(IF)	staining:	Following	fixation	of	cells,	cells	were	washed	
with	PBS	and	then	permeabilised	with	0.4%	(v/v)	Triton	X-100	for	10	min	at	room	
temperature,	except	in	cases	where	cells	were	fixed	in	ice	cold	methanol	where	no	
extra	permeabilisation	step	was	carried	out.	Cells	were	then	 incubated	 in	a	PGAS	
blocking	solution	composed	of	PBS,	0.2%	(v/v)	fish	gelatin	and	0.02%	(w/v)	saponin	
and	filtered	through	a	stericup	0.22	µm	pore	size	 (Merck	Millipore)	at	4°C	for	at	
least	2	hours.	Cells	were	incubated	with	the	primary	antibody	in	PGAS	solution,	in	a	
humidified	chamber	for	30-60	min	at	room	temperature	followed	by	three	washes	
in	PGAS	solution.	Secondary	antibodies	were	incubated	with	cells	in	PGAS	solution	
at	a	1/250	dilution	for	30	min	at	room	temperature	in	the	dark.	Finally,	cells	were	
washed	3	times	in	PGAS	solution	with	a	subsequent	3	washes	in	PBS	before	being	
mounted	for	imaging.	
2.4.2	Antibodies	 for	 IF:	 Secondary	 antibodies	 used	were	 donkey	 anti-mouse	 Cy2	
(715-225-150),	Cy3	and	Cy5-coupled	goat	anti-mouse	(115-165-146,	115-175-156),	
Cy3	 and	 Cy5-coupled	 donkey	 anti-rabbit	 (711-165-152,	 711-175-152)	 (Jackson	
ImmunoResearch).	Primary	antibodies	used	for	immunocytochemistry	are	listed	in	
table	2.1	below.	Anti-ATG5	(C-terminal)	primary	antibody	(Sigma)	was	a	generous	
gift	from	Dr.	Noor	Gammoh	(The	University	of	Edinburgh).	
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Table	2.1:	Antibodies	used	for	immunocytochemistry.		
Name	 Class	 Host	 Antigen	 Catalogue	
number	
Dilution	 Fixation	
method	
Anti-ATPB	
(abcam)	
Monoclonal	 Mouse	 Whole	 heart	
mitochondria	
(human)	
Ab14730	 1:250		 4%	 (w/v)	
PFA	
Anti-GFP	(Life	
Technologies)	
Polyclonal	 Rabbit	 GFP	 isolated	
from	Aequorea	
victoria	
A6455	 1:400		 4%	 (w/v)	
PFA	
Anti-ERp72	
(Enzo	 Life	
Sciences)	
Polyclonal	 Rabbit	 a.a.	623-638	of	
ERp72	
ADI-SPS-
720	
1:100	 Methanol	
Anti-EEA1	
(Cell	Signaling	
Technology)	
Polyclonal	 Rabbit	 Synthetic	
peptide	
corresponding	
to	 residues	
surrounding	
Gly14	 of	
human	EEA1	
2411S	 1:100	 4%	 (w/v)	
PFA	
Anti-c-Myc	
clone	 9E10	
(Invitrogen)	
Monoclonal	 Mouse	 Synthetic	
peptide	 a.a	
408-438	 of	
human	c-Myc	
MA1-980	 1:500-
1000	
4%	 (w/v)	
PFA	
Anti-ATG5	(C-
terminal)	
(Sigma)		
Polyclonal	 Rabbit	 Amino	 acids	
262-275	 of	
mouse	ATG5	
A0731	 1:200	 4%	 (w/v)	
PFA	
followed	
by	
methanol	
treatment	
for	2	min	
	
2.5	Immunoblotting	
2.5.1	Western	 Blotting:	 Protein	 was	 harvested	 from	 cells	 48	 h	 post-transfection	
using	SDS	sample	buffer	composed	of	80	mM	Tris-HCl	pH6.9,	2%	(w/v)	SDS,	100	mM	
DTT,	10%	(v/v)	glycerol,	or	in	RIPA	lysis	buffer	made	up	of	1%	NP40	(v/v),	0.1%	SDS	
(w/v),	 150	 mM	 NaCl,	 0.5%	 (w/v)	 sodium	 deoxycholate,	 50	 mM	 Tris	 pH	 8	 with	
complete	 protease	 inhibitor	 (Roche).	 Total	 protein	was	 quantified	 by	 Pierce	 BCA	
protein	assay	kit	(Thermo	Fisher	Scientific).	Samples	were	heated	at	85°C	for	15	min	
and	then	run	on	an	NuPAGE	4-12%	Bis-Tris	gel	(Invitrogen)	in	MES	SDS	running	buffer	
(Invitrogen)	 at	 120	 V.	 Proteins	 were	 transferred	 to	 a	 PVDF	 Immobilon-P	 (EMD	
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Millipore)	 membrane	 soaked	 in	 methanol	 and	 then	 in	 NuPAGE	 transfer	 buffer	
containing	10-20%	(v/v)	methanol.	Protein	transfer	was	performed	at	100	V	for	60	
min	 in	 the	 presence	 of	 an	 ice-block	 and	 constant	magnetic	 stirring.	 Non-specific	
antibody	binding	was	inhibited	by	blocking	PVDF	membranes	in	PBS	containing	5%	
(w/v)	 non-fat	 dry	 milk	 and	 0.1%	 (v/v)	 Tween-20	 for	 at	 least	 60	 min	 at	 room	
temperature	while	rocking.	Primary	antibodies	(as	listed	in	table	2.2)	were	incubated	
with	the	membrane	in	blocking	solution	at	4°C	overnight,	followed	by	3	washes	at	
room	 temperature	 with	 PBS	 containing	 0.1%	 (v/v)	 Tween-20.	 Proceeding	 this,	
membranes	 were	 incubated	 with	 horseradish-peroxidase	 conjugated	 secondary	
antibodies	in	blocking	solution	at	a	1/5000	dilution	at	room	temperature	for	1	hour,	
followed	by	enhanced	chemiluminescent	substrate	(ECL)	detection	made	up	of	a	1:1	
ratio	of	hydrogen	peroxide	and	Luminol	or,	in	cases	where	protein	concentrations	
were	very	low,	Amersham	ECL	western	blotting	detection	reagent	(GE	Healthcare)	
was	 used.	 Blots	were	 exposed	on	X-ray	 film	 (FUJIFILM).	Densitometry	 analysis	 of	
blots	was	carried	out	on	FIJI	image	analysis	software.								
2.5.2	Antibodies	for	Western	blotting:	Secondary	antibodies	used	were	horseradish-
peroxidase	 conjugated	 goat	 anti-rabbit	 (111-035-003)	 and	 goat	 anti-mouse	 (115-
035-146)	(Jackson	ImmunoResearch).	Primary	antibodies	used	for	Western	blotting	
are	listed	in	table	2.2	below.								
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Table	2.2:	Antibodies	used	for	Western	blotting.			
Name	 Class	 Host	 Antigen	 Catalogue	
Number	
Dilution	
Anti-MFN2	
(Abcam)	
Monoclonal	 Mouse	 Amino	acids	661-
758	 of	 human	
MFN2	
Ab56889	 1:5000	
Anti-	 a-
Tubulin	 (EMD	
Millipore)	
Monoclonal	 Mouse	 Amino	acids	426-
450	of	human	a-
tubulin	
05-829	 1:50,000	
Anti-c-Myc	
clone	 9E10	
(Invitrogen)	
Monoclonal	 Mouse	 Amino	acids	408-
438	 of	 human	 c-
Myc	
MA1-980	 1:20,000	
Anti-Histone	
H3	 CT	 (Merck	
Millipore)	
Polyclonal	 Rabbit	 Synthetic	peptide	
corresponding	 to	
the	C-terminus	of	
human	 Histone	
H3	
07-690	 1:100,000	
Anti-VAPA	
(Murex	
Bioservices)	
Polyclonal	 Rabbit	 As	 published	 in	
(Skehel	 et	 al.,	
2000)	
N/A	 1:1000-
10,000	
Anti-VAPB	
clone	 #6	
(Murex	
Bioservices)	
Monoclonal	 Rabbit	 Bacterially	
expressed	 VAPB	
MSP	 domain	
(unpublished).	
N/A	 1:500-5,000	
Anti-VAPB	
clone	 #38	
(Murex	
Bioservices)	
Polyclonal	 Rabbit	 Bacterially	
expressed	
carboxy	 terminal	
deleted	 soluble	
VAPB	
(unpublished).		
N/A	 1:500-5,000	
	
2.6	Ca
2+	
Measurements	
NSC34	 cells	 were	 transiently	 transfected	 to	 express	 a	 mitochondrially-targeted	
fluorescent	Mito-RCaMP	probe	whereby	regions	of	higher	fluorescence	intensity	are	
indicative	 of	 higher	 calcium	 concentrations	 (Akerboom	 et	 al.,	 2013).	 3D	 live-cell	
images	were	obtained	by	confocal	microscopy.	Mean	fluorescence	intensity	value	of	
each	 of	 the	 disconnected	 components	 of	 the	 mitochondria	 network	 signal	 was	
quantified	on	Imaris.	To	quantify	fluorescence	intensity	specifically	of	mitochondrial	
regions	associated	with	BiFC	puncta,	the	Venus	signal	was	used	as	a	mask	for	the	
mitochondria	channel	and	all	pixel	intensity	values	outside	of	this	mask	were	set	to	
0.	The	mean	fluorescent	intensity	value	for	all	remaining	mitochondrial	signal	was	
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then	quantified	 and	 expressed	 relative	 to	 the	mean	 total	mitochondrial	 intensity	
value.	
For	Gq	DREADD	receptor	optimisation	experiments,	NSC34	cells	were	transfected	
with	0.05	µg	EF1a-DI0-Gq-mCherry,	0.5	µg	AAV-EF1a-Cre	and	0.45	µg	GCaMP3-cyt	
per	well	 in	a	12-well	plate.	For	optimisation,	cells	were	 imaged	with	a	DFC350	FX	
digital	 camera	 on	 a	 Leica	 AF6000	 LX	 microscope	 on	 a	 20X	 objective.	 To	 induce	
DREADD	receptor	activation,	1	µM	of	Clozapine	N-oxide	 (CNO)	diluted	 in	 live-cell	
imaging	media.	Cells	were	imaged	using	a	standard	GFP	filter	set.	Images	were	taken	
every	 3	 seconds.	 Change	 in	 mean	 fluorescence	 was	 measured	 according	 to	 the	
equation	F/F0	where	F	=	 fluorescence	 intensity	 value	and	F0	=	 the	mean	 intensity	
value	 of	 baseline	 fluorescence	 before	 the	 addition	 of	 CNO,	 averaged	 over	 three	
images.	As	a	negative	control,	cells	were	imaged	for	the	same	length	of	time	without	
the	addition	of	CNO.	Analysis	of	fluorescence	intensity	values	was	carried	out	with	
Leica	Application	suite	X	imaging	software.		
For	quantification	of	BiFC	puncta	in	response	to	Gq	DREADD	mediated	Ca2+	release,	
NSC34	cells	were	transfected	with	V1-ER/V2-Mito	reporter	plasmids	in	addition	to	
0.1	µg	EF1a-D10-Gq-mCherry	and	0.5	µg	AAV-EF1a-Cre	in	a	live-cell,	glass-bottomed	
imaging	dish	(Mattek)	equalling	2	µg	total	DNA.	Cells	were	imaged	live	on	a	Nikon	
A1R	 FLIM	microscope	 for	 1	min	 before	 the	 addition	 of	 1	µM	CNO.	 Images	were	
acquired	every	3.81	seconds.	Changes	in	the	number	of	BiFC	puncta	were	measured	
as	described	in	section	2.9.5.							
2.7	Sub-cellular	organelle	fractionation			
Transgenic	homozygous	or	heterozygous	rat	models	for	the	VapbP56S	mutation	and	
homozygous	 Vapb	 knock-out	 rats	 were	 previously	 generated	 using	 long	 single-
stranded	DNA	(lssDNA)	to	the	rat	Vapb	gene	to	insert	the	P56S	mutation	into	a	floxed	
exon	2	of	rat	Vapb	via	the	CRISPR/Cas	gene	editing	system	by	Tomoji	Mashimo	(as	
mentioned	in	(Meek	et	al.,	2017)).	Sub-cellular	organelle	fractionation	of	brain	and	
liver	tissue	from	wild-type,	heterozygous	VapbP56S	and	homozygous	Vapb	knock-out	
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transgenic	rats	was	carried	out	using	the	protocol	as	published	in	(Wieckowski	et	al.,	
2009).	All	of	the	described	steps	were	carried	out	on	ice	or	in	centrifuges	chilled	to	
4°C.	In	summary,	brain	and	liver	tissue	was	extracted	from	2	month	old	or	5	month	
old	 animals	 as	 indicated	 in	 the	 specific	 figure	 legends	 and	 immediately	 placed	 in	
isolation	buffer	composed	of	225	mM	mannitol,	75	mM	sucrose,	0.5%	(w/v)	BSA,	0.5	
mM	 EGTA	 and	 30	 mM	 Tris-HCl	 pH	 7.4.	 Animals	 were	 housed	 and	 sacrificed	 in	
accordance	with	UK	Home	Office	 guidelines.	 Tissue	was	washed	3	 times	 in	wash	
buffer	(225	mM	mannitol,	75	mM	sucrose	and	30	mM	Tris-HCl	pH	7.4)	before	being	
homogenised	manually.	The	homogenate	was	centrifuged	at	740g	for	5	min	at	4°C	
and	the	pellet	was	discarded.	This	was	followed	by	an	additional	spin	at	740g	for	5	
min	 after	which	 the	 supernatant	was	 centrifuged	at	 9,000g	 for	 10	min.	Both	 the	
supernatant	 (lysosomal	 and	 ER	 fraction)	 and	 pellet	 (crude	mitochondria	 fraction)	
obtained	from	this	step	were	collected	for	further	processing.	The	supernatant	was	
centrifuged	at	20,000g	for	30	min	to	separate	the	lysosomal	fraction	(pellet)	and	ER	
fraction	(supernatant)	after	which	a	further	centrifugation	step	of	the	supernatant	
at	100,000g	for	1	hour	was	performed	to	isolate	the	ER	fraction	as	a	pellet.	The	ER	
fraction	was	resuspended	in	a	resuspension	buffer	consisting	of	250	mM	mannitol,	
5	 mM	 HEPES	 (pH	 7.4)	 and	 0.5	 mM	 EGTA.	 The	 crude	 mitochondria	 pellet	 was	
resuspended	with	a	soft	paintbrush	in	20	mL	of	buffer	consisting	of	22	mM	mannitol,	
75	mM	sucrose,	0.5%	(w/v)	BSA	and	30	mM	Tris-Hcl	pH	7.4	and	centrifuged	twice	at	
10,000g	for	10	min,	discarding	the	supernatant.	This	pellet	was	resuspended	in	2	mL	
of	 resuspension	 buffer	 and	 a	 small	 aliquot	 of	 this	 was	 taken	 as	 the	 crude	
mitochondrial	 fraction.	 Percoll	 medium	 consisting	 of	 225	 mM	mannitol,	 25	 mM	
HEPES	(pH	7.4),	1	mM	EGTA	and	30%	Percoll	(v/v)	was	made	up	and	4	mL	of	this	was	
placed	 in	 polyallomer	 ultracentrifuge	 tubes	 (13	 x	 51mm)	 (Beckman).	 1mL	 of	 the	
mitochondrial	 suspension	was	 layered	on	 top	of	 this	 and	 tubes	were	weighed	 to	
ensure	that	they	were	all	equivalent	weights	before	ultracentrifugation.	Tubes	were	
centrifuged	at	95,000g	for	30	min	in	a	Beckman	Coulter	Optima	MAX	Ultracentrifuge	
in	an	MLS-50	aluminium	swinging-bucket	rotor	(Beckman	Coulter).	A	band	of	purified	
mitochondria	is	present	near	the	bottom	of	the	tube	while	a	second	band	containing	
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the	MAM	fraction	is	located	above	this	about	two	thirds	of	the	way	up	the	tube	(Fig	
2.2).	 Both	 fractions	 were	 collected	 with	 a	 Pasteur	 pipette,	 diluted	 five-fold	 in	
resuspension	 buffer	 and	 centrifuged	 at	 6,300g	 for	 10	 min.	 MAM	 fraction	
supernatants	 were	 transferred	 to	 Beckman	 ultracentrifuge	 tubes	 and	 spun	 at	
100,000g	 for	 1	 hour.	 The	 supernatant	 was	 discarded	 and	 the	 MAM	 pellet	 was	
resuspended	 in	 50	 µl	 of	 resuspension	 buffer.	 The	 pure	 mitochondria	 pellet	 was	
resuspended	in	the	resuspension	buffer	and	centrifuged	one	final	time	at	6,300g	for	
10	min.	The	supernatant	was	discarded	and	the	pellet	was	resuspended	with	a	soft	
paintbrush	in	50	–	100	µl	of	resuspension	buffer.	The	relative	purity	of	the	ER,	crude	
mitochondrial,	 pure	 mitochondrial	 and	 MAM	 fractions	 was	 tested	 by	 western	
blotting.																															
	
Fig	2.2.	Schematic	diagram	of	steps	performed	to	purify	MAM	and	mitochondrial	
fractions.	Following	centrifugation	in	Percoll	medium,	the	MAM	and	mitochondrial	
fractions	appear	as	dense	bands	as	indicated	in	the	diagram.	Further	centrifugation	
steps	allow	for	the	purification	of	both	of	these	fractions.	Adapted	from	(Wieckowski	
et	al.,	2009).			
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2.8	Microscopy		
2.8.1	Confocal	microscopy:	A	Nikon	A1R	FLIM	microscope	was	used	to	acquire	all	
confocal	images.	Excitation	laser	wavelengths	used	were	for	CFP	and	DAPI	401.5	nm,	
GFP,	YFP	(Venus)	and	Cy2	488	nm,	Cy3,	DsRed2	and	mCherry	56	1nm,	and	Cy5	641	
nm.	 Microscope	 control	 and	 image	 acquisition	 were	 performed	 with	 the	 NIS-
Elements-v4.13	 software.	 High-resolution	 imaging	 of	 single-cells	 was	 carried	 out	
using	a	60X	Plan	ApoVC	NA	1.4	oil	objective	with	a	z-step	size	of	150	nm.	For	Fig	3.7B	
and	Fig5.1B	images	were	acquired	with	a	20X	Plan	Apo	NA	0.75	objective	lens	using	
the	same	laser	power,	detector	gain	and	acquisition	parameters.			
2.8.2	Live-cell	imaging:	Cells	were	plated	on	poly-D-lysine/fibronectin	coated	35	mm	
glass-bottomed	culture	dishes	with	a	14	mm	microwell	diameter	and	glass	thickness	
No.	1.5	(MatTEK).	Prior	to	imaging,	DMEM	was	replaced	with	optically	clear,	HEPES	
buffered	live-cell	imaging	solution	(Thermo	Fisher	Scientific).	Live-cell	imaging	was	
performed	on	a	Nikon	A1R	confocal	microscope	in	a	heated	chamber	at	37°C	with	
5%	CO2	(Okolab)	using	a	60X	oil	objective	lens	(Plan	ApoVC	NA	1.4	oil).	For	live-	cell	
imaging,	 mitochondria	 were	 labelled	 using	 25	 nM	 red	 fluorescent	 MitoTracker	
CMXRos	dye	or	MitoTracker	Deep	Red	FM	far	red	fluorescent	dye	(Thermo	Fisher	
Scientific)	for	30	min	in	pre-warmed	DMEM	followed	by	three	five	minute	washes	
with	pre-warmed	live-cell	imaging	solution.				
2.8.3	CW-gSTED	microscopy:	Continuous	wave	gated	stimulated	emission	depleted	
(CW-gSTED)	 microscopy	 was	 performed	 on	 a	 Leica	 SP5	 confocal	 laser	 scanning	
microscope	equipped	with	a	592	nm	depletion	laser	and	100	x	1.4	NA	HCX	PL	Apo	oil	
immersion	objective	lens.	YFP	fluorophores	were	excited	by	a	white	laser	tuned	to	
514	 nm	 with	 an	 80MHz	 pulse	 rate.	 STED	 was	 achieved	 by	 concurrent	 592	 nm	
depletion	aligned	 to	 the	excitation	 laser.	524-580nm	emission	was	 isolated	by	an	
acousto-optical	beamsplitter	and	detected	with	a	Leica	HyD	hybrid	detector	gated	
to	detect	0.5-8	ns	following	each	excitation	pulse.	Single	slice	images	were	acquired	
with	a	0.02	µm	pixel	size	to	achieve	Nyquist	sampling.		
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2.9	Image	Analysis					
2.9.1	Deconvolution:	Deconvolution	of	confocal	images	was	carried	out	on	Huygens	
Essential	 deconvolution	 software	 (Huygens	 Software	 4.5.1p3)	 before	 subsequent	
analysis.		
2.9.2	Colocalisation	Analysis:	Colocalisation	analyses	were	performed	on	3D	stack,	
deconvolved	 images	 using	 ImarisColoc	 feature	 of	 Imaris	 image	 analysis	 software	
(Bitplane	Inc,	software	available	at	http://bitplane.com).	The	extent	of	colocalisation	
was	quantified	by	Pearson’s	Correlation	Coefficient	(PCC)	and	Mander’s	Correlation	
Coefficient	 (MCC)	 and	 results	 were	 exported	 in	 Microsoft	 Excel.	 Images	 were	
thresholded	manually	by	pixel	intensity	values.					
2.9.3	Quantification	of	BiFC	signal:	BiFC	puncta	were	quantified	using	the	3D	volume	
rendering	 function	 of	 Imaris	 and	 thresholded	 by	 pixel	 intensity	 value.	 The	 “total	
number	 of	 disconnected	 components”	 measurement	 value	 was	 then	 used	 to	
automate	counting	of	fluorescent	puncta.	Total	BiFC	volume	or	mitochondria	volume	
was	quantified	in	the	same	manner	using	the	3D	volume	rendering	function	followed	
by	the	“volume”	measurement	value.		
For	 quantification	 of	 fluorescent	 signal	 overlap	 of	 BiFC	 puncta	 and	 fluorescently	
tagged	organelles	(Fig3.8),	the	“Spots”	function	of	Imaris	was	used	to	quantify	the	
number	of	fluorescent	puncta	based	on	a	maximum	intensity	pixel	value.	Using	this	
same	threshold	value,	a	colocalisation	channel	was	built	between	the	BiFC	signal	and	
the	fluorescently	labelled	organelle.	Finally,	the	number	of	spots	in	the	colocalisation	
channel	was	counted	 in	 the	same	way	and	the	number	of	puncta	with	a	point	of	
colocalisation	with	 the	specific	organelle	signal	was	expressed	as	a	percentage	of	
total	BiFC	puncta.		
2.9.4	STED	image	quantification:	Deconvolution	of	STED	images	was	not	performed	
due	 to	 the	 relative	 low	 strength	 of	 the	 fluorescent	 signal.	Measurements	 of	 the	
diameter	of	fluorescent	puncta	was	carried	out	using	the	“straight	line”	tool	in	Fiji	
(ImageJ)	(Schindelin	et	al.,	2012;	Schneider	et	al.,	2012).	Simply,	a	straight	line	was	
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manually	drawn	across	the	widest-most	point	of	each	BiFC	puncta	and	the	length	of	
the	line	was	calculated	in	µm.									
2.9.5	Live-cell	 imaging	quantification:	 Imaris	image	analysis	software	was	used	to	
automate	the	quantification	of	the	number	of	BiFC	puncta	per	frame	using	the	3D	
volume	 rendering	 function	 on	 the	 Venus	 channel,	 thresholded	 by	 fluorescence	
intensity	value,	to	detect	the	total	number	of	BiFC	puncta.	Measurement	values	of	
the	number	of	disconnected	components	per	time	point	were	then	automated	by	
the	software.		
For	measuring	the	distance	and	speed	travelled	by	the	BiFC	puncta,	each	individual	
object	was	organised	based	on	track	duration	i.e.	the	length	of	time	each	individual	
puncta	was	visible	within	the	focal	plane	of	the	live-cell	video.	A	selection	bias	was	
added	such	that	only	distance	and	speed	measurements	for	those	puncta	present	
for	a	large	proportion	of	the	video	were	taken,	to	exclude	any	BiFC	puncta	that	only	
appear	in-focus	for	a	very	brief	amount	of	time.	For	each	of	the	selected	BiFC	puncta,	
the	mean	 speed	 value	 in	µm/s	 and	 the	mean	displacement	 length	 from	 the	 first	
frame	where	the	object	appears	until	the	final	frame	that	it	is	in	focus	in	µm.			
For	 measuring	 the	 distance	 travelled	 by	 the	 BiFC	 puncta	 and	 its	 associated	
mitochondria,	the	“straight	line”	tool	of	ImageJ	was	used	to	measure	the	distance	
between	the	starting	point	of	each	object	and	their	position	in	the	final	frame	of	the	
live-cell	video.			
2.9.6	 Fluorescence	 intensity	 quantification:	 For	 optimisation	 of	 Gq-DREADD	
mediated	 increases	 in	 cytoplasmic	 calcium	 levels,	 changes	 in	 cytoplasmically-
targeted	GCaMP	 fluorescence	was	 analysed	 on	 Leica	 Application	 Suite	 X	 imaging	
software.	A	region	of	 interest	was	defined	for	a	 large	selection	of	cells	within	the	
field	of	view	(27	cells)	and	the	mean	fluorescence	intensity	value	was	quantified	for	
each	frame	of	the	live-cell	video.	Three	random	spots	of	background	were	quantified	
and	averaged	to	give	the	mean	background	signal	value	which	was	then	subtracted	
from	each	of	the	cells	measured.	
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For	all	other	measurements	of	fluorescence	intensity,	quantification	was	carried	out	
on	Imaris.	3D	surface	rendering	was	used	to	add	a	volume	to	the	fluorescent	signal,	
thresholded	 by	 maximum	 fluorescence	 intensity	 value	 and	 then	 the	 mean	
fluorescence	intensity	value	could	be	quantified.			
2.9.7	 Concentric	 circle	 profiling	 of	 mitochondrial	 fluorescence	 intensity:	 A	
concentric	circles	plugin	for	 ImageJ	 image	analysis	software	was	used	to	calculate	
the	mitochondrial	signal	intensity	falling	on	the	perimeter	of	eight,	equally	spaced	
concentric	 circles	 radiating	 from	 the	 nucleus	 to	 the	 cell	 perimeter	 (Available	 at	
https://imagej.nih.gov/ij/plugins/concentric-circles.html)	(Schindelin	et	al.,	2012).		
2.9.8	Distance	measurements	of	spots	to	surfaces:	For	calculating	the	percentage	
BiFC	 puncta	 falling	 within	 a	 certain	 distance	 of	 the	 nucleus	 (Fig4.3C)	 and	 for	
determining	the	distance	of	BiFC	puncta	 to	POLG2-DsRed2	puncta	 (Fig4.10B),	 the	
“Spots	 Close	 to	 Surface”	 tool	 of	 Imaris	 XTension	 was	 used.	 The	 surface	 objects	
(nucleus	 or	 POLG2-DsRed2	 puncta)	 were	 defined	 by	 3D	 volume	 rendering	 using	
fluorescence	intensity	values	as	a	threshold.	The	“spots”	function	was	then	used	to	
define	each	BiFC	puncta	as	a	single	spot	using	an	estimated	XY	diameter	of	0.5	µm	
and	thresholding	by	signal	 intensity	values.	The	number	of	spots	present	within	a	
defined	distance	from	the	nearest	surface	could	then	be	determined.	Values	were	
exported	to	Microsoft	Excel	and	presented	as	the	number	of	spots	within	a	defined	
distance	as	a	percentage	of	total	spots	per	cell.															
2.10	Statistical	analysis	
All	experiments	were	replicated	a	minimum	of	three	times	for	statistical	analysis.	All	
statistics	were	performed	using	GraphPad	Prism	version	6.0	(GraphPad	Software,	La	
Jolla	 California	 USA,	 www.graphpad.com).	 Statistical	 significance	 was	 measured	
using	unpaired	two-tailed	t-test,	paired	t-test	or	one-way	ANOVA	followed	by	either	
Holm-Sidak’s	or	Dunnett’s	multiple	comparison	test	as	indicated	in	each	individual	
figure	legend.	To	identify	outliers,	a	technique	known	as	ROUT	was	used	that	fits	a	
curve	using	a	Lorentzian	distribution	and	then	identifies	outliers	of	the	curve	using	a	
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threshold	 False	 Discovery	 Rate	 (FDR)	 value	 which	 was	 set	 at	 1%	 (Motulsky	 and	
Brown).	 This	makes	 the	assumption	 that	 fewer	 than	1%	of	 statistically	 significant	
values	will	 be	 false	 values.	Values	 falling	outside	of	 this	 threshold	were	 removed	
using	the	ROUT	automated	function	on	GraphPad	Prism.	All	error	bars	represent	the	
standard	error	of	the	mean	(SEM).	Statistical	significance	is	annotated	by	*	P	<	0.05,	
**	 P	 <	 0.01,	 ***	 P	 <	 0.001,	 ns	 (non-significant)	 P	 >	 0.05.	 For	 xy	 plots,	 a	 linear	
regression	best-fit	line	was	fitted	and	the	R-squared	value	calculated.								
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Chapter	3	
Bi-Fluorescence	Complementation	Assay	
(BiFC)	
3.1	Background	
Membrane	 contact	 sites	 regulate	 a	 wide	 range	 of	 physiological	 processes	 and	
perturbations	 to	 the	 formation	or	maintenance	of	 these	 contact	 points	 can	have	
devastating	 consequences,	 as	 has	 been	 observed	 in	 various	 neurodegenerative	
disorders	(as	discussed	in	section	1.2.3	of	chapter	1).	Therefore,	 it	 is	of	particular	
research	interest	to	be	able	to	visualise	and	quantify	organelle	contact	points	in	cells.	
Our	 lab	 has	 a	 specific	 interest	 in	 the	 detection	 of	 MAMs	 and	 at	 the	 time	 of	
commencement	of	this	research	project,	several	strategies	to	quantify	MAMs	and	
other	organelle	contact	sites	had	been	published,	which	will	be	summarised	below.	
3.1.1	Techniques	for	detecting	MAMS						
In	contrast	to	the	rest	of	the	ER,	MAMs	are	enriched	for	proteins	involved	with	lipid	
biosynthesis	 (Rusinol	 et	 al.,	 1994)	 and	 other	 functions	 however,	 the	majority	 of	
proteins	found	at	these	sites	are	also	present	along	the	bulk	of	the	ER	and	on	other	
organelles,	 making	 the	 identification	 of	 specific	 markers	 of	 the	 MAMs	 to	 be	 a	
challenge.	 Interestingly,	 antibodies	 against	 phosphatidylethanolamine	 N-
methyltransferase,	 an	 enzyme	 that	 synthesises	 phosphatidylcholine	 from	
phosphatidylethanolamine	in	the	liver,	specifically	labelled	the	MAMs	and	not	the	
bulk	ER	in	hepatocytes	(Cui	et	al.,	1993).	However,	this	antibody	has	been	of	limited	
value	as	a	marker	of	MAMs	in	other	cell	types	(Vance,	2014).		
Many	studies	use	high	resolution	electron	microscopy	images	to	detect	and	quantify	
MAMs	(Vance,	1990;	Giacomello	and	Pellegrini,	2016;	Csordas	et	al.,	2006)	which	
appear	as	close	parallel	juxtaposition	of	the	OMM	and	ER	membrane	that	can	extend	
for	 hundreds	 of	 nanometres	 (Sood	 et	 al.,	 2014)(Fig	 3.1A).	 While	 this	 technique	
provides	 detailed	 structural	 and	morphological	 data	 on	 ER-mitochondria	 contact	
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sites,	in	addition	to	being	technically	challenging,	it	can	only	be	carried	out	on	fixed	
cells	and	has	limited	value	in	studying	contact	dynamics.	
In	 contrast	 to	 EM,	 fluorescent-based	 methods	 for	 detecting	 MAMs	 have	 the	
advantage	that	they	can	be	used	in	live-cell	imaging	and	can	be	quantified	in	a	large	
number	 of	 cells	 with	 relative	 ease.	 One	 simple	 method	 that	 has	 been	 used	 to	
measure	 changes	 in	 ER-mitochondria	 associations	 is	 to	 quantify	 the	 signal	 co-
localisation	of	fluorescently	labelled	ER	and	mitochondria	membranes	whereby	an	
increase	or	decrease	in	the	extent	of	co-localisation	is	representative	of	increased	or	
decreased	contacts	 respectively	 (Bravo	et	al.,	 2011;	de	Brito	and	Scorrano,	2008;	
Filadi	 et	 al.,	 2015)(Fig3.1B).	 However,	 unless	 super-resolution	 microscopy	
techniques	 are	 utilised,	 this	 method	 is	 restricted	 by	 the	 diffraction	 limit	 of	 light	
microscopy	 [as	 reviewed	 by	 (Heilemann,	 2010)],	 and	 so	 will	 quantify	 signals	 as	
overlapping	if	they	are	within	approximately	200-250	nm	of	each	other,	well	beyond	
the	 defined	 distance	 of	 ER-mitochondria	 junctions.	 Furthermore,	 this	 method	 is	
sensitive	to	any	alterations	in	organelle	morphology	(Filadi	et	al.,	2015).			
Csordas	et	al	quantified	MAMs	by	taking	advantage	of	FRET	analysis	using	a	donor	
CFP-	 and	 acceptor	 YFP-tagged,	 rapamycin-inducible	 ER-mitochondria	 linker	 pair	
system	 in	which	the	addition	of	 rapamycin	 induced	covalent	 linkage	between	the	
protein	pairs	at	areas	of	close	apposition	and	an	increase	in	fluorescence	(Csordas	et	
al.,	 2010).	 An	 increase	 in	 ER-mitochondria	 associations	 can	 be	 implied	 from	 an	
increase	in	the	donor	and	acceptor	fluorescent	probe	emissions.	FRET	has	a	higher	
resolution	 than	 fluorescence	 co-localisation	 however,	 spots	 of	 fluorescent	 signal	
only	briefly	labelled	pre-existing	ER-mitochondria	contact	sites	before	a	“zippering”	
type	mechanism	took	over	whereby	the	artificial	tightening	of	the	contact	sites	by	
the	linker	proteins	brought	more	of	the	donor	pairs	within	close	proximity	to	one	
another,	resulting	in	a	gradual	expansion	of	the	fluorescent	signal	around	the	surface	
of	the	mitochondria	until	it	appeared	to	cover	the	majority	of	the	OMM	(Csordas	et	
al.,	 2010).	 The	 addition	 of	 rapamycin	 itself	 may	 also	 induce	 increased	 ER-
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mitochondria	 contacts	 as	 it	 initiates	 autophagy	 and	 as	 previously	 described,	 the	
formation	of	autophagosomes	may	partly	occur	at	the	MAMs.					
An	in	situ	proximity	ligation	assay	was	used	to	quantify	interactions	between	VDAC1	
and	IP3R	receptors	at	the	MAMs	by	probing	the	proteins	with	secondary	antibodies	
conjugated	to	oligonucleotide	extensions	(Tubbs	et	al.,	2014).	The	principle	behind	
this	technique	is	that	when	the	oligonucleotides	are	within	close	proximity	to	one	
another	they	hybridise,	allowing	their	visualisation	by	subsequent	hybridisation	of	a	
fluorescently-labelled	 complimentary	 oligonucleotide	 to	 give	 a	 discrete	 spot	 of	
fluorescent	signal	(Tubbs	et	al.,	2014).	This	method	has	the	advantage	of	visualising	
MAMs	without	subjecting	cells	to	any	potential	artefacts	of	protein	overexpression	
and	the	signal	can	be	amplified	so	that	even	weak	interactions	can	be	quantified.	
However,	this	technique	relies	on	the	specificity	of	antibody	binding	and	the	distance	
permitting	 oligonucleotide	 hybridisation	 depends	 on	 both	 target	 protein	
conformation	and	size	including	the	bound	antibody	which	could	surpass	the	defined	
distance	of	these	junction	sites	(Tubbs	et	al.,	2014).	Furthermore,	it	requires	fixation	
of	samples	and	may	be	affected	by	the	expression	levels	of	the	target	proteins.							
Dimerization-dependent	fluorescent	proteins	(ddFP)	are	fluorescent	protein	variants	
involving	 the	 reversible	 interaction	 of	 two	 non-fluorescing	 monomers	 to	 form	 a	
fluorescent	protein	complex	(Fig3.1C).	In	one	study,	monomeric	pairs	were	fused	to	
TOMM20	OMM	protein	and	the	ER	protein	calnexin	respectively	(Alford	et	al.,	2012).	
Expression	 of	 either	 fusion	 protein	 alone	 yielded	 no	 fluorescent	 signal	 but	 co-
expression	 gave	 a	 fluorescent	 signal	 that	 partially	 colocalised	 with	 both	 the	
mitochondria	and	the	ER	(Alford	et	al.,	2012).	This	technique	has	the	benefit	of	being	
applicable	 in	 live-cell	 imaging,	 has	 improved	 resolution	over	 confocal	microscopy	
and	can	be	adjusted	to	give	new	colour	variants	however,	it	may	be	susceptible	to	
artefacts	 induced	 by	 protein	 overexpression	 and	 first	 generation	 ddFPs	 had	 low	
brightness	and	contrast,	limiting	their	value	in	live-cell	imaging	(Alford	et	al.,	2012).							
An	 alternative	 to	 fluorescent-based	 methods	 has	 been	 used	 to	 quantitatively	
measure	the	number	of	ER-mitochondria	contact	sites	in	live-cells	using	split-Renilla	
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luciferase	 constructs	 with	 each	 half	 being	 targeted	 to	 the	 ER	 and	 mitochondria	
respectively	(Lim	et	al.,	2015).	When	the	two	halves	are	in	close	proximity	i.e.	at	the	
MAMs	the	luciferase	reporter	protein	is	restored	and	light	is	emitted.	The	advantage	
of	this	technique	is	that	the	quantification	of	ER-mitochondria	associations	can	be	
automated	 over	 a	 large	 population	 of	 cells	 very	 rapidly	 but	 it	 does	 not	 allow	
visualisation	 of	 the	 MAMs	 nor	 provide	 any	 structural	 information	 within	 an	
individual	cell	and	requires	the	addition	of	a	substrate	to	the	cell	media.			
	
Fig	3.1:	Representation	of	some	of	the	techniques	used	to	quantify	MAMs.	(A)	EM	
image	of	MAMs	as	published	 in	 (Sood	et	al.,	2014).	 (B)	Co-localisation	analysis	of	
fluorescently	labelled	ER	and	mitochondria	illustrating	a	reduction	in	the	extent	of	
co-localisation	induced	by	a	knock-down	of	Mfn2	expression	as	published	in	(Filadi	
et	 al.,	 2015).	 (C)	 Schematic	 representation	 of	 the	 principle	 of	 dimerization-
dependent	fluorescent	proteins.	The	interaction	of	the	non-fluorescing	monomers	
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at	 the	MAMs	 forms	a	 fluorescent	protein	dimer.	Reprinted	with	permission	 from	
(Alford	et	al.,	2012).	Copyright	2012	American	Chemical	Society.		
	
3.2	Chapter	aims	
As	 outlined	 above,	 there	 are	 a	 number	 of	 currently	 available	 techniques	 to	
investigate	 ER-mitochondria	 contact	 sites	 but	 there	 are	 several	 limitations	
associated	with	these	methods,	particularly	in	their	usefulness	in	studying	contact	
dynamics	in	living	cells.		
Therefore,	 the	 initial	 aim	 of	 the	 thesis	 was	 to	 develop	 a	 Bi-Fluorescence	
Complementation	(BiFC)	assay	based	on	split	fluorescent	Venus	fragments	targeted	
to	 the	 ER	 and	 OMM	 respectively.	 Venus	 is	 a	 modified	 version	 of	 YFP	 (Yellow	
Fluorescent	Protein)	containing	an	F46L	mutation	to	enhance	its	stability	(Nagai	et	
al.,	2002).	The	principle	of	this	technique	is	that	neither	Venus	fragment	alone	will	
fluoresce	but	when	brought	within	close	proximity	 to	one	another	such	as	at	 the	
MAMs,	it	will	result	in	the	restoration	of	the	reporter	protein	and	the	emission	of	a	
fluorescent	signal	(Fig	3.2).	This	will	allow	for	the	visualisation	and	quantification	of	
close	ER-mitochondria	associations	that	could	be	used	in	both	fixed	and	living-cells.	
After	development	of	 the	 technique,	 the	aim	was	 to	 validate	 its	 effectiveness	by	
attempting	to	replicate	known	changes	 in	ER-mitochondria	contacts	as	previously	
observed	with	high-resolution	EM	studies.					
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Fig	 3.2:	 Schematic	 illustration	 of	 the	 principle	 of	 the	 bi-fluorescence	
complementation	 (BiFC)	assay.	Split	 venus	 fragments	are	 targeted	 to	 the	ER	and	
outer	mitochondrial	membrane	 respectively.	When	 these	 fragments	 are	 brought	
within	close	proximity	it	results	in	the	reformation	of	the	fluorescent	Venus	protein	
and	 the	emission	of	a	detectable	 fluorescent	 signal.	 Illustration	was	produced	on	
BioRender	[Available	at	https://app.biorender.io].				
	
3.3	Results	
3.3.1	 Venus	 reporter	 fusion	 proteins	 are	 correctly	 targeted	 to	 the	 ER	 and	
mitochondria.	
To	allow	the	BiFC	system	to	report	on	membrane	contact	sites	between	the	ER	and	
mitochondria,	the	Venus1	and	Venus2	fragments	were	targeted	separately	to	these	
organelles.	Previous	work	in	the	Skehel	lab	targeted	the	N-terminal	Venus1	fragment	
to	the	cytoplasmic	face	of	the	ER	membrane	by	fusion	to	the	either	the	full-length	
sequence	 or	 just	 the	 ER-targeting	 C-terminal	 25	 amino	 acids	 of	 mouse	 VAPB,	
containing	the	GxxxG	dimerization	motif,	to	produce	V1-VAPB	(Gkogkas	et	al.,	2008)	
and	 V1-ER	 (Harmon	 et	 al.,	 2017)	 reporter	 plasmids	 respectively.	 The	 C-terminal	
Venus2	fragment	was	fused	to	the	first	34	amino	acids	of	TOMM20	in	order	to	target	
it	to	the	OMM,	generating	the	V2-Mito	plasmid.	Alternating	between	the	use	of	the	
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smaller	V1-ER	fusion	protein	or	the	larger	V1-VAPB	protein	in	conjunction	with	the	
complementary	 V2-Mito	 fragment	 means	 that	 ER-mitochondria	 junctions	 of	
different	 sizes	can	be	 reported	on.	The	correct	 localisation	of	 the	Venus	 reporter	
proteins	to	the	ER	and	mitochondria	was	confirmed	by	immunofluorescent	staining	
with	a	polyclonal	anti-GFP	antibody	 that	 recognises	both	 fragments	of	 the	Venus	
protein,	in	the	mouse	motor	neuron-like	cell	line,	NSC34	(Fig	3.3).	Co-localisation	of	
the	 anti-GFP	 signal	 with	 a	 fluorescent	 ER-DsRed2	 and	 anti-ATPB	 mitochondrial	
marker	was	quantified	by	Pearson’s	Correlation	Coefficient	 (PCC)	 (Table	3.1).	V1-
VAPB	and	V1-ER	showed	a	high	level	of	co-localisation	with	the	ER	marker	but	not	
with	 the	 mitochondrial	 protein	 ATPB.	 In	 contrast,	 V2-Mito	 co-localised	 with	 the	
mitochondrial	protein	but	had	a	very	 low	level	of	co-localisation	with	the	ER.	The	
results	 indicate	 that	 the	 Venus	 reporter	 proteins	 are	 correctly	 targeted	 to	 the	
appropriate	organelles.			
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Fig	 3.3:	 The	 split	 Venus	 fusion	 proteins	 are	 correctly	 targeted	 to	 the	 ER	 and	
mitochondria	respectively.	NSC34	cells	transiently	transfected	with	(A)	V1-VAPB,	(B)	
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V1-ER,	 or	 (C)	 V2-Mito,	 were	 probed	 with	 a	 polyclonal	 anti-GFP	 antibody	 which	
recognises	both	Venus	fragments.	The	ER	was	labelled	by	co-transfection	of	an	ER-
DsRed2	 plasmid	 and	 mitochondria	 were	 labelled	 by	 immunofluorescent	 staining	
with	an	anti-ATPB	antibody.	Co-localisation	of	the	Venus	proteins	with	the	organelle	
markers	were	analysed	by	Pearson’s	Correlation	Coefficient	(PCC)	(Table	3.1).	n	=	3	
independent	 experiments	 (9-10	 cells	 total).	 Scale	 bars,	 10	 µm.	 As	 published	 in	
(Harmon	et	al.,	2017).			
	
Table	3.1:	Fluorescent	signal	co-localisation	of	Venus	probes	and	organelle	markers	
quantified	by	PCC.	Values	 indicate	mean	PCC	±	SEM	for	the	co-localisation	of	the	
indicated	 fluorescent	 labels.	 n	 =	 3	 independent	 experiments	 (9-10	 cells	 per	
experimental	group).		
Fluorescent	labels	 PCC	
V1-VAPB	/	ER-DsRed2	 0.876	±	0.009	
V1-VAPB	/	ATPB	 0.035	±	0.010	
V1-ER	/	ER-DsRed2	 0.870	±	0.017	 	
V1-ER	/	ATPB	 0.070	±	0.020	
V2-Mito	/	ER-DsRed2	 0.050	±	0.011	
V2-Mito	/	ATPB	 0.910	±	0.008	
	
3.3.2	Co-expression	of	complementary	Venus	reporter	fusion	proteins	generates	
detectable	BiFC	signals	consistent	with	a	MAM	localisation	
Expression	 of	 either	 Venus	 fragment	 alone	 in	 NSC34	 cells	 yields	 no	 detectable	
fluorescent	signal	but	when	co-expressed,	the	Venus	fusion	proteins	readily	produce	
a	pattern	of	fluorescent	signal	that	varies	greatly	depending	on	the	combination	of	
the	 Venus	 fusion	 protein	 used	 (Fig3.4).	 This	 result	 indicates	 that	 any	 fluorescent	
signal	 obtained	 solely	 represents	 sites	 of	 reformed	 Venus	 reporter	 proteins.	 Co-
expression	of	V1-VAPB	and	V2-Mito	yields	a	fluorescent	signal	that	surrounds	a	large	
proportion	of	the	surface	area	of	almost	all	mitochondria	of	the	cell	(Fig	3.5A).	 In	
contrast,	 when	 V1-ER	 and	 V2-Mito	 are	 co-transfected,	 it	 generates	 discrete	
fluorescent	puncta	that	are	closely	associated	with	a	subset	of	mitochondria.	These	
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BiFC	puncta	are	restricted	to	the	sites	of	close	apposition	of	the	ER	and	mitochondria	
as	shown	by	immunostaining	for	ERp72	and	ATPB	and	therefore,	are	consistent	with	
a	MAM	localisation	(Fig	3.5B).				
 
Fig	3.4:	Co-expression	of	complementary	Venus	reporter	fusion	proteins	yields	a	
detectable	 fluorescent	 signal.	 Co-transfection	 of	 V1-VAPB/V2-Mito	 or	 V1-ER/V2-
Mito	produces	readily	detectable	fluorescent	signal	whereas	transfection	of	either	
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plasmid	 alone	 yields	 no	 detectable	 signal.	 Expression	 of	 the	 Venus	 proteins	 was	
confirmed	by	immunostaining	with	an	anti-GFP	antibody	that	can	detect	both	Venus	
fragments.	As	published	in	(Harmon	et	al.,	2017).					
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Fig	3.5:	Co-expression	of	complementary	V1-VAPB	or	V1-ER	with	V2-mito	in	NSC34	
cells	generates	distinct	patterns	of	BiFC	signal	depending	on	the	V1-fusion	protein	
used.	(A)	Representative	images	of	NSC34	cells	transfected	with	V1-ER/V2-Mito	(Top	
row)	 or	 V1-VAPB/V2-Mito	 (Bottom	 row).	 BiFC	 signal	 is	 associated	 with	 the	
mitochondria	as	indicated	by	ATPB	labelling.	(B)	Labelling	of	the	ER	(anti-ERp72,	blue)	
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and	mitochondria	 (anti-ATPB,	 red)	 illustrate	 that	 BiFC	 puncta	 occur	 at	 regions	 of	
overlap	of	ER	and	mitochondria	signal.	 (B.I)	Higher	magnification	of	boxed	region	
from	merged	 panel.	 (B.II)	3D	 volume	 rendering	 of	magnified	 region	 using	 Imaris	
image	 analysis	 software.	 Scale	 bars	 10	 µm,	 or	 0.4	 µm	 in	 panels	 B.I	 and	 B.II.	 As	
published	in	(Harmon	et	al.,	2017).				
	
For	the	experiments	presented	in	the	rest	of	this	chapter,	the	shorter	V1-ER	reporter	
protein	in	combination	with	V2-Mito	was	used	due	to	the	discrete	punctate	pattern	
of	 fluorescence	 obtained	 and	 to	 avoid	 any	 potential	 artefacts	 of	 VAPB	
overexpression.	The	BiFC	puncta	observed	upon	co-expression	of	these	Venus	fusion	
proteins	was	not	unique	to	NSC34	cell	 lines	and	was	also	observed	in	the	primate	
COS-7	 and	 human	 HEK293	 cell	 lines	 (Fig3.6).	 No	 gross	 changes	 to	 organelle	
morphology	were	observed	in	any	of	the	cell	lines	tested.		
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Fig	3.6:	The	pattern	of	BiFC	signal	is	comparable	between	different	cell	types.	Co-
expression	 of	 V1-ER/V2-Mito	 generates	 a	 similar	 pattern	 of	 discrete	 BiFC	 puncta	
closely	associated	with	a	subset	of	mitochondria	(as	labelled	by	anti-ATPB)	in	mouse	
NSC34	cells,	primate	COS-7	cells	and	human	HEK293	cells.	As	published	in	(Harmon	
et	al.,	2017).			
	
3.3.3	 Increasing	 levels	of	Venus	 reporter	proteins	does	not	 alter	 the	pattern	or	
number	of	BiFC	puncta	
One	of	the	concerns	associated	with	this	technique	is	that	the	expression	of	V1-ER	
and	V2-Mito	may	artificially	induce	or	tighten	ER-mitochondria	contact	sites.	If	this	
was	the	case,	we	hypothesised	that	increasing	the	relative	protein	levels	of	V1-ER	
and	V2-Mito	may	 increase	 the	mean	number	of	BiFC	puncta	per	 cell	 or	 alter	 the	
pattern	of	fluorescent	signal.	Differing	total	DNA	concentrations	of	V1-ER	and	V2-
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Mito	 in	a	1:1	ratio	were	transfected	in	NSC34	cells	and	the	mean	number	of	BiFC	
puncta	per	cell	 (each	being	 taken	 to	 represent	one	ER-mitochondria	contact	 site)	
was	quantified	(Fig3.7A).	The	fluorescent	Venus	signal	always	appeared	as	discrete	
puncta	associated	with	a	subset	of	mitochondria	regardless	of	the	concentration	of	
DNA	 transfected.	 No	 significant	 difference	 was	 detected	 between	 any	 of	 the	
experimental	 groups.	 An	 equivalent	 increase	 in	 protein	 levels	 resulting	 from	
increased	 concentrations	 of	 DNA	 was	 determined	 by	 anti-GFP	 immunostaining	
(Fig3.7B).	 For	 subsequent	 experiments,	 a	 concentration	 of	 1	 µg	 total	 DNA	 was	
transfected.	 As	 will	 be	 seen	 in	 section	 3.3.6	 below,	 the	 Venus	 reporter	 signal	
increases	in	response	to	chemical	and	stress-induced	changes	to	the	cell,	indicating	
that	expression	of	the	Venus	reporter	plasmids	alone	at	this	concentration	does	not	
saturate	the	number	of	ER-mitochondria	contact	sites	formed	in	the	cell.	
Furthermore,	we	generated	an	NSC34	cell	line	stably	expressing	V1-ER	and	V2-Mito	
plasmids	and	 long-term	expression	of	 the	Venus	 fusion	proteins	did	not	alter	 the	
discrete	fluorescent	puncta	pattern	as	observed	in	transiently	transfected	cells	(data	
not	shown).	Combined,	these	results	show	that	increasing	protein	levels	or	time	of	
expression	does	not	alter	the	BiFC	signal	and	therefore,	suggests	that	expression	of	
V1-ER	and	V2-Mito	 is	not	artificially	 inducing	contacts	but	 rather,	 is	 labelling	pre-
existing	sites	of	close	apposition	between	the	ER	and	mitochondria.							
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Fig	3.7:	Increasing	the	concentration	of	Venus	reporter	proteins	does	not	influence	
the	number	of	BiFC	puncta	per	cell.	(A)	NSC34	cells	were	transfected	with	0.5	µg,	1	
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µg	or	1.5	µg	total	DNA	concentration	at	a	1:1	ratio	of	V1-ER:	V2-Mito	and	imaged	by	
confocal	 microscopy.	 The	 mean	 number	 of	 BiFC	 puncta	 per	 cell	 was	 quantified.	
Statistical	significance	was	determined	by	one-way	Anova	followed	by	Holm-Sidak’s	
multiple	comparison	test.	Values	indicate	the	mean	number	of	BiFC	puncta	per	cell.	
n	=	3	independent	experiments	(23-27	cells	total).	Error	bars	represent	SEM.	(B)	An	
equivalent	increase	in	protein	levels	produced	from	increased	concentrations	of	DNA	
transfected	was	shown	using	anti-GFP	immunostaining	(red)	to	illustrate	an	increase	
in	 the	number	of	 cells	 showing	detectable	 fluorescence.	Cell	nuclei	were	 labelled	
with	DAPI	(blue).	Images	were	acquired	by	confocal	microscopy	with	a	20x	objective	
using	identical	acquisition	settings	per	experimental	group.	As	published	in	(Harmon	
et	al.,	2017).			
			
3.3.4	BiFC	puncta	are	highly	associated	with	the	ER	and	mitochondria	but	not	with	
other	organelles	of	the	cell	
The	reformation	of	the	Venus	reporter	proteins	only	depends	on	spatial	proximity	
and	therefore,	it	is	possible	that	a	positive	fluorescent	signal	could	be	observed	at	
other	sites	where	these	proteins	may	be	in	close	apposition.	To	investigate	this,	the	
percentage	 of	 BiFC	 puncta	 with	 a	 point	 of	 co-localisation	 to	 various	 organelle	
markers	was	quantified	(Fig3.8,	Table	3.2).	The	vast	majority	of	the	Venus	signal	was	
associated	with	ER	and	mitochondria	markers	with	very	few	puncta	co-localising	with	
EEA1	positive	endosomes,	the	Golgi	apparatus	or	the	nucleus.	Due	to	the	diffraction	
limit	of	confocal	microscopy,	BiFC	puncta	would	score	positive	for	co-localisation	if	
they	are	within	approximately	200	nm	of	the	organelle	marker.								
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Fig	3.8:	BiFC	puncta	are	highly	associated	with	the	ER	and	mitochondria	and	not	
with	other	organelles	of	the	cell.	Representative	images	of	NSC34	cells	transiently	
expressing	 V1-ER/V2-Mito	 plasmids	 with	 various	 organelle	 markers.	 The	 ER	 and	
Golgi	 were	 labelled	 by	 co-transfection	 of	 ER-DsRed2	 and	 Golgi-CFP	 expression	
plasmids	respectively	(Clontech).	Early	endosomes	and	mitochondria	were	labelled	
by	 immunostaining	with	anti-EEA1	 (endosomes)	or	anti-ATPB	 (mitochondria).	The	
cell	 nucleus	was	 labelled	with	 DAPI.	 Imaris	 image	 analysis	 software	was	 used	 to	
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quantify	the	total	number	of	BiFC	overlapping	with	the	corresponding	fluorescent	
organelle	 signal	 as	 detailed	 in	 chapter	 2,	 section	 2.9.3.	 Scale	 bars,	 10	µm.	n	 =	 3	
independent	 experiments	 (10-15	 cells	 per	 experimental	 group).	 As	 published	 in	
(Harmon	et	al.,	2017).					
Table	3.2.	Quantification	of	number	of	BiFC	puncta	overlapping	with	corresponding	
fluorescent	organelle	marker.	Values	indicate	%	BiFC	puncta	overlapping	with	the	
specific	organelle	marker	±	SEM.	n	=	3	 independent	experiments	 (10-15	cells	per	
experimental	group).			
Protein/organelle	labelled	 %	BiFC	puncta	co-localised	with	
organelle	marker	
ATPB	(Mitochondria)	 	 97.07	±	1.34		
ER-DsRed2	(ER)	 99.07	±	0.27	
EEA1	(Endosomes)	 10.74	±	2.36	
Golgi-CFP	(Golgi	Apparatus)	 8.95	±	3.47	
DAPI	(Nucleus)	 6.81	±	0.57	
	
3.3.5	 Super-resolution	 STED	 microscopy	 indicates	 that	 the	 BiFC	 puncta	 are	
continuous	structures	
Although	 the	 BiFC	 puncta	 appeared	 as	 discrete	 structures,	 due	 to	 the	 diffraction	
limitations	of	confocal	microscopy,	 it	could	not	be	ruled	out	that	these	structures	
could	be	composed	of	close,	unresolvable	objects.	To	investigate	this,	NSC34	cells	
expressing	V1-ER	and	V2-Mito	reporter	plasmids	were	imaged	by	super-resolution	
stimulated	 emission	 depletion	 (STED)	 microscopy	 that	 is	 capable	 of	 imaging	
structures	 below	 the	 diffraction	 limit	 of	 conventional	 light	 microscopy.	 	 Puncta	
imaged	with	 the	STED	 laser	had	 improved	 resolution	and	were	heterogeneous	 in	
shape	(Fig3.9A),	however	they	remained	as	discrete,	singular	structures	for	the	most	
part	and	therefore	it	was	concluded	that	diffraction	limited	scanning	laser	confocal	
microscopy	was	sufficient	for	quantifying	the	number	of	BiFC	puncta	within	a	cell.	
Measuring	 the	 size	 of	 these	 objects	 revealed	 that	 puncta	 ranged	 between	
approximately	100-700	nm	in	length	with	a	mean	diameter	of	310	nm	(Fig3.9B).			
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Fig	3.9:	Super-resolution	STED	microscopy	illustrates	that	BiFC	puncta	are	discrete	
singular	objects.	(A)	Representative	image	of	an	NSC34	cell	transiently	expressing	
the	Venus	reporter	proteins	imaged	with	a	confocal	versus	STED	microscope.	Scale	
bar,	1	µm.	(B)	Frequency	distribution	graph	illustrating	the	relative	frequency	of	BiFC	
puncta	size	with	bin	centres	in	0.1	µm	increments.	Puncta	were	measured	using	the	
“straight	line”	tool	on	ImageJ	across	the	widest	point	of	each	individual	punctum.	n	
=	111	BiFC	puncta	(7	cells	total).	Mean	value	=	0.31	µm.	As	published	in	(Harmon	et	
al.,	2017).					
	
	
	
	 93	
3.3.6	ER	stress	and	serum	deprivation	significantly	increases	the	mean	number	of	
BiFC	puncta	per	cell		
ER-mitochondria	contacts	are	dynamic	in	nature	and	have	been	shown	to	change	in	
response	 to	certain	 stress	 conditions	 (Bravo	et	al.,	2011;	Csordas	et	al.,	2006).	 In	
order	 to	 validate	 the	 BiFC	 method	 and	 test	 if	 it	 was	 sensitive	 to	 stress-induced	
changes,	NSC34	and	COS-7	cells	were	transfected	with	the	Venus	reporter	plasmids	
and	 treated	 for	 6	hours	with	2	µg	or	 10	µg	 tunicamycin,	 an	 inhibitor	of	N-linked	
glycosylation	 that	 consequently	 induces	 an	 ER	 stress	 response	 and	 G1	 cell	 cycle	
arrest	(Han	et	al.)	(Fig3.10A).	As	the	previous	super-resolution	STED	microscopy	data	
illustrated	that	the	BiFC	puncta	are	discrete,	singular	objects,	the	mean	number	of	
BiFC	puncta	per	cell	was	quantified	such	that	each	individual	fluorescent	spot	was	
taken	to	represent	one	site	of	ER-mitochondria	contact.	The	induction	of	ER	stress	
at	both	concentrations	of	tunicamycin	significantly	increased	the	mean	number	of	
BiFC	puncta	per	cell	in	comparison	to	DMSO	treated	controls	(Fig3.10B).	An	increase	
in	the	total	volume	of	Venus	signal	as	a	percentage	of	total	mitochondrial	volume	in	
both	 cell	 types	was	 also	observed,	 demonstrating	 that	 the	 increased	numbers	of	
fluorescent	puncta	were	not	due	to	an	increase	in	mitochondrial	network	(Fig3.10C).	
The	induction	of	ER	stress	was	confirmed	by	detection	of	spliced	XBP1	mRNA	and	it	
is	noteworthy	 that	 transfection	of	 the	V1-ER	and	V2-Mito	plasmids	alone	did	not	
induce	any	ER	stress	on	the	cell	(Fig3.10D).					
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Fig	 3.10:	 ER	 stress	 significantly	 increases	 the	mean	number	 of	 ER-mitochondria	
contacts	 per	 cell.	 (A)	Representative	 images	 of	 NSC34	 cells	 transfected	with	 V1-
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ER/V2-Mito	 plasmids	 treated	with	DMSO,	 2	 µg/ml	 or	 10	 µg/ml	 tunicamycin.	 The	
induction	of	ER	stress	significantly	increases	the	mean	number	of	BiFC	puncta	per	
cell	in	(B)	NSC34	and	(Bi)	COS-7	cells	and	(C)	significantly	increases	the	total	volume	
of	BiFC	signal	as	a	percentage	of	total	mitochondria	volume	in	all	cell	types.	n	=	3	
independent	 experiments	 (32-34	 cells	 for	 NSC34,	 29-32	 cells	 for	 COS-7).	 Values	
indicate	overall	mean	values	 from	the	three	 independent	experiments.	Error	bars	
indicate	SEM.	Statistical	significance	was	measured	using	one-way	ANOVA	followed	
by	Holm-Sidak’s	mutiple	comparison	test,	ns	(non-significant),	*p	<	0.05,	**p	<	0.01.	
(D)	ER	stress	was	confirmed	by	the	detection	of	spliced	Xbp1	mRNA	in	NSC34	cells	
by	gel	electrophoresis	and	under	UV	light.	Scale	bars,	10	µm.	Image	adapted	from	
(Harmon	et	al.,	2017).		   
Previous	 studies	 also	 showed	 that	 the	 extent	 of	 interaction	 between	 the	 ER	 and	
mitochondria	 varies	 in	 response	 to	 serum	 deprivation	 (Csordas	 et	 al.,	 2006).	 To	
further	test	the	validity	of	our	approach,	we	also	investigated	a	change	in	the	number	
of	BiFC	puncta	in	cells	grown	in	serum-free	media	for	24	hours.	Mirroring	the	effect	
seen	with	ER	stress	induction,	the	mean	number	of	BiFC	puncta	per	cell,	as	well	as	
the	 total	 volume	of	 Venus	 signal	 as	 a	 percentage	 of	 total	mitochondrial	 volume,	
significantly	 increased	 in	 comparison	 to	 cells	 grown	 in	media	 supplemented	with	
10%	 (v/v)	 foetal	 bovine	 serum	 (Fig3.11).	 These	 changes	were	 in	 agreement	with	
previously	published	studies	(Csordas	et	al.,	2006).							
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Fig	3.11:	Serum	deprivation	increases	the	number	of	ER-mitochondria	contacts	per	
cell.	 (A)	 Representative	 images	 of	 NSC34	 cells	 transfected	 with	 V1-ER/V2-Mito	
reporter	plasmids	grown	in	DMEM	supplemented	with	10%	(v/v)	FBS	or	in	serum-
free	DMEM	for	24	hours	post-transfection.	Serum	deprivation	significantly	increases	
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the	mean	 number	 of	 BiFC	 puncta	 in	 (B)	 NSC34	 cells	 and	 (Bi)	 COS-7	 cells	 and	 (C)	
significantly	 increases	 the	 total	 volume	 of	 BiFC	 signal	 as	 a	 percentage	 of	 total	
mitochondrial	volume	in	both	cell	types.	n	=	3	independent	experiments	(36-37	cells	
for	 NSC34,	 32-35	 cells	 for	 COS-7).	 Values	 indicate	 overall	 mean	 values	 from	 3	
independent	 experiments.	 Error	 bars	 represent	 SEM.	 	 Statistical	 significance	was	
measured	using	unpaired	two-tailed	t-test,	*p<0.05,	**p<0.01.	Scale	bars,	10	µm.	
Image	adapted	from	(Harmon	et	al.,	2017).				
	
In	 order	 to	 test	 the	 strength	 of	 the	 BiFC	 technique	 in	 comparison	 to	 one	 of	 the	
existing	methods	for	detecting	ER-mitochondria	associations,	we	exposed	cells	with	
fluorescently	 labelled	 ER	 and	mitochondria	 to	 the	 same	 stress	 conditions	 tested	
above.	 In	this	method,	any	changes	 in	overall	co-localisation	between	the	ER	and	
mitochondria	 signals	 is	 indicative	 of	 an	 increase	 or	 decrease	 in	 ER-mitochondria	
contacts.	 In	 cells	 treated	with	 tunicamycin	 there	was	a	 significant	 increase	 in	 the	
extent	of	co-localisation	between	the	ER	and	mitochondria	signals	in	agreement	with	
the	 change	 observed	 with	 the	 BiFC	 technique	 (Fig3.12A).	 However,	 using	 this	
method,	no	significant	change	in	co-localisation	was	detected	in	serum	deprived	cells	
(Fig3.12B).	This	suggests	that	the	BiFC	method	is	capable	of	detecting	changes,	also	
observed	with	high	resolution	EM	techniques	(Csordas	et	al.,	2006),	that	simple	co-
localisation	analyses	may	not	be	sensitive	enough	to	detect.					
	
	
	 98	
	
Fig	 3.12: Colocalisation	 analysis	 of	 fluorescently	 labelled	 ER	 and	mitochondria	
shows	an	increase	in	ER-mitochondria	contacts	in	cells	treated	with	tunicamycin	
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but	not	 in	 serum-deprived	NSC34	 cells.	 (A)	Representative	 image	of	NSC34	 cells	
transfected	with	ER-DsRed2	(Green)	and	immunostained	with	anti-ATPB	(Magenta)	
to	 label	 the	 ER	 and	 mitochondria	 respectively,	 treated	 with	 DMSO	 or	 10	 µg/ml	
tunicamycin.	Co-localisation	of	ER	and	mitochondria	signals	was	quantified	by	(A(i))	
Pearon’s	 Correlation	 Coefficient	 (PCC)	 and	 (A(ii))	Mander’s	 Correlation	 Coefficient	
(MCC).	n	=	4	independent	experiments	(26	cells	total).	(B)	Co-localisation	of	ER	and	
mitochondria	 signals	 was	 also	 quantified	 in	 control	 NSC34	 cells	 versus	 serum	
deprived	cells	showing	no	significant	change	in	co-localisation	as	measured	by	either	
(B(i))	 PCC	 or	 (B(ii))	 MCC.	 n	 =	 3	 independent	 experiments	 (19	 cells	 total).	 Values	
indicate	 the	 overall	 mean	 co-localisation	 values.	 Statistical	 significance	 was	
measured	using	unpaired	two-tailed	t-test,	ns	(non-significant),	*p<0.05,	**p<0.01.	
Error	bars	represent	SEM.	Scale	bars,	10	µm.	Image	adapted	from	(Harmon	et	al.,	
2017).					
	
3.3.7	 siRNA	 knockdown	 of	 Mitofusin-2	 expression	 increases	 ER-mitochondria	
interactions.		
Mitofusin-2	 (MFN2)	 is	a	well-studied	 tether	of	ER-mitochondria	contacts,	 forming	
homo-	 and	 heterodimers	 with	MFN1	 on	 the	 outer	mitochondrial	membrane	 (de	
Brito	 and	 Scorrano,	 2008).	 However,	 the	 exact	 role	 of	 this	 protein	 in	 regulating	
associations	 is	 controversial.	 Early	 reports	 using	 fluorescence	 co-localisation	
analyses	reported	that	MFN2	is	a	positive	regulator	of	ER-mitochondria	contact	sites	
with	an	overexpression	of	the	protein	leading	to	an	increase	in	associations	while		
knocking-down	expression	reduced	the	number	of	contacts	(de	Brito	and	Scorrano,	
2008).	Subsequent	studies	however,	suggested	that	MFN2	may	exhibit	a	negative	
regulation	over	organelle	junctions	and	knocking-down	of	MFN2	actually	increases	
the	number	of	contacts	as	shown	by	EM	(Leal	et	al.,	2016;	Filadi	et	al.,	2015).	It	has	
been	 suggested	 that	 these	 discrepancies	 in	 observations	 may	 be	 due	 to	 the	
sensitivity	 of	 the	 fluorescence	 co-localisation	 method	 to	 changes	 in	 organelle	
morphology	(Filadi	et	al.,	2015).	
Here,	 our	 BiFC	method	was	 used	 to	 investigate	 any	 changes	 in	 ER-mitochondria	
contacts	brought	upon	by	siRNA	mediated	silencing	of	MFN2	expression	in	NSC34	
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cells	stably	expressing	the	V1-ER/V2-Mito	reporter	plasmids.	A	significant	increase	
in	 the	 number	 of	 BiFC	 puncta	 resulting	 from	 an	 approximately	 80%	 reduction	 in	
MFN2	 protein	 levels	 was	 observed	 (Fig	 3.13).	 This	 increase	 in	 contacts	 is	 in	
agreement	with	the	previously	published	EM	studies,	suggesting	that	MFN2	may	be	
a	 negative	 regulator	 of	 ER-mitochondria	 contacts	 (Leal	 et	 al.,	 2016;	 Filadi	 et	 al.,	
2015).													
   
 
Fig	3.13:	Silencing	of	MFN2	expression	significantly	 increases	the	number	of	ER-
mitochondria	contacts.	Transfection	of	siRNA	against	MFN2	reduced	relative	protein	
levels	 to	 approximately	 20%	 in	 NSC34	 cells	 stably	 expressing	 V1-ER/V2-Mito	 as	
confirmed	by	western	blot.	a-Tubulin	was	used	as	a	loading	control.	Knock-down	of	
expression	was	associated	with	a	 significant	 increase	 in	 the	mean	number	of	 ER-
mitochondria	contacts	per	cell.	n	=	3	independent	experiments	(30-32	cells	total).	
Values	indicate	the	overall	mean	values	of	the	three	independent	experiments.	Error	
bars	represent	SEM.	Statistical	significance	was	determined	by	unpaired	two-tailed	
t-test,	***p<0.001.	Image	as	published	in	(Harmon	et	al.,	2017).			
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3.3.8	The	BiFC	technique	can	be	adapted	to	report	on	ER-endosome	contact	sites	
As	 the	 BiFC	 technique	 only	 relies	 on	 spatial	 proximity	 of	 the	 complementary	
fragments,	easy	adaptations	can	be	made	by	varying	the	targeting	sequences	of	the	
Venus	 fusion	 reporter	proteins	 to	 label	different	organelle	contact	 sites.	Previous	
work	in	the	Skehel	lab,	carried	out	by	Ms.	Emma	Lund,	generated	Venus-2	fragments	
fused	to	the	full-length	endosomal	protein	VAMP4	sequence	(V2-VAMP4)	or	just	to	
the	C-terminal	endosomal	targeting	sequence	(V2-VAMP4-CT)	as	outlined	in	chapter	
2.	It	was	hypothesised	that	transfecting	V2-VAMP	or	V2-VAMP4-CT	in	combination	
with	the	V1-ER	plasmid	would	 label	sites	of	close	apposition	between	the	ER	and	
endosomes.	Co-expression	of	V1-ER	with	the	shorter	length	V2-VAMP4-CT	plasmid	
generated	 discrete	 fluorescent	 puncta	 that	 was	 reminiscent	 of	 the	 pattern	 of	
fluorescence	seen	with	the	V1-ER/V2-Mito	combination	(Fig3.14).	However,	when	
V1-ER	was	co-expressed	with	the	full-length	V2-VAMP4	reporter	protein,	a	typical	
cell	had	large	fluorescent	aggregates	that	were	mostly	localised	around	the	nucleus,	
with	only	relatively	few	fluorescent	puncta	dispersed	throughout	the	periphery	of	
the	cell	(Fig3.14).	The	larger	length	V2-VAMP4	protein	could	be	artificially	inducing	
contacts	and	may	be	detrimental	to	the	cell	or	the	presence	of	the	aggregates	could	
indicate	a	defect	in	vesicular	trafficking.	These	results	mirror	those	obtained	by	Ms.	
Emma	Lund	in	the	Skehel	lab	who	illustrated	that	the	presence	of	the	full-length	V1-
VAPB	plasmid	in	combination	with	either	the	full	length	V2-VAMP4	or	V2-VAMP4-CT	
also	 led	 to	 the	appearance	of	 large	 fluorescent	 aggregates.	 The	difference	 in	 the	
fluorescent	signal	detected	may	be	due	to	the	length	of	the	reporter	proteins	used	
or	by	an	effect	of	VAMP4	overexpression	(Unpublished	data,	data	not	shown).												
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Fig	 3.14:	 Co-expression	 of	 V1-ER	 and	 V2-VAMP4-CT	 yields	 discrete	 fluorescent	
puncta.	Representative	images	of	an	NSC34	cell	transfected	with	V1-ER	/	V2-VAMP4-
CT	showing	distinct	fluorescent	puncta	dispersed	throughout	the	cell	or	an	NSC34	
cell	transfected	with	V1-ER	and	the	larger	V2-VAMP4	showing	the	presence	of	large	
fluorescent	aggregates	surrounding	the	nucleus.		
	
3.4	Discussion	
3.4.1	V1-VAPB	and	V1-ER	differentially	label	ER-mitochondria	contact	sites	
In	 this	 chapter,	data	 is	presented	on	 the	development	and	validation	of	 the	BiFC	
system	for	detecting	MAMs	by	targeting	split	 fluorescent	Venus	 fragments	to	the	
cytoplasmic	face	of	the	ER	and	the	outer	mitochondrial	membrane	(Harmon	et	al.,	
2017).	 The	 pattern	 of	 fluorescence	 obtained	 from	 co-transfection	 of	 the	
complementary	Venus	fragments	varied	greatly	depending	on	whether	the	Venus	
fragment	 fused	 to	 the	 full-length	 VAPB	 protein	 (V1-VAPB)	 or	 to	 just	 the	 VAPB	
transmembrane	domain	(V1-ER)	was	transfected.	Expression	of	V1-VAPB	with	V2-
Mito	 generated	 a	 fluorescent	 signal	 that	 appeared	 to	 be	 associated	 with	 every	
mitochondrion	 of	 the	 cell	 and	 extended	 around	 a	 large	 proportion	 of	 the	
mitochondrial	 surface	area.	 This	was	 in	 stark	 contrast	 to	 the	discrete	 fluorescent	
punctate	signal	detected	upon	co-transfection	of	the	V1-ER/V2-Mito	plasmids	that	
was	closely	associated	to	only	a	sub-set	of	mitochondria	in	the	cell.	The	differences	
in	fluorescent	signal	may	be	due	to	VAPB	overexpression-induced	increases	in	ER-
	 103	
mitochondria	contacts,	as	has	been	previously	reported	(Stoica	et	al.,	2014)	or	as	a	
result	 of	 the	 longer	 length	 of	 the	 V1-VAPB	 reporter	 protein,	 allowing	 for	 the	
detection	 of	 wider	 ER-mitochondria	 junctions.	 The	 effects	 of	 the	 lengths	 of	 the	
reporter	 proteins	 on	 the	 fluorescent	 signal	 obtained	 could	 be	 examined	 by	 the	
addition	of	non-functional	linker	sequences	to	the	reporter	proteins	which	may	allow	
for	 the	 adaptation	 of	 the	 BiFC	 system	 to	 detect	 ER-mitochondria	 junctions	 of	
different	lengths.		
A	recent	study,	published	at	the	same	time	as	our	BiFC	method,	also	used	a	split-GFP	
based	technique	to	detect	ER-mitochondria	contact	sites	(Cieri	et	al.,	2018).	Similar	
to	what	we	observe	upon	co-transfection	of	V1-ER	and	V2-Mito,	this	group	detect	
discrete	 fluorescent	 puncta	 associated	 with	 a	 subset	 of	 mitochondria	 with	 their	
reporter	 constructs.	 Furthermore,	 using	 this	 approach,	 they	 too	 could	 quantify	
stress-induced	changes	to	the	MAMs,	providing	supporting	evidence	for	the	strength	
of	 fluorescence	 complementation	 assays	 in	 the	 detection	 of	 ER-mitochondria	
associations.	 Interestingly,	 this	 group	 used	 two	 different	 reporter	 proteins	 that	
varied	in	the	lengths	of	the	amino	acid	linker	sequences,	allowing	one	construct	to	
detect	on	close	junctions	of	around	10	nm	and	the	other	to	reporter	on	wider	contact	
sites	of	approximately	40	–	50	nm.	This	result	illustrates	how	altering	the	length	of	
the	 reporter	 proteins	 used	 can	 indeed	detect	 organelle	 contact	 sites	 of	 different	
sizes,	 independent	 of	 any	 functional	 consequence	 of	 specific	 protein	 over-
expression	(Cieri	et	al.,	2018).			
3.4.2	The	BiFC	technique	can	recapitulate	changes	in	ER-mitochondria	contacts	in	
agreement	with	high-resolution	EM	studies	
Super-resolution	 imaging	 of	 the	 BiFC	 puncta	 indicated	 that	 these	 contacts	 are	
heterogeneous	in	size,	ranging	from	about	100-700	nm	in	length.	This	size	range	is	
within	the	scope	of	what	has	previously	been	quantified	by	EM	data,	showing	that	
regions	of	close	apposition	between	the	ER	and	mitochondria	can	extend	for	several	
hundred	nanometres	around	the	surface	of	the	mitochondria	(Sood	et	al.,	2014).	The	
fact	that	the	BiFC	puncta	remain,	for	the	most	part,	as	singular	objects	even	with	the	
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improved	resolution	of	the	STED	images,	justifies	our	use	of	confocal	microscopy	to	
accurately	quantify	the	total	number	of	BiFC	puncta	per	cell.	The	relative	ease	by	
which	 the	data	 can	be	analysed	highlights	one	of	 the	great	 strengths	of	 the	BiFC	
system	for	the	detection	of	ER-mitochondria	contacts.		
To	validate	the	usefulness	of	the	BiFC	technique,	a	significant	increase	in	the	number	
of	 ER-mitochondria	 contacts	 induced	by	 ER	 stress,	 serum	deprivation	 and	 knock-
down	of	Mfn2	was	detected,	which	supported	the	existing	 literature	(Filadi	et	al.,	
2015;	Csordas	et	al.,	2006).	Of	all	the	techniques	used	to	detect	MAMs,	EM	has	by	
far	the	highest	resolution	but	is	technically	challenging	and	can	only	be	carried	out	
on	fixed	samples.	We	have	shown	here	that	the	BiFC	technique	can	report	on	the	
same	increases	in	ER-mitochondria	contacts	as	shown	by	EM,	while	having	a	much	
higher	through-put	and	the	benefit	of	being	able	to	be	used	in	living	cells,	allowing	
investigations	 into	 MAM	 dynamics	 (explored	 further	 in	 chapter	 4).	 This	 also	
highlights	the	advantage	of	the	BiFC	system	over	the	proximity	ligation	assays	that	
are	also	 limited	 to	 fixed	samples	 (Tubbs	et	al.,	2014).	The	strength	of	 the	BiFC	 in	
comparison	 to	 fluorescent	 co-localisation	 analysis	 is	 clearly	 demonstrated	 in	 (Fig	
3.12B)	 where	 the	 sensitivity	 of	 the	 co-localisation	 analysis	 was	 insufficient	 in	
detecting	 serum	 deprivation	 induced	 changes	 in	 ER-mitochondria	 associations.	
Dimerization-dependent	 fluorescent	proteins	 (ddFPs),	 similar	 to	 the	BiFC	method,	
depend	 on	 the	 association	 of	 two	 protein	 monomers	 targeted	 to	 separate	
membranes	which	improves	detection	limits	and	can	also	be	used	in	live-cell	imaging	
(Alford	et	al.,	2012).	However,	a	potential	advantage	of	the	BiFC	method	over	ddFPs	
is	improved	signal-to-noise	ratio	as	individual	venus	fragments	emit	no	fluorescence	
and	this	could	allow	for	the	detection	of	weaker	reporter	signals.			
The	 use	 of	 the	 V1-ER	 and	 V2-Mito	 reporter	 plasmids	 effectively	 allows	 for	 the	
detection	of	tight	ER-mitochondria	contacts	with	a	maximum	predicted	junction	size	
of	 10	 nm.	 Csordas	 et	 al	 (2006)	generated	 artificial	 protein	 tethers	 to	 tighten	 ER-
mitochondria	contacts	which	consisted	of	46	amino	acid	residues	in	addition	to	a	red	
fluorescent	protein,	creating	a	construct	of	approximately	5	nm	in	length	(Csordas	
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et	al.,	2006).	 In	combination,	 the	 linker	sequences	of	V1-ER	and	V2-mito	adds	85	
amino	acids	in	addition	to	the	Venus	protein	and	therefore,	these	proteins	are	likely	
reporting	on	distances	between	the	ER	and	OMM	of	around	6-10	nm,	depending	on	
the	 exact	 conformations	 of	 the	 reporter	 proteins.	 It	 has	 been	 hypothesised	 that	
different	 size	 junctions	 between	 the	 ER	 and	mitochondria	 could	 be	 reflective	 of	
different	protein	compositions	at	these	sites	where	specific	functions	of	the	MAMs	
are	 carried	 out	 [As	 reviewed	 by	 (Giacomello	 and	 Pellegrini,	 2016).	 The	 exact	
functional	 significance	 of	 tight	 ER-mitochondria	 contacts	 <10	 nm	 is	 yet	 to	 be	
elucidated.			
3.4.3	Limitations	of	the	BiFC	technique	
One	concern	that	arises	from	the	BiFC	system	is	the	potential	for	the	Venus	fusion	
proteins	 to	 induce	 the	 creation	 of	 ER-mitochondria	 contacts	 rather	 than	 only	
reporting	on	pre-existing	ones,	particularly	in	light	of	studies	showing	that	artificial	
protein	tethers	can	be	used	to	induce	ER-mitochondria	associations	(Csordas	et	al.,	
2010;	Csordas	et	al.,	2006).	However,	EM	data	has	shown	the	presence	of	very	tight	
contacts	>6	nm	in	wild-type,	untreated	RBL-2H3	cells	illustrating	that	contact	sites	of	
this	 range	 are	 not	 solely	 an	 artefact	 of	 the	 BiFC	 system	 (Csordas	 et	 al.,	 2006).	
Furthermore,	when	Csordas	et	al	(2010)	used	rapamycin	inducible	ER-mitochondria	
linkers,	 there	 was	 a	 rapid	 induction	 of	 ER-mitochondria	 associations	 and	 a	
“zippering”	effect	of	the	proteins	around	the	surface	of	the	mitochondria	upon	the	
addition	 of	 rapamycin	 (Csordas	 et	 al.,	 2010).	 Even	 after	 long-term	 expression	 in	
stably	transfected	NSC34	cells,	the	fluorescent	signal	generated	from	expression	of	
the	 V1-ER	 /	 V2-Mito	 BiFC	 reporter	 proteins	 always	 remains	 as	 discrete	 puncta	
associated	 with	 a	 subset	 of	 mitochondria.	 As	 shown	 in	 Fig3.3	 by	 anti-GFP	
immunostaining,	the	Venus	fusion	proteins	are	targeted	all	along	the	surface	of	the	
respective	organelles	and	therefore,	if	the	association	of	the	complementary	Venus	
fragments	was	 inducing	contact	formation,	one	could	expect	a	similar	“zippering”	
effect	to	be	observed.	Future	experiments	using	EM	to	quantify	the	mean	number	
of	ER-mitochondria	contact	sites	<10	nm	in	untransfected	cells	and	comparing	this	
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to	the	mean	number	of	contact	sites	detected	by	the	BiFC	technique,	would	provide	
supporting	 evidence	 on	whether	 the	 Venus	 reporter	 proteins	were	 induced	 new	
contact	formation	or	exclusively	labelling	pre-existing	contact	sites.		
The	ability	of	the	BiFC	system	to	detect	reductions	 in	ER-mitochondria	contacts	 is	
unclear	 from	 the	 results	 of	 this	 chapter	 as	 all	 of	 the	 stresses	 tested	 significantly	
increased	organelle	associations.	Additionally,	the	reversibility	of	the	BiFC	system	is	
questionable	and	 the	dissociation	of	 the	complementary	 fragments	has	yet	 to	be	
clearly	 shown	 (Kerppola,	 2006).	 However,	 even	 if	 the	 reformation	 of	 the	 Venus	
fragments	is	irreversible,	it	is	still	interesting	as	to	why	BiFC	puncta	remain	restricted	
to	a	subset	of	mitochondria	and	this	pattern	of	fluorescence	does	not	vary	greatly	
over	 time.	 This	 could	 suggest	 that	 there	 are	 some	 unique	 properties	 of	 these	
mitochondria	that	allow	them	to	form	particularly	tight	contact	sites	in	comparison	
to	 the	majority	 of	 the	mitochondrial	 population	 or	 perhaps	 junctions	 of	 this	 size	
could	 be	 linked	 to	 specific	 functions	 of	 the	 MAMs	 for	 example,	 mitochondria	
undergoing	fission	events.	The	significance	of	these	tight	ER-mitochondria	contacts	
will	be	discussed	in	further	detail	in	chapter	4	of	this	thesis.	As	described	in	section	
3.1.1	of	this	chapter,	any	of	the	proteins	enriched	at	ER-mitochondria	contact	sites	
are	also	present	along	the	portions	of	ER	and	mitochondrial	membranes	not	lying	
within	close	proximity	to	one	another.	Therefore,	it	is	not	possible	to	compare	the	
BiFC	 puncta	 signal	 with	 that	 of	 any	 other	 MAM-specific	 protein	 by	
immunofluorescent	staining.	Consequently,	the	protein	compositions	of	these	tight	
contact	sites	remain	unclear	at	this	time.	As	the	interaction	of	VAPB	with	its	MAM-
binding	partner,	PTPIP51,	relies	on	the	entire	cytosolic	face	of	VAPB	(De	Vos	et	al.,	
2012),	 it	 implies	 that	 PTPIP51	 is	 not	 necessarily	 an	 essential	 component	 of	 the	
contact	sites	labelled	by	the	V1-ER	reporter	protein.	However,	it	is	worth	noting	that	
the	TMD	domain	of	VAPB	present	in	the	V1-ER	reporter	plasmid	still	possesses	the	
GxxxG	dimerization	motif	that	may	permit	oligomerisation	of	the	reporter	protein	
with	endogenous	VAPB.	This	may	exert	some	influence	over	the	localisation	of	the	
reporter	proteins	and	the	specific	contact	sites	labelled.	The	introduction	of	a	point	
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mutation	 to	 this	motif	would	determine	 if	 the	VAPB	TMD	domain	 influences	 the	
specific	MAMs	labelled	by	the	BiFC	system.		
3.4.4	Adaptations	to	the	BiFC	technique		
Finally,	we	 have	 shown	how	 a	 simple	 adaptation	 to	 the	 technique,	 changing	 the	
mitochondrial	targeting	sequence	to	the	endosomal	targeting	sequence	of	VAMP4	
can	 be	 used	 to	 report	 on	 ER-endosome	 contact	 sites.	 In	 this	 manner,	 the	 BiFC	
method	could	be	utilised	to	investigate	any	kind	of	organelle	contact	site.	Current	
work	in	the	Skehel	lab	is	now	attempting	to	incrementally	increase	the	lengths	of	the	
linker	 sequences	 of	 the	V1-ER	 fusion	 proteins	 to	 report	 on	 junctions	 of	 different	
lengths	and	finally,	ongoing	work	is	trying	to	replace	the	split	Venus	probe	with	split	
sf-Cherry	 probes	 (Kamiyama	 et	 al.,	 2016).	 The	 combination	 of	 these	 adaptations	
would	allow	for	the	simultaneous	detection	of	different	organelle	contact	sites	or	
simultaneous	 detection	 of	 different	 length	 junctions,	 further	 highlighting	 the	
strength	and	versatility	of	the	BiFC	technique.									
3.5	Chapter	conclusion	
In	conclusion,	the	BiFC	system	is	capable	of	detecting	and	visualising	MAMs	in	both	
fixed	and	living	cells	and	using	this	technique,	we	can	report	on	known	changes	to	
ER-mitochondria	 interactions	 in	 agreement	 with	 previously	 published,	 electron	
microscopy	 data.	 This	 technique	 offers	 considerable	 benefits	 over	 pre-existing	
techniques	that	have	been	employed	to	investigate	the	MAMs	and	the	system	can	
be	adapted	to	detect	ER-mitochondria	junctions	of	different	sizes.	The	V1-ER	and	V2-
Mito	 fusion	 proteins	 report	 on	 contact	 sizes	 of	 approximately	 6-10	 nm	 and	 the	
discrete,	 punctate	 pattern	 of	 fluorescence	 generated	 by	 co-transfection	 of	 these	
proteins	 is	 always,	 closely	 associated	 to	 a	 sub-set	 of	mitochondria	 within	 a	 cell.	
Further	work	is	required	to	elucidate	the	functional	significance	of	these	particularly	
tight	contacts	and	to	determine	any	particular	properties	of	this	sub-population	of	
mitochondria	in	relation	to	Ca2+	signalling	or	biogenesis	etc.	which	will	be	explored	
in	the	next	chapter	of	this	thesis.											
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Chapter	4	
Functional	significance	of	tight	ER-
mitochondria	contact	sites		
4.1	Background	
Sites	of	close	apposition	between	the	ER	and	mitochondria	are	heterogeneous	 in	
their	 structure	 and	 can	 vary	 in	 the	 overall	 surface	 area	 of	 the	 mitochondria	
membrane	that	is	held	in	close	proximity	to	the	ER	(the	“length”	of	the	contact	site)	
(Fig	4.1A)	or	the	distance	at	which	the	organelles	are	held	apart	(contact	“thickness”	
or	 “distance”)	 [As	 reviewed	 by	 (Giacomello	 and	 Pellegrini,	 2016)]	 (Fig4.1B).	 High	
resolution	EM	 images	have	shown	that	 the	ER	membrane	can	extend	around	the	
OMM	and	 retain	 close	 contact	 for	 several	 hundred	 nanometres	 and	 has	 a	mean	
junction	distance	of	around	9-15	nm	at	the	smooth	ER,	with	junction	sizes	increasing	
to	around	30	nm	at	the	rough	ER	(Csordas	et	al.,	2006;	Sood	et	al.,	2014).	However,	
tighter	junctions	<6	nm	have	also	been	identified	as	well	as	much	larger	contact	sites	
reaching	distances	of	up	to	60	nm	(Csordas	et	al.,	2006;	Wang	et	al.,	2015).	Some	of	
this	variability	in	MAM	structure	may	be	cell-type	specific,	however,	in	the	previous	
chapter	we,	in	addition	to	several	other	published	studies,	have	shown	that	these	
structures	 are	 plastic	 and	 can	 vary	 in	 response	 to	metabolic	 changes	 of	 the	 cell	
(Bravo	et	al.,	 2011;	Harmon	et	al.,	 2017;	Csordas	et	al.,	 2006).	This	 suggests	 that	
ultrastructural	reorganisation	of	the	length	and	thickness	of	the	MAMs	could	be	an	
important	factor	in	regulating	the	specific	functions	of	the	contact	sites.	It	is	not	yet	
clear	what	signalling	mechanisms	induce	these	changes	and	the	exact	mechanisms	
of	 contact	 plasticity	 have	 yet	 to	 be	 elucidated	 but	 it	 is	 plausible	 to	 think	 that	 a	
disruption	 in	either	of	 these	adaptive	processes	could	be	 linked	 to	defects	 in	 the	
MAMs	as	seen	in	neurodegeneration	(Giacomello	and	Pellegrini,	2016).		
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Fig	4.1:	ER-mitochondria	contact	sites	are	structurally	heterogeneous.	(A)	Cryo-EM	
images	 of	mouse	 hepatocytes	 show	 variations	 in	 the	 lengths	 of	 ER-mitochondria	
contacts	on	different	mitochondria	(left	panel).	ER-mitochondria	contacts	formed	at	
the	 rough	ER	are	highlighted	 in	purple	while	 those	 formed	at	 the	 smooth	ER	are	
highlighted	 in	 blue,	 illustrating	 the	 tighter	 junctions	 of	 those	 formed	 between	
mitochondria	 and	 smooth	 ER	 (right	 panel).	 (B)	 Cryo-EM	 image	 of	 mouse	 liver	
hepatocyte	(top	panel).	Zoomed	image	of	the	boxed	region	shows	variation	in	the	
thickness	of	the	junction	across	a	contact	site	(bottom	panel).	Image	adapted	with	
copyright	permission	from	(Giacomello	and	Pellegrini,	2016)	obtained	via	RightsLink.					
	
Although	there	is	a	certain	degree	of	flexibility	in	the	structure	of	ER-mitochondria	
contacts,	it	is	possible	that	this	range	of	variability	is	restricted	by	the	specific	protein	
composition	at	these	sites.	Protein	complexes	identified	as	having	a	tethering	role	in	
organelle	complexes	are	heterogeneous	in	size	and	the	presence	of	different	tethers	
at	contact	sites	may	define	the	sizes	of	those	particular	junctions.	For	example,	the	
calcium	exchange	function	of	the	MAMs	relies	on	the	formation	of	a	protein	complex	
between	IP3R	and	VDAC	mediated	by	the	chaperone	protein	grp75	(Szabadkai	et	al.,	
2006).	Artificial	tightening	of	the	ER-mitochondria	junction	to	below	7	nm	massively	
reduced	mitochondrial	calcium	uptake	and	it	is	predicted	that	this	distance	was	too	
short	 to	 properly	 facilitate	 the	 formation	 of	 the	 calcium	 transport	 machinery	
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(Csordas	 et	 al.,	 2010;	 Giacomello	 and	 Pellegrini,	 2016).	 Similarly,	 contact	 sites	
greater	 than	 25	 nm	 in	 thickness	 are	 assumed	 to	 be	 too	 large	 to	 allow	 for	 these	
proteins	 on	 opposing	membranes	 to	 bind	 (Giacomello	 and	 Pellegrini,	 2016).	 This	
highlights	 the	 interesting	 possibility	 that	 if	 junctions	 of	 a	 particular	 distance	 are	
required	to	facilitate	the	formation	of	certain	MAM	protein	complexes,	then	perhaps	
different	 sized	 junctions	 could	be	 attributed	 to	 carrying	out	 specific	 functions.	 In	
further	 support	 of	 this,	 early	markers	 of	 autophagy	 can	 be	 localised	 to	wide	 ER-
mitochondria	contact	sites	of	around	50	nm	and	it	is	hypothesised	that	this	large	gap	
might	 be	 necessary	 to	 facilitate	 the	 autophagic	machinery	 and	 formation	 of	 the	
omegasome	(Hamasaki	et	al.,	2013;	Giacomello	and	Pellegrini,	2016).	Therefore,	it	
may	not	be	accurate	to	define	MAMs	as	singular	structures	carrying	out	a	wide	range	
of	 functions	 but	 rather,	 as	more	 evidence	 emerges,	 it	 could	 be	 possible	 to	 sub-
classify	them	based	on	their	size	range	and	functional	roles.	
	
4.2	Chapter	aims				
In	the	previous	chapter,	the	development	of	split-Venus	fusion	proteins	that	report	
on	 ER-mitochondria	 contacts	 <10	 nm	 was	 described.	 However,	 the	 functional	
significance	of	MAMs	of	this	tight	distance	is	not	well	understood.	Additionally,	it	is	
not	clear	why	the	fluorescent	signal	obtained	from	co-transfection	of	the	reporter	
proteins	was	associated	with	only	a	sub-set	of	mitochondria	within	a	cell.	Therefore,	
the	 overall	 aims	 of	 this	 chapter	 were	 to	 investigate	 the	 structural	 and	 dynamic	
properties	of	contacts	<10	nm	in	thickness	as	reported	on	by	the	BiFC	technique	and	
to	try	and	attribute	contacts	of	this	size	to	any	specific	functions	of	ER-mitochondria	
contact	sites.	This	was	achieved	by	trying	to	correlate	the	 localisation	of	 the	BiFC	
puncta	 with	 a	 variety	 of	 fluorescently-labelled	 proteins	 associated	 with	 specific	
functions	of	the	MAMs.	Furthermore,	we	aimed	to	elucidate	any	unique	properties	
of	the	sub-set	of	mitochondria	associated	with	contacts	of	this	size	by	investigating	
changes	in	mitochondrial	membrane	potential	and	resting	calcium	concentrations.			
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4.3	Results	
4.3.1	 BiFC	 puncta	 are	 stable	 structures	 and	 remain	 closely	 associated	with	 the	
mitochondria	in	living	cells.	
As	 discussed	 previously,	 a	 strong	 advantage	 of	 the	 BiFC	 technique	 over	 some	
alternative	methods	for	investigating	ER-mitochondria	interactions	is	its	ability	to	be	
used	in	living	cells,	allowing	for	investigations	into	MAM	dynamics	to	be	carried	out.	
For	this	purpose,	COS-7	cells	were	chosen	due	to	their	flat	morphology,	minimising	
the	number	of	BiFC	that	would	move	in	and	out	of	the	focal	plane	over	the	duration	
of	the	live-cell	videos	(Fig4.2A).	Quantifying	changes	in	the	number	of	BiFC	puncta	
per	 frame	 over	 the	 course	 of	 10	minute	 videos,	 imaged	 at	 a	 single	 focal	 plane,	
revealed	that	the	BiFC	puncta	are	very	stable	structures	and	their	numbers	do	not	
vary	much	over	the	duration	of	the	time	measured	(Fig4.2B)(Video	4.1,	Appendix	I).	
Using	 Imaris	 image	 analysis	 software,	 the	 displacement	 length	 of	 each	 individual	
fluorescent	puncta,	from	its	initial	position	at	the	start	of	the	video	to	its	position	in	
the	 final	 frame,	 could	 be	 automatically	 quantified,	 in	 addition	 to	 the	 mean	
movement	speed.	Plotting	these	values	against	one	another	revealed	a	mild,	positive	
correlation	 between	 the	 two	 (Fig4.2C).	 Due	 to	 the	 highly	 dynamic	 nature	 and	
constant	 restructuring	 of	 the	 mitochondrial	 network,	 automated	 tracking	 of	 the	
mitochondria	 was	 a	 challenge.	 To	 overcome	 this,	 ImageJ	 was	 used	 to	 manually	
measure	 the	 straight-line	 distance	 of	 individual	 BiFC	 puncta,	 as	 well	 as	 their	
associated	mitochondrion,	from	the	initial	to	end-point	positions	over	the	course	of	
the	live-cell	video.	Not	unexpectedly,	a	very	high	correlation	between	the	movement	
of	the	two	structures	suggests	that	the	movement	of	the	fluorescent	BiFC	puncta	is	
dependent	on	the	movement	of	its	associated	mitochondrion	(Fig4.2D).			
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Fig	4.2:	BiFC	puncta	are	stable	structures	and	remain	closely	associated	to	their	
corresponding	mitochondrion	in	real-time.	(A)	Representative	still-frame	image	of	
a	10	minute	live-cell	video	of	a	COS-7	cell	transiently	expressing	V1-ER	/	V2-Mito	and	
stained	with	MitoTracker	Deep	Red	FM	dye.	Scale	bar,	10	µm.	Images	acquired	at	
0.25	FPS	(B)	The	number	of	BiFC	puncta	per	cell	in	the	first	frame	of	the	live-cell	video	
was	quantified	and	normalised	to	give	a	value	of	100%.	The	number	of	BiFC	puncta	
in	every	subsequent	frame	was	then	quantified	over	the	course	of	a	10	minute	video	
and	expressed	as	a	percentage	of	the	initial	number	of	BiFC	puncta,	indicating	that	
these	are	stable	structures	and	their	numbers	do	not	deviate	much	over	the	duration	
of	time	imaged.	Error	bars	represent	SEM.	n	=	4	independent	experiments	(18	cells	
total).	 Values	 represent	 overall	 mean	 value	 from	 each	 of	 the	 4	 independent	
experiments	 per	 time	 point.	 Red	 line	 indicates	 the	 best-fit	 line.	 (C)	 Imaris	 image	
analysis	 software	 was	 used	 to	 track	 the	 displacement	 length	 and	 speed	 of	 each	
individual	BiFC	puncta	per	cell	 (as	described	in	materials	and	methods)	showing	a	
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very	mild	correlation	between	the	distance	travelled	and	speed	of	the	movement.	R-
square	 value	 =	 0.2869.	 n	 =	 208	 BiFC	 puncta	 (18	 cells	 total).	 (D)	The	 straight-line	
distance	between	the	starting	position	of	an	individual	fluorescent	puncta,	as	well	as	
its’	associated	mitochondria,	and	its	position	in	the	final	frame	of	the	live-cell	video	
was	 quantified	 and	 the	 relationship	 between	 the	 two	 was	 plotted.	 A	 very	 high	
correlation	between	the	two	sets	of	values	suggests	that	the	movement	of	the	BiFC	
puncta	 is	 dependent	 on	 the	movement	 of	 its	 associated	mitochondria.	 R-square	
value	=	0.8684.	n	=	30	BiFC	puncta	(6	cells	total).						
	
4.3.2	ER	stress	does	not	significantly	affect	the	localisation	of	the	mitochondria	or	
BiFC	puncta	in	NSC34	cells.	
Previous	work	by	Bravo	et	al	(2011)	has	shown	that	upon	the	induction	of	ER	stress,	
there	is	a	migration	of	mitochondria	towards	the	perinuclear	area	in	cultured	HeLa	
cells	with	a	concomitant	increase	in	ER-mitochondria	contacts,	as	well	as	an	increase	
in	resting	membrane	potential	and	Ca2+	levels	of	redistributed	mitochondria	only	and	
no	significant	changes	in	the	mitochondria	which	were	not	seen	to	migrate	(Bravo	et	
al.,	 2011).	 In	 light	 of	 our	 data	 showing	 a	 very	 high	 correlation	 between	 the	
movement	 of	 a	 BiFC	 puncta	 and	 its	 associated	 mitochondrion	 (Fig4.2D),	 we	
hypothesised	 that	 in	 ER	 stress	 induced	 cells,	 a	 migration	 of	 the	 mitochondrial	
network	should	be	accompanied	by	an	increased	proportion	of	BiFC	puncta	in	the	
perinuclear	area.	However,	if	there	was	some	bias	for	new	contact	sites	to	be	formed	
in	a	particular	subcellular	location	e.g.	at	the	cell	periphery	or	in	the	perinuclear	area,	
it	 could	 influence	 this	 result.	To	 investigate	 this,	 the	 same	cells	were	analysed	as	
shown	in	the	previous	chapter	in	Fig.3.10	whereby	a	statistically	significant	increase	
in	 the	 number	 of	 BiFC	 puncta	 from	 tunicamycin	 treatment	 had	 already	 been	
determined.	A	radial	profile	of	mitochondrial	fluorescence	intensity	in	treated	versus	
control	cells	was	calculated	using	a	concentric	circle	plugin	of	ImageJ	whereby	the	
intensity	 of	 the	 fluorescent	 signal	 within	 eight,	 equally	 spaced	 concentric	 circle	
regions	 radiating	 from	 the	 centre	 of	 the	 nucleus	 towards	 the	 cell	 periphery	was	
quantified	(Fig4.3A).		
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Fig	4.3:	ER	stress	does	not	significantly	alter	the	distribution	of	mitochondria	or	
BiFC	puncta	within	NSC34	cells.	(A)	Representative	image	of	NSC34	cell	showing	a	
radial	profile	of	concentric	circles	in	ImageJ	image	analysis	software.	Mitochondria	
are	 immunofluorescently	 labelled	 with	 anti-ATPB.	 (B)	 Normalised	 mitochondrial	
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fluorescence	intensity	values	calculated	along	each	of	the	eight	concentric	circles	in	
cells	 treated	with	2	µg/ml	or	10	µg/ml	tunicamycin	or	DMSO	as	a	control.	Values	
represent	 the	 overall	 mean	 values	 from	 3	 independent	 experiments.	 n	 =	 3	
independent	experiments	 (30-33	cells	per	experimental	group).	 (C)	Percentage	of	
BiFC	 puncta	within	 defined	 distances	 of	 the	 nucleus	 in	 control	 and	 treated	 cells.	
Values	 represent	 the	 overall	 mean	 values	 of	 the	 means	 of	 3	 independent	
experiments.	n	=	3	independent	experiments	(30-33	cells	per	experimental	group).	
Statistical	 significance	 was	 tested	 using	 one-way	 ANOVA	 followed	 by	 Dunnett’s	
multiple	comparisons	test,	comparing	the	mean	values	to	the	mean	of	the	control	
group	for	each	individual	group.	p	<	0.05	for	all	groups.	Error	bars	represent	SEM.					
	
Although	a	trend	was	observed	whereby	there	was	increased	mitochondrial	signal	in	
tunicamycin	 treated	cells	 surrounding	 the	nucleus	and	a	decrease	 in	signal	 in	 the	
central	regions	of	the	cell	when	compared	to	control	cells,	suggestive	of	a	migration	
of	 the	mitochondria	 towards	 the	 nucleus,	 this	was	 deemed	 to	 be	 non-significant	
(Fig4.3B).	Next,	we	wished	to	examine	the	distribution	of	BiFC	puncta	within	control	
and	treated	cells	by	calculating	the	percentage	of	the	total	number	of	contact	points	
that	fell	within	a	certain	distance	of	the	nucleus	(capped	at	a	maximum	distance	of	
14	µm	from	the	nucleus)(Fig4.3C).	Here,	the	same	trend	was	observed	whereby	an	
elevated	percentage	of	BiFC	puncta	were	found	close	to	the	nucleus	in	tunicamycin	
treated	cells	and	a	relatively	higher	percentage	of	BiFC	puncta	in	control	cells	was	
present	 in	 the	 central	 regions	 of	 the	 cell	 but	 again,	 this	 was	 not	 statistically	
significant.	With	higher	sample	numbers,	it	is	possible	that	a	significant	effect	would	
be	observed.	
	
4.3.3	BiFC	puncta	are	associated	with	a	sub-population	of	mitochondria	of	higher	
than	average	resting	membrane	potential.	
As	 shown	previously,	 the	 tight	 ER-mitochondria	 contact	 sites	 reported	 on	 by	 the	
Venus	 fusion	 proteins	 are	 consistently	 associated	 with	 only	 a	 sub-population	 of	
mitochondria,	in	all	cell	lines	tested.	However,	it	is	unclear	why	the	BiFC	puncta	are	
associated	 with	 these	 particular	 mitochondria	 and	 whether	 that	 is	 due	 to	 some	
unique	properties	of	these	mitochondria	or	to	some	specific	function	of	the	MAMs	
actively	 occurring	 at	 these	 sites	 is	 yet	 to	 be	 determined.	 There	 are	 several	
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fundamental	 properties	 on	 which	 mitochondria	 could	 vary	 but	 due	 to	 the	 close	
relationship	between	contact	thickness	and	mitochondrial	calcium	levels	(Csordas	et	
al.,	2006),	we	investigated	whether	any	difference	in	mitochondrial	calcium	levels	
could	 be	 detected	 between	 those	 that	 were	 associated	 with	 a	 BiFC	 puncta,	
representing	 a	 contact	 site	 <10	 nm,	 and	 those	 that	 were	 not.	 Furthermore,	
mitochondrial	 resting	 membrane	 potential	 is	 a	 good	 indicator	 of	 mitochondrial	
health	and	is	caused	by	the	accumulation	of	protons	in	the	intermembrane	space	
through	the	respiratory	electron	transport	chain	that	generates	a	charge	gradient	
for	 ATP	 production	 [As	 reviewed	 by	 (Nicholls	 and	 Budd,	 2000)].	 In	 addition,	 the	
aforementioned	work	by	Bravo	et	al	(2011)	shows	that	ER	stress-induced	increases	
in	 ER-mitochondria	 contacts	 are	 accompanied	 by	 increases	 in	 both	 resting	
membrane	potential	and	Ca2+	levels	and	therefore,	these	are	the	two	parameters	we	
chose	to	investigate	in	our	work.							
	
To	measure	mitochondrial	membrane	potential,	NSC34	 cells	were	 treated	with	 a	
MitoTracker	CMXRos	dye.	MitoTracker	CMXRos	is	a	rhodamine-based	dye	that	does	
not	 fluoresce	 until	 it	 becomes	 oxidised	within	 a	 living	 cell	 and	 then	 accumulates	
electrophoretically	 within	 mitochondria	 in	 response	 to	 a	 negative	 membrane	
potential,	such	that	higher	fluorescence	intensity	is	indicative	of	hyperpolarisation	
of	the	mitochondrial	membrane	(Kholmukhamedov	et	al.,	2013)	(Fig4.4A).	3D	live-
cell	imaging	of	cells	then	allowed	us	to	measure	the	fluorescence	intensity	values	of	
mitochondrial	 regions	 associated	with	 a	 BiFC	 puncta	 in	 comparison	 to	 the	mean	
intensity	 value	 of	 the	mitochondrial	 network	 (Fig4.4B).	 The	 results	 indicate	 that	
regions	of	mitochondria	associated	with	a	BiFC	puncta	have	a	slight,	but	significant,	
increase	in	fluorescence	intensity	in	comparison	to	the	mean	intensity	value	of	the	
mitochondria	network,	representing	increased	membrane	potential	at	these	contact	
sites	(Fig4.4C(i)).	If	the	normalised	mean	fluorescence	intensity	values	of	each	of	the	
disconnected	components	of	the	total	mitochondrial	network	are	plotted	against	the	
normalised	 intensity	 values	 of	 the	 regions	 associated	 with	 a	 BiFC	 puncta	 in	 a	
frequency	distribution	graph,	it	demonstrates	that	BiFC	puncta	are	not	exclusively	
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associated	 with	 regions	 of	 higher	 than	 average	 membrane	 potential	 and	 can	
occasionally	 be	 found	 associated	 with	 mitochondria	 of	 lower	 than	 average	
membrane	potential	(Fig4.4C(ii)).	However,	overall	there	is	a	shift	in	the	distribution	
to	show	a	favoured	association	of	the	BiFC	puncta	with	mitochondria	of	higher	than	
average	resting	membrane	potential.								
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Fig	4.4:	BiFC	puncta	are	associated	with	regions	of	mitochondria	of	high	membrane	
potential.	 (A)	Representative	 image	 of	NSC34	 cell	 labelled	with	MitoTracker	 Red	
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CMXRos	dye	and	pseudo-coloured	on	ImageJ	based	on	signal	intensity	according	to	
the	 key	 shown.	 Scale	 bar,	 10	 µm	 (B)	Using	 the	 Venus	 channel	 as	 a	mask,	mean	
fluorescence	intensity	of	all	regions	of	mitochondria	correlating	with	a	BiFC	puncta	
were	quantified	 and	 compared	 to	 the	overall	mean	 fluorescence	 intensity	 of	 the	
mitochondria	 signal	within	a	given	cell.	Bottom	right	panels	 represent	 zoomed	 in	
region	 from	 overlay	 image	 before	 and	 after	 mask	 is	 applied.	 (Ci)	Mitochondrial	
fluorescence	 intensity	 of	 regions	 associated	 with	 a	 BiFC	 puncta	 was	 significantly	
higher	in	comparison	to	overall	mean	mitochondrial	fluorescence	intensity.	Values	
from	 each	 of	 three	 independent	 experiments	 are	 colour-coded.	 Bars	 represent	
overall	mean	±	SEM.	Statistical	significance	was	measured	used	paired	t-test.	n	=	3	
independent	experiments	(31	cells	per	experimental	group).	(Cii)	Distribution	graph	
of	 the	 relative	 frequencies	 of	 the	 mean	 fluorescence	 intensity	 values	 of	 each	
disconnected	component	of	the	total	mitochondrial	channel/regions	associated	with	
a	BiFC	puncta	as	detected	by	Imaris.	Fluorescence	intensity	values	were	normalised	
to	the	mean	overall	mitochondrial	fluorescence	intensity	value	which	was	denoted	
by	a	value	of	1.		
4.3.4	Oligomycin	induced	increases	in	mitochondrial	membrane	potential	do	not	
alter	the	number	of	BiFC	puncta	per	cell.	
Although	BiFC	puncta	were	 shown	 to	associate	with	mitochondria	of	higher	 than	
average	resting	membrane	potential,	it	is	not	evident	whether	a	higher	membrane	
potential	promotes	contact	formation	or	whether	the	formation	of	a	tight	physical	
contact	 drives	 an	 increase	 in	 membrane	 potential.	 We	 aimed	 to	 test	 this	 by	
chemically	increasing	the	resting	mitochondrial	membrane	potential	by	treating	cells	
with	 the	 proton	 transporting	 ATP	 synthase	 inhibitor	 oligomycin	 (Jastroch	 et	 al.,	
2010).	If	an	increase	in	resting	membrane	potential	promotes	contact	formation,	one	
would	predict	an	increase	in	the	number	of	BiFC	puncta	per	cell	however,	studies	
using	 the	 mitochondria	 uncoupler	 carbonyl	 cyanide	 m-chlorophenyl	 hydrazone	
(CCCP)	 to	 induce	 massive	 mitochondrial	 membrane	 potential	 depolarisation	
demonstrated	an	induction	of	mitophagy	and	increase	in	ER-mitochondria	contacts	
and	so	perhaps,	an	oligomycin-induced	rise	in	membrane	potential	could	result	in	a	
compensatory	reduction	in	contacts	(Gelmetti	et	al.,	2017).	NSC34	cells	transiently	
expressing	 the	 V1-ER	 and	 V2-Mito	 reporter	 proteins	 were	 treated	 with	 a	 DMSO	
control	or	5	µg/ml	oligomycin	for	24	hours	to	investigate	any	changes	in	the	mean	
number	of	BiFC	puncta	per	cell	(Fig4.5A).	Hyperpolarisation	of	the	mitochondrial	
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membrane	induced	by	oligomycin	treatment	was	proven	by	an	increase	in	mean	
fluorescence	intensity	of	cells	stained	with	MitoTracker	CMXRos	dye	(Fig4.5B).	
The	results	showed	no	significant	change	in	the	mean	number	of	BiFC	puncta	per	
cell	 following	 oligomycin	 treatment	 (Fig4.5(B(i)).	 Although	 non-significant,	 a	
difference	of	12%	in	the	mean	number	of	BiFC	puncta	in	control	versus	treated	
cells	 was	 detected	 and	 so	 with	 a	 larger	 sample	 size,	 this	 effect	 could	 be	
significant	however,	a	change	of	this	magnitude	is	well	below	the	40-50%	change	
in	the	number	of	BiFC	puncta	we	have	observed	with	any	of	the	other	stresses	
tested.	Furthermore,	as	the	reversibility	of	the	BiFC	technique	is	questionable,	it	
may	not	accurately	pick	up	on	reductions	in	ER-mitochondria	contacts	so	in	order	
to	 test	 if	 oligomycin	 reduces	 contact	 sites,	 we	 used	 the	 fluorescence	 co-
localisation	method	of	measuring	MAMs	(Fig4.5C).	Again,	the	results	showed	no	
significant	change	in	oligomycin	treated	cells	(Fig4.5C(i)).		
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Fig	 4.5:	 Treatment	with	 oligomycin	 does	 not	 change	 the	mean	 number	 of	 BiFC	
puncta	per	cell	in	NSC34	cells.	(A)	Representative	images	of	NSC34	cells	expressing	
V1-ER	 and	 V2-Mito	 reporter	 plasmids	 treated	 with	 a	 DMSO	 control	 or	 5	 µg/ml	
oligomycin	for	24	h	post-transfection.	Mitochondria	were	immunolabelled	with	
anti-ATPB.	(B)	A	statistically	significant	increase	in	fluorescence	intensity	in	cells	
treated	 with	 oligomycin	 in	 comparison	 to	 those	 treated	 with	 DMSO	 was	
observed.	n	=	19-22	cells	per	experimental	group.	(B(i))	No	significant	change	in	
mean	BiFC	number	per	cell	was	detected	 in	control	versus	oligomycin	 treated	
cells.	 n	 =	 4	 independent	 experiments	 (38-56	 cells	 per	 experimental	 group).	
Values	indicate	overall	mean	values	from	the	4	independent	experiments.	Error	
bars	represent	SEM.	Statistical	significance	was	determined	by	unpaired	t-test.	
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ns	 =	 non-significant,	 P>0.05.	 (C)	 Representative	 images	 of	 NSC34	 cells	
transfected	with	 ER-DsRed2	 to	 label	 the	 ER	 (green)	and	 immunolabelled	with	
anti-ATPB	to	stain	the	mitochondria	(magenta),	treated	with	5	µg/ml	oligomycin	
or	 an	 equivalent	 volume	 of	 DMSO.	 (C(i))	 Fluorescence	 co-localisation	 was	
quantified	by	PCC.	n	=	3	independent	experiments	(15-17	cells	per	experimental	
group).	 Statistical	 significance	 was	 determined	 by	 unpaired	 t-test.	 ns	 =	 non-
significant,	P>0.05.				
	
In	summary,	hyperpolarisation	of	the	mitochondrial	membrane	does	not	drive	
the	formation	of	new	ER-mitochondria	contact	sites.	No	significant	reduction	in	
the	number	of	BiFC	contact	sites	was	detected	through	either	the	BiFC	technique	
or	fluorescence	co-localisation	analysis.	We	can	conclude	that	the	association	of	
the	BiFC	puncta	with	mitochondria	of	high	membrane	potential	is	more	likely	a	
consequence	of	tight	contact	formation	as	opposed	to	a	driver	for	increased	ER-
mitochondria	associations.				
4.3.5	 BiFC	 puncta	 are	 associated	 with	 a	 sub-population	 of	 mitochondria	 with	
elevated	resting	calcium	concentrations	
Differences	 in	 mitochondrial	 Ca2+	 levels	 of	 mitochondria	 associated	 with	 a	 BiFC	
puncta	in	comparison	to	those	that	were	not,	were	investigated	using	a	genetically	
encoded,	 mitochondrially	 targeted	 Mito-RCaMP	 probe.	 This	 class	 of	 calcium	
indicator	is	based	on	circularly	permuted	fluorescent	proteins	fused	C-terminally	to	
a	 calmodulin	 domain	 and	 to	 a	 Ca2+-calmodulin	 binding	 peptide,	 M13,	 at	 the	 N-
terminal	(Nagai	et	al.,	2001).	The	binding	of	Ca2+	induces	a	conformational	change	to	
the	fluorescent	protein,	causing	an	increase	in	the	intensity	of	the	fluorescent	signal,	
proportional	to	the	concentration	of	Ca2+	(Nagai	et	al.,	2001).	NSC34	cells	transfected	
with	the	V1-ER/V2-Mito	reporter	plasmids	and	the	Mito-RCaMP	calcium	indicator	
were	 imaged	live	and	the	fluorescence	 intensity	of	regions	associated	with	a	BiFC	
puncta	were	measured	and	compared	 to	 the	overall	mean	 fluorescence	 intensity	
value	of	the	mitochondrial	network	(Fig4.6A).	The	results	show	a	significantly	higher	
fluorescence	intensity	value	of	mitochondrial	regions	directly	associated	with	a	BiFC	
puncta	 in	 comparison	 to	 the	 mean	 fluorescence	 intensity	 value	 of	 the	 total	
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mitochondrial	 network,	 suggesting	 that	 BiFC	 contacts	 are	 associated	 with	
mitochondria	 of	 high	 calcium	 concentrations	 (Fig4.6B(i)).	 When	 the	 normalised	
values	are	displayed	as	a	frequency	distribution	graph,	the	results	again	demonstrate	
that	 although	 these	 tight	 contact	 sites	 are	 not	 exclusively	 formed	 on	 regions	 of	
higher	 than	 average	 Ca2+	 concentrations,	 there	 is	 a	 strong	 shift	 favouring	 the	
association	at	the	areas	of	high	calcium	concentration	(Fig4.6B(ii)).		
In	 summary,	 the	data	 shows	 that	 the	BiFC	puncta	 are	 associated	with	 regions	of	
mitochondria	of	higher	than	average	resting	membrane	potential	and	mitochondrial	
Ca2+	 concentrations.	 This	 result	 could	 indicate	 that	 these	 properties	 of	 this	 sub-
population	of	mitochondria	could	be	encouraging	them	to	form	tight	associations	
with	the	ER	however,	 it	could	also	be	the	case	that	elevated	membrane	potential	
and	Ca2+	levels	could	be	a	consequence	of	contact	formation	rather	than	a	cause	and	
further	work	would	be	required	in	order	to	determine	this.					
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Fig	4.6:	BiFC	puncta	are	associated	with	mitochondria	of	elevated	resting	calcium	
concentrations.	(A)	Representative	image	of	NSC34	cell	transiently	transfected	with	
	 125	
the	Venus	reporter	plasmids	and	MitoRCaMP	probe.	Using	the	Venus	channel	as	a	
mask,	mean	fluorescence	intensity	of	all	regions	of	mitochondria	correlating	with	a	
BiFC	puncta	were	quantified	and	compared	to	the	total	mean	fluorescence	intensity	
of	the	mitochondria	signal	within	a	given	cell.	Bottom	right	panels	represent	zoomed	
in	region	from	overlay	image	before	and	after	mask	is	applied.	Scale	bar,	10	µm	(Bi)	
Mitochondrial	fluorescence	intensity	of	regions	associated	with	a	BiFC	puncta	was	
significantly	 higher	 in	 comparison	 to	 overall	 mean	 mitochondrial	 fluorescence	
intensity.	 Values	 from	 each	 of	 three	 independent	 experiments	 are	 colour-coded.	
Bars	represent	overall	mean	value	±	SEM.	Statistical	significance	was	measured	used	
paired	t-test.	n	=	3	independent	experiments	(33	cells	per	experimental	group).	(Bii)	
Distribution	 graph	of	 the	 relative	 frequencies	 of	 the	mean	 fluorescence	 intensity	
values	of	each	disconnected	component	of	the	total	mitochondrial	channel/regions	
associated	with	a	BiFC	puncta	as	detected	by	Imaris.	Fluorescence	intensity	values	
were	 normalised	 to	 the	mean	 overall	 mitochondrial	 fluorescence	 intensity	 value	
which	was	denoted	by	a	value	of	1.		
	
	
4.3.6	BiFC	puncta	are	not	sensitive	to	Gq-DREADD	receptor	mediated	elevations	in	
cytoplasmic	Ca
2+	
levels.		
As	previously	described,	there	is	an	intimate	relationship	between	ER-mitochondria	
associations	 and	 calcium	 signalling,	 with	 tighter	 contacts	 enhancing	 calcium	
exchange	 from	 the	ER,	 leading	 to	 increased	mitochondria	 calcium	 levels	 at	 these	
sites	 (Csordas	 et	 al.,	 2006).	 Our	 data	 above	 illustrates	 that	 the	 BiFC	 signal	 is	
associated	with	mitochondria	that	have	high	Ca2+	concentrations	but	doesn’t	inform	
us	whether	elevated	mitochondrial	calcium	levels	can	encourage	the	formation	of	
physical	 contact	 sites	with	 the	 ER	 or	whether	 the	 organelle	 coupling	 causes	 this	
increase	in	mitochondrial	Ca2+.		
To	 investigate	 this,	we	 used	Designer	 Receptor	 Exclusively	 Activated	 by	Designer	
Drugs	(DREADD),	a	platform	which	involves	the	modification	of	protein	receptors	to	
be	activated	exclusively	by	a	synthetic	drug	known	as	Clozapine	N-oxide	(CNO),	an	
agonist	 of	 DREADD	 receptors	 that	 is	 not	 known	 to	 activate	 any	 endogenously	
expressed	receptors	(Armbruster	et	al.,	2007).		
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In	this	study,	we	used	a	modified	Gq–coupled	receptor	protein	(Armbruster	et	al.,	
2007),	that	is	part	of	the	G	protein-coupled	receptor	superfamily	that	are	sensitive	
to	 external	 ligands	 to	 activate	 internal	 signalling	 pathways.	 Specifically,	 the	
activation	 of	 Gq-coupled	 receptors	 stimulates	 plasma	 membrane	 bound	
phospholipase	 Cb	 to	 cleave	 phosphatidylinositol	 biphosphate	 (PIP2)	 into	 two	
secondary	messengers	which	includes	IP3	to	activate	IP3R	mediated	calcium	release	
(Kero	et	al.,	2007).	Therefore,	upon	addition	of	CNO	to	our	cells	we	should	activate	
the	Gq-coupled	DREADD	to	in	turn	activate	the	IP3R	receptors	and	stimulate	calcium	
release	from	the	ER,	resulting	in	a	sharp	spike	in	cytoplasmic	Ca2+	concentrations.	In	
order	 to	 test	 this,	 NSC34	 cells	 were	 transfected	 with	 a	 cytoplasmically	 targeted	
fluorescent	GCaMP	calcium	indicator	along	with	the	EF1a-DI0-Gq-mCherry	DREADD	
plasmid,	 the	 expression	of	which	 is	 dependent	 on	Cre	 recombinase	 and	 an	AAV-
EF1a-Cre	plasmid.	During	live-cell	imaging,	using	a	Leica	fluorescent	imaging	system,	
the	addition	of	1	µM	CNO	resulted	in	a	sharp	increase	of	GFP	signal	that	returned	to	
baseline	fluorescence	approximately	20	seconds	later,	as	can	be	seen	from	the	still	
frame	 images	 in	 (Fig4.7A)	 and	 in	 (VIDEO	 4.2,	 Appendix	 I).	 Quantification	 of	 this	
change	in	fluorescence	showed	a	2-fold	increase	in	the	mean,	normalised	intensity	
value	in	cells	treated	with	CNO	whereas	no	change	in	fluorescence	was	observed	in	
cells	imaged	without	any	addition	of	CNO	(Fig4.7B).	The	results	indicate	a	rapid,	Gq-
DREADD	mediated	increase	in	cytoplasmic	calcium	levels	after	the	addition	of	CNO	
which	then	returns	to	baseline	levels	as	calcium	homeostasis	is	maintained.			
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Fig	4.7:	Gq	DREADD	mediated	spikes	in	cytosolic	Ca
2+	
levels	do	not	influence	the	
number	of	BiFC	puncta	per	cell.	(A)	Single	slice	images	from	live-cell	optimisation	of	
Gq-DREADD	 receptor	 transfection.	 NSC34	 cells	 transfected	 with	 EF1a-DI0-Gq-
mCherry,	 AAV-EF1a-Cre	 and	 a	 GCaMP3-cyt	 cytoplasmic	 calcium	 indicator	 probe	
were	 imaged	 live	 to	 test	 for	elevation	 in	cytoplasmic	Ca2+	 levels	mediated	by	Gq-
DREADD	receptor	activation.	1	µM	CNO	was	added	to	the	cells	which	resulted	in	an	
immediate	 increase	 in	GCaMP3-cyt	fluorescent	signal	which	gradually	returned	to	
baseline	levels.	(B)	Change	in	GCaMP3	fluorescence	was	measured	by	the	equation	
F/F0	as	outlined	in	the	methods	section,	demonstrating	a	2-fold	increase	in	intensity	
after	the	addition	of	CNO	which	returns	to	baseline	 levels	after	approximately	20	
seconds.	Error	bars	represent	SEM.	Red	line	represents	the	F/F0	value	of	untreated	
cells.	 n	 =	 27	 cells	 (C)	 Representative	 still	 frame	 image	 of	 live-cell	 NSC34	 cell	
transfected	with	V1-ER/V2-Mito	reporter	plasmids	(green)	along	with	EF1a-DI0-Gq-
mCherry	(red)	and	AAV-EF1a-Cre	plasmids.	Scale	bar,	10	µm	(C(i))	The	number	of	BiFC	
puncta	per	time	point	was	analysed	by	Imaris	image	analysis	software.	1µM	CNO	was	
added	at	1	min	showing	no	robust	change	in	BiFC	puncta	number	from	Gq	mediated	
cytoplasmid	 Ca2+	 elevation.	 n	 =	 8	 cells	 (3	 independent	 experiments).	 Error	 bars	
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represent	SEM.	Values	indicate	the	mean	value	of	the	8	individual	cells,	due	to	low	
sample	size	number.					       
	
Following	on	from	this,	the	aim	was	to	see	if	the	BiFC	puncta	are	sensitive	to	rapid	
increases	 in	 cytoplasmic	 Ca2+.	 It	 was	 predicted	 that	 this	 could	 encourage	 ER-
mitochondria	 associations	 or	 tightening	 of	 pre-existing	 contact	 sites	 in	 order	 to	
promote	mitochondrial	calcium	uptake	leading	to	rapid	increases	in	BiFC	numbers.	
To	test	this,	NSC34	cells	expressing	the	Venus	reporter	proteins	and	the	Gq-coupled	
DREADD	receptor	showing	a	plasma	membrane	localisation,	were	imaged	live	and	
treated	with	1	µM	CNO	after	60	seconds	on	a	Nikon	confocal	microscope	to	have	a	
high	enough	resolution	to	detect	subtle	alterations	in	BiFC	number	(Fig4.7C)(Video	
4.3,	 Appendix	 I).	 As	 this	 was	 a	 different	 imaging	 system	 used	 to	 that	 for	 the	
optimisation	of	the	technique,	a	live-cell	imaging	dish	of	cells	expressing	the	DREADD	
receptor	and	Cyto-GCaMP	calcium	indicator	was	first	imaged	and	treated	with	CNO	
to	illustrate	the	same	increase	in	GCaMP	fluorescence	as	with	the	Leica	system	(data	
not	 shown).	 Quantification	 of	 the	 number	 of	 BiFC	 puncta	 per	 frame	 showed	 no	
immediate	changes	in	BiFC	number	upon	the	addition	of	CNO	and	overall,	there	was	
no	real	change	in	the	mean	number	of	BiFC	puncta	over	the	duration	of	the	video	
(Fig4.7C(i)).	However,	there	are	some	limitations	associated	with	this	which	will	be	
discussed	in	further	detail	in	section	4.3	below.				
	
4.3.7	BiFC	puncta	do	not	represent	the	sites	of	autophagosome	formation	
MAMs	 are	 believed	 to	 be	 one	 of	 the	 sites	 contributing	 membrane	 for	
autophagosome	formation	and	in	agreement	with	this,	the	early	autophagy	markers	
ATG5	and	ATG14	were	shown	to	re-localise	to	ER-mitochondria	contact	sites	when	
autophagy	was	induced	by	serum	deprivation	(Hamasaki	et	al.,	2013).	By	inducing	
autophagy	in	cells	expressing	our	Venus	reporter	proteins,	we	aimed	to	see	whether	
the	re-localisation	of	ATG5	and	ATG14	into	punctate	structures	co-localise	with	the	
fluorescent	 BiFC	 puncta	 which	 would	 indicate	 that	 these	 tight	 ER-mitochondria	
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contact	sites	could	represent	the	sites	of	autophagosome	formation.	Alternatively,	
the	sub-population	of	mitochondria	associated	with	a	BiFC	puncta	could	represent	a	
population	 of	 damaged	 mitochondria	 and	 therefore	 one	 might	 expect	 that	
mitophagic	vacuoles	could	be	formed	at	these	sites.		
In	NSC34	cells	grown	in	serum-free	media	for	24	h	and	immunostained	with	an	anti-
ATG5	 antibody,	 there	 was	 a	 reorganisation	 of	 ATG5	 from	 a	 diffuse	 cytoplasmic	
distribution	 to	 punctate	 structures	 in	 agreement	 with	 the	 published	 literature	
(Fig4.8A)(Hamasaki	et	al.,	2013).	For	the	most	part,	there	was	no	co-localisation	of	
fluorescent	ATG5	puncta	with	the	BiFC	puncta	(Fig4.8B).	Similarly,	when	mCherry-
ATG14	was	expressed	in	serum-deprived	NSC34	cells,	the	distribution	of	the	protein	
re-localises	 into	 punctate	 structures	 that	 do	 not	 co-localise	 with	 BiFC	 puncta	
(Fig4.8C).	We	can	conclude	that	the	tight	ER-mitochondria	contact	sites	reported	on	
by	the	Venus	fusion	proteins	do	not	represent	sites	of	autophagosome	formation.								
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Fig	4.8:	BiFC	puncta	do	not	correlate	with	early	markers	of	autophagy	induced	by	
serum	deprivation.	(A)	Representative	images	of	NSC34	cells	immunostained	with	
an	anti-ATG5	antibody	grown	in	control	DMEM	supplemented	with	10%	(v/v)	FBS	or	
serum	deprived	in	DMEM	with	no	FBS	for	24h,	showing	the	re-localisation	of	ATG5	
from	 a	 cytosolic	 pattern	 to	 punctate	 structures.	 Zoomed	 image	 represents	 area	
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within	boxed	region	of	serum	deprived	panel.	Scale	bars,	20	µm	(B)	Serum	deprived	
NSC34	cells	expressing	V1-ER	and	V2-Mito	reporter	plasmids	and	immunostained	for	
ATG5	 and	 an	 anti-ATPB	 mitochondrial	 marker	 24	 h	 post	 starvation	 (C)	 Serum	
deprived	NSC34	cells	expressing	the	Venus	reporter	plasmids	and	mCherry-ATG14.	
Scale	bars,	10	µm.			
4.3.8	 BiFC	 puncta	 are	 within	 close	 proximity	 of	 actively	 replicating	 mtDNA	
nucleoids	
In	mammalian	cells,	mtDNA	is	harboured	within	circular,	closed	molecules	along	the	
inner	mitochondrial	matrix	known	as	nucleoids	(Brown	et	al.,	2011).	The	replication	
of	the	mitochondrial	genome	is	carried	out	at	these	sites	by	the	mtDNA	polyermase	
gamma	complex,	composed	of	a	p140	catalytic	subunit	and	a	p55	accessory	subunit	
encoded	for	by	the	POLG2	gene	(Young	et	al.,	2015).	Recent	evidence	has	shown	that	
these	nucleoids	are	spatially	linked	within	1	µm	of	mitochondrial	division	events	and	
as	 described	 in	 section	1.2.2.8	of	 the	 introduction	 chapter,	 these	division	 events	
occur	at	 sites	of	close	apposition	between	the	ER	and	mitochondria	 (Lewis	et	al.,	
2016).	Therefore,	in	order	to	test	if	BiFC	puncta	represented	nascent	mitochondrial	
division	 sites,	 fluorescently	 tagged	 POLG2	was	 used	 to	 label	 a	 sub-population	 of	
actively	replicating	nucleoids	as	demonstrated	by	Lewis	et	al	(2016).		
Fluorescently-tagged	POLG2	plasmids	were	cloned	as	described	in	chapter	2,	section	
2.2	to	generate	a	POLG2-DsRed2	plasmid	containing	the	full-length	POLG2	sequence	
or	a	POLG21-25-DsRed2	plasmid	consisting	of	only	the	N-terminal	25	amino	acids	of	
POLG2	that	make	up	the	mitochondrial	targeting	domain	(Young	et	al.,	2015).	To	test	
the	 sub-cellular	 localisation	 of	 these	 constructs	 and	 to	 test	 whether	 they	 still	
specifically	 labelled	 replicating	 nucleoids,	 they	 were	 individually	 transfected	 into	
COS-7	cells	along	with	POLG2-GFP	and	the	extent	of	co-localisation	was	quantified	
by	 Pearson’s	 Correlation	 Coefficient	 (Fig	 4.9,	 Table	 4.1).	 The	 full-length	 POLG2-
DsRed2	showed	a	very	high	level	of	co-localisation	with	POLG2-GFP	(PCC	=	0.798	±	
0.021)	indicating	that	the	change	in	fluorophore	did	not	alter	the	localisation	of	the	
protein.	 In	 contrast,	 POLG21-25-DsRed2	 demonstrated	 only	 a	 low	 level	 of	 co-
localisation	with	POLG2-GFP	(PCC	=	0.291	±	0.046)	but	co-localised	highly	with	an	
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ATPB	mitochondrial	marker	(0.765	±	0.059),	suggesting	that	the	C-terminal	domain	
of	POLG2	is	essential	for	its	specific	targeting	to	nucleoids.			
As	the	overall	aim	of	the	experiment	was	to	investigate	an	association	of	the	BiFC	
puncta	with	 replicating	 nucleoids,	we	 only	 proceeded	with	 the	 full	 length	 POLG-
DsRed2	construct.				
	
Fig	 4.9	 Full-length	 and	 truncated	 POLG2-DsRed2	 proteins	 are	 differentially	
localised	within	 COS-7	 cells.	 Plasmids	 were	 generated	 containing	 a	 DsRed2	 ORF	
fused	 in-frame	 between	 the	 N-terminal	 25	 codons	making	 up	 the	mitochondrial	
targeting	domain	and	the	remaining	C-terminal	cDNA	sequence	of	POLG2	(POLG2-
DsRed2)	or	a	DsRed2	ORF	including	a	stop	codon	was	fused	after	the	first	25	codons	
such	that	only	the	POLG2	mitochondrial	domain	fused	to	the	DsRed2	fluorophore	
was	translated	(POLG21-25-DsRed2).	POLG2-DsRed2	showed	a	punctate	localisation	
and	co-localised	very	highly	with	POLG2-GFP	as	quantified	by	PCC	(0.798	±	0.021).	In	
contrast,	POLG21-25-DsRed2	demonstrated	a	low	level	of	co-localisation	with	POLG2-
GFP	(0.291	±	0.046)	but	a	high	level	of	co-localisation	with	the	mitochondrial	marker	
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ATPB	as	labelled	by	immunofluorescent	staining	(0.765	±	0.059).	The	results	show	
that	 the	C-terminal	domains	of	POLG2	are	 required	 for	 its	 specific	 localisation	 to	
replicating	nucleoids.	Scale	bar,	10	µm.		
	
	
	
Table	 4.1:	 Fluorescent	 signal	 co-localisation	 quantified	 by	 Pearson’s	 Correlation	
Coefficient	(PCC).	Values	indicate	mean	PCC	±	SEM	for	the	co-localisation	of	POLG2-
DsRed2	 with	 POLG2-GFP	 or	 POLG21-25-DsRed2	 with	 POLG2-GFP	 and	 the	
mitochondrial	 marker	 ATPB.	 n	 =	 3	 independent	 experiments	 (9-11	 cells	 per	
experimental	group).		
Fluorescently	labelled	proteins	 PCC	
POLG2-DsRed2	/	POLG2-GFP	 0.798	±	0.021	
	
POLG21-25-DsRed2	/	POLG2-GFP	 0.291	±	0.046	
	
POLG21-25-DsRed2	/	ATPB	 0.765	±	0.059	
	 	
	
Previously	 published	 data	 had	 determined	 that	 the	 vast	 majority	 of	 actively	
replicating	 nucleoids,	 as	 labelled	 by	 POLG2-GFP,	 were	 found	within	 1	 µm	 of	 ER-
mitochondria	contact	sites	(Lewis	et	al.,	2016).	These	images	however,	were	taken	
by	diffraction-limited	confocal	microscopy	and	ER-mitochondria	contact	sites	were	
scored	based	on	co-localisation	of	an	ER	and	mitochondria	marker,	at	best	giving	a	
resolution	of	 around	200	nm	and	 therefore	giving	no	 information	on	 the	 specific	
thickness	of	these	junction	sites.	In	our	study,	we	wanted	to	look	for	a	correlation	
between	POLG2	puncta	and	ER-mitochondria	contact	sites	<	10	nm	to	determine	if	
tight	contacts	are	functionally	linked	to	mitochondrial	division	events.	We	observed	
that	33.5%	±	4.3	of	BiFC	puncta	were	within	200	nm	of	a	POLG2-DsRed2	puncta	and	
66%	 ±	 6	were	within	 1	 µm	 as	 quantified	 across	 13	 cells	 over	 three	 independent	
experiments.	The	mean	number	of	POLG2	puncta	in	COS-7	cells	was	approximately	
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double	the	mean	number	of	BiFC	puncta	and	covered	double	the	percentage	surface	
area	of	the	total	mitochondrial	network	in	comparison	to	BiFC	puncta	(Table	4.2).		
	
	
Table	4.2:	Quantification	of	mean	numbers	of	BiFC	and	POLG2-DsRed2	puncta	per	
cell	and	total	surface	area	of	BiFC	or	POLG2-DsRed2	signal	as	a	percentage	of	the	
surface	area	of	the	total	mitochondrial	network.	Values	indicate	number	of	puncta	
or	percentage	surface	area	(%)	±	SEM.	n	=	3	independent	experiments	(13	cells	total).		
Mean	 number	 of	
BiFC	puncta	per	cell	
Mean	 number	 of	
POLG2-DsRed2	
puncta	per	cell	
Mean	 total	 surface	
area	 of	 BiFC	 puncta	 /	
mean	 mitochondrial	
surface	area	(µm
2
)	
Mean	 total	 surface	 area	
of	POLG2-DsRed2	puncta	
/	 mean	 mitochondrial	
surface	area	(µm
2
)	
47	±	12	 97	±	14	 6.6	±	1	%	 12.8	±	3.35	%	
	
A	correlation	was	observed	between	the	number	of	POLG2	puncta	and	the	number	
of	BiFC	puncta	in	a	cell	however,	the	number	of	both	structures	showed	high	positive	
correlation	 with	 the	 overall	 surface	 area	 of	 the	 mitochondrial	 network	 and	
therefore,	we	cannot	determine	from	this	data	alone	if	the	presence	of	one	protein	
is	influencing	the	levels	of	the	other	(Fig	4.10A).	More	likely,	the	number	of	these	
structures	is	simply	dependent	on	the	overall	size	of	the	mitochondrial	network.	As	
the	mean	number	of	POLG2	puncta	is	a	lot	higher	than	the	number	of	BiFC	puncta	
per	 cell,	 it	 is	 unlikely	 that	BiFC	puncta	 solely	 represent	 the	 sites	 of	mitochondria	
division.	However,	it	cannot	be	ruled	out	that	POLG2	puncta	are	highlighting	sites	of	
nascent	mitochondrial	fission	events	where	constriction	of	the	mitochondria	by	ER	
tubules	has	not	 yet	 taken	place	 and	 therefore,	 the	 junction	between	 the	 ER	 and	
mitochondria	may	not	have	fallen	within	the	detectable	range	of	the	Venus	reporter	
proteins.	To	 investigate	this	possibility,	COS-7	cells	expressing	the	Venus	reporter	
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proteins	and	POLG2-DsRed2,	with	the	mitochondria	labelled	by	MitoTracker	Deep	
Red	FM	were	 imaged	live	 in	an	attempt	to	visualise	mitochondrial	division	events	
(Fig	4.10B).	Unfortunately,	simultaneous	three-colour	 imaging	on	a	 laser	scanning	
confocal	microscope	has	relatively	slow	acquisition	speeds	and	therefore,	we	were	
unable	 to	capture	any	mitochondrial	division	events	with	any	degree	of	 certainty	
(VIDEO	4.4,	Appendix	 I).	 Further	work	will	be	 required	 in	order	 to	draw	a	strong	
conclusion	 of	 the	 association	 of	 tight	 ER-mitochondria	 contact	 sites	 with	
mitochondrial	division	events.				
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Fig	4.10:	A	large	proportion	of	BiFC	puncta	are	within	close	proximity	to	replicating	
nucleoids.	(A)	The	number	of	BiFC	puncta	and	POLG2-DsRed2	puncta	show	a	high	
positive	correlation	with	the	overall	surface	area	of	the	mitochondrial	network.	R2	=	
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0.4509	 for	 BiFC	 puncta	 (p-value	 0.0120)	 and	 0.4763	 for	 POLG2-DsRed2	 (p-value	
0.009).	n	=	13	cells.	(B)	Representative	single	frame	image	of	COS-7	cells	transfected	
with	V1-ER	/	V2-Mito	(green)	and	POLG2-DsRed2	(red)	and	stained	with	MitoTracker	
Deep	Red	(blue).	Scale	bar,	10	µm.					
	
4.4	Discussion	
4.4.1	The	BiFC	system	can	be	effectively	utilised	in	living	cells	in	the	investigation	
of	organelle	contact	site	dynamics	
As	discussed	in	section	4.1	of	this	chapter,	organelle	contact	sites	can	respond	to	
certain	 stress	 conditions	by	altering	 junction	 length	and	 thickness	but	 the	driving	
force	 behind	 this	 plasticity	 of	MAMs	 is	 unclear.	 However,	 the	 variation	 in	MAM	
length	and	thickness	could	be	attributed	to	specific	functions	of	these	contact	sites.	
In	this	chapter,	we	have	presented	data	on	the	specific	functional	significance	of	tight	
ER-mitochondria	 contact	 sites	 <	 10	 nm,	 as	 reported	 on	 by	 our	 BiFC	 system.	 To	
systematically	investigate	specific	functions	of	the	MAMs	and	determine	any	unique	
properties	 of	 mitochondria	 with	 tight	 membrane	 contact	 sites,	 we	 have	 taken	
advantage	of	the	capability	of	the	BiFC	technique	to	be	used	in	living	cells.	As	seen	
with	fixed	cells,	the	BiFC	puncta	are	very	closely	associated	with	the	mitochondria	
and	remain	as	such	throughout	the	course	of	live-cell	videos	taken	over	a	10	minute	
period.	 The	 BiFC	 puncta	 show	 high	 photostability	 as	 the	 signal	 intensity	 did	 not	
diminish	during	image	acquisition,	strengthening	this	techniques	usefulness	in	living	
systems.	Here,	we	have	shown	that	the	BiFC	puncta	are	very	stable	structures	and	
their	numbers	do	not	change	over	a	10	minute	time	frame.	Of	course,	as	discussed	
in	 section	 3.4,	 the	 reversibility	 of	 the	 BiFC	 technique	 has	 not	 been	 conclusively	
shown	and	therefore,	it	might	not	be	possible	to	detect	contact	dissociation	in	real-
time	using	this	approach	(Kerppola,	2006).	However,	we	also	do	not	see	any	increase	
in	BiFC	puncta	number,	which	suggests	that	these	tight	contact	sites	are	very	defined	
structures	and	perhaps,	can	only	be	formed	at	specific	membrane	regions.	Although	
for	the	most	part,	these	structures	did	not	move	much	within	a	cell,	there	was	a	very	
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high	correlation	between	the	movement	of	the	BiFC	puncta	and	the	movement	of	
its	associated	mitochondrion.	In	support	of	this,	it	had	been	previously	been	shown	
by	live-cell	imaging	that	the	ER	and	mitochondria	remain	co-localised	as	they	moved	
along	acetylated	microtubules	(Friedman	et	al.,	2010).	However,	the	experiment	by	
Friedman	et	al	was	only	suggestive	of	maintained	association	between	the	ER	and	
mitochondria	as	it	relied	on	diffraction-limited	co-localisation	in	comparison	to	our	
results	which	more	definitively	shows	maintained	organelle	contact	by	labelling	ER-
mitochondria	junctions	of	defined	distances	(Friedman	et	al.,	2010).	The	utility	of	the	
BiFC	 system	 in	 living-cells	 in	 these	 sets	 of	 experiments	 also	 highlights	 the	major	
advantage	of	this	technique	over	alternative	methods	such	as	electron	microscopy	
or	the	 in	situ	proximity	ligation	assay	which	are	limited	to	fixed	cells	(Tubbs	et	al.,	
2014).					
4.4.2	The	formation	of	tight	ER-mitochondria	junctions	results	in	an	elevation	of	
mitochondrial	calcium	concentration	and	hyperpolarisation	of	the	membrane	
As	mentioned,	the	punctate	pattern	of	fluorescence	generated	by	expression	of	the	
V1-ER	 /	 V2-Mito	 plasmids	 is	 consistently	 associated	 with	 a	 sub-population	 of	
mitochondria	within	the	cell.	Our	data	here	shows	that	this	sub-set	of	mitochondria,	
associated	 with	 a	 tight	 membrane	 contact	 site,	 have	 higher	 than	 average	
mitochondrial	calcium	levels	and	membrane	potential	 in	comparison	to	the	mean	
values	of	the	whole	mitochondrial	network.	The	elevation	in	mitochondrial	calcium	
concentrations	and	hyper-polarisation	of	the	membrane	may	be	driving	factors	that	
encourage	the	formation	of	tight	contact	sites	with	the	ER	membrane	or	they	could	
be	a	consequence	of	contact	formation.	When	cells	were	treated	with	oligomycin	to	
hyper-polarise	mitochondrial	membrane	potential,	there	was	no	significant	change	
in	the	number	of	ER-mitochondria	contact	sites	as	quantified	by	our	BiFC	method	or	
by	fluorescence	co-localisation	analysis.	Similarly,	rapid	elevations	in	cytosolic	Ca2+	
mediated	by	Gq-coupled	DREADD	receptor	activation	did	not	significantly	increase	
the	number	of	BiFC	puncta	per	cell,	however,	it	is	has	been	suggested	that	because	
of	 the	 time	 needed	 for	 fluorophore	 maturation	 after	 reformation	 of	 the	 split	
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fluorescent	fragments,	the	BiFC	technique	is	not	suitable	for	detecting	rapid	changes	
in	real-time	(Kerppola,	2006).	It	is	possible	that	a	chronic,	more	gradual	elevation	in	
cytosolic	Ca2+		could	increase	the	number	of	BiFC	puncta	per	cell	as	a	mechanism	to	
maintain	 calcium	homeostasis	 (Wang	 et	 al.,	 2000;	Goetz	 et	 al.,	 2007)	 It	 is	 also	 a	
possibility	that	any	change	in	ER-mitochondria	associations	could	specifically	effect	
contact	 sites	 with	 a	 junction	 thickness	 outside	 of	 the	 spatial	 range	 of	 the	 BiFC	
reporter	proteins,	which	would	suggest	that	contact	sites	<	10	nm	in	thickness	are	
not	specifically	involved	with	the	calcium	exchange	function	of	MAMs.	This	would	be	
in	 agreement	 with	 previously	 published	 data	 indicating	 that	 a	 tightening	 of	 ER-
mitochondria	junctional	complexes	to	a	distance	of	7	nm	was	not	permissive	to	inter-
organelle	calcium	exchange	(Csordas	et	al.,	2010).	The	collective	data	is	suggestive	
of	increased	mitochondrial	membrane	potential	and	calcium	concentrations	being	a	
consequence	of	contact	formation,	but	further	experiments	could	be	carried	out	to	
strengthen	this	observation.	Indeed,	an	inversely	proportional	relationship	between	
the	 length	 of	 an	 ER-mitochondria	 contact	 site	 and	 mitochondrial	 calcium	
concentrations	 has	 been	 experimentally	 demonstrated	 and	 furthermore,	
chemically-induced	 elevations	 in	 ER-mitochondria	 contacts	 were	 associated	 with	
increases	 in	 both	mitochondrial	 calcium	 concentrations	 and	membrane	 potential	
(Bravo	et	al.,	2011;	Csordas,	2006).	
4.4.3	Contact	sites	labelled	by	the	Venus	reporter	proteins	may	not	be	permissive	
for	the	autophagosome	initiation	complex		
It	 has	 been	 proposed	 that	 MAMs	 are	 contributors	 of	 membrane	 during	
autophagosome	 formation	 but	 it	 is	 believed	 that	 this	 process	 is	 restricted	 to	
particularly	 wide	 junctions	 of	 approximately	 50	 nm,	 far	 beyond	 the	 maximum	
distance	the	split	Venus	proteins	can	report	on	(Hamasaki	et	al.,	2013;	Giacomello	
and	Pellegrini,	2016).	In	agreement	with	this,	we	have	shown	that	ATG5	and	ATG14	
puncta,	 early	markers	 of	 autophagosome	 formation,	 do	not	 co-localise	with	BiFC	
puncta.	This	data	provides	supporting	evidence	that	specific	functions	of	the	MAMs	
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can	be	attributed	to	different	sized	junctions	and	that	ER-mitochondria	contact	sites	
<	10	nm	are	not	wide	enough	to	facilitate	autophagosome	formation.	
4.4.4	BiFC	puncta	may	be	spatially	linked	to	mitochondrial	fission	events	
Finally,	we	investigated	the	association	of	the	BiFC	puncta	with	another	function	of	
the	MAMs,	the	regulation	of	mitochondrial	 fission	events	 (Friedman	et	al.,	2011).	
This	was	carried	out	by	quantifying	the	number	of	BiFC	puncta	within	close	proximity	
to	replicating	nucleoids	as	labelled	by	fluorescently	tagged	POLG2.	Previously,	it	was	
shown	that	73%	of	POLG2	puncta	 localised	within	1	µm	of	mitochondrial	division	
events	 and	 were	 spatially	 linked	 to	 ER-mitochondria	 sites	 of	 undefined	 junction	
thickness	(Lewis	et	al.,	2016).	Due	to	the	approximately	two-fold	difference	in	the	
number	of	POLG2	puncta	in	comparison	to	BiFC	puncta	per	cell	as	we	have	seen	here,	
it	 is	 unlikely	 that	 mitochondrial	 division	 occurs	 exclusively	 at	 ER-mitochondria	
contact	sites	<	10	nm.	However,	we	have	demonstrated	that	66	±	6	%	of	BiFC	puncta	
are	within	1	µm	of	a	replicating	nucleoid,	a	figure	that	is	comparable	to	that	seen	by	
Lewis	et	al	and	33.5	±	4.3	%	were	in	very	close	proximity	at	only	200	nm	apart	and	
therefore,	 there	may	 be	 a	 functional	 association	 between	 tight	 ER-mitochondria	
contact	 sites	 and	 mitochondrial	 fission	 events.	 To	 test	 this	 more	 robustly,	 this	
experiment	should	be	repeated	using	an	additional	punctate	protein	marker	with	no	
known	 association	with	MAMs	 in	 order	 to	 test	 the	 statistical	 significance	 of	 any	
association	between	MAMs	and	POLG2	puncta	versus	random	overlap.	Additionally,	
the	laser	scanning	confocal	microscopy	(LSCM)	system	used	for	these	experiments	
has	a	relatively	slow	acquisition	speed	and	therefore	it	was	not	possible	to	accurately	
capture	mitochondrial	division	events	in	real-time.	Replication	of	these	experiments	
using	a	system	such	as	a	spinning-disk	confocal	microscope	that	scans	an	image	with	
multiple	pin-holes	simultaneously	and	has	acquisition	speeds	 in	the	magnitude	of	
100-1000	times	faster	than	LSCM	systems,	would	allow	us	to	correlate	mitochondrial	
fission	events	with	BiFC	puncta	in	living	cells.		
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4.5	Chapter	conclusion	
Overall,	 the	 data	 presented	 in	 this	 chapter	 suggests	 that	 tight	 ER-mitochondria	
contact	sites	<	10	nm	in	thickness	are	not	associated	with	autophagosome	formation	
nor	 are	 they	 involved	 in	 regulating	 calcium	homeostasis.	 It	may	be	 the	 case	 that	
these	processes	are	functionally	linked	to	wider	organelle	contact	sites	and	future	
experiments	using	BiFC	reporter	proteins	with	elongated	linker	sequences	could	be	
carried	out	to	test	this	hypothesis.	A	proportion	of	contact	sites	labelled	by	the	BiFC	
system	may	be	spatially	linked	to	replicating	nucleoids	and	possibly,	mitochondrial	
division	events	but	additional	experiments	will	be	required	in	order	to	strengthen	
this	observation.	Furthermore,	the	formation	of	these	tight	contact	sites	results	in	
an	elevation	of	mitochondrial	calcium	concentration	and	hyper-polarisation	of	the	
mitochondrial	membrane	for	a	sub-population	of	mitochondria.		
As	membrane	contact	sites	are	dynamic	and	complex	structures,	it	is	unlikely	that	
any	 one	 function	 of	 the	MAMs	 can	 be	 exclusively	 attributed	 to	 ER-mitochondria	
junctions	of	a	tightly	defined	thickness	range.	While	these	contact	sites	can	vary	in	
their	length	and	thickness,	it	is	important	to	consider	that	they	may	also	vary	in	their	
protein	 compositions,	 a	 variable	 that	 is	 not	 discriminated	by	 the	BiFC	 technique.	
Therefore,	MAMs	of	the	same	thickness	could	still	be	performing	different	functions	
depending	on	the	specific	protein	levels	at	these	sites.				
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Chapter	5	
VAPB	and	mitochondrial	associated	
membranes		
5.1	Background	
As	 outlined	 in	 the	 introduction	 to	 this	 thesis,	 the	 VAP	 protein	 family	 are	 key	
regulators	of	organelle	contact	sites	and	specifically,	VAPB	has	a	very	strong	link	to	
neurodegeneration	through	the	P56S	point	mutation	resulting	in	the	onset	of	ALS	
(Nishimura	et	al.,	2004).	Therefore,	it	is	plausible	to	hypothesise	that	a	dysfunction	
to	 MAMs,	 consequent	 of	 the	 VAPB	 mutation,	 may	 play	 a	 role	 in	 disease	
pathogenesis.	Percoll	gradient	fractionation	of	subcellular	organelles	revealed	that	
VAPB	 is	 enriched	 specifically	 in	 the	MAM	 fraction	 and	 associates	with	 the	 outer	
mitochondrial	membrane	protein	PTPIP51	to	regulate	ER-mitochondria	associations	
(De	Vos	et	al.,	2012).	VAPB-P56S	shows	increased	binding	with	PTPIP51	over	wild-
type	VAPB	with	approximately	3-4	 times	higher	 levels	of	PTPIP51	being	detected	
associated	with	the	mutant	protein	in	immunoprecipitation	experiments	(De	Vos	et	
al.,	2012).	Furthermore,	there	was	a	2-fold	enrichment	of	VAPB-P56S	in	the	MAM	
fraction	compared	to	the	wild-type	protein	(De	Vos	et	al.,	2012).	To	investigate	how	
expression	 levels	of	VAPB	may	 influence	the	MAMs	structurally,	Stoica	et	al	used	
high	resolution	EM	studies	and	quantified	areas	of	the	OMM	that	were	within	30	nm	
of	the	ER	and	demonstrated	that	siRNA-mediated	knock-down	of	VAPB	or	PTPIP51	
reduced	 associations	 from	 approximately	 12%	 of	 the	mitochondrial	 surface	 area	
being	 in	 close	 apposition	 to	 around	 6%	 (Stoica	 et	 al.,	 2014).	 In	 contrast,	
overexpression	of	VAPB	or	PTPIP51	increased	associations	to	around	20-30%	while	
co-expression	 of	 both	 proteins	 had	 a	 distinct	 phenotype	whereby	 approximately	
50%	of	the	OMM	was	in	contact	with	the	ER	(Stoica	et	al.,	2014).	Overexpression	of	
VAPB	or	PTPIP51	was	found	to	inhibit	autophagy	while	loosening	ER-mitochondria	
contacts	 by	 siRNA	 knock-down	 of	 VAPB	 or	 PTPIP51	 was	 permissive	 to	
autophagosome	 formation	 and	 increased	 the	 presence	 of	 autophagic	 markers	
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(Gomez-Suaga	 et	 al.,	 2017).	 The	 influence	 over	 autophagosome	 formation	 was	
linked	to	changes	in	Ca2+	exchange	from	the	mitochondria	to	the	ER	as	a	result	of	
altering	 contact	 thickness	 (Gomez-Suaga	 et	 al.,	 2017).	 The	 data	 indicates	 both	 a	
morphological	and	functional	disruption	to	the	MAMs	by	altering	the	levels	of	VAPB	
or	its	binding	partner,	PTPIP51.	
Through	the	generation	of	various	fusion	proteins	encompassing	different	domains	
of	VAPB,	it	was	shown	that	the	interaction	between	VAPB	and	PTPIP51	relies	on	the	
entire	 cytosolic	 face	 of	 VAPB	 (Stoica	 et	 al.,	 2014).	 As	 discussed	 in	 detail	 in	 the	
introductory	chapter	 (sections	1.3.1	–	1.3.3),	VAPB	 is	composed	of	an	N-terminal	
MSP	domain	and	a	central	coiled-coil	domain,	making	up	the	cytoplasmic	face	of	the	
protein,	 and	 a	C-terminal	 hydrophobic	 transmembrane	domain	 (Nishimura	et	 al.,	
1999).	 As	mentioned	 previously	 the	MSP	 domain	 of	 VAP	 proteins	 is	 cleaved	 and	
secreted	and	immunoblotting	a	selection	of	tissue	from	an	adult	male	rat	showed	
that	 the	MSP	 domain	 of	 VAPB	 is	 cleaved	 specifically	 in	 neuronal	 tissue	 while	 in	
contrast,	cleaved	products	of	VAPA	are	observed	in	a	number	of	different	tissues	but	
only	 low	 levels	 of	 truncated	 protein	 were	 detected	 in	 forebrain	 and	 cerebellum	
tissue	(Gkogkas	et	al.,	2008).	The	presence	of	these	truncated	VAP	species	appears	
to	be	developmentally	regulated	and	are	enriched	in	adult	tissue	in	comparison	to	
embryonic	tissue	(Gkogkas	et	al.,	2011).	While	cleavage	of	wild-type	VAPB	in	neurons	
can	generate	an	intact	MSP	domain,	the	ALS-linked	VAPB-P56S	protein	was	resistant	
to	this	proteolytic	event	when	expressed	in	rat	primary	neuronal	cultures	(Gkogkas	
et	al.,	2011).	The	presence	of	the	P56S	point	mutation	had	previously	been	shown	
to	disrupt	the	native	structure	of	the	MSP	domain	while	also	conferring	the	ability	of	
the	MSP	domain	to	interact	with	lipids	and	adopt	a	highly-helical	conformation	(Qin	
et	 al.,	 2013;	 Shi	 et	 al.,	 2010).	 This	 structural	 change	may	 be	 responsible	 for	 the	
mutant	protein’s	resistance	to	cleavage	of	the	MSP	domain.	
Interestingly,	 expressing	 fluorescently	 tagged	 full-length	 and	 truncated	 CC-CT	
(coiled-coil-C-terminus)	 forms	of	VAPB	demonstrated	 that	 the	 two	proteins	 show	
extensive	co-localisation	on	the	ER	but	there	was	a	proportion	of	truncated	protein	
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that	 did	 not	 co-localise	 and	 may	 indicate	 a	 unique	 localisation	 of	 this	 protein	
(Gkogkas	 et	 al.,	 2011).	 Dissimilar	 patterns	 of	 proteolytic	 processing	 of	 VAPA	 and	
VAPB	could	highlight	some	yet	undiscovered	differences	between	the	two	proteins	
or	 in	 the	 case	 of	 VAPB,	 suggests	 the	 presence	 of	 a	 neuron-specific	 protease.	 An	
alternative	 suggestion	 is	 that	 differences	 in	 the	 sub-cellular	 localisation	 of	 these	
proteins	 could	 expose	 them	 to	 different	 proteolytic	 complexes	 (Gkogkas	 et	 al.,	
2011).	In	peripheral	blood	leukocytes	(PBL)	and	cerebrospinal	fluid	(CSF)	taken	from	
healthy	 patients	 and	 non-ALS	 controls,	 a	 high	 concentration	 of	 VAPB	 cleavage	
products	and	very	low	levels	of	VAPB	were	detected,	suggestive	of	high	proteolytic	
processing	of	VAPB	(Deidda	et	al.,	2014).	This	was	in	stark	contrast	to	SALS	patients	
where	VAPB	cleavage	products	were	only	detected	 in	 the	CSF	of	40%	of	patients	
even	 though	 no	 VAPB	mutations	were	 detected	 in	 these	 patients	 (Deidda	 et	 al.,	
2014).	 This	 result	 provides	 supporting	 evidence	 for	 a	 wider	 role	 of	 VAPB	 in	 ALS	
pathogenesis,	not	just	restricted	to	specific	ALS8	cases	and	furthermore,	implicates	
that	a	disruption	to	the	truncation	of	VAPB	may	play	a	role	in	disease	progression	
(Deidda	 et	 al.,	 2014).	 In	 C.elegans,	 VAP	 MSP	 domains	 secreted	 from	 neurons	
regulates	mitochondrial	localisation	and	function	in	muscle	tissue	(Han	et	al.,	2012)	
and	impairment	of	MSP	signalling	to	the	muscle	causes	altered	lipid	homeostasis	and	
impaired	 energy	 metabolism,	 which	 could	 account	 for	 the	 energy	 metabolism	
defects	observed	in	ALS	patients	(Han	et	al.,	2013b).	If	the	cleavage	of	VAPB	or	the	
presence	 of	 the	 truncated	 protein	 has	 a	 specific	 effect	 on	 ER-mitochondria	
associations,	it	has	yet	to	be	elucidated.									
5.2	Chapter	aims	
Published	EM	data	has	shown	a	role	of	VAPB	in	influencing	ER-mitochondria	contact	
sites	of	<30	nm	and	a	disruption	to	the	MAMs	is	observed	when	the	levels	of	this	
protein	are	altered	(Stoica	et	al.,	2014).	In	this	chapter,	we	aimed	to	investigate	any	
changes	in	tight	ER-mitochondria	interactions,	as	reported	on	by	BiFC	system,	that	
may	arise	from	altering	the	levels	of	VAPA	and	VAPB.	Furthermore,	we	sought	to	test	
the	effect	of	expression	of	the	ALS-linked	VAPB-P56S	mutant	protein	on	the	contact	
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sites.	Finally,	sub-cellular	organelle	fractionation	techniques	were	employed	on	rat	
brain	and	liver	tissue	to	explore	the	proteolytic	cleavage	of	VAPA	and	VAPB	in	more	
depth.																						
5.3	Results	
5.3.1	Overexpression	of	VAPB-P56S	but	not	wild-type	VAPB	significantly	increases	
tight	ER-mitochondria	contacts	
Previously	 published	 data	 has	 provided	 supporting	 evidence	 that	 overexpressing	
VAPB	in	mammalian	cell	lines	increases	the	mean	percentage	area	of	the	OMM	that	
is	 in	 close	 proximity	 to	 the	 ER	 (Stoica	 et	 al.,	 2014).	 However,	 this	 data	 does	 not	
provide	 information	 on	 whether	 overexpressing	 wild-type	 VAPB	 promotes	 the	
formation	of	new	contact	 sites	or	whether	 it	 simply	 tightens	pre-existing	 contact	
sites	 that	 are	 tethered	 by	 the	 VAPB/PTPIP51	 interaction.	 Immunoprecipitation	
experiments	have	shown	an	increased	association	of	VAPB-P56S	with	PTPIP51	at	the	
MAMs	in	comparison	to	wild-type	VAPB	and	therefore,	we	could	predict	that	this	
interaction	may	also	increase	ER-mitochondria	contacts	although	this	has	not	been	
conclusively	 shown	 (De	 Vos	 et	 al.,	 2012).	 Here,	 we	 have	 overexpressed	 double	
epitope-tagged	 wild-type	 VAPB,	 the	 ALS-linked	 VAPB-P56S	 or	 a	 non-pathogenic	
VAPB	variant,	VAPB-N29S,	that	was	identified	in	human	patients	but	is	not	known	to	
cause	any	disease	(unpublished	data).	In	NSC34	cells	stably	expressing	the	V1-ER	and	
V2-Mito	 reporter	 proteins	 and	 immunolabelled	 with	 an	 anti-Myc	 antibody,	 we	
observe	 the	 characteristic	 ER	 localisation	 of	 VAPB	 and	 VAPB-N29S	 while	 in	 cells	
expressing	VAPB-P56S	there	is	a	clear	mislocalisation	of	the	protein	from	the	ER	into	
large	 aggregates	 as	 has	 been	 observed	 in	 a	 number	 of	 other	 studies	
(Fig5.1A)(Nishimura	 et	 al.,	 2004;	 Gkogkas	 et	 al.,	 2008).	 Increases	 in	 the	 relative	
protein	 levels	 produced	 from	 different	 concentrations	 of	 DNA	 transfected	 were	
confirmed	 by	 anti-Myc	 immunofluorescent	 staining	 (Fig5.1B)	 and	 by	 western	
blotting	 (Fig5.1C).	 The	 data	 indicates	 that	 wild-type	 VAPB	 and	 VAPB-N29S	 are	
expressed	 at	 equivalent	 levels	 whereas	 a	 much	 lower	 level	 of	 VAPB-P56S	 is	
detectable	from	the	same	concentrations	of	DNA	transfected,	an	observation	which	
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has	also	been	seen	in	other	published	studies	(Kanekura	et	al.,	2006).	This	difference	
in	protein	 levels	 is	believed	to	be	due	to	the	rapid	rate	of	degradation	of	mutant	
VAPB-P56S	 in	 comparison	 to	 wild-type	 VAPB	 by	 the	 UPS	 (Papiani	 et	 al.,	 2012).	
Quantification	 of	 the	mean	 number	 of	 BiFC	 puncta	 per	 cell	 showed	 a	 significant	
increase	 in	 cells	 transfected	 with	 both	 concentrations	 of	 VAPB-P56S	 tested	 in	
comparison	 to	 control	 cells	 transfected	 with	 a	 CMV-Globin	 vehicle	 control.	 No	
significant	 change	was	 detected	 in	 cells	 overexpressing	wild-type	VAPB	 or	 VAPB-
N29S	(Fig5.1D).		
In	 summary,	 the	 data	 shows	 a	 significant	 increase	 in	 the	 number	 of	 BiFC	 puncta	
induced	by	expression	of	the	ALS-linked	VAPB-P56S	but	not	from	wild-type	VAPB	or	
VAPB-N29S.	However,	as	these	proteins	were	not	expressed	to	the	same	levels,	we	
cannot	 rule	 out	 that	 at	 equivalent	 levels	 of	 expression,	wild-type	VAPB	may	 also	
induce	an	increase	in	tight	ER-mitochondria	contacts.	To	test	this,	the	levels	of	Myc-
VAPB-HA	 and	 Myc-VAPB-P56S-HA	 DNA	 were	 titrated	 and	 the	 relative	 levels	 of	
expression	were	tested	by	western	blotting.	The	data	indicates	approximately	equal	
levels	of	VAPB	and	VAPB-P56S	are	produced	when	the	levels	of	Myc-VAPB-P56S-HA	
DNA	transfected	are	ten-fold	concentrated	(10	ng	to	100	ng	DNA)	(Fig5.2A).	We	then	
examined	whether	lower	levels	of	VAPB	would	significantly	alter	the	number	of	BiFC	
puncta	 by	 transfecting	 10	 ng	 of	Myc-VAPB-HA,	 100	 ng	 of	Myc-VAPB-P56S-HA	 to	
express	equivalent	protein	levels	and	which	we	have	already	shown	to	significantly	
increase	the	BiFC	puncta	number	and	100	ng	of	Myc-VAPB-HA	which	previously	had	
no	effect	on	BiFC	number.	The	results	showed	no	significant	change	in	BiFC	number	
from	expression	of	either	concentration	of	VAPB	but	again,	a	significant	increase	was	
detected	 from	expression	of	 the	mutant	VAPB-P56S	 (Fig5.2B).	The	data	 indicates	
that	 expression	 of	 VAPB-P56S	 significantly	 increases	 the	 number	 of	 tight	 ER-
mitochondria	 interactions	 in	 NSC34	 cells	 however,	 it	 is	 not	 clear	 whether	 this	 is	
through	an	enhanced	physical	tethering	role	at	the	MAMs	or	through	an	indirect,	
secondary	mechanism.	 Although	 the	 evidence	 is	 controversial,	 overexpression	 of	
wild-type	 or	 mutant	 VAPB	 in	 cells	 has	 been	 seen	 to	 trigger	 UPR	 through	 IRE1-
mediated	 XBP1	 splicing	 (Langou	 et	 al.,	 2010)	 and	 silencing	 of	 VAP	 expression	
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prevented	 the	 chemical-induced	 activation	 of	 UPR	 (Kanekura	 et	 al.,	 2006).	 Our	
previous	data	has	shown	that	treating	cells	with	tunicamycin	to	induce	an	ER	stress	
significantly	increased	the	mean	number	of	BiFC	puncta	per	cell	and	therefore,	it	is	
possible	 that	VAPB-P56S	may	be	 increasing	ER-mitochondria	associations	 through	
the	 activation	 of	 the	 UPR.	 To	 test	 this,	 RNA	 was	 extracted	 from	 NSC34	 cells	
expressing	wild-type	VAPB,	VAPB-P56S	or	VAPB-N29S	and	reverse	transcriptase	PCR	
was	performed	to	look	for	the	splicing	of	XBP1	mRNA,	indicative	of	UPR	activation.	
No	 splicing	 of	 XBP1	 mRNA	 was	 detected	 in	 any	 of	 the	 groups	 and	 therefore,	
overexpression	 of	 any	 of	 the	VAPB	 variants	 did	 not	 seem	 to	 induce	 an	 ER	 stress	
response	through	the	IRE1-XBP1	pathway	(Fig5.2C).	Furthermore,	when	treated	with	
tunicamycin,	splicing	of	XBP1	mRNA	was	detectable	 from	all	experimental	groups	
and	 thus,	we	can	conclude	 that	overexpression	of	wild-type	VAPB,	VAPB-P56S	or	
VAPB-N29S	does	not	inhibit	the	chemical-activation	of	UPR	in	NSC34	cells	(Fig5.2C).	
Therefore,	 we	 can	 conclude	 that	 the	 increase	 in	 BiFC	 puncta	 caused	 by	
overexpression	of	VAPB-P56S	is	not	due	to	activation	of	the	IRE1/XBP1	pathway	and	
may	 be	 due	 to	 some	 other	 secondary	 mechanism	 or	 its	 enhanced	 binding	 with	
PTPIP51.									
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Fig	5.1:	Overexpression	of	VAPB
P56S	
significantly	increases	the	number	of	tight	ER-
mitochondria	 contacts	 per	 cell.	 (A)	 Representative	 images	 of	 NSC34	 cells	 stably	
expressing	V1-ER	/	V2-Mito	reporter	plasmids	and	transiently	transfected	with	either	
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Myc-	 and	Ha-	 tagged	wild-type	VAPB,	ALS-linked	VAPB-P56S	or	 a	 non-pathogenic	
variant	VAPB-N29S.	Anti-myc	immunostaining	(magenta)	was	carried	out	to	illustrate	
the	mis-localisation	of	VAPB-P56S	from	the	ER	into	cytoplasmic	aggregates.	(B)	Anti-
myc	immunostaining	(red)	of	NSC34	cells	expressing	the	different	VAPB	constructs.	
Nuclei	are	labelled	with	DAPI	(blue).	(C)	Western	blot	analysis	of	whole	cell	lysates	
extracted	 by	 SDS	 detergent,	 showing	 relative	 protein	 levels	 produced	 from	
equivalent	 concentrations	of	 transfected	DNA.	Histone	H3	was	used	 as	 a	 loading	
control.	(D)	Overexpression	of	VAPB-P56S	at	both	concentrations	tested	significantly	
increases	 the	mean	 number	 of	 BiFC	 puncta	 per	 cell	 but	 no	 significant	 change	 is	
detected	from	overexpression	of	wild-type	VAPB	or	VAPB-N29S.	n	=	3-4	independent	
experiments	 (3	 replicates	 for	 VAPB-P56S	 experimental	 group,	 4	 replicates	 for	
control,	 wild-type	 VAPB	 and	 VAPB-N29S),	 33-47	 cells	 per	 experimental	 group.	
Statistical	significance	was	carried	out	by	one-way	ANOVA,	comparing	the	means	of	
each	group	to	the	control	group,	followed	by	Dunnett’s	multiple	comparisons	test.	
ns	 (non-significant)	 P>0.05,	 **P<0.01,	 ***P<0.001.	 Values	 indicate	 overall	 mean	
values	from	each	independent	replicate.	Error	bars	indicate	SEM.	
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Fig	5.2:	At	equivalent	protein	levels,	VAPB
P56S	
but	not	wild-type	VAPB	significantly	
increases	the	mean	number	of	 tight	ER-mitochondria	contacts.	 (A)	Western	blot	
analysis	showing	the	relative	protein	levels	detected	from	different	concentrations	
of	 transfected	 plasmid	 DNA	 in	 NSC34	 cells.	 (B)	 Overexpression	 of	 VAPBP56S	
significantly	 increases	 the	 mean	 number	 of	 BiFC	 puncta	 per	 cell.	 No	 significant	
change	was	observed	from	expression	of	either	concentration	of	wild-type	VAPB	in	
comparison	 to	 controls.	 n	 =	 3	 independent	 experiments	 (29-35	 cells	 per	
experimental	group).	Statistical	significance	was	determined	using	one-way	ANOVA,	
comparing	the	mean	of	each	experimental	group	to	the	mean	of	the	control	group,	
followed	 by	 Dunnett’s	 multiple	 comparisons	 test.	 ns	 (non-significant).	 P>0.05,	
*P<0.05.	Error	bars	represent	SEM.	Values	indicate	overall	mean	values	from	each	
of	the	three	independent	experiments.	(C)	A	lack	of	XBP1	mRNA	splicing	from	NSC34	
cells	overexpressing	wild-type	VAPB,	VAPBP56S	or	VAPBN29S	showed	that	no	ER	stress	
was	induced	from	expression	of	any	of	the	VAPB	variants	alone.	Treatment	of	cells	
with	 10	 µg/ml	 Tunicamycin	 for	 6	 h	 induced	 splicing	 of	 XBP1	 in	 all	 experimental	
groups.					
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5.3.2	 Knock-down	 of	 VAP	 expression	 has	 no	 effect	 on	 the	 number	 of	 tight	 ER-
mitochondria	contact	sites	
Although	the	overexpression	of	VAPB	had	no	significant	 impact	on	the	number	of	
tight	 ER-mitochondria	 interactions,	we	wanted	 to	 test	whether	 a	 knock-down	 of	
expression	of	either	VAPA	or	VAPB	or	both	would	influence	organelle	associations.	
Previous	data	has	illustrated	a	reduction	of	approximately	50%	in	the	surface	area	of	
the	OMM	closely	opposed	to	the	ER	from	a	VAPB	knock-down	when	contact	sites	up	
to	30	nm	in	thickness	were	quantified	(Stoica	et	al.,	2014).		
Western	blot	analysis	using	antibodies	against	whole	VAPA	and	VAPB	(VAPB	serum	
#38	was	used	and	is	simply	referred	to	as	VAPB	antibody	in	the	rest	of	the	text)	was	
used	 to	 demonstrate	 a	 specific	 knock-down	 of	 VAP	 protein	 levels	 in	 NSC34	 cells	
mediated	by	siRNA	transfections	(Fig	5.3A).	VAPA	and	VAPB	ran	slightly	higher	than	
would	be	expected	from	its	primary	structure	at	around	34	kDa	but	the	knock-down	
of	 signal	 in	 samples	 treated	 with	 the	 corresponding	 VAPA	 or	 VAPB	 siRNA	
demonstrates	that	this	is	the	correct	band.	Furthermore,	this	was	also	observed	in	
previous	experiments	carried	out	by	Skehel	et	al	(Gkogkas	et	al.,	2011).	No	change	
in	 VAPA	 levels	 resulted	 from	 a	 knock-down	 of	 VAPB	 expression	 and	 vice	 versa.	
Furthermore,	depletion	of	 the	ER-mitochondria	 tether	MFN2,	did	not	alter	either	
VAPA	or	VAPB	levels,	in	agreement	with	data	by	Stoica	et	al	(Stoica	et	al.,	2014).	The	
data	 indicates	 that	 in	 the	 NSC34	 cell	 line,	 the	 levels	 of	 VAP	 do	 not	 seem	 to	 be	
influenced	by	one	another	nor	are	they	dependent	on	the	MAM	protein	MFN2.	In	
our	 stable	NSC34	 cell	 consistently	 expressing	 the	Venus	 fusion	 reporter	proteins,	
siRNA	knock-down	of	VAPA,	VAPB	or	both	VAPA	and	VAPB	had	no	significant	impact	
on	the	mean	number	of	BiFC	puncta	per	cell	(Fig5.3B).													
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Fig	 5.3:	 Knock-down	 of	 VAP	 expression	 does	 not	 significantly	 alter	 the	 mean	
number	of	BiFC	puncta	in	stably	transfected	NSC34	cells.	(A)	Western	blot	analysis	
showing	a	knock-down	of	VAPA	expression	 in	 lanes	treated	with	VAPA	siRNA	and	
both	VAPA	and	VAPB	siRNA	and	a	knock-down	of	VAPB	expression	in	lanes	treated	
with	VAPB	siRNA	and	both	VAPA	and	VAPB	siRNA.	No	change	in	VAPA	or	VAPB	levels	
was	detected	from	a	knock-down	of	the	MAM	protein	MFN2.	Control	well	represents	
cells	treated	with	Dharmacon	non-targeting	siRNA	control	pool.	Histone	H3	was	used	
as	a	loading	control.	50	nM	of	siRNA	was	transfected	per	experimental	group	for	48	
h.	(B)	Treatment	of	NSC34	cells	stably	expressing	V1-ER	/	V2-Mito	reporter	proteins	
with	VAPA	siRNA,	VAPB	siRNA	or	both	VAPA	and	VAPB	siRNA	showed	no	significant	
changes	in	the	mean	number	of	BiFC	puncta	per	cell.	n	=	3	independent	experiments	
(35-49	cells	per	experimental	group).	Statistical	significance	was	tested	by	one-way	
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ANOVA	comparing	 the	mean	of	each	column	to	 the	mean	of	 the	control	column,	
followed	by	Dunnett’s	multiple	comparison	test.	P>0.05.	
It’s	possible	that	a	knock-down	of	VAP	proteins	could	be	decreasing	the	number	of	
ER-mitochondria	 contacts	 but	 this	 may	 not	 be	 detectable	 by	 the	 BiFC	 method,	
depending	on	the	reversibility	of	the	technique.	To	try	and	overcome	this	potential	
limitation,	siRNA	against	VAPA	and	VAPB	was	transfected	into	NSC34	cells,	24	hours	
before	the	transient	transfection	of	V1-ER	and	V2-Mito	reporter	proteins.	By	doing	
so,	 it	would	allow	any	VAP-dependent	changes	 in	 the	MAMs	 to	occur	before	 the	
expression	of	the	Venus	fusion	reporter	proteins.	Western	blot	analysis	showed	that	
in	this	manner,	there	was	still	a	strong	knock-down	of	VAPA	and	VAPB	levels	from	
the	appropriate	siRNA	transfections	(Fig	5.4A).	Quantification	of	the	mean	number	
of	BiFC	puncta	per	cell	again	demonstrated	no	significant	change	from	a	loss	of	VAP	
expression	in	comparison	to	control	groups	(Fig	5.4B).						
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Fig	5.4:	 siRNA	mediated	knock-down	of	VAP	protein	 levels	before	 the	 transient	
expression	of	Venus	fusion	proteins	does	not	significantly	change	the	number	of	
BiFC	puncta	in	NSC34	cells.	(A)	Western	blot	analysis	showing	that	a	knock-down	of	
VAPA	and	VAPB	still	occurs	even	when	V1-ER	and	V2-Mito	plasmids	are	transiently	
transfected	24	hours	after	the	transfection	of	siRNA.	(B)	No	significant	change	in	BiFC	
puncta	number	in	comparison	to	control	group	was	detected.	Statistical	significance	
was	tested	by	one-way	ANOVA	comparing	the	mean	of	each	column	to	the	mean	of	
the	control	column,	followed	by	Dunnett’s	multiple	comparison	test.	P>0.05.	n	=	4	
independent	experiments	(42-48	cells	per	experimental	group).					
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Overall,	we	can	conclude	that	tight	ER-mitochondria	contacts,	approximately	6-10	
nm	in	length,	reported	on	by	the	Venus	reporter	proteins	are	not	dependent	on	the	
expression	 of	 VAP	 proteins.	 The	 previously	 reported	 alterations	 in	 the	 MAMs,	
induced	by	changes	 in	VAP	expression,	may	allude	to	a	distinct	sub-population	of	
MAMs	 greater	 than	 10	 nm	 in	 thickness	 that	 are	mediated	 by	 the	 levels	 of	 VAPB	
(Stoica	et	al.,	2014).							
5.3.3	 Percoll	 gradient	 centrifugation	 successfully	 purifies	 ER,	 mitochondria	 and	
MAM	fractions	from	rat	liver	tissue	homogenates.	
Through	a	series	of	centrifugation	steps	in	Percoll	gradient	medium	(as	described	in	
section	2.7	of	chapter	2	of	this	thesis),	it	allows	for	the	biochemical	purification	of	
the	MAMs	from	animal	tissue	homogenates.	This	permits	the	detection	of	protein	
species	specifically	within	the	MAMs	in	comparison	to	the	bulk	ER	or	mitochondria.	
In	order	 to	optimise	 the	 technique	and	prove	 the	 relative	purity	of	 the	 fractions,	
whole	liver	and	brain	tissue	was	extracted	from	a	5	month	old	wild-type	rat	and	the	
bulk	 ER,	 crude	 mitochondria	 (consisting	 of	 mitochondria	 and	 MAMs	 together),	
purified	mitochondria	and	purified	MAM	fractions	were	isolated	and	equal	protein	
concentrations	of	 each	 fraction	were	 loaded	on	an	SDS-PAGE	gel	 and	probed	 for	
different	 markers	 with	 immunoblotting.	 The	 ATP-synthase	 subunit	 b	 (ATPB)	 is	
targeted	to	the	inner	mitochondrial	membrane	(Giorgio	et	al.,	2013)	and	therefore	
it	 should	be	enriched	 in	 the	mitochondrial	 fractions	 and	absent	 from	 the	ER	and	
MAM	fractions	in	liver	tissue	which	can	be	clearly	observed	in	Fig5.5A.	In	contrast,	
VAPB	was	detectable	within	the	ER	and	MAM	fractions	as	expected	and	VAPA	was	
also	 enriched	 in	 the	 MAM	 and	 ER	 fractions	 with	 a	 faint	 signal	 in	 the	 crude	
mitochondrial	 fraction	 in	 homogenised	 rat	 liver	 tissue	 (Fig5.5A).	 Interestingly,	 a	
lower	 molecular	 weight	 protein	 species	 was	 detected	 by	 the	 VAPA	 antibody	
specifically	in	the	MAM	fraction,	which	corresponds	to	the	size	of	the	cleaved	VAPA	
protein	species	previously	observed	in	whole	liver	tissue	in	the	Skehel	lab	(Gkogkas	
et	al.,	2008).	These	 results	 indicate	 that	Percoll	gradient	centrifugation	efficiently	
purifies	subcellular	organelle	fractions	however,	in	fractionated	brain	tissue	from	the	
wild-type	 rat,	 there	was	no	detectable	 signal	 in	 the	MAM	 fraction	 for	 any	of	 the	
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antibodies	 tested	 (data	not	 shown).	To	 test	 if	 this	was	 simply	due	 to	 low	protein	
concentrations,	brain	tissue	from	two	wild-type	rats	was	pooled	and	gram	for	gram	
equivalent	amounts	of	starting	brain	tissue	and	liver	tissue	were	used	for	subsequent	
organelle	fractionation.	Although	the	same	amount	of	starting	material	was	used,	
BSA	protein	quantification	showed	lower	protein	levels	in	all	of	the	brain	fractions	in	
comparison	to	the	equivalent	liver	fractions,	however,	we	were	still	able	to	obtain	a	
detectable	 brain	 MAM	 fraction	 signal	 in	 this	 case	 which	 showed	 the	 expected	
pattern	of	expression	of	VAPB	and	VAPA	in	agreement	with	liver	fractions	(Fig5.5B).	
In	contrast	to	the	liver	fractions	however,	no	truncated	VAPA	species	was	detected	
in	 brain	 tissue	which	 is	 in	 agreement	 to	 the	 published	 literature	 (Gkogkas	 et	 al.,	
2008).	We	did	observe	a	truncated	VAPB	product	of	the	same	molecular	weight	as	
the	VAPA	cleavage	product	which	was	confined	specifically	to	the	bulk	ER	fraction	
and	an	intermediate	product	of	around	20	kDa	that	followed	the	expression	pattern	
of	the	full-length	protein	(Fig5.5B).	In	pure	neuronal	cultures,	protein	levels	of	full-
length	and	truncated	VAPB	are	comparable	but	when	glial	cells	were	also	present,	
relative	 levels	of	 full-length	VAPB	were	higher	 (Gkogkas	et	al.,	2011).	As	we	have	
fractionated	whole	brain	 tissue,	 it	 is	not	unexpected	 that	we	see	 relatively	 lower	
levels	of	truncated	product	(Fig5.5B).	It	is	important	to	note	that	these	results	were	
obtained	 from	 only	 two	 animals	 and	 therefore,	more	 replications	 are	 needed	 in	
order	to	draw	a	strong	conclusion	however,	the	results	do	highlight	an	interesting	
possibility	that	the	proteolytic	processing	of	VAPA	and	VAPB	may	occur	in	different	
subcellular	compartments	in	brain	and	liver	tissue.														
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Fig	5.5:	Protein	species	in	subcellular	fractions	generated	from	wild-type	rat	liver	
and	 brain	 tissue.	 (A)	 Immunoblotting	 of	 rat	 liver	 fractions	 indicates	 the	 relative	
purity	 of	 each	 of	 the	 fractions,	 showing	 the	 presence	 of	 the	 inner	mitochondrial	
membrane	protein	ATPB	within	 the	crude	and	pure	mitochondrial	 fractions	while	
VAPB	 (as	 labelled	 by	 anti-VAPB	 #6)	 and	 VAPA	 are	 enriched	 in	 the	 ER	 and	MAM	
fractions,	 with	 a	 low	 signal	 of	 VAPA	 being	 detected	 in	 the	 crude	 mitochondrial	
fraction	which	also	contains	 some	MAM	proteins.	Consistent	with	all	other	blots,	
VAP	species	ran	slightly	higher	than	expected	at	approximately	34	kDa.	Truncated	
VAPA	protein	is	present	specifically	within	the	MAM	fraction	and	is	indicated	by	the	
arrow	symbol.	(B)	In	pooled	brain	tissue	from	two	wild-type	animals,	VAPA	and	VAPB	
proteins	 (As	 labelled	 by	 both	 anti-VAPB	 #6	 and	 #38)	 are	 detectable	 within	 the	
appropriate	fractions.	In	contrast	to	the	liver	fractions,	no	truncated	VAPA	protein	is	
detectable	however,	truncated	VAPB	species	of	around	20	kDa	are	detectable	in	the	
ER,	crude	mitochondria	and	MAM	fractions	while	there	is	a	lower	molecular	weight	
product,	confined	to	the	ER	fraction	as	indicated	by	the	arrow.		
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5.4	Discussion	
5.4.1	Tight	ER-mitochondria	contact	sites	appear	to	be	formed	independently	of	
VAP	protein	levels	
In	the	first	part	of	this	chapter,	data	is	presented	on	the	influence	of	VAP	protein	
levels	 on	 tight	 ER-mitochondria	 junctions	 as	 reported	 on	 by	 the	 BiFC	 reporter	
proteins.	When	wild-type	VAPB	or	a	non-pathogenic	point	mutation	of	VAPB,	VAPB-
N29S,	were	overexpressed	 in	NSC34	 cells,	 there	was	no	 significant	 change	 in	 the	
number	of	BiFC	puncta	per	cell	and	immunofluorescent	staining	revealed	a	reticular	
localisation	pattern	 for	 both	proteins.	 Previous	work	by	 Stoica	et	 al	 showed	 that	
overexpression	 of	 wild-type	 VAPB	 did	 induce	 an	 increase	 in	 ER-mitochondria	
associations	however,	this	is	not	necessarily	in	contradiction	to	our	data	as	firstly,	
this	 group	 looked	 at	 extensions	 in	 the	 surface	 area	 of	 the	mitochondria	 in	 close	
proximity	 to	 the	 ER	 of	 pre-existing	 contact	 sites,	 a	 measurement	 which	 is	 not	
detectable	from	the	diffraction-limited	imaging	of	cells	expressing	the	BiFC	reporter	
proteins	(Stoica	et	al.,	2014).	Secondly,	this	group	measured	contact	sites	of	up	to	30	
nm	 in	 thickness	 whereas	 our	 reporter	 proteins	 would	 quantify	 contact	 sites	 of	
approximately	10	nm	in	thickness	(Stoica	et	al.,	2014).	Therefore,	increases	in	VAPB	
may	influence	ER-mitochondria	contact	sites	but	this	may	be	limited	to	increasing	
the	lengths	of	pre-existing	VAPB-mediated	contacts	or	specifically	it	could	promote	
the	formation	of	new	contact	sites	>10	nm	in	thickness,	outside	of	the	detectable	
range	of	 the	BiFC	reporter	proteins.	We	did	observe	a	significant	 increase	 in	BiFC	
puncta	 upon	 the	 expression	 of	 the	 ALS-linked	 VAPB-P56S,	 accompanied	 by	 the	
appearance	of	large	intracellular	aggregates,	even	though	the	relative	protein	levels	
of	VAPB-P56S	were	much	lower	than	levels	of	wild-type	VAPB	or	VAPB-N29S.	It	is	not	
clear	from	our	data	whether	this	increase	is	due	to	direct	binding	of	the	mutant	VAPB	
protein	with	 its	MAM-tethering	 partner	 PTPIP51	 or	 if	 this	 is	 an	 indirect	 increase	
resulting	 from	 some	 secondary	mechanism.	 As	 discussed	 in	 section	 1.4.1	 of	 the	
introduction	of	this	thesis,	although	controversial,	there	is	some	evidence	to	suggest	
that	 expression	 of	 VAPB-P56S	 induces	 an	 ER	 stress	 response	 via	 the	 IRE1/XBP1	
pathway	(Langou	et	al.,	2010).	In	section	3.3.6	of	chapter	3	of	this	thesis,	we	have	
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shown	that	 the	 induction	of	ER	stress	significantly	 increases	the	mean	number	of	
BiFC	puncta	per	cell,	however	our	data	here	shows	that	overexpression	of	wild-type	
or	mutant	VAPB	in	NSC34	cells	does	not	induce	splicing	of	XBP1	mRNA	and	therefore	
we	can	conclude	that	the	increase	in	contact	sites	is	not	due	to	the	activation	of	the	
IRE1	ER	stress	response.	It	has	been	shown	that	VAPB-P56S	has	enhanced	binding	to	
PTPIP51	and	is	present	in	the	MAM	fraction	at	greater	levels	in	comparison	to	wild-
type	VAPB	(De	Vos	et	al.,	2012)	and	therefore,	it	is	possible	that	this	increase	in	ER-
mitochondria	 contact	 sites	 could	 be	 a	 direct	 result	 of	 increased	 tethering	 at	 the	
MAMs.	However,	 if	 this	was	the	case,	one	might	expect	that	this	effect	would	be	
recapitulated	upon	over-expression	of	wild-type	VAPB,	particularly	as	the	wild-type	
protein	is	expressed	at	much	greater	levels.	Furthermore	VAPB-P56S	aggregates	do	
not	 co-localise	 well	 with	 BiFC	 puncta,	 providing	 supporting	 evidence	 that	 the	
increase	 in	 contacts	 is	 more	 likely	 due	 to	 some	 secondary	 effect	 of	 VAPB-P56S	
expression,	 although	 further	 work	 will	 be	 required	 in	 order	 to	 elucidate	 the	
mechanism	of	action.	Future	work	could	 involve	 the	over-expression	of	wild-type	
VAPB	or	VAPB-P56S	 in	 cells	with	a	knock-out	of	PTPIP51	expression	which	would	
demonstrate	 that	 any	 resulting	 increase	 in	 ER-mitochondria	 contacts	 would	 be	
independent	of	VAPB-PTPIP51	binding.	Determining	the	protein	composition	of	tight	
ER-mitochondria	 contact	 sites	 as	 labelled	 by	 the	 BiFC	 system	 could	 also	 provide	
valuable	 insight	 into	 the	 VAPB-P56S-mediated	 increases	 in	 puncta	 number.	 It	 is	
unclear	whether	VAPB	is	a	component	of	these	tight	junctions	but	future	pull-down	
assays	may	indicate	the	extent	to	which	endogenous	full-length	VAPB	oligomerises	
with	the	V1-ER	construct,	which	could	be	suggestive	of	its	presence	at	sites	labelled	
by	 the	 BiFC	 proteins.	 Additionally,	 immunogold	 labelling	 of	 VAPB	 in	 combination	
with	 high-resolution	 EM	 studies	 could	 further	 shine	 some	 light	 on	 the	 protein	
compositions	of	MAMS	<10	nm	in	thickness.	If	these	contact	sites	are	too	tight	to	
permit	 the	 formation	 of	 the	 VAPB-PTPIP51	 complex,	 it	 would	 indicate	 that	 the	
mutant	VAPB	–related	increases	in	BiFC	number	are	more	likely	due	to	an	indirect	
secondary	 effect	 of	 the	mutation	 rather	 than	 as	 a	 consequence	of	 direct	 protein	
binding.		
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Similarly,	siRNA	knock-down	of	either	VAPA	or	VAPB	had	no	significant	impact	on	the	
number	of	BiFC	puncta	per	cell,	even	when	VAP	protein	levels	were	knocked-down	
before	 the	 expression	 of	 the	 BiFC	 reporter	 proteins	 to	 overcome	 the	 potential	
limitation	of	the	irreversibility	of	the	BiFC	technique.	These	results	suggest	that	tight	
ER-mitochondria	 contact	 sites	 <10	 nm	 are	 formed	 independently	 of	 VAP	 protein	
levels	 and	 based	 on	 the	 existing	 literature,	 it	 is	 more	 likely	 that	 VAPB/PTPIP51	
regulates	contact	sites	between	10-30	nm	in	thickness.	EM	imaging	could	be	used	to	
provide	strength	to	this	observation,	simultaneously	illustrating	that	altering	VAPB	
levels	 regulates	 contact	 sites	 >10	 nm	 as	 previously	 shown	 by	 Stoica	 et	 al,	while	
having	 no	 effect	 on	 the	 number	 of	 contact	 sites	 <10	 nm	 (Stoica	 et	 al.,	 2014).	
However,	 as	 this	 was	 an	 siRNA-mediated	 reduction	 in	 VAP	 protein	 levels,	 it	 is	
possible	 that	 the	 remaining	 low	 VAP	 protein	 levels	 were	 sufficient	 to	 maintain	
organelle	contact	formation.	Future	work	using	transgenic	cell	lines	with	a	knock-out	
of	the	VAP	genes	could	strengthen	the	conclusions	made	from	this	experiment.						
	
5.4.2	 Subcellular	 organelle	 fractionation	 suggests	 differences	 in	 the	 proteolytic	
processing	of	VAP	proteins	
In	addition	 to	optical	 imaging	 techniques,	MAMs	can	be	purified	biochemically	 in	
order	 to	 quantify	 MAM	 proteins	 specifically	 in	 comparison	 to	 other	 subcellular	
compartments.	 In	 the	 second	 part	 of	 this	 chapter,	 data	 is	 presented	 on	 the	
subcellular	organelle	fractionation	of	rat	brain	and	liver	tissue.	As	stated	previously,	
the	data	presented	here	 is	preliminary	due	to	time	constraints	and	 limitations	on	
animal	availability.	To	optimise	the	technique	and	prove	the	relative	purity	of	the	
fractions,	 organelle	 fractionation	was	performed	on	 liver	 and	brain	 tissue	 from	a	
wild-type	5	month	old	 rat	and	while	a	 strong	 signal	was	detectable	 for	all	 of	 the	
antibodies	tested	within	the	liver	fractions,	no	protein	signal	was	observed	within	
the	MAM	fractions	of	brain	tissue.	It	was	unclear	at	this	time	whether	this	was	simply	
a	result	of	low	protein	concentrations	or	perhaps	there	was	relatively	lower	MAMs	
in	brain	tissue	in	comparison	to	liver.	When	brain	tissue	from	two	wild-type	rats	was	
pooled	and	weighed	to	ensure	equivalent	starting	weights	of	brain	and	liver	tissue,	
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BCA	 protein	 quantification	 of	 the	 obtained	 fractions	 showed	 lower	 protein	
concentrations	 within	 the	 brain	 tissue	 for	 every	 fraction	 when	 compared	 to	 the	
equivalent	fraction	in	liver	tissue,	demonstrating	that	gram	for	gram,	brain	tissue	has	
lower	protein	concentration	than	liver.	A	detectable	signal	could	be	obtained	in	the	
MAM	 fractions	 of	 pooled	 brain	 tissue,	 providing	 supporting	 evidence	 that	 the	
previous	absence	of	signal	was	due	to	low	protein	concentrations	and	is	important	
to	bear	in	mind	for	future	experiments.			
Previously,	the	cleavage	of	VAPA	and	VAPB	in	mammals	had	only	been	demonstrated	
on	 a	whole	 tissue	 level	 (Gkogkas	 et	 al.,	 2008)	 but	 our	 data	 suggests	 site	 specific	
cleavage	of	VAPA	in	the	MAM	fraction	and	VAPB	within	the	bulk	of	the	ER	(Fig5.5).	
Although	only	shown	from	one	animal,	 it	highlights	the	interesting	possibility	that	
the	 observed	differences	 in	 the	 proteolytic	 processing	 of	 the	 closely	 related	VAP	
proteins	 could	be	due	 to	differences	 in	where	 this	 cleavage	event	 takes	place	or	
alternatively,	it	may	indicate	differences	in	where	the	truncated	product	is	retained	
post-cleavage.	This	data	could	also	 imply	that	VAP	proteins	present	at	 the	MAMs	
could	behave	differently	to	those	 localised	to	the	bulk	of	the	ER	for	example,	the	
binding	of	VAPB	to	PTPIP51	on	the	OMM	requires	the	entire	cytosolic	domains	of	
VAPB	 (Stoica	 et	 al.,	 2014)	 and	 therefore,	 it	 is	 possible	 that	 the	 formation	 of	 this	
protein	complex	at	the	MAMs	could	inhibit	the	cleavage	event	in	some	manner	and	
hence,	we	only	observe	truncated	VAPB	within	the	bulk	of	the	ER.	 If	 this	was	the	
case,	it	could	also	offer	an	explanation	as	to	why	the	P56S	point	mutation	is	resistant	
to	this	cleavage	event,	as	the	mutation	causes	an	enrichment	of	the	protein	within	
the	MAM	fraction	with	enhanced	binding	to	PTPIP51	(De	Vos	et	al.,	2012).	As	the	
cleavage	of	VAPB	has	implications	in	the	wider	field	of	ALS	beyond	ALS8	specifically	
(Deidda	 et	 al.,	 2014),	 elucidating	 the	 specific	mechanisms	 of	 VAPB	 proteolysis	 is	
important	 and	 although	 it	 is	 preliminary,	 the	 data	 here	 presents	 significant	
opportunity	for	further	investigation	in	this	area	in	the	future.		
The	 biochemical	 purification	 of	 MAM	 fractions	 from	 rat	 tissue	 has	 presented	 a	
significant	 avenue	 for	 future	 research	 into	 the	 role	 of	 VAPs	 in	 these	 subcellular	
compartments.	As	our	previous	data	presented	an	interesting	suggestion	on	possible	
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subcellular	 compartment	 specific	 processing	 of	 VAPA	 and	 VAPB,	 we	 wanted	 to	
further	 investigate	 this	 proteolytic	 event	 in	 transgenic	 rat	 models	 with	 either	 a	
homozygous	 knock-out	 of	 exon	 1	 of	 VAPB	 or	 expressing	 the	 ALS-linked	 VAPBP56S	
mutation	(as	outlined	in	chapter	2,	section	2.7)	and	some	preliminary	experiments	
have	 already	 been	 carried	 out	 to	 detect	 these	 protein	 species.	 Not	 a	 lot	 of	
information	is	known	about	the	proteolytic	processing	of	VAPA	and	VAPB	or	the	role	
of	the	truncated	proteins	at	the	MAMs,	other	than	that	the	cleavage	of	VAPB	seems	
to	occur	specifically	within	nerve	tissue	while	processing	of	VAPA	takes	place	 in	a	
much	greater	variety	of	tissues	(Gkogkas	et	al.,	2008).	Additionally,	the	presence	of	
the	 P56S	 point	 mutation	 appears	 to	 inhibit	 this	 proteolytic	 processing	 event	
(Gkogkas	et	al.,	2011).	Due	to	the	aforementioned	restrictions	on	animal	availability,	
the	experiments	could	only	be	carried	out	on	liver	tissue	for	the	time	being	as	this	
was	sufficiently	concentrated	to	give	detectable	signals	within	the	MAM	fractions.	
Early	data	seems	to	suggest	that	a	knock-out	of	VAPB	or	the	presence	of	the	VAPB-
P56S	mutation	does	not	seem	to	influence	the	cleavage	of	VAPA	in	liver	tissue,	as	
the	~15	kDa	truncated	protein	species	is	detected	within	all	transgenic	models	tested	
but	additional	experiments	are	needed	in	this	area.	
5.5	Chapter	conclusion		
Overall,	 the	 data	 presented	 in	 this	 chapter	 shows	 that	 tight	 ER-mitochondria	
contacts	<10	nm	in	thickness	are	not	influenced	by	the	overexpression	of	exogenous	
VAPA	or	VAPB	but	do	 increase	upon	 the	expression	of	 the	ALS-linked	VAPB-P56S	
protein.	This	increase	is	not	due	to	the	induction	of	ER	stress	via	the	IRE1	pathway	
and	further	work	will	be	required	to	determine	the	exact	nature	of	the	 increased	
organelle	associations	and	to	deduce	the	phenotypic	consequences	of	this	change.	
Moreover,	the	number	of	BiFC	puncta	does	not	change	in	response	to	a	reduction	of	
VAP	 protein	 levels	 however,	 as	 this	 was	 carried	 out	 by	 siRNA-mediated	 protein	
knock-down,	 it	 is	 possible	 that	 remaining	 VAP	 protein	 levels	 were	 sufficient	 for	
maintaining	organelle	contact	sites.	Future	work	in	this	area	could	involve	the	use	of	
transgenic	cell	lines	with	a	complete	knock	out	of	VAP	genes	to	further	assess	the	
impact	of	VAP	knock-out	on	tight	ER-mitochondria	contact	sites.		
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The	data	 here	 also	 highlights	 significant	 avenues	 for	 future	work	 into	 subcellular	
compartment-specific	processing	of	VAPA	and	VAPB	proteins.	Early	work	suggests	
the	 possibility	 of	 site	 specific	 processing	 of	 VAPA	 and	 VAPB	 within	 different	
subcellular	 compartments	 of	 brain	 and	 rat	 tissue	 from	 animal	 models.	
Demonstration	of	the	relative	purities	of	the	biochemically	isolated	MAM	fractions	
also	provides	the	potential	for	investigation	into	alterations	of	protein	levels	of	other	
MAM	proteins	in	the	VAPB	knock-out	or	VAPB-P56S	transgenic	rat	models.																	
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Chapter	6	
General	discussion	and	concluding	remarks	
6.1	 The	BiFC	 system	 successfully	 reports	 on	 tight	 ER-mitochondria	 contact	 sites	
that	may	carry	out	a	distinct	sub-set	of	MAM-related	functions		
The	identification	of	membrane	contact	sites	emphasises	the	fact	that	organelles	of	
the	 cell	 are	 not	 isolated	 entities	 but	 are	 part	 of	 an	 inter-connected	 network,	
coordinating	a	host	of	important	cellular	processes.	An	emerging	body	of	evidence	
has	 linked	 a	 dysfunction	 to	 organelle	 contact	 sites	 with	 neurodegeneration	 as	
reviewed	in	this	thesis	and	highlights	a	commonality	between	the	diverse	pathways	
affected	 in	 disease	 progression	 and	 neuronal	 cell	 death.	 As	 these	 junctional	
complexes	are	in	the	range	of	tens	of	nanometres,	existing	methods	for	detecting	
organelle	contact	sites	are	unable	to	obtain	a	high	enough	resolution	to	accurately	
define	an	organelle	contact	site	or	in	the	case	of	electron	microscopy	techniques,	are	
unsuitable	for	the	study	of	membrane	contact	dynamics	in	living	cells.		
In	 this	 thesis,	 data	 is	 presented	 on	 the	 development	 of	 a	 bi-fluorescence	
complementation	assay	 for	 the	detection	of	membrane	contact	 sites	 that	 can	be	
used	in	both	fixed	and	living	cells.	Although	applied	to	a	diffraction-limited	imaging	
system,	this	technique	effectively	allows	for	the	quantification	of	organelle	contact	
sites	 up	 to	 a	 predicted	 thickness	 of	 10	 nm,	 dependent	 on	 the	 total	 lengths	 and	
orientations	 of	 the	 reformed	Venus	 reporter	 proteins.	 Future	 adaptations	 to	 this	
technique	could	allow	for	the	detection	of	contact	sites	of	different	size	ranges	by	
the	addition	of	linker	sequences	to	the	reporter	proteins.	This	could	have	important	
implications	for	studying	distinct	properties	and	functions	of	junction	sites	of	varying	
thickness.	 The	 heterogeneity	 of	 organelle	 contact	 sites	 and	 the	 mechanisms	
underpinning	their	flexibility	has	not	been	fully	elucidated.	Here,	data	is	presented	
to	 support	 the	 hypothesis	 that	 contact	 sites	 of	 a	 particular	 distance	 can	 only	
accommodate	the	formation	of	particular	protein	complexes	and	therefore,	can	be	
attributed	 to	performing	 specific	 functions.	This	 sub-classification	of	 contact	 sites	
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has	not	been	extensively	investigated	in	the	literature	and	further	research	in	this	
area	is	required	(Giacomello	and	Pellegrini,	2016).		
While	some	of	the	negative	data	presented	in	this	thesis	is	suggestive	of	which	MAM-
related	functions	the	BiFC	labelled	ER-mitochondria	contact	sites	are	not	 involved	
with,	their	actual	functional	role	remains	unclear.		In	their	review	paper,	Giacomello	
and	 Pellegrini	 (2016)	 propose	 terminology	 for	 specific	 mitochondria-ER	 contacts	
(MERCs)	 that	 considers	 the	 functional	 role	 in	 which	 they	 are	 involved	 e.g.	 lipid-
MERCs	 for	 those	 involved	 in	 lipid	 transfer	 or	 Ca2+-MERCs	when	 describing	 those	
mediated	 calcium	 exchange	 (Giacomello	 and	 Pellegrini,	 2016).	Our	 data	 suggests	
that	 ER-mitochondria	 sites	 <	 10	 nm	 in	 size	 are	 not	 involved	 in	 autophagosome	
formation	nor	do	they	seem	to	form	to	promote	mitochondrial	calcium	uptake	but	
they	are	found	to	be	associated	with	a	sub-population	of	mitochondria	of	higher	than	
average	resting	membrane	potential	and	calcium	concentrations.	Determining	any	
unique	 properties	 of	 these	 tight	 contact	 sites	 has	 important	 implications	 for	
understanding	MAM	heterogeneity	and	the	potential	pathogenic	consequences	of	
alterations	 to	 these	 junctional	 complexes	 as	 observed	 in	 neurodegenerative	
disorders.	
In	one	proposed	model	for	the	relationship	between	MAM	size	and	function,	tight	
ER-mitochondria	 contacts	 up	 to	 10	 nm	 in	 size	 are	 specifically	 permissive	 to	 lipid	
transfer	between	the	organelles	(Giacomello	and	Pellegrini,	2016;	Schauder	et	al.,	
2014)(Fig	6.1).	This	 is	based	on	the	hypothesis	that	 lipids	are	exchanged	between	
closely	opposed	organelles	through	hydrophobic	tunnels	created	by	the	formation	
of	 protein	 complexes	 involving	 members	 of	 the	 TULIP	 (tubular	 lipid	 binding)	
superfamily	of	lipid-binding	proteins	(Schauder	et	al.,	2014).	A	role	of	TULIP	proteins	
in	 lipid	 transfer	 at	 membrane	 contact	 sites	 was	 first	 implicated	 from	 the	
identification	of	the	ERMES	(ER-mitochondria	encounter	structure)	complex	in	yeast	
at	ER-mitochondria	contacts	(Kornmann	et	al.,	2009).	This	complex	 is	an	essential	
component	for	phospholipid	transfer	in	yeast	and	three	of	the	core	proteins	of	the	
ERMES	complex	belong	to	the	TULIP	superfamily	(Kornmann	et	al.,	2009;	Alva	and	
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Lupas).	 According	 to	 this	model	 of	 lipid	 exchange,	 tight	 ER-mitochondria	 contact	
sites	 such	 as	 those	 labelled	 by	 the	 BiFC	 reporter	 proteins	 may	 be	 functionally	
involved	in	 lipid	transfer	between	organelles.	However,	to	try	and	strengthen	this	
observation	experimentally	through	fluorescence	microscopy	using	the	BiFC	system	
would	present	significant	challenges.	As	 is	 the	case	with	other	markers	of	MAMs,	
although	 lipid-transport	proteins	are	enriched	at	these	contact	sites,	 they	are	not	
exclusively	localised	here	(Stone	and	Vance,	2000).	However,	with	further	structural	
information	on	these	lipid	transport	tunnels,	it	may	be	possible	to	specifically	label	
these	protein	complexes	and	assess	their	co-localisation	with	BiFC	labelled	contact	
sites.						
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Fig	 6.1:	 Schematic	model	 of	 the	 relationship	 between	MAM	 size	 and	 function.	
Wider	 junctions	 are	 permissive	 to	 calcium	 exchange	 between	 the	 ER	 and	
mitochondria	 but	 tightening	 the	 distance	 between	 the	 organelles,	 inhibits	 this	
process.	Tight	ER-mitochondria	junctions	are	permissive	to	the	binding	of	proteins	
involved	in	the	transport	of	lipids.	Image	adapted	from	(Giacomello	and	Pellegrini).			
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6.2	Future	adaptations	to	the	BiFC	technique	may	be	used	to	distinguish	MAMs	
based	on	variability	in	size	or	protein	composition	
Although	it	may	be	possible	to	sub-categorise	MAMs	based	on	size,	it	is	improbable	
that	 different	 sized	 junctions	 could	 be	 attributed	 to	 carrying	 out	 one	 function	
exclusively.	This	is	because	in	addition	to	variations	in	MAM	length	and	thickness,	
contact	sites	may	also	vary	in	their	protein	compositions.	This	highlights	a	limitation	
of	the	BiFC	technique	in	that	it	only	discriminates	MAMs	based	on	size	and	not	the	
protein	content.	As	touched	upon	briefly	in	chapter	3,	section	3.4,	current	work	in	
the	Skehel	lab	is	attempting	to	clone	split	sfCherry	probes	for	an	adaptation	to	the	
BiFC	 technique	 to	 allow	 for	 simultaneous	 detection	 of	 two	 differently	 coloured	
reporter	 proteins.	 This	would	 allow	 the	 applications	 of	 this	 technique	 to	 expand	
towards	simultaneous	detection	of	different	sized	junctions	or	if	fused	to	particular	
MAM-associated	proteins,	it	might	reveal	protein	tethers	uniquely	associated	with	
different	 contact	points.	 Furthermore,	 it	 could	also	be	used	 for	 the	 simultaneous	
detection	of	different	types	of	organelle	membrane	contact	sites.	In	this	thesis,	we	
have	already	demonstrated	how	fusing	one	fluorescent	Venus	fragment	to	a	VAMP4	
endosomal	targeting	sequence	instead	of	an	OMM	targeting	sequence	allows	for	the	
detection	of	endosomal	contact	 sites	and	 this	 same	principle	could	be	applied	 to	
investigate	any	variety	of	inter-organelle	contacts.		
In	 addition	 to	 variability	 in	 the	 total	 number	 of	 contact	 points	 in	 a	 cell	 and	 the	
thickness	of	these	junctions,	MAMs	also	exhibit	heterogeneity	in	the	length	of	the	
membranes	that	run	in	close	proximity	to	one	another.	Stoica	et	al	(2014)	illustrated	
changes	of	this	nature	from	alterations	to	the	levels	of	VAPB	or	PTPIP51	(Stoica	et	
al.,	 2014).	 As	 it	 stands,	 the	 BiFC	 technique	 is	 unable	 to	 detect	 these	 kinds	 of	
structural	 changes	 in	 the	 contact	 sites	 due	 to	 resolution	 limits	 of	 confocal	
microscopy.	 It	 is	 possible	 that	 using	 the	 Venus	 reporter	 plasmids	 with	 a	 super-
resolution	imaging	technique	such	as	structured	illumination	microscopy	(SIM)	may	
allow	 for	 combined	 detection	 of	membrane	 contact	 changes	 in	 both	 length	 and	
thickness.	However,	 this	would	 depend	on	 the	 extent	 of	 the	 change	 as	 SIM	only	
doubles	the	resolution	limit	to	around	120	nm	in	the	lateral	plane	(Gustafsson	et	al.,	
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2008).	 If	 split	 photoactivatable	 fluorescent	 proteins	 (fluorophores	 that	 can	 be	
switched	from	a	“dark”	to	a	“bright”	state	by	a	certain	wavelength	of	light)	become	
available	in	the	future,	this	technique	could	then	be	applied	to	a	super-resolution	
imaging	 technique	 such	 as	 photoactivated	 localisation	microscopy	 (PALM)	 which	
localises	 objects	 to	 around	 20	 nm	 lateral	 resolution,	 giving	much	more	 accurate	
measurements	of	changes	to	the	MAMs	(Betzig	et	al.,	2006).		
6.3	The	BiFC	technique	and	neurodegeneration	
Throughout	this	thesis,	a	large	body	of	evidence	has	been	presented	highlighting	the	
link	between	organelle	contact	sites	and	neurodegeneration.	Here,	we	have	applied	
the	BiFC	technique	specifically	in	neurodegenerative	disease	research	as	illustrated	
by	 the	 example	 of	 ALS8	 associated	 VAPB-P56S.	 Although	 previously	 published	
studies	 stated	 that	 ER-mitochondria	 contacts	 increased	 in	 response	 to	 an	 over-
expression	of	both	wild-type	VAPB	and	mutant	VAPB-P56S,	in	our	study	BiFC	puncta	
number	only	increased	from	the	presence	of	VAPB-P56S	(De	Vos	et	al.,	2012;	Stoica	
et	 al.,	 2014).	 This	 data	 could	 suggest	 that	 VAPB	 regulates	 ER-mitochondria	
associations	 beyond	 the	 detection	 range	 of	 the	 BiFC	 reporter	 proteins	 and	 that	
mutant	VAPB-P56S	may	possess	some	unique	properties	that	causes	it	to	exert	an	
influence	over	tight	contact	sites	<	10	nm	specifically.	Further	investigation	into	the	
mechanism	 of	 VAPB-P56S	 regulation	 over	 contact	 sites	 and	 the	 exact	 functional	
significance	 of	 these	 tight	 junctions	 may	 have	 important	 connotations	 for	 ALS	
pathogenesis.	
As	 discussed	 in	 the	 introduction	 to	 this	 thesis,	 defects	 in	 lipid	metabolism	 are	 a	
common	 pathogenic	 mechanism	 observed	 in	 a	 variety	 of	 neurodegenerative	
disorders.	 In	 ALS	 specifically,	 a	 reduction	 in	 phospholipids	 and	 sphingolipids	 is	
detected	 in	 animal	 models	 of	 the	 disease	 in	 both	 the	 symptomatic	 and	 pre-
symptomatic	stages	(Henriques	et	al.).	If	indeed	tight	ER-mitochondria	junctions	are	
functionally	 related	 to	 lipid	 transport,	 the	 BiFC	 technique	 could	 be	 utilised	 to	
investigate	whether	 there	 is	a	correlation	between	the	number	of	 tight	organelle	
contact	sites	and	the	onset	of	lipid	metabolic	defects.	Furthermore,	as	these	reporter	
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proteins	are	genetically	encoded,	a	 feasible	 future	 investigation	could	 involve	the	
generation	of	transgenic	animal	models	constitutively	expressing	the	BiFC	reporter	
proteins.	This	could	allow	us	to	track	the	structure	and	dynamics	of	these	contact	
sites	throughout	development	and	deduce	at	what	stage	of	disease	progression	an	
alteration	in	the	number	of	BiFC	puncta	is	detected.	In	skeletal	muscle	tissue	from	
mouse	 models	 of	 ALS,	 mitochondrial	 abnormalities	 and	 oxidative	 damage	 are	
detected	even	while	the	animals	are	asymptomatic	 [As	reviewed	by	(Zhou	et	al.).	
Combining	 in	 vivo	experiments	 such	as	 these	alongside	 the	BiFC	 technique	might	
further	support	the	hypothesis	that	perturbations	 in	organelle	membrane	contact	
sites	are	an	early	pathogenic	mechanism	underlying	many	of	the	molecular	defects	
observed	in	neurodegeneration.	If	this	is	the	case,	organelle	membrane	contact	sites	
may	be	an	attractive	therapeutic	target	in	the	future.				
6.4	VAP	proteins	may	be	processed	within	different	sub-cellular	compartments			
Finally,	 some	 preliminary	work	was	 presented	 on	 the	 biochemical	 purification	 of	
MAM	proteins	 from	 rat	 liver	 and	brain	 tissue.	By	using	 the	 sub-cellular	organelle	
fractionation	technique,	our	data	suggests	that	the	proteolytic	cleavage	of	VAPA	and	
VAPB	 seems	 to	 be	 confined	 to	 specific	 sub-cellular	 compartments	 and	 that	 the	
processing	of	VAPA	and	VAPB	may	predominantly	take	place	in	different	sub-cellular	
locations.	Although	preliminary,	it	highlights	the	strength	of	purifying	MAM	fractions	
as	previously,	this	cleavage	event	had	only	been	examined	on	a	whole	tissue	level	
(Gkogkas	et	al.,	2008).	Future	work	in	this	area	could	confirm	these	differences	in	
VAP	protein	processing	and	could	be	used	to	test	for	any	changes	in	VAP	cleavage	
events	 in	 our	 VAPB-P56S	 and	 VAPB	 knock-out	 mutant	 rat	 models	 of	 which	
preliminary	studies	have	already	been	carried	out.	Several	studies	have	shown	that	
under	certain	conditions,	proteins	can	re-distribute	between	sub-cellular	fractions	
for	 example,	 when	 autophagy	 is	 induced	 ATG5	 and	 ATG14	 localise	 to	 the	MAM	
fraction	(Hamasaki	et	al.,	2013).	While	this	may	not	be	reflected	in	quantifications	of	
total	protein	levels,	sub-cellular	organelle	experiments	could	identify	these	changes.	
Future	 experiments	 could	 correlate	 any	 changes	 in	 the	 distributions	 of	 MAM-
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associated	proteins	with	the	presence	of	the	ALS8	point	mutation	that	may	indicate	
important	 mechanisms	 in	 the	 neurodegenerative	 process.	 In	 addition,	 the	 BiFC	
technique	 could	be	applied	 to	primary	 cell	 cultures	 from	 the	aforementioned	 rat	
models	to	observe	any	difference	in	the	number	of	tight	organelle	contact	sites.					
In	summary,	the	use	of	split	fluorescent	probes	is	an	effective	method	of	labelling	
organelle	 contact	 sites	 in	 both	 fixed	 and	 living	 cells.	 The	 publication	 of	 two	
independent	studies	over	the	course	of	this	thesis	also	using	split	fluorescent	probes	
to	 label	MAMs	is	a	testament	to	the	strength	of	this	technique	(Cieri	et	al.,	2018;	
Yang	et	al.,	2018).	By	using	this	method,	we	were	able	to	replicate	changes	in	the	
MAMs	in	agreement	with	higher	resolution	EM	studies	while	also	conducting	studies	
into	ER-mitochondria	contact	dynamics	 in	 living	cells.	Future	modifications	to	this	
technique	will	expand	its	range	of	applications,	making	the	BiFC	technique	a	diverse	
and	efficient	tool	in	the	field	of	organelle	membrane	contact	sites.							
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Appendix	1	
Video	Files	
The	following	four	video	files	can	be	found	on	the	enclosed	USB	sticks:	
Video	4.1:	COS-7	cells	transfected	with	V1-ER/V2-mito	reporter	plamids	and	
stained	with	MitoTracker	CMXRos	imaged	live	for	10	min.		
Video	4.2:	NSC34	cells	expressing	Gq-coupled	DREADD	receptors	show	an	increase	
in	Cyto-GCaMP	fluorescence	upon	the	addition	of	CNO	
Video	4.3:	The	number	of	BiFC	puncta	does	not	significantly	change	in	response	to	
rapid	elevations	of	cytoplasmic	Ca2+	concentrations	mediated	by	CNO	activation	of	
Gq-coupled	DREADD	receptors	
Video	4.4:	Live-cell	video	of	COS-7	cells	transfected	with	V1-ER/V2-Mito	and	
POLG2-DsRed2	with	the	mitochondria	labelled	in	MitoTracker	Deep	Red	FM	
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A Bi-fluorescence complementation 
system to detect associations 
between the Endoplasmic 
reticulum and mitochondria
Mark Harmon1, Philip Larkman1, Giles Hardingham2, Mandy Jackson1 & Paul Skehel1
Close contacts between the endoplasmic reticulum membrane and the mitochondrial outer membrane 
facilitate efficient transfer of lipids between the organelles and coordinate Ca2+ signalling and 
stress responses. Changes to this coupling is associated with a number of metabolic disorders and 
neurodegenerative diseases including Alzheimer’s, Parkinson’s and motor neuron disease. The distance 
between the two membranes at regions of close apposition is below the resolution of conventional 
light microscopy, which makes analysis of these interactions challenging. Here we describe a new 
bifluorescence complementation (BiFC) method that labels a subset of ER-mitochondrial associations 
in fixed and living cells. The total number of ER-mitochondria associations detected by this approach 
increases in response to tunicamycin-induced ER stress, serum deprivation or reduced levels of 
mitofusin 2 (MFN2). This method will facilitate the analysis of dynamic interactions between the ER and 
mitochondrial membranes.
Regions of close association between the outer membrane of mitochondria (OMM) and the endoplasmic retic-
ulum (ER) were originally identified by ultrastructure analysis1,2, and subsequently shown to represent spe-
cialised structures that facilitate coordinated Ca2+ transfer and signalling between the two organelles3. These 
regions of the ER membrane have been biochemically purified as Mitochondrial Associated Membranes, or 
“MAMs”, and shown to be enriched for a range of proteins including enzymes responsible for lipid synthesis4 
and transfer between the two membrane systems5–7. mtDNA synthesis and mitochondrial division appear to be 
co-ordinated at sites of close apposition with the ER8,9, as is the formation of the autophagosome10. More recently 
the properties of ER-mitochondrial junctions have been implicated in a number of pathologies. Metabolic activ-
ities associated with MAMs are increased in Alzheimer’s Disease11,12 and transgenic mice expressing P301L tau 
appear to have more ER membrane associated with mitochondria13. In familial Parkinson’s loss of DJ-1 reduces 
ER-mitochondria associations and disrupts mitochondrial Ca2+ homeostasis14 and α-synuclein has been local-
ized to MAMs15,16. An interaction between the ER protein VAPB and mitochondrial PTPIP51/Rmdn3 influences 
the coupling of Ca2+ levels in these organelles by a mechanism that is sensitive to TDP-43 activity17 thus linking 
ER-mitochondrial interactions to both spontaneous and familial forms of Amyotrophic Lateral Sclerosis18–20. In 
addition the metabolic homeostasis signalling through ER-mitochondrial contacts is suggested to have a central 
role in metabolic diseases21,22.
Close appositions between the ER and OMM measured in fixed cells using electron microscopy vary in 
distance between 5–30 nm and the extent of mitochondrial area covered by the ER depends on cell type and 
metabolic activity3,23. Membrane associations have been detected and quantified by co-localisation analysis of 
fluorescent signals targeted to the separate membranes24, but this has a limited spatial resolution of 150–200 nm 
and cannot, therefore, distinguish between ER/OMM contacts of differing distance. Alternative methods to detect 
and quantify ER mitochondrial associations have been successfully developed based on proximity ligation in 
fixed cells25, luciferase complementation and dimerization-dependent fluorescent protein (ddFP) approaches 
in living cells26,27. Here we report a Bimolecular Fluorescence Complementation BiFC system28 in which two 
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complementing fragments of a fluorescent protein are expressed on the ER or mitochondria. When the mem-
branes of these organelles are in very close apposition the two complementing fragments of the fluorescent pro-
tein can associate and reconstitute a functional fluorescent protein. The BiFC signal is only generated when the 
OMM and the cytoplasmic face of the ER are in close apposition. Therefore, this method provides structural 
information at a higher resolution than co-localisation and with a lower background than ddFP. As with ddFP this 
method may readily be applied to follow the dynamics and distribution of membrane juxtapositions within living 
cells in real time. Furthermore, as the complementing fragments can only produce fluorescence when directly 
interacting and are not fluorescent individually, the quantification of organelle contacts with BiFC is potentially 
less sensitive to changes in the local protein concentrations protein concentrations than ddFP methods.
Results
To generate a BiFC reporter for the close apposition of the ER and OMM the two complementing fragments 
of the split YFP Venus protein were targeted separately to the ER and OMM. In principle a functional YFP will 
only be generated at regions where the two membranes are sufficiently close for the direct interaction of the 
two complementing Venus fragments. The N-terminal fragment Venus128 was targeted to the cytoplasmic face 
of the ER membrane by fusion to either the full length or the C-terminal 25 amino acids of the mouse VAPB 
protein, creating V1-VAPB and V1-ER respectively. The C-terminal fragment Venus 2 was targeted to the outer 
mitochondrial membrane by fusion to the first 34 amino acids of TOMM20, to generate V2-Mito29. Limiting the 
size of the targeting sequences ensures that only the closest associations of the membranes will be detected. The 
sub-cellular localisation of these fusion proteins in the cell line NSC34 was determined by immunocytochemical 
analysis using a polyclonal anti-serum against GFP that recognises both N- and C-terminal fragments of the 
Venus protein (Fig. 1). The immunofluorescent signal from V1-VAPB co-localized with the co-expressed ER 
marker ER-DsRed2 (Clontech), but not with the mitochondrial protein ATPB (Fig. 1A and Table 1). Similarly, 
V1-ER also co-localized with the ER marker, but not with the mitochondrial protein ATPB (Fig. 1B and 
Table 1). In contrast, V2-Mito co-localized with ATPB but not with co-expressed ER-DsRed2 (Fig. 1C, Table 1). 
Co-expression of either V1-VAPB or V1-ER with V2-Mito in NSC34 cells produced readily detectable BiFC sig-
nals (Fig. 2). V1-VAPB/V2-Mito produced a fluorescence pattern surrounding almost all mitochondria, similar 
to that reported by dimerization-dependent fluorescent proteins targeted to the ER and OMM27. Co-expression 
Figure 1. The complementing YFP Venus fusion proteins are correctly targeted to the ER and mitochondria. 
NSC 34 cells transiently expressing V1-VAPB (A), V1-ER (B), or V2-Mito (C), were analysed by 
immunocytochemistry using an anti-GFP antibody that recognises both fragments of YFP. The endoplasmic 
reticulum was identifed by co-expression of ER-DsRed2 (Clontech), and mitochondria were labelled 
immunolcytochemically for ATPB. The extent of colocalisation of Venus fusion proteins with the orgamelle 
markers was analysed by Pearon’s Correlation Coefficient (PCC) (Table 1). Values indicate mean PCC ± SEM; 
n = 3 independent experiments (9–10 cells total). Antibody details Table 3. Scale bars, 10 µm.
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of the shorter V1-fusion protein, V1-ER with V2-Mito generated a distinct fluorescent signal with discrete puncta 
of fluorescence associated with a subset of mitochondria (Fig. 2). These signals appear to lie exclusively at areas 
of close apposition of the ER and mitochondria as revealed by immunolabelling for ERp72 and ATPB respec-
tively (Fig. 2). Expression of either V1-VAPB, V1-ER or V2-Mito individually produced no YFP signal (Fig. S1). 
Co-expression of V1-ER with V2-Mito over 48 hrs produced no gross changes to ER or mitochondria morphol-
ogy in NSC34, COS7 or HEK293 cells (Fig. S2). The V1-ER with V2-Mito BiFC was further characterised in the 
remainder of the study.
Figure 2. ER-targetted Venus 1 fusion proteins generate BiFC signals when co-expressed with mitochonrial 
Venus 2. V1-ER and V1-VAPB were co-expressed with V2-Mito in NSC34 cells (A). The resulting BiFC signal 
was associated with mitochondria as indicated by ATPB expression. The two Venus 1 fusion proteins differ 
in length by 218 aa, and produce distinct subcellular BiFC paterns. Triple labelling of the ER (Erp72, blue) 
and mitochondria (ATPB, red) demonstrate that the V1-ER/V2-Mito BiFC lables descete puncta at junctions 
between the ER and mitochodria (B). Higher magnification of boxed region (B.I), processed and rendered in 
3D by Imaris image analysis software (B.II). Scale bar 10 µm, or 0.4 µm in panels B.I and B.II.
V1-VAPB/ER-DsRed2 0.876 ± 0.009
V1-VAPB/ATPB 0.035 ± 0.010
V1-ER/ER-DsRed2 0.870 ± 0.017
V1-ER/ATPB 0.070 ± 0.020
V2-Mito/ER-DsRed2 0.050 ± 0.011
V2-Mito/ATPB 0.910 ± 0.008
Table 1. Fluorescent signal co-localisation quantified by Pearson’s Correlation Coefficient (PCC).
www.nature.com/scientificreports/
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It would be anticipated that if the presence of V1-ER and V2-Mito was inducing ER-mitochondria associa-
tions as an artefact, then increasing the expression levels of V1-ER and V2-Mito would distort ER morphology 
and lead to an increase in the number or size of BiFC signals, but this was not the case (Fig. S3). Transfection with 
increasing amounts of V1-ER and V2-Mito expression plasmid DNA lead to an increase in the number of fluores-
cent cells but the average number of fluorescent signals in any transfected cell was unaltered (Fig. S3). Therefore, 
the presence of V1-ER and V2-Mito seems not to directly induce the formation of membrane associations, but 
labels existing sites of close apposition between the ER and OMMs.
The ER comes in close apposition to other organelles including the Golgi apparatus and endosomes30–33. 
However the BiFC puncta generated by V1-ER and V2-Mito appear selective for the ER and OMM, with very few 
signals associated with the Golgi apparatus, the nucleus or EEA1-positive endosomes (Fig. 3, Table 2). Details of 
the antibodies used are shown in Table 3.
Many of the BiFC signals were at the limit of resolution for conventional confocal microscopy. In order to gain 
a more accurate measurement super resolution STED microscopy was done on NSC34 cells transiently expressing 
V1-ER and V2-Mito (Fig. 4). The pattern of signals was heterogeneous, with areas of association detected in a 
single optical section ranging in length between 100–700 nm. This super resolution microscopic analysis indi-
cated that puncta are discrete single structures, the number of which may be quantified by conventional confocal 
microscopy.
ER stress has been shown to increase the amount of ER-mitochondria membrane association34. To test if the 
BiFC system was sensitive to this dynamic change an ER stress was induced in NSC34 cells co-expressing V1-ER 
and V2-Mito by incubating with 2 or 10 µg/ml tunicamycin for 6 hours. A robust ER stress response was induced 
at both drug concentrations as indicated by splicing of XBP1 mRNA35 (Fig. 5). The highest tunicamycin level 
induced a two-fold increase in the average number of punctate fluorescent signals per cell and an increase of sim-
ilar magnitude in the size of this fluorescent signal as a percentage of the total mitochondrial volume, consistent 
with an increase in membrane associations (Fig. 5(Ai&ii)). Previous studies have used co-localisation analysis 
of fluorescent signals separately targeted to the ER and mitochondria as a measure of association between the 
membranes of the two organelles. To compare such co-localisation analysis with the BiFC method, ER stress was 
induced in parallel cultures and analysed by co-localisation of ER-targeted DsRed2 and the mitochondrial protein 
ATPB. In this case, co-localisation detected a similar increase in ER – mitochondria associations as that reported 
by the BiFC. These results are consistent with previous observations (Fig. 5C)34.
Serum deprivation has also been shown to increase the number of tight associations (<16 nm) between the ER 
and OMM36. 24 hrs following removal of serum, a significant increase in the number of fluorescent puncta was 
detected in NSC34 cells co-expressing V1-ER and V2-Mito (Fig. 6). However, in this case, co-localisation analysis 
of fluorescence from separately labelled ER and mitochondria did not detect a significant change as quantified by 
two different methods of analysis (Fig. 6). This illustrates that this BiFC method can detect changes in ER-OMM 
associations that may be undetected by simple co-localization analysis.
The role of Mitofusin-2 (MFN2) in maintaining ER/mitochondria associations has been controversial. Initial 
reports that reduced levels or absence of MFN2 resulted in less ER-mitochondrial contacts led to the suggestion 
that the protein acts as a tether between the two membranes37. However, more recent analysis of cells from mfn2 
(−/−) animals detected an increased level of ER-mitochondrial juxtapostion and Ca2+ coupling between the 
organelles38,39. Changes in mitochondrial shape may interfere with fluorescence-based co-localization reporter 
systems37 but the exact role of MFN2 in maintaining ER-mitochondria contacts remains controversial40–42. To 
further test the utility of the BiFC system, MFN2 levels were reduced in NSC34 cells using siRNA knockdown. An 
80% reduction in MFN2 resulted in a significant increase in the number of fluorescent puncta detected by V1-ER/ 
V2-Mito BiFC (Fig. 7). This suggests that the ER-OMM associations detected here by BiFC are not dependent on 
MFN2.
These results indicate that the BiFC system presented can report changes in ER-mitochondrial associations 
under three different conditions, and that in some instances it is more sensitive than previous fluorescence 
co-localization approaches.
Discussion
A BiFC reporter system for close associations between the ER and mitochondria has been produced by targeting 
the two complementing fragments of the split Venus fluorescent protein to the cytoplasmic faces of the ER and 
the outer membrane of mitochondria. Tethering the complementing YFP Venus fragments with fusion proteins 
of different size generated distinct fluorescent signals, indicating that associations of different distance may be 
reported by a BiFC system. BiFC, therefore, may be used to distinguish between membrane associations of var-
ying distance, which are thought to have specific functional roles36,43. The closest contacts as detected by the 
V1-ER/V2-Mito combination formed on a subset of mitochondria and were heterogeneous in size ranging from 
100–700 nm in length. Csordas et al.44, artificially forced the close association of ER and OMM by expressing a 
fluorescent fusion protein containing both an ER targeting sequence and a mitochondrial targeting sequence. In 
that case, the fusion protein had 84 amino acids in addition to the fluorescent protein, and resulted in an asso-
ciation between the ER and OMM with a distance of approximately 6 nm between the two membranes36. The 
combination of the V1-ER and V2-Mito fusion proteins adds a total of 85 additional amino acids to the Venus 
protein, suggesting that the contact sites reported by the V1-ER/V2-Mito combination are of similar dimensions 
to those previously reported36. Assuming the extra-membrane residues to be in a fully extended conformation 
would give an upper estimate of the largest gap compatible with fluorescent protein formation of approximately 
10 nm. Therefore the distance between the ER and mitochondrial membranes detected by this BiFC combination 
is most likely in the range of 6 to 10 nm.
www.nature.com/scientificreports/
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Figure 3. Quantification of V1-ER/V2-Mito BiFC signal overlapping with organelle markers. The number of 
BiFC puncta in NSC 34 cells expressing V1-ER/V2-Mito was quantified using a maximum intensity threshold in 
Imaris image analysis software (A). The co-localisation channels were then built between the YFP channel and 
fluorescent organelle markers. The ER and Golgi were labeled by co-expression of ER-DsRed2 and Golgi-ECFP 
respectively (Clontech), early endosomes and mitochondria were immunolabeled for EEA1 or ATPB, and the 
nucleus was labeled with DAPI. anti-ATPB (mitochondria), ER-DsRed (ER), anti-EEA1 (Endosomes), Golgi-
CFP (Golgi), DAPI (Nucleus). Using the same intensity threshold value, the number of BiFC puncta that had 
a point of colocalisation with the fluorescent organelle signal were quantified. n = 3 independent experiments 
(10–15 cells total). Scale bars, 10 µm. Values indicate the mean number of colocalised BiFC puncta over three 
independent experiments ± SEM (Table 2, Antibody details Table 3).
www.nature.com/scientificreports/
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Large receptor proteins and complexes such as the IP3R and ribosomes may impose limits on the close asso-
ciation of the ER and OMM. Giacomello and Pellegrini have proposed that different gaps between the mem-
branes reflect functionally distinct domains participating in Ca2+ signalling, lipid biosynthesis and transfer, and 
autophagocytosis43. The predicted 6–10 nm gap identified here would be consistent with sites of lipid transfer 
mediated by members of the tubular lipid-binding (TULIP) superfamily of membrane proteins, forming a 9 nm 
long channel that may mediate lipid transfer between organelles (reviewed45). Increased associations between ER 
cisternae and mitochondria are made following induction of the Unfolded Protein Response46. Since ribosomes 
are localised to ER cisternae the observation that BiFC puncta numbers increase following tunicamycin treatment 
suggests that V1-ER and V2-Mito can interact at ER cisternae despite the restrictions imposed by ribosome size.
When tight contacts between the ER and OMM are induced artificially, gross changes in organelle morphol-
ogy can occur over time44. In contrast, the pattern of the V1-ER/V2-Mito BiFC signal is generally stable over time 
with no gross changes in ER or mitochondrial morphology seen in transient or stably transfected cells. Therefore 
the association of the separate halves of the Venus protein appears insufficient to disrupt the normal pattern 
of ER-mitochondria associations. The BiFC system complements existing methods to detect organelle associa-
tions. Electron microscopy has the highest resolution however localising specific proteins to particular regions 
of apposition requires correlative electron and fluorescent microscopy or immune gold labelling, both of which 
are technically very challenging and must be done on fixed material. Fluorescent proximity ligation assays are 
more readily quantified and can detect specific proteins at regions of contact (25). Again, however, this method 
is used on fixed samples. Fluorescent protein- based methods have the significant advantage that they can be 
readily detected in living cells or tissues. An example of BiFC in living cells in shown in Supplementary video S4. 
Co-localization of distinct fluorescent proteins localised on separate membranes has a limited resolution and can-
not distinguish between contacts less than approximately 150 nm. Dimerization dependent Fluorescent proteins 
(ddFPs) and BiFC have improved detection limits as they both depend on the direct association of polypeptides 
targeted to separate membranes. In both cases the proximity of membrane associations that can be detected 
depends on the size of the targeting and linker sequences of the respective fusion proteins. One potential advan-
tage of a BiFC approach over ddFPs is a reduced background as the complementing halves of the YFP show no 
fluorescence. The resulting improvement of signal to noise would allow the detection of weaker transient signals.
The average number of BiFC puncta increases in response to homeostatic stress and reduction in MFN2 levels. 
This seems incompatible with the proposal that MFN2 is required to maintain close ER-mitochondria associa-
tions. However, it is possible that the V1-ER/V2-Mito BiFC as configured may detect MFN2-independent con-
tacts induced following a mitochondrial stress resulting from a reduction of MFN2 levels. Alternatively, MFN2 
may not be directly responsible for maintaining ER-mitochondria associations as suggested. The magnitude of the 
increase in V1-ER/V2-Mito signal following MFN2 knock-down here is similar to that seen for ER-mitochondria 
fluorescence co-localisation in studies using mfn2−/− mice38.
All mitochondria appear to come into contact with the ER, as indicated by the V1-VAPB/V2-Mito BiFC signal 
(Fig. 2A) and previously using dimerization-dependent fluorescent proteins27. However, not all mitochondria 
have an ER association detectable by V1-ER/V2-Mito. Ultrastructure analysis of mouse liver indicated that 25% 
of mitochondria have close ER associations and it is suggested that this heterogeneity is a cell type specific char-
acteristic and changes in response to the physiological environment23. The mitochondria identified as interacting 
Figure 4. Super-resolution imaging of fluorescent BiFC puncta in NSC34 cells. Representative confocal image 
versus STED super-resolution image of the same region of an NSC34 cell transiently expressing the V1-ER and 
V2-Mito reporters (A). Scale bar, 1 µm. Pixel size = 0.2 µm. Frequency distribution graph illustrating the relative 
distribution of BiFC punctum size as measured by the straight line tool in ImageJ across the widest point of an 
individual fluorescent punctum (B). n = 111 BiFC puncta (7 cells total, mean value = 0.31 µm).
ATPB (mitochondria) 97.07 ± 1.34
ER-DsRed2 (ER) 99.07 ± 0.27
EEA1 (Endosomes) 10.74 ± 2.36
Golgi-CFP (Golgi) 8.95 ± 3.47
DAPI (Nucleus) 6.81 ± 0.57
Table 2. % of BiFC puncta overlapping with fluorescent organelle marker.
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with the ER by this BiFC system might therefore have distinct morphologies, respiratory rates and/or, distinct 
Ca2+ signalling activities.
Subtle changes in distances between ER and mitochondrial membranes are not measurable by co-localization 
of fluorescence as they may fall bellow the resolution limit of conventional optical microscopy. Notably, induction 
of an Unfolded Protein Response produced changes in ER mitochondria associations that were detectable by both 
Figure 5. ER Stress significantly increases the number of ER-mitochondria contacts in NSC34 cells. NSC34 
cells expressing V1-ER/V2-Mito were treated with 2 µg/ml or 10 µg/ml tunicamycin to induce an ER stress (A). 
ER stress significantly increases the mean number of BiFC puncta per cell in and (A(i)) significantly increases 
the total volume of BiFC signal as a percentage of total mitochondrial volume (A(ii)). n = 3 independent 
experiments (32–34 cells total). Values indicate mean values of three independent experiments. Error bars 
indicate SEM. Statistical significance was measured using one-way ANOVA followed by Holm-Sidak’s multiple 
comparison test, ns (non-significant) P > 0.05, *P < 0.05, **P < 0.01. ER stress was confirmed by detection of 
spliced XBP1 mRNA. Expression of the Venus reporter plasmids alone did not induce an ER stress (B). For 
comparison, in parallel NSC34 cultures the ER and mitochondria were labeled by co-expression of ER-DsRed2 
(Green) and anti-ATPB (Magenta) respectively (C). A significant increase in the co-localisation of ER-DsRed 
and ATPB signals was detected following ER stress induced with 10 µg/ml tunicamycin as quantified by both 
Pearsons’ Correlation Coefficient (C(i)) and Manders’ Correlation Coefficient (C(ii)). n = 4 independent 
experiments (26 cells total). Statistical significance was measured using unpaired two-tailed t-test. *P < 0.05, 
**P < 0.01. Error bars indicate SEM.
Name Company Class Host Antigen
Catalogue 
number Dilution
Anti-ATPB Abcam Monoclonal Mouse Whole heart mitochondria (human) ab14730 1:250 (IF)
Anti-MFN2 Abcam Monoclonal Mouse a.a. 661–758 of MFN2 ab56889 1:5000 (WB)
Anti-GFP Life Technologies Polyclonal Rabbit GFP isolated from Aequorea victoria A6455 1:400 (IF)
Anti-ERp72 (PDI) Enzo Life Sciences Polyclonal Rabbit a.a. 623–638 of ERp72 ADI-SPS-720 1:100 (IF)
Anti- α-Tubulin EMD Millipore Monoclonal Mouse a.a. 426–450 of α-Tubulin 05–829 1:50,000 (WB)
Anti-EEA1 Cell Signaling Technology Polyclonal Rabbit
Synthetic peptide corresponding 
to residues surrounding Gly14 of 
human EEA1
2411 S 1:100 (IF)
Table 3. Source and concentrations of the primary antibodies used in the study.
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Figure 6. Serum deprivation significantly increases the number of ER-mitochondria contacts in NSC34 
cells. NSC34 cells transiently expressing V1-ER/V2-Mito were grown in 10% FBS (control) or 0% FBS (serum 
deprived) for 24 h post transfection (A). Serum deprivation significantly increases the mean number of BiFC 
puncta per cell (A(i)) and the total volume of BiFC signal as a percentage of total mitochondrial volume (A(ii)). 
n = 3 independent experiments (36–37 cells total). Statistical significance was measured using unpaired two-
tailed t-test, *P < 0.05, **P < 0.01. Values indicate mean value of three independent experiments. Error bars 
indicate SEM. Co-localisation of ER and mitochondrial fluorescence does not detect a significant change in ER/
mitochondrial contact (B). In parallel NSC34 cultures the ER and mitochondria were labeled by co-expression 
of ER-DsRed2 (Green) and anti-ATPB (Magenta) respectively. No significant change in the co-localisation 
of ER and mitochondria was detected as measured by either Pearson’s Correlation Coefficient (PCC) (B(i)), 
or Mander’s Correlation Coefficient (MCC) (B(ii)). n = 3 independent experiments (19 cells total); ns (non-
significant) P > 0.05. Error bars indicate SEM. Scale bars, 10 µm.
Figure 7. Mitofusin-2 (MFN2) levels influence the number of V1-ER/V2-Mito BiFC signals. siRNA was 
used to induced a knock-down of MFN2 to less than 20% of normal levels in NSC34 cells stably expressing 
V1-ER/V2-Mito (A(i)). This was associated with an increase the mean number of BiFC puncta per cell (A(ii)). 
n = 3 independent experiments (30–32 cells total). Values indicate the mean values from three independent 
experiments. Error bars represent SEM. Statistical significance was determined using unpaired two-tailed t-test, 
***P < 0.01.
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the V1-ER/V2-Mito BiFC and fluorescence co-localisation. In contrast, serum removal only produced a signifi-
cant change in V1-ER/V2-Mito BiFC puncta number, and not fluorescence co-localisation. BiFC, therefore, may 
represent a more sensitive in vivo technique that also avoids the technically challenging ultrastructure analysis 
using electron microscopy on fixed samples.
The increase in BiFC puncta following tunicamycin treatment is consistent with studies showing increases in 
ER mitochondrial contacts in the early phases of ER stress24. It may also be the case that the associations detected 
by BiFC are related to sites of mitochondrial fusion and biogenesis34, and the signal is somewhat reminiscent of 
Miro1 labelling in COS-7 cells47. However, it has been suggested that mitochondria biogenesis is independent of 
UPR stress activity from the ER48. Further studies are required to determine if these mitochondria contacted via 
these BiFC puncta have particular properties relating to biogenesis, Ca2+ signalling or respiratory activity.
Materials and Methods
Plasmids and primers. V1-VAPB has been described previously49. V1-ER was derived from V1-VAPB 
by a deletion PCR mutagenesis using the primers gggtcctccggaatgggcctgagcgcccggctgct and cattccggaggacccac-
cacctccagagc generating a Venus 1–C terminal fusion with the C-terminal 25 amino acids from mouse VAPB, 
GLSARLLALVVLFFIVGVIIGKIAL.
V2-Mito contains the first 34 amino acids of human TOMM20, fused to the terminus of Venus(2). The cod-
ing sequence for MVGRNSAIAAGVCGALFIGYCIYFDRKRRSDPN was generated from the human TOMM20 
cDNA by a PCR using oligonucleotide primers cggcggccgctccggaccatggtgggccggaacagcgcc and atctagattaatcgattg-
cagacccgatgccgctgc, The PCR product was digested and ligated into the NotI and ClaI restrictions sites of 
pcDNA3.1 Venus(2)-zip. (Generous gift of S.W.Michnick), to create Mito-V2 fusion gene.
Primers used for RT-PCT across slice junction of mouse XBP1 mRNA: ccaaggggaatgaagtgagg and aagggaggctg 
gtaaggaac.
Cell culture and transfection. NSC3450, COS-751, and HEK-29352 cells were maintained at 37 °C and 5% 
CO2 in Dulbecco’s modified high glucose Eagle’s medium supplemented with 10% fetal bovine serum and 1% 
antibiotic-antimycotic (Thermo Fisher Scientific). For imaging, cells were plated on glass coverslips coated with 
poly-L-lysine (50 µg/ml) and bovine plasma fibronectin (10 µg/ml) (Life Technologies). Plasmid transfections 
were done using Lipofectamine 2000 (Invitrogen) in Opti-MEM media (Thermo Fisher Scientific). Cells were 
imaged or harvested 48 h post-transfection. V1-ER and V2-Mito reporter plasmids were transfected at a 1:1 
ratio at a total DNA of concentration of 1 µg per well of a 12 well dish (except where otherwise indicated). MFN2 
siRNA (Dharmacon) transfection was performed with lipofectamine RNAiMAX at an siRNA concentration of 
50 nM for 48 h.
Stably transfected NSC34 cells co-expressing V1-ER and V2-Mito were selected on 400 µg/ml zeocin 
(InvivoGen).
ER stress was induced with tunicamycin (Calbiochem) at 2 µg/ml or 10 µg/ml for 6 h, with an equivalent vol-
ume of DMSO as vehicle only control.
Immunoblot analysis. Cell proteins were extracted in RIPA buffer (1.0% NP40, 0.1% SDS (w/v), 150 mM 
NaCl, 0.5% (w/v) Sodium deoxycholate, 50 mM Tris pH 8.0, Complete protease inhibitors (Roche)), and quanti-
fied by BCA protein assay (Thermo Scientific). Samples in SDS sample buffer (80 mM Tris HCl pH6.9, 2%(w/v) 
SDS, 100 mM DTT, 10% (v/v) glycerol, were heated at 80 °C for 15 min, prior to separation on NuPAGE 4–12% 
Bis-Tris Gel (Invitrogen) in MES SDS running buffer (Invitrogen). Proteins were then transferred to PVDF 
Immobilon P (EMD Millipore) in NuPAGE transfer buffer contain 10% (v/v) methanol. Non-specific protein 
binding sights on the membranes were blocked by incubating for at least 60 mins in PBS containing 5% (w/v) 
non-fat dry milk and 0.1% (v/v) Tween-20. Primary antibodies were used in blocking solution at indicated con-
centrations overnight at 4 °C, following which membranes were washed at room temperature 3 times for 5 min 
in PBS containing 0.1% (v/v) Tween-20. Bound antibody was detected using horseradish peroxidase-conjugated 
secondary antibodies at 1:5,000 dilution (Jackson ImmunoResearch) followed by ECL detection (Amersham GE 
Life Sciences) using X-ray film (FUJIFILM). Band intensities were quantified by densitometric analysis using 
ImageJ.
Immunocytochemistry. Cells were fixed in 4% (w/v) paraformaldehyde in phosphate buffered saline (PBS) 
for 15 min at room temperature, except for anti-ERp72 where methanol at −20 °C was used for 5 min. After 
washing with PBS, cells were permeabilised with 0.4% (v/v) Triton X-100 for 10 min at room temperature. Cells 
were then incubated in a blocking solution consisting of PBS, 0.2% fish gelatin and 0.02% saponin (PGAS), at 4 °C 
overnight. Primary and secondary antibodies were diluted in PGAS. Primary antibodies were incubated at room 
temperature for 30–60 min. Following each incubation cells were washed 3 times with PGAS and an additional 
final 3 washes were carried out using PBS before coverslips were mounted using Vectashield with DAPI (Vector 
Laboratories, Inc. Burlingame, CA 94010) or ProLong Diamond Antifade mountant (Thermo Fisher Scientific).
Secondary antibodies used were from Jackson ImmunoResearch. Horseradish-peroxidase conjugated goat 
anti-rabbit (111-035-003), donkey anti-mouse Cy2 (715-225-150), Cy3 and Cy5-coupled goat anti-mouse (115-
165-146, 115-175-156), Cy3 and Cy5-coupled donkey anti-Rabbit (711-175-152, 711-175-152).
RNA extraction and PCR. Total RNA was extracted from NSC34 cells using the RNeasy mini kit (Qiagen) 
as per manufacturers instructions. cDNA was generated using the Omniscript reverse transcription kit (Qiagen) 
followed by PCR amplification using Taq DNA polymerase (Qiagen). PCR products were visualised on a 3.5% 
(w/v) TAE agarose gel stained with SyberSafe (Invirogen).
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Confocal Microscopy. Confocal images were acquired using a Nikon A1R microscope. For the quantifica-
tion and colocalisation analysis experiments, z-stack images were taken with a pixel size of 60 × 60 nm2 and z-step 
size of 150 nm using a 60X (Plan ApoVC NA 1.4 oil) objective. Excitation laser wavelengths were for YFP (Venus) 
488 nm, Cy3 and DsRed 561 nm, CFP and DAPI 401.5 nm and Cy5 641 nm. For comparison of the relative levels 
of protein expression shown in SFig. 2, single plane images were acquired with a 20X objective lens (Plan Apo 
NA 0.75) with excitation laser wavelengths set at 401.5 nm (DAPI) and 561 nm (Cy3) by keeping the same laser 
power, detector gain and acquisition parameters. Microscope control and image acquisition were done using the 
NIS-Elements-v4.13 software.
Live-Cell Imaging. NSC34 cells were plated on poly-D-lysine/fibronectin coated 35 mm glass-bottomed 
petri dishes (14 mm microwell diameter, glass thickness No. 1.5) (MatTEK). Mitochondria were labeled with 
25 nM MitoTracker CMXRos (Invitrogen) for 30 min in pre-warmed DMEM, followed by three five minute 
washes with DMEM. Two channel, single plane imaging of live-cells was performed in a heated chamber at 37 °C 
with 5% CO2 (Okolab) using a 60X objective lens (Plan ApoVC NA 1.4 oil) at an acquisition rate of 0.25 fps.
CW-gSTED microscopy. Continuous wave gated stimulated emission depletion (CW-gSTED) microscopy 
was done using a Leica SP5 confocal laser scanning microscope equipped with a 592 nm depletion laser and 
100 × 1.4 NA HCX PL Apo oil immersion objective lens. YFP was excited using a white light laser tuned to 
514 nm with an 80 MHz pulse rate. STED was achieved by concurrent 592 nm depletion aligned to the excitation 
laser. 524–580 nm emission was isolated by an acousto-optical beamsplitter and detected with a Leica HyD hybrid 
detector gated to detect 0.5–8 ns following each excitation pulse. Single slice images were acquired with a 0.02 µm 
pixel size to achieve Nyquist sampling.
Image analysis. Deconvolution of confocal images was performed using Huygens Essential (Huygens 
Software 4.5.1p3) before subsequent analysis. Colocalisation analyses were done on 3D, deconvolved images 
and quantified using ImarisColoc (Imaris v8.2.1, Bitplane Inc, software available at http://bitplane.com). 
Quantification of BiFC puncta was automated using the 3D volume rendering function of Imaris followed by the 
‘total number of disconnected components’ measurement. For quantification of the signal overlap between fluo-
rescent puncta and organelle markers (Fig. 3) first the number of BiFC puncta in a cell was quantified on Imaris 
with the ‘Spots’ function using the maximum intensity value as a threshold. Using this same threshold intensity 
value, a colocalisation channel was built between the BiFC and organelle marker channel. Finally, the number of 
spots in the colocalisation channel was quantified in the same manner and expressed as a percentage of total BiFC 
puncta. Analysis of images acquired by STED microscopy was carried out using the “straight line” tool in ImageJ. 
A straight line was drawn manually across the point of widest distance of each individual fluorescent puncta and 
the length of the line calculated in µm.
All image analysis and quantification of images acquired with confocal microscopy were performed on decon-
volved images without any additional processing. Brightness and contrast settings were adjusted in ImageJ for 
presentation purposes only.
Statistical analysis. All experiments were repeated at least three times for statistical analysis. Statistical 
analysis was carried out using Prism version 6.0 h (GraphPad). Unless otherwise stated, statistical significance was 
measured using unpaired two-tailed t-test or one-way ANOVA followed by Holm-Sidak’s multiple comparison 
test; *P < 0.05, **P < 0.01, ***P < 0.001.
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